[
  {
    "text": "Below are frequently asked questions and our answers to them.  We have also provided links to learn more information about each of the specific topics identified below. Feel free to contact the FDA - CFSAN - Outreach and Information Center (salesforce-sites.com)External Link Disclaimer for general cosmetic questions or for specific questions regarding Modernization of Cosmetics Regulation Act of 2022 (MoCRA), please contact QuestionsAboutMoCRA@fda.hhs.gov.\n1. Does FDA regulate cosmetics?\n2. How",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "022 (MoCRA), please contact QuestionsAboutMoCRA@fda.hhs.gov.\n1. Does FDA regulate cosmetics?\n2. How do I know if my products are regulated as cosmetics, and not as drugs or some other product category?\n3. Do I need to have my cosmetic products or ingredients approved by FDA?\n4. What do I need to know about using color additives in cosmetics?\n5. Do I need to register my cosmetic product facility or list products with FDA?\n6. Can I manufacture cosmetics in my home or salon?\n7. Can I label my cosme",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "list products with FDA?\n6. Can I manufacture cosmetics in my home or salon?\n7. Can I label my cosmetics “natural” or “organic”?\n8. Must I test my products and ingredients?\n9. Using available safety data\n10. Doing additional testing\n11. Can I use a Post Office (P.O.) box or website for the address on the label?\n12. Where can I learn more about labeling requirements?\n13. What are the local requirements for starting a cosmetics business?\n14. Do I need to get a license from FDA to manufacture or ma",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "ents for starting a cosmetics business?\n14. Do I need to get a license from FDA to manufacture or market cosmetics?\n15. Where can I find more information on FDA requirements I need to know about?\nYes. FDA regulates cosmetics under the Federal Food, Drug and Cosmetic Act (FD&C Act). Under MoCRA, which expanded FDA’s authority under the FD&C Act law, cosmetics must not be adulterated or misbranded. For example, they must be safe for consumers under labeled or customary conditions of use, and they",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "For example, they must be safe for consumers under labeled or customary conditions of use, and they must be properly labeled. Any color additives they contain must be approved for the intended use, and some must be from batches certified in FDA’s own labs. Packaging and labeling must not be deceptive. If you manufacture or market cosmetics, you have a legal responsibility for the safety and labeling of your products.\nTo learn more, see “Resources for You: Industry” and “Cosmetics: Guidance and R",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "ng of your products.\nTo learn more, see “Resources for You: Industry” and “Cosmetics: Guidance and Regulations,” where you will find overviews of the laws, links to the laws and regulations themselves, and more.\nA product’s intended use is determined by factors such as product claims, consumer expectations, and certain ingredients. A product is a cosmetic if it is intended for uses such as cleansing the human body, making a person more attractive, or changing a person’s appearance. Here are some",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "ng the human body, making a person more attractive, or changing a person’s appearance. Here are some examples of products marketed as cosmetics:\nIf a product is intended to affect the way a person’s body works, or to treat or prevent disease, it’s a drug, but sometimes it is both a cosmetic and a drug depending on its claims. Drugs must meet different requirements.\nSome “personal care products” are regulated by FDA as medical devices or as dietary supplements, while others, including some soaps,",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "e regulated by FDA as medical devices or as dietary supplements, while others, including some soaps, are regulated by the Consumer Product Safety Commission (CPSC). To learn more about these product categories, including how FDA determines a product’s intended use, see Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?).\nHere are some more resources:\nThe law does not require cosmetic products and ingredients, except for color additives, to be approved by FDA before they go on the market. However",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "ingredients, except for color additives, to be approved by FDA before they go on the market. However, cosmetics must not be adulterated or misbranded. This means that they must be safe for consumers when used according to the labeling, or as people customarily use them, and they must be properly labeled. To learn more, see Key Legal Concepts: Interstate Commerce, Adulterated, and Misbranded.\nWith the exception of color additives and ingredients that are prohibited or restricted by FDA regulation",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "the exception of color additives and ingredients that are prohibited or restricted by FDA regulations, you may use any ingredient in your cosmetic, as long as it does not cause the product to be adulterated in any way. You are legally responsible for making sure your cosmetics are safe and properly labeled, in compliance with all the laws and regulations that apply to them.\nRemember, however, that not all “personal care products” are regulated as cosmetics under U.S. law. For example, some are r",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "not all “personal care products” are regulated as cosmetics under U.S. law. For example, some are regulated as drugs. If your product is a drug under U.S. law, it must meet the requirements for drugs, such as premarket approval. For more information about how some “personal care products” are regulated by FDA as medical devices, while others are regulated by the CPSC, see #2 above.\nA color additive, other than coloring materials intended for use as coal-tar hair dyes, must be approved by FDA fo",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "ve, other than coloring materials intended for use as coal-tar hair dyes, must be approved by FDA for the intended use. These color additives are listed in regulations called “listing regulations.” Some may be used only if they are from batches certified in FDA’s own labs. Here are some resources to help you learn more:\nYes, you may need to register your facility and list your cosmetics products. Please see our Draft Guidance that describes the Modernization of Cosmetics Regulation Act of 2022 (",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "Please see our Draft Guidance that describes the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) requirements for facility registration and product listing, and the exemptions under MoCRA for certain small businesses.\nMoCRA exempts certain small businesses from facility registration and product listing.\nHowever, such exemptions do not apply to manufacturers or facilities that manufacture or process the following cosmetic products:\nExemptions also exist for certain products and faciliti",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "or process the following cosmetic products:\nExemptions also exist for certain products and facilities that are subject to requirements for drugs and devices (For ex. Class 1 and Class II Device Exemptions).\nIf, however, your products are drugs, or both cosmetics and drugs, they must meet the requirements for drug registration. Similarly, importers of cosmetic ingredients that are also classified as food products must meet the registration requirements of the Bioterrorism Act of 2002External Lin",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "as food products must meet the registration requirements of the Bioterrorism Act of 2002External Link Disclaimer.\nIt’s not against the law to manufacture cosmetics in your home. Keep in mind, however, that it’s your responsibility to manufacture products in an environment that will not cause them to become adulterated.\nHere are some of the ways in which a cosmetic can become adulterated:\nFDA intends to conduct rulemaking as part of the implementation of MoCRA, which requires FDA to establish goo",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "ds to conduct rulemaking as part of the implementation of MoCRA, which requires FDA to establish good manufacturing practices (GMP) that, to the extent practicable and appropriate, are consistent with national and international standards. If you manufacture homemade cosmetics or own a salon, exemption from GMP requirements may apply. For more information on GMP, please see:\nThe same requirements for safety and labeling apply to all cosmetics, no matter what their source. This includes, for examp",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "or safety and labeling apply to all cosmetics, no matter what their source. This includes, for example, making sure that all your labeling is truthful and not misleading.\nFDA has not defined the term “natural” and has not established a regulatory definition for this term in cosmetic labeling.\nFDA also does not have regulations for the term \"organic\" for cosmetics. The U.S. Department of Agriculture (USDA) regulates the use of the term “organic” for agricultural products under the National Organi",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "e (USDA) regulates the use of the term “organic” for agricultural products under the National Organic Program (NOP). If you have questions about the use of the term “organic,” contact USDA. Answers to some common questions about \"organic\" cosmetics are available on our website under “‘Organic’ Cosmetics.”\nDon’t use terms such as “natural” as part of an ingredient statement, because ingredients must be listed by their common or usual names, without additional description.\nAnd remember, choosing i",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "t be listed by their common or usual names, without additional description.\nAnd remember, choosing ingredients from sources you consider “organic” or “natural” is no guarantee that they are safe. You are still responsible for making sure your ingredients are safe when used according to the labeling, or as they are customarily used, no matter what kinds of ingredients you use.\nIn general, a manufacturer, packer or distributor whose name appears on the label of a cosmetic product is required to en",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "turer, packer or distributor whose name appears on the label of a cosmetic product is required to ensure adequate substantiation of safety of their cosmetic product and to maintain records that support substantiation. Adequate substantiation of safety means tests or studies, research, analyses, or other evidence or information that is considered, among experts qualified by scientific training and experience to evaluate the safety of cosmetic products and their ingredients, sufficient to support",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "experience to evaluate the safety of cosmetic products and their ingredients, sufficient to support a reasonable certainty that a cosmetic product is safe. Animal testing is not a requirement. It’s important, however, that all data used to support the safety are derived from scientifically robust methods.\nFDA does not require specific tests to demonstrate the safety of individual cosmetic products or ingredients. Nor does FDA require cosmetic companies to share their safety information with FDA",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "or ingredients. Nor does FDA require cosmetic companies to share their safety information with FDA prior to marketing of their products. However, if certain conditions are met, FDA can access and copy records, including safety substantiation data for cosmetic products and their ingredients.\nFDA has consistently advised manufacturers to use whatever testing is necessary to ensure the safety of their products and ingredients. Firms may substantiate safety in a number of ways. FDA has stated that",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "ir products and ingredients. Firms may substantiate safety in a number of ways. FDA has stated that \"the safety of a product can be adequately substantiated through:\nAdditionally, there are regulations that prohibit or restrict the use of several ingredients in cosmetic products. (See 21 CFR 700.11-700.35.)\nFor more resources on cosmetics safety substantiation, please see Product Testing of Cosmetics.\nManufacturers can use relevant safety data that is already available to support the safety of t",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "ics.\nManufacturers can use relevant safety data that is already available to support the safety of their products.\nHere are some examples:\nThe Cosmetic Ingredient ReviewExternal Link Disclaimer (CIR) website has information on the safety of cosmetic ingredients that they have reviewed. (CIR is an industry-funded panel of scientific and medical experts who review the safety of cosmetic ingredients. FDA participates in CIR meetings, but does not vote, and we may agree or disagree with CIR conclusi",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "FDA participates in CIR meetings, but does not vote, and we may agree or disagree with CIR conclusions. However, we do take CIR reviews into consideration when we evaluate cosmetic ingredient safety.)\nYou may also need to do toxicological testing to fill in any gaps in the information that’s available. Toxicology or other testing methods may be necessary to determine the safety of each ingredient and the finished product. And don’t forget microbiological safety. Cosmetics do not have to be ster",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "and the finished product. And don’t forget microbiological safety. Cosmetics do not have to be sterile, but they must not contain any harmful microorganisms, and the number of aerobic microorganisms per gram must be low. To learn more, see “Microbiological Methods for Cosmetics.”\nMany factors can affect how your product may become contaminated, including use by consumers, such as dipping one’s fingers into a jar. If you do not have the technical expertise to determine the best way to ensure tha",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "ngers into a jar. If you do not have the technical expertise to determine the best way to ensure that your product is protected from contamination, you may want to work with a consultant.\nFor more resources on cosmetics safety substantiation, please see Product Testing of Cosmetics.\nA post office box or website address is not adequate for this labeling requirement.\nThe FD&C Act requires cosmetic labels to identify the name and place of business of the manufacturer, packer, or distributor. By reg",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "abels to identify the name and place of business of the manufacturer, packer, or distributor. By regulation, this includes the street address, city, state, and ZIP code, although you may omit the street address if your firm is listed in a current city or telephone directory. You may use the main place of business instead of the actual place where the cosmetic was manufactured, packed, or distributed, unless such a statement would be misleading.\nIf you use the distributor’s address, you must use",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "ed, unless such a statement would be misleading.\nIf you use the distributor’s address, you must use a phrase such as \"Distributed by\" or \"Manufactured for,\" followed by that firm's name and place of business. The name of the firm must be the corporate name. See the regulation on name and place of business at 21 CFR 701.12.\nCosmetic labeling is not subject to premarket approval by FDA. It’s your responsibility to make sure your labeling meets all requirements. For specific labeling questions, ple",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "sponsibility to make sure your labeling meets all requirements. For specific labeling questions, please contact the FDA - CFSAN - Outreach and Information Center (salesforce-sites.com)External Link Disclaimer or for specific questions regarding Modernization of Cosmetics Regulation Act of 2022 (MoCRA), please contact QuestionsAboutMoCRA@fda.hhs.gov.\nHere are some useful resources:\nSome cosmetic labeling requirements are regulated by other federal agencies. For example, the U.S. Federal Trade Com",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "beling requirements are regulated by other federal agencies. For example, the U.S. Federal Trade Commission regulates claims of “Made in USA.” Other country of origin labeling is regulated by U.S. Customs and Border Protection (see “Chapter 13-Country of Origin Marking”).\nYou may wish to work with a labeling consultant. FDA, as a government agency, does not provide referrals to private consultants.\nYou will need to contact your state and local authorities for that information. The Small Business",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": ".\nYou will need to contact your state and local authorities for that information. The Small Business Administration can also help.\nFDA does not license cosmetics firms. However, state or local authorities may require licensing or have other requirements you need to know about. You will need to contact your state or local authorities directly. Again, the Small Business Administration may be able to help.\nSee “ Resources for You: Industry\" for a list of resources for members of the cosmetics indus",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "help.\nSee “ Resources for You: Industry\" for a list of resources for members of the cosmetics industry, large and small. You will find information on labeling, color additives, imports, exports, other agencies you need to know about, links to the laws and regulations, and more.",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/small-businesses-homemade-cosmetics-fact-sheet"
  },
  {
    "text": "Cosmetics marketed on a retail basis to consumers must have an ingredient list. But under the law, this list cannot be used to make a company disclose “trade secrets.” A trade secret may consist of any commercially valuable plan, formula, process, or device that is used for the making, preparing, compounding, or processing of trade commodities and that can be said to be the end product of either innovation or substantial effort. There must be a direct relationship between the trade secret and th",
    "url": "https://www.fda.gov/cosmetics/labeling/trade-secret-ingredients"
  },
  {
    "text": "nnovation or substantial effort. There must be a direct relationship between the trade secret and the productive process. (Title 21, Code of Federal Regulations (CFR), Part 20.61(a)).\nWhat does this mean for cosmetic labeling?\nFDA requires cosmetics to have an “ingredient declaration,” a list of all the ingredients in a given cosmetic. FDA requires this under the Fair Packaging and Labeling ActExternal Link Disclaimer (FPLA). This law is intended to make sure consumers have information they can",
    "url": "https://www.fda.gov/cosmetics/labeling/trade-secret-ingredients"
  },
  {
    "text": "ernal Link Disclaimer (FPLA). This law is intended to make sure consumers have information they can use to compare the value of different products and make informed choices.\nBut according to the FPLA, regulations for this list of ingredients must not be used to force a company to disclose “trade secrets” (FPLA, section 1454(c)(3)).\nTo request “trade secret” status for any ingredient, a cosmetic company needs to follow a process detailed in the cosmetic regulations.\nRequests for “trade secret” st",
    "url": "https://www.fda.gov/cosmetics/labeling/trade-secret-ingredients"
  },
  {
    "text": "mpany needs to follow a process detailed in the cosmetic regulations.\nRequests for “trade secret” status are granted on rare occasions based on a strict set of criteria. To make such a request, submit your cosmetic formulation or raw material composition statement to FDA. The statement must include the information FDA will need to evaluate the factual and legal grounds justifying trade secrecy for the ingredient in question. There are two key elements to disclose for our evaluation:\nFDA will not",
    "url": "https://www.fda.gov/cosmetics/labeling/trade-secret-ingredients"
  },
  {
    "text": "the ingredient in question. There are two key elements to disclose for our evaluation:\nFDA will not disclose the information you provide while the ingredient is under review. If we grant your “trade secret” request, the information you provide will not be subject to release under the Freedom of Information Act. If we deny your “trade secret” request, we will return the information you provided back to you without retaining any copies.\nNo fees are required for this type of request.\nReview time v",
    "url": "https://www.fda.gov/cosmetics/labeling/trade-secret-ingredients"
  },
  {
    "text": "ck to you without retaining any copies.\nNo fees are required for this type of request.\nReview time varies. You will receive at least an interim response within 180 days, but not necessarily a final decision at that time. For example, the last “trade secret” request FDA granted was completed in one year.\nYou can choose either to request “trade secret” status for a cosmetic ingredient from FDA or to apply for a patent from the U.S. Patent and Trademark Office (USPTO). You cannot request both. To l",
    "url": "https://www.fda.gov/cosmetics/labeling/trade-secret-ingredients"
  },
  {
    "text": "apply for a patent from the U.S. Patent and Trademark Office (USPTO). You cannot request both. To learn more about applying for a patent, see the USPTO’s information under “Patents.”",
    "url": "https://www.fda.gov/cosmetics/labeling/trade-secret-ingredients"
  },
  {
    "text": "December 15, 2023\nThe FDA published an updated Structured Product Labeling (SPL) Implementation Guide with Validation Procedures on December 14, 2023. The guide includes updates to the cosmetics product facility registrations and product listings that are included within the SPL framework.\n\nOctober 13, 2023\nThe U.S. Food and Drug Administration has published a Structured Product Labeling (SPL) Implementation Guide with Validation Procedures. Cosmetics product facility registrations and product",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-publishes-structured-product-labeling-spl-implementation-guide-validation-procedures-cosmetic"
  },
  {
    "text": "plementation Guide with Validation Procedures. Cosmetics product facility registrations and product listings are now included within the SPL framework. The Implementation Guide can be used to develop SPL authoring tools. In the future, once FDA begins accepting data, users may transmit SPL-formatted submissions through FDA’s Electronic Submissions Gateway (ESG), or SPL authoring software including Xforms, for cosmetic product facility registrations and product listings, mandated by the Moderniza",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-publishes-structured-product-labeling-spl-implementation-guide-validation-procedures-cosmetic"
  },
  {
    "text": "Xforms, for cosmetic product facility registrations and product listings, mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).  FDA also intends to make the Cosmetics Direct electronic submission portal available in the future at https://direct.fda.gov/. Cosmetics Direct will be an FDA provided SPL authoring tool that contains user friendly data entry forms, performs initial validations, creates and saves the SPL submission, and submits the SPL to FDA for internal processi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-publishes-structured-product-labeling-spl-implementation-guide-validation-procedures-cosmetic"
  },
  {
    "text": "validations, creates and saves the SPL submission, and submits the SPL to FDA for internal processing without having to use the ESG.\nSPL, an established document sanctioned by health level seven (HL7) for the exchange of product and facility-related information, serves as a foundational reference for regulatory guidance documents and product labeling content exchange. It enforces control over crucial product information, resulting in a standard for product labeling. The FDA has adopted SPL to e",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-publishes-structured-product-labeling-spl-implementation-guide-validation-procedures-cosmetic"
  },
  {
    "text": "cial product information, resulting in a standard for product labeling. The FDA has adopted SPL to enhance patient/customer safety and product usability within its consumer base. In 2005, the FDA mandated the use of XML compliant with the SPL standard for electronic submissions. This standard defines the content and structure of product labeling required for submission to the FDA. Consistent structure and standard terminology are employed to enhance the accuracy and reliability of product inform",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-publishes-structured-product-labeling-spl-implementation-guide-validation-procedures-cosmetic"
  },
  {
    "text": "ture and standard terminology are employed to enhance the accuracy and reliability of product information.\nAdditional Information\nTechnical assistance is available for users by contacting the ESG at ESGHelpDesk@fda.hhs.gov.\nSUBSCRIBE",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-publishes-structured-product-labeling-spl-implementation-guide-validation-procedures-cosmetic"
  },
  {
    "text": "What ingredients are prohibited or restricted from use in cosmetics? You can find the information on what the law and FDA regulations say about cosmetic ingredients and safety below.\nAre harmful ingredients allowed in cosmetics?\nIt’s against the law for a cosmetic to contain any ingredient that makes the product harmful when consumers use it according to directions on the label, or in the customary or expected way. This is true whether or not there is a regulation that specifically prohibits or",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "y or expected way. This is true whether or not there is a regulation that specifically prohibits or restricts the use of the ingredient in cosmetics.\nThe one exception is for coal-tar hair dyes, which the law treats differently. Under the law, FDA cannot take action against a coal-tar hair dye for safety reasons as long as it has a special warning statement on the label and directions for a skin test. The caution statement reads as follows:\nCaution - This product contains ingredients which may c",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "est. The caution statement reads as follows:\nCaution - This product contains ingredients which may cause skin irritation on certain individuals and a preliminary test according to accompanying directions should first be made. This product must not be used for dyeing the eyelashes or eyebrows; to do may cause blindness.\nIt’s also important to understand that some cosmetics that are safe when people use them correctly may be unsafe when used the wrong way. Cosmetics must have any directions for us",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "use them correctly may be unsafe when used the wrong way. Cosmetics must have any directions for use or warning statements needed to make sure people use the products safely. For example, some ingredients may be safe in products such as cleansers that we wash off the skin immediately, but not in products that we leave on the skin for hours. Similarly, ingredients that are safe for use on the hair or nails may be unsafe when used on the skin or near the eyes.\nUnder U.S. law, cosmetic products an",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "or nails may be unsafe when used on the skin or near the eyes.\nUnder U.S. law, cosmetic products and ingredients, other than color additives, do not need FDA approval before they go on the market. Cosmetic manufacturers have a legal responsibility for the safety and labeling of their products.  FDA can and does take action against cosmetics on the market that do not comply with the law.\nWhat ingredients are prohibited or restricted by FDA regulations?\nAlthough it’s against the law to use any in",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "edients are prohibited or restricted by FDA regulations?\nAlthough it’s against the law to use any ingredient that makes a cosmetic harmful when used as intended, FDA has regulations that specifically prohibit or restrict the use of the following ingredients in cosmetics:\nWhat about color additives?\nWhat about drug ingredients?\nIf a product is intended for a therapeutic purpose, such as treating or preventing disease, it’s a drug under the law and must meet those requirements, such as premarket a",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "preventing disease, it’s a drug under the law and must meet those requirements, such as premarket approval by FDA, even if it affects the appearance. The presence of certain ingredients with a therapeutic use that is well-known to the public and industry is one factor that can determine whether a product is intended for use as a drug. FDA makes these decisions on a case-by-case basis. To learn more, see “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?).”\nWhy are different ingredients prohibi",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "re, see “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?).”\nWhy are different ingredients prohibited in some other countries?\nDifferent countries and regions regulate cosmetics under different legal frameworks.\nUnder U.S. law, FDA does not have the authority to require cosmetic manufacturers to submit their safety data to FDA, and the burden is on FDA to prove that a particular product or ingredient is harmful when used as intended. We make these decisions based on reliable scientific informa",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "dient is harmful when used as intended. We make these decisions based on reliable scientific information available to us. FDA can take other countries’ decisions into consideration, but we can only take action within the legal and regulatory framework for cosmetics in the United States.\nMore Resources\n* \"Specified risk material\" means the brain, skull, eyes, trigeminal ganglia, spinal cord, vertebral column (excluding the vertebrae of the tail, the transverse processes of the thoracic and lumbar",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "ral column (excluding the vertebrae of the tail, the transverse processes of the thoracic and lumbar vertebrae, and the wings of the sacrum), and dorsal root ganglia of cattle 30 months and older and the tonsils and distal ileum of the small intestine of all cattle.\n** Tallow must be produced from tissues that are not prohibited cattle materials or must contain not more than 0.15 percent insoluble impurities as determined by the method entitled \"Insoluble Impurities\" (AOCS Official Method Ca 3a-",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "impurities as determined by the method entitled \"Insoluble Impurities\" (AOCS Official Method Ca 3a-46), American Oil Chemists' Society (AOCS), 5th Edition, 1997, incorporated by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part 51, or another method equivalent in accuracy, precision, and sensitivity to AOCS Official Method Ca 3a-46. You may obtain copies of the method from AOCSExternal Link Disclaimer, 2211 W. Bradley Ave. Champaign, IL 61821",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "Link Disclaimer, 2211 W. Bradley Ave. Champaign, IL 61821",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/prohibited-restricted-ingredients"
  },
  {
    "text": "The resources listed below provide information on tanning products that are regulated as cosmetics.\nFor information on tanning beds and booths, which are regulated as radiation-emitting devices and not as cosmetics, see Sunlamps and Sunlamp Products (Tanning Beds/Booths).\nSunscreens are regulated as drugs. Products intended both as makeup and sun protection are both cosmetics and drugs. To learn more, see \"Makeup.\"\nRead more on:",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/cosmetic-tanning-products"
  },
  {
    "text": "ore, see \"Makeup.\"\nRead more on:",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/cosmetic-tanning-products"
  },
  {
    "text": "Consumers sometimes ask about use of claims such as \"Cruelty-Free\" or \"Not Tested on Animals\" on cosmetic labeling.\nSome cosmetic companies promote their products with claims of this kind in their labeling or advertising. The unrestricted use of these phrases by cosmetic companies is possible because there are no legal definitions for these terms.\nSome companies may apply such claims solely to their finished cosmetic products. However, these companies may rely on raw material suppliers or contra",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/cruelty-freenot-tested-animals"
  },
  {
    "text": "ir finished cosmetic products. However, these companies may rely on raw material suppliers or contract laboratories to perform any animal testing necessary to substantiate product or ingredient safety. Other cosmetic companies may rely on combinations of scientific literature, non-animal testing, raw material safety testing, or controlled human-use testing to substantiate their product safety.\nMany raw materials, used in cosmetics, were tested on animals years ago when they were first introduced",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/cruelty-freenot-tested-animals"
  },
  {
    "text": "y raw materials, used in cosmetics, were tested on animals years ago when they were first introduced. A cosmetic manufacturer might only use those raw materials and base their \"cruelty-free\" claims on the fact that the materials or products are not \"currently\" tested on animals.\nMore Resources\nMarch 14, 1995; Updated February 24, 2000. This document is current and is updated only as needed.",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/cruelty-freenot-tested-animals"
  },
  {
    "text": "English\n如果您在使用化妆品后出现不良反应或问题，首先应立即停止使用该产品，并联系您的医疗保健提供者。美国食品药品监督管理局 (下称 FDA、我们）不提供医疗建议。其次，向 FDA 报告问题。\n报告化妆品投诉\n如遇以下情况请向 FDA 报告\n被视为化妆品的产品类型\n化妆品不同于药品，FDA 对化妆品的监管方式也有所不同。以下为一些化妆品示例：\n消费者和医疗专业人员如何向 FDA 报告化妆品问题\n如果您是消费者或医疗专业人员，希望报告与化妆品相关的投诉或不良事件（如疾病、过敏反应、皮疹、刺激、疤痕或脱发），您可以：\nMedWatchFood and Drug Administration5600 Fishers LaneRockville, MD 20852传真至：(800) 332-0178（免费）。\n企业如何报告严重不良事件\n2022 年《化妆品法规现代化法案》(MoCRA) 于 2022 年 12 月 29 日通过。MoCRA 对《联邦食品、药品和化妆品法案》第六章进行了修订，是自 1938 年以来 FDA 在化妆品监管权限方面最重大的扩展。\nMoCRA 规定，责任人（见下方",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ruhebaogaohuazhuangpinxiangguantousu"
  },
  {
    "text": "2022 年 12 月 29 日通过。MoCRA 对《联邦食品、药品和化妆品法案》第六章进行了修订，是自 1938 年以来 FDA 在化妆品监管权限方面最重大的扩展。\nMoCRA 规定，责任人（见下方定义）必须在 15 个工作日内向 FDA 报告与在美国境内化妆品使用产品相关的严重不良事件（见下方定义）。责任人必须提供该化妆品零售包装上或包装内的标签副本。如果责任人在向 FDA 提交初始报告后 1 年内收到有关该不良事件的医疗或其他信息，则必须在 15 个工作日内向 FDA 提交此类新信息。在检查期间，FDA 还可以查阅不良事件报告。\n企业责任人必须使用当前《FDA 表 3500A》（强制性报告表）提交化妆品严重不良事件报告（SAER)，该表格可经 MedWatch：FDA 安全信息和不良事件报告计划（强制性报告）(PDF) 下载和填写。\n请参阅《FDA 3500A 表填写说明》。\n请将以下材料：\n通过以下方式提交至 FDA： 电子邮件：CosmeticAERS@fda.hhs.gov 或邮寄至：\nFDA CDER Mail CenterAttn:Cosmetics MedWatch",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ruhebaogaohuazhuangpinxiangguantousu"
  },
  {
    "text": "下材料：\n通过以下方式提交至 FDA： 电子邮件：CosmeticAERS@fda.hhs.gov 或邮寄至：\nFDA CDER Mail CenterAttn:Cosmetics MedWatch reportsWhite Oak Campus, Building 22, G020710903 New Hampshire Ave.Silver Spring, MD 20993\nFDA 现正开发化妆品不良事件强制性电子报告提交流程。\n虽然 MoCRA 不要求企业责任人向 FDA 提交化妆品非严重不良事件报告，但企业可自愿使用 FDA 3500A 表提交非严重不良事件报告，提交流程与上述强制性不良事件报告提交流程相同。\n关键术语\n严重不良事件：指出现以下情况的不良事件：\n（A）导致：\n(B) 根据合理的医疗判断，需要进行医疗或手术干预以预防上述（A）类所述后果。\n责任人：化妆品的生产商、包装商或经销商，根据《食品、药品和化妆品法》第 609(a) 条或《公平包装和标签法》第 4(a) 条的规定，化妆品的标签上需印上其名称。",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ruhebaogaohuazhuangpinxiangguantousu"
  },
  {
    "text": "商或经销商，根据《食品、药品和化妆品法》第 609(a) 条或《公平包装和标签法》第 4(a) 条的规定，化妆品的标签上需印上其名称。",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ruhebaogaohuazhuangpinxiangguantousu"
  },
  {
    "text": "This document outlines a working agreement between the Center for Food Safety and Applied Nutrition (CFSAN) and the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA). The agreement clarifies the authority of CFSAN and CDER over certain products that are intended to affect the structure or function of the human body or intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. The agreement is intended to achieve a more efficie",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "mitigation, treatment, or prevention of disease. The agreement is intended to achieve a more efficient allocation of resources and better coordination of regulatory actions for products that meet the statutory definition of a cosmetic and also meet the statutory definition of a drug.\nThe agreement does not apply to products that meet the statutory definition of a cosmetic that are also subject to the jurisdiction of other FDA Centers (Center for Biologics Evaluation and Research, Center for Vete",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "the jurisdiction of other FDA Centers (Center for Biologics Evaluation and Research, Center for Veterinary Medicine, or Center for Devices and Radiological Health).\nThis agreement is intended to assist FDA in implementing the cosmetic and the drug provisions of the Federal Food, Drug, and Cosmetic Act (the Act) by clarifying the respective responsibilities of CDER and CFSAN in light of overlapping product jurisdiction between the Centers. The agreement is entirely procedural in nature and is not",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "product jurisdiction between the Centers. The agreement is entirely procedural in nature and is not intended to affect the Agency's approach to the regulation of these products. The agreement does not formally bind FDA and does not affect the rights or obligations of any regulated entities.\nFor further information contact either:\nDirector\nOffice of Compliance\nCenter for Drug Evaluation and Research\nWO Bldg. 51, Room # 5270\n10903 New Hampshire Avenue\nSilver Spring, MD 20993\nOr\nDirector\nOffice of",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "ch\nWO Bldg. 51, Room # 5270\n10903 New Hampshire Avenue\nSilver Spring, MD 20993\nOr\nDirector\nOffice of Cosmetics and Colors, HFS-100\nCenter for Food Safety and Applied Nutrition\n4300 River Road\nCollege Park, MD 20740\nOn this page:\nCDER is generally the FDA's lead Center for the regulation of human drugs, as defined in Section 201(g) of the Federal Food, Drug, and Cosmetic Act (the Act). CFSAN is generally the FDA's lead Center for the regulation of cosmetics, as defined in Section 201(i) of the Ac",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "erally the FDA's lead Center for the regulation of cosmetics, as defined in Section 201(i) of the Act.\nUnder Section 201(i) of the Act, the term \"cosmetic\" means:\n(1) articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, and\n(2) articles intended for use as a component of any such articles ....\"\nIf a product meets the statutory",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "rticles intended for use as a component of any such articles ....\"\nIf a product meets the statutory definition of a cosmetic and is also intended to affect the structure or any function of the human body, or is intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, that product is also subject to regulation as a drug per Section 201(g) of the Act.\nUnder this agreement, CDER and CFSAN shall have concurrent jurisdiction over products that meet the statutory defin",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "ement, CDER and CFSAN shall have concurrent jurisdiction over products that meet the statutory definition of a cosmetic and that also meet the statutory definition of a drug. CDER or CFSAN may bring an enforcement action relating to such a product. CFSAN will not include drug charges (including Sections 501, 502, and 505 of the Act) in such an action without first notifying CDER of the charges that will be included. CDER will not include cosmetic charges (including Sections 601 and 602 of the Ac",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "t will be included. CDER will not include cosmetic charges (including Sections 601 and 602 of the Act) in such an action without first notifying CFSAN of the charges that will be included.\nEach Center agrees to consult regularly with the other Center to ensure consistency of approach and priorities, provide updates on regulatory actions, and discuss jurisdictional and other challenges relating to the subject of this agreement.\nCFSAN will not make any policy statements (e.g., in guidance document",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "the subject of this agreement.\nCFSAN will not make any policy statements (e.g., in guidance documents) about the meaning of the term \"drug\" or the concept of intended use as applied to drugs without first obtaining CDER's concurrence. CDER will not make any policy statements (e.g., in guidance documents) about the meaning of the term \"cosmetic\" or the concept of intended use as applied to cosmetics without first obtaining CFSAN's concurrence.\nIn order to ensure adequate communication and a consi",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "s without first obtaining CFSAN's concurrence.\nIn order to ensure adequate communication and a consistent approach to the interpretation and application of this agreement, appropriate representatives from CDER's Office of Compliance and CFSAN's Office of Compliance and Office of Cosmetics and Colors will meet:\nIn order to avoid duplication of effort, each Center will notify the other in advance of expending significant resources on a matter subject to this agreement that is likely to result in m",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "expending significant resources on a matter subject to this agreement that is likely to result in multiple warning or untitled letters (such as related to a specific initiative), an import alert, seizure, injunction, or prosecution.\nAppropriate experts in CDER's Office of New Drugs may be asked to perform health hazard evaluations, when necessary and appropriate, in connection with cases subject to this agreement when CDER would have the lead jurisdiction. CDER's Product Jurisdiction Officer wi",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "to this agreement when CDER would have the lead jurisdiction. CDER's Product Jurisdiction Officer will be consulted on policies and decisions related to interpretation of the meaning of the term “drug.” CDER Office of Compliance will act as a liaison for requests to other parts of CDER when such requests are necessary to support an enforcement action.\nCDER's Office of Policy for Pharmaceutical Quality will be consulted on policies related to the quality of products under concurrent jurisdiction.",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "lity will be consulted on policies related to the quality of products under concurrent jurisdiction. CFSAN's Office of Cosmetics and Colors will be consulted on policies related to the quality of products under concurrent jurisdiction.\nThis agreement becomes effective on August 1, 2018. This agreement may only be modified with 60 days written notice and unanimous consent of both CFSAN and CDER. The agreement may be terminated by either party upon 30 days written notice to the other party. This a",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "e agreement may be terminated by either party upon 30 days written notice to the other party. This agreement may be modified by consent of both partners or terminated by any party immediately upon written notice in the event that a Federal statute is enacted or a regulation is issued by a Federal partner that materially affects this Inter-center Agreement.\nJanet Woodcock, M.D.\nDirector, Center for Drug Evaluation and Research\nSusan T. Mayne, Ph.D.\nDirector, Center for Food Safety and Applied Nut",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "Drug Evaluation and Research\nSusan T. Mayne, Ph.D.\nDirector, Center for Food Safety and Applied Nutrition",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/cder-cfsan-agreement"
  },
  {
    "text": "This section provides resources on regulatory requirements for cosmetic labeling. For a thorough explanation of cosmetic labeling regulations, see FDA's Cosmetic Labeling Guide and the cosmetic labeling regulations themselves (21 CFR parts 701 and 740). Firms also may wish to discuss their labeling needs with a consultant.\nOn this page:\nIn this section:\nMore Resources:\nThe following information is a brief introduction to labeling requirements. For a more thorough explanation of cosmetic labeling",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "a brief introduction to labeling requirements. For a more thorough explanation of cosmetic labeling regulations, refer to FDA's Cosmetic Labeling Guide and the cosmetic labeling regulations themselves (21 CFR parts 701 and 740). Firms also may wish to discuss their labeling needs with a consultant.\nProper labeling is an important aspect of putting a cosmetic product on the market. FDA regulates cosmetic labeling under the authority of both the Federal Food, Drug, and Cosmetic Act (FD&C Act) and",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "osmetic labeling under the authority of both the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling Act (FPLA). These laws and their related regulations are intended to protect consumers from health hazards and deceptive practices and to help consumers make informed decisions regarding product purchase.\nIt is illegal to introduce a misbranded cosmetic into interstate commerce, and such products are subject to regulatory action. Some of the ways a cosmetic can bec",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "te commerce, and such products are subject to regulatory action. Some of the ways a cosmetic can become misbranded are:\nDoes FDA pre-approve cosmetic product labeling?\nNo. FDA does not have the resources or authority under the law for pre-market approval of cosmetic product labeling. It is the manufacturer's and/or distributor's responsibility to ensure that products are labeled properly. Failure to comply with labeling requirements may result in a misbranded product.\nSome labeling terms to know",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "to comply with labeling requirements may result in a misbranded product.\nSome labeling terms to know\nBefore proceeding with a discussion of labeling requirements, it is helpful to know what some labeling terms mean:\nIs it permitted to label cosmetics \"FDA Approved\"?\nNo. As part of the prohibition against false or misleading information, no cosmetic may be labeled or advertised with statements suggesting that FDA has approved the product. This applies even if the establishment is registered or th",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "esting that FDA has approved the product. This applies even if the establishment is registered or the product is on file with FDA's Voluntary Cosmetic Registration Program (VCRP) (see 21 CFR 710.8 and 720.9, which prohibit the use of participation in the VCRP to suggest official approval). False or misleading statements on labeling make a cosmetic misbranded [FD&C Act, sec. 602; 21 U.S.C. 362].\nWhat about therapeutic claims?\nBe aware that promoting a product with claims that it treats or prevent",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "at about therapeutic claims?\nBe aware that promoting a product with claims that it treats or prevents disease or otherwise affects the structure or any function of the body may cause the product to be considered a drug. FDA has an Import Alert in effect for cosmetics labeled with drug claims. For more information on drug claims, refer to Is It a Drug, a Cosmetic, or Both? (Or Is It Soap?).\nHow should products be labeled if they are both drugs and cosmetics?\nIf a product is an over-the-counter (O",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "uld products be labeled if they are both drugs and cosmetics?\nIf a product is an over-the-counter (OTC) drug as well as a cosmetic, its labeling must comply with the regulations for both OTC drug and cosmetic ingredient labeling [21 CFR 701.3(d)]. The drug ingredients must appear according to the OTC drug labeling requirements [21 CFR 201.66(c)(2) and (d)] and the cosmetic ingredients must appear separately, in order of decreasing predominance [21 CFR 201.66(c)(8) and (d)]. Contact the Center fo",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "separately, in order of decreasing predominance [21 CFR 201.66(c)(8) and (d)]. Contact the Center for Drug Evaluation and Research (CDER) for further information on drug labeling.\nWhat languages are acceptable?\nAll labeling information that is required by law or regulation must be in English. The only exception to this rule is for products distributed solely in a U.S. territory where a different language is predominant, such as Puerto Rico. If the label or labeling contains any representation in",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "anguage is predominant, such as Puerto Rico. If the label or labeling contains any representation in a foreign language, all label information required under the FD&C Act must also appear in that language [21 CFR 701.2(b)]. For information on dual declaration of ingredients, see Ingredient Names.\nWhat labeling information is required?\nThe following information must appear on the principal display panel:\nThe following information must appear on an information panel:",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "panel:\nThe following information must appear on an information panel:",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-regulations"
  },
  {
    "text": "Consumers and manufacturers may have questions about the safety of diethanolamine (DEA) and related ingredients in cosmetics. The following information is from the National Toxicology Program (NTP) and FDA.\nThe NTP completed a study in 1998 that found an association between the topical application of DEA and certain DEA-related ingredients and cancer in laboratory animals. For the DEA-related ingredients, the NTP study suggests that the carcinogenic response is linked to possible residual levels",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/diethanolamine"
  },
  {
    "text": "edients, the NTP study suggests that the carcinogenic response is linked to possible residual levels of DEA. The NTP study did not establish a link between DEA and the risk of cancer in humans.\nDEA and DEA-related ingredients function as emulsifiers or foaming agents in cosmetics, or to adjust a product's pH (acidity). Based on information filed with FDA's Voluntary Cosmetic Registration Program, it appears that DEA and DEA-related ingredients are used much less frequently in cosmetic products t",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/diethanolamine"
  },
  {
    "text": "it appears that DEA and DEA-related ingredients are used much less frequently in cosmetic products than they were when the NTP completed its study.\nGenerally speaking, except for most color additives and those ingredients that are prohibited or restricted by regulation from use in cosmetics, a manufacturer may use any ingredient in the formulation of a cosmetic product provided that the ingredient and the finished cosmetic are safe, the product is properly labeled, and the use of the specific su",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/diethanolamine"
  },
  {
    "text": "and the finished cosmetic are safe, the product is properly labeled, and the use of the specific substance does not otherwise cause the cosmetic to be adulterated or misbranded under the laws that FDA enforces.\nFDA believes that at the present time there is no reason for consumers to be alarmed based on the use of these substances in cosmetics. However, consumers wishing to avoid cosmetics containing DEA or DEA-related ingredients may do so by reviewing the ingredient statement that is required",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/diethanolamine"
  },
  {
    "text": "ning DEA or DEA-related ingredients may do so by reviewing the ingredient statement that is required to appear on the outer container label of cosmetics offered for retail sale to consumers. The following are some of the most commonly used ingredients that may contain DEA:\nIf FDA determines that a health hazard exists, the agency will advise the industry and the public and will consider its legal options under the authority of the Federal Food, Drug, and Cosmetic Act in protecting the health and",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/diethanolamine"
  },
  {
    "text": "options under the authority of the Federal Food, Drug, and Cosmetic Act in protecting the health and welfare of consumers.\nRelated Resources\nDecember 21, 1999; Updated October 27, 2006. This document is current. It is updated only as needed.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/diethanolamine"
  },
  {
    "text": "Inglés (English)\nNOTA sobre los jabones antibacterianos: Para obtener la información más reciente, consulte la norma final emitida por la FDA sobre la seguridad y la eficacia de los jabones antibacterianos.\nSegún la ley, el uso previsto de un producto determina si es un cosmético o un medicamento. Se aplican diferentes leyes y reglamentos a cada tipo de producto. Las empresas a veces violan la ley al comercializar un cosmético con una declaración de medicamento o al comercializar un medicamento",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "al comercializar un cosmético con una declaración de medicamento o al comercializar un medicamento como si fuera un cosmético, sin cumplir con los requisitos de los medicamentos.\n¿Qué es un cosmético según la ley?\nLa Ley Federal de Alimentos, Mediamentos y Cosméticos (FD&C, por sus siglas en inglés) define los cosméticos como “artículos destinados a frotarse, verterse, rociarse o esparcirse sobre el cuerpo humano, introducirse en él o aplicarse de cualquier otro modo... para limpiarlo, embellec",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "el cuerpo humano, introducirse en él o aplicarse de cualquier otro modo... para limpiarlo, embellecerlo, aumentar su atractivo o modificar su aspecto” [Ley FD&C, sec. 201(i)]. Entre los productos incluidos en esta definición se encuentran los humectantes para la piel, los perfumes, los lápices labiales, los esmaltes de uñas, el maquillaje, los champús limpiadores, las ondas permanentes, los tintes para el cabello y los desodorantes, así como cualquier sustancia destinada a usarse como component",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "s para el cabello y los desodorantes, así como cualquier sustancia destinada a usarse como componente de un producto cosmético.\nLa Ley de Modernización de la Regulación de Cosméticos (MoCRA, por sus siglas en inglés) de 2022 modificó la ley FD&C para incluir el “producto cosmético”, que se define como “un preparado de ingredientes cosméticos con una composición cualitativa y cuantitativamente establecida para su uso en un producto terminado” [Ley FD&C, sec. 361]. Este nuevo término se aplica a l",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "blecida para su uso en un producto terminado” [Ley FD&C, sec. 361]. Este nuevo término se aplica a las enmiendas de la Ley FD&C.\n¿Qué es un medicamento según la ley?\nLa Ley FD&C define los medicamentos, en parte, según su uso previsto, como “artículos destinados a usarse en el diagnóstico, la cura, la mitigación, el tratamiento o la prevención de enfermedades” y “artículos (distintos de los alimentos) destinados a afectar la estructura o cualquier función del cuerpo del hombre o de otros animale",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "tos) destinados a afectar la estructura o cualquier función del cuerpo del hombre o de otros animales” [Ley FD&C, sec. 201(g)(1)].\n¿Cómo puede un producto ser un cosmético y un medicamento?\nAlgunos productos cumplen con las definiciones de cosméticos y medicamentos. Esto puede ocurrir cuando un producto tiene más de un uso previsto. Por ejemplo, un champú anticaspa es un cosmético porque su uso previsto es limpiar el cabello, y también es un medicamento porque su uso previsto es tratar la caspa.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "evisto es limpiar el cabello, y también es un medicamento porque su uso previsto es tratar la caspa. Entre otras combinaciones cosméticas y farmacológicas se encuentran las pastas dentales que contienen flúor y pretenden refrescar el aliento y limpiar los dientes. Del mismo modo, los desodorantes que también son antitranspirantes y las cremas hidratantes y el maquillaje que se comercializan con declaraciones de protección solar son productos cosméticos/medicamentos. Dichos productos deben cumpli",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "claraciones de protección solar son productos cosméticos/medicamentos. Dichos productos deben cumplir con los requisitos tanto para cosméticos como para medicamentos.\n¿Qué pasa con los “cosmecéuticos”?\nLa Ley FD&C no reconoce ninguna categoría como “cosmecéuticos”. Un producto puede ser un medicamento, un cosmético o una combinación de ambos, pero el término “cosmecéutico” no tiene ningún significado según la ley.\n¿Cómo se establece el uso previsto de un producto?\nEl uso previsto se puede establ",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "ado según la ley.\n¿Cómo se establece el uso previsto de un producto?\nEl uso previsto se puede establecer de varias maneras. A continuación, se muestran algunos ejemplos:\nEste principio también es válido para los “aceites esenciales”. Por ejemplo, una fragancia comercializada para promover el atractivo es un cosmético. Sin embargo, una fragancia comercializada con ciertas afirmaciones de “aromaterapia”, como las afirmaciones de que el aroma ayudará al consumidor a dormir o dejar de fumar, cumple",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "pia”, como las afirmaciones de que el aroma ayudará al consumidor a dormir o dejar de fumar, cumple con la definición de medicamento debido a su uso previsto. Del mismo modo, un aceite de masaje que simplemente tiene la intención de lubricar la piel e impartir fragancia es un cosmético, pero si el producto está destinado a un uso terapéutico, como aliviar el dolor muscular, es un medicamento.\n¿En qué se diferencian las leyes y los reglamentos para los cosméticos y los medicamentos?\nLa siguiente",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "qué se diferencian las leyes y los reglamentos para los cosméticos y los medicamentos?\nLa siguiente información no es una descripción completa de las leyes y los reglamentos sobre cosméticos o medicamentos. Su único objetivo es alertarlo sobre algunas diferencias y similitudes importantes entre las leyes y los reglamentos sobre cosméticos y medicamentos en las áreas de aprobación, buenas prácticas de fabricación, registro y etiquetado. Las preguntas relacionadas con las leyes y reglamentos sobre",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "de fabricación, registro y etiquetado. Las preguntas relacionadas con las leyes y reglamentos sobre medicamentos se deben dirigir al Centro de Evaluación e Investigación de Medicamentos (CDER, por sus siglas en inglés) de la FDA.\n¿En qué se diferencian los requisitos de aprobación?\nSegún la Ley FD&C, los productos e ingredientes cosméticos, a excepción de los aditivos colorantes, no requieren la aprobación de la FDA antes de salir al mercado. Sin embargo, los medicamentos generalmente deben rec",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "aprobación de la FDA antes de salir al mercado. Sin embargo, los medicamentos generalmente deben recibir la aprobación previa a la comercialización de la FDA mediante el proceso de solicitud de nuevos medicamentos (NDA, por sus siglas en inglés) o cumplir con una “monografía” para una categoría de medicamento en particular, según lo establecido en la Revisión de medicamentos de venta libre (OTC, por sus siglas en inglés) de la FDA. Estas monografías especifican las condiciones en las que los ing",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "or sus siglas en inglés) de la FDA. Estas monografías especifican las condiciones en las que los ingredientes de los medicamentos OTC generalmente se reconocen como seguros y eficaces (GRASE, por sus siglas en inglés) y no se etiquetan mal. Ciertos medicamentos OTC pueden permanecer en el mercado sin la aprobación de la NDA hasta que se finalice una monografía para su clase de medicamentos como reglamento. Sin embargo, una vez que la FDA haya tomado una determinación final sobre el estado de una",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "glamento. Sin embargo, una vez que la FDA haya tomado una determinación final sobre el estado de una categoría de medicamentos OTC, los productos deben estar sujetos a un acuerdo de confidencialidad aprobado [Ley FD&C, sec. 505(a) y (b)], o cumplir con la monografía correspondiente para un medicamento OTC.\n¿Qué significan estos términos?\nPuede encontrar información en el sitio web de la FDA, en la sección Proceso de desarrollo y aprobación (medicamentos), especialmente Cómo se desarrollan y apru",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "sección Proceso de desarrollo y aprobación (medicamentos), especialmente Cómo se desarrollan y aprueban los medicamentos. Si aún tiene preguntas sobre las NDA y las monografías OTC, o sobre cualquier otro aspecto de la regulación de los medicamentos, póngase en contacto con el CDER. También puede ponerse en contacto con Ayuda a los pequeños comercios y a la industria del CDER en CDERSBIA@fda.hhs.gov o, para consultas generales relacionadas con medicamentos, con la División de Información sobre",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "gov o, para consultas generales relacionadas con medicamentos, con la División de Información sobre Medicamentos del CDER en druginfo@fda.hhs.gov.\n¿Los cosméticos y los medicamentos tienen diferentes requisitos de buenas prácticas de fabricación?\nEn la actualidad, la FDA tiene un borrador de Guía para la industria: Buenas prácticas de fabricación de cosméticos para ayudar a la industria y a otras partes interesadas a identificar las normas y los problemas que pueden afectar a la calidad de los p",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "partes interesadas a identificar las normas y los problemas que pueden afectar a la calidad de los productos cosméticos. La MoCRA modificó la Ley FD&C para exigir que la FDA establezca requisitos de buenas prácticas de fabricación (BPF) para las instalaciones que fabrican o procesan productos cosméticos distribuidos en Estados Unidos. Según la MoCRA, la FDA debe establecer estas regulaciones de BPF para cosméticos a más tardar el 29 de diciembre de 2025. La ley exigirá el cumplimiento estricto p",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "F para cosméticos a más tardar el 29 de diciembre de 2025. La ley exigirá el cumplimiento estricto por parte de la industria de estos requisitos de BPF, con ciertas exenciones. Los productos cosméticos que no cumplan con estos requisitos de BPF serán adulterados [Ley FD&C, sec. 601(f)]. Estas regulaciones tienen por objeto proteger la salud pública y garantizar que los productos cosméticos no estén adulterados ni mal etiquetados.\nEn cuanto a los medicamentos, la ley exige el cumplimiento estrict",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "n adulterados ni mal etiquetados.\nEn cuanto a los medicamentos, la ley exige el cumplimiento estricto de los requisitos de las BPF para los medicamentos y existen reglamentos que especifican los requisitos mínimos actuales de las BPF para los medicamentos [Título 21 del Código de Reglamentos Federales (CFR, por sus siglas en inglés), partes 210 y 211]. Los medicamentos que no cumplen con los requisitos de BPF se consideran adulterados [Ley FD&C, sec. 501(a)(2)(B)].\n¿En qué se diferencian los req",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "sitos de BPF se consideran adulterados [Ley FD&C, sec. 501(a)(2)(B)].\n¿En qué se diferencian los requisitos de registro?\nSegún la MoCRA, el registro de las instalaciones de productos cosméticos y la lista de productos cosméticos son obligatorios, con ciertas exenciones para las pequeñas empresas. Obtenga más información en Registro y listado de instalaciones y productos de cosméticos. También es obligatorio que las empresas farmacéuticas registren sus establecimientos y publiquen sus productos f",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "bligatorio que las empresas farmacéuticas registren sus establecimientos y publiquen sus productos farmacéuticos en la FDA [Ley FD&C, sec. 510; 21 CFR 207]. Consulte el Sistema de registro y listado de medicamentos (DRLS y eDRLS, por sus siglas en inglés).\n¿En qué se diferencian los requisitos de etiquetado?\nUn producto cosmético se debe etiquetar de acuerdo con las normas de etiquetado de cosméticos. Consulte Etiquetado de cosméticos para obtener orientación y enlaces a las regulaciones relacio",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "cos. Consulte Etiquetado de cosméticos para obtener orientación y enlaces a las regulaciones relacionadas con el etiquetado de cosméticos.\nLos medicamentos OTC se deben etiquetar de acuerdo con las regulaciones sobre medicamentos OTC, incluida la etiqueta con la “información sobre el medicamento”, tal como se describe en 21 CFR 201.66 Los productos combinados de cosméticos y medicamentos OTC deben tener una etiqueta que combine cosméticos y medicamentos OTC. Por ejemplo, los ingredientes de los",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "tener una etiqueta que combine cosméticos y medicamentos OTC. Por ejemplo, los ingredientes de los medicamentos deben estar listados alfabéticamente como “Ingredientes activos”, seguidos de los ingredientes cosméticos, listados en orden descendente de predominio como “Ingredientes inactivos”.\n¿Y si es “jabón”?\nEl jabón pertenece a una categoría que necesita una explicación especial. Esto se debe a que la definición reglamentaria de “jabón” es diferente de la forma en que las personas suelen usa",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "a que la definición reglamentaria de “jabón” es diferente de la forma en que las personas suelen usar la palabra. Los productos que cumplen con la definición de “jabón” están exentos de las disposiciones de la Ley FD&C porque, aunque la Sección 201(i)(1) de la ley incluye “artículos... para limpieza” en la definición de cosmético, la Sección 201(i)(2) excluye el jabón de la definición de cosmético.\n¿Qué es el “jabón” según la FDA?\nNo todos los productos comercializados como jabón cumplen con la",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": ".\n¿Qué es el “jabón” según la FDA?\nNo todos los productos comercializados como jabón cumplen con la definición del término de la FDA. La FDA interpreta que el término “jabón” se aplica solo cuando\nLos productos que cumplen con esta definición de jabón están regulados por la Comisión de Seguridad de Productos del Consumidor (CPSC, por sus siglas en inglés), no por la FDA. Dirija sus preguntas sobre estos productos, como los requisitos de seguridad y etiquetado, a la CPSC.\nSi un limpiador no cumpl",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "estos productos, como los requisitos de seguridad y etiquetado, a la CPSC.\nSi un limpiador no cumple con todos los criterios del jabón...\nSi un producto destinado a limpiar el cuerpo humano no cumple con todos los criterios para el jabón, como se indica anteriormente, es un cosmético o un medicamento. Por ejemplo:\nSi un producto:\nestá regulado como cosmético. Los ejemplos de usos cosméticos incluyen hacer que el usuario sea más atractivo, actuando como desodorante, impartiendo fragancia al usua",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "yen hacer que el usuario sea más atractivo, actuando como desodorante, impartiendo fragancia al usuario o hidratando la piel.\nSi un producto:\nestá regulado como medicamento o, posiblemente, como medicamento y cosmético. Entre los ejemplos se incluyen limpiadores antibacterianos y limpiadores también destinados a tratar el acné.\nSi un producto:\nse puede identificar en el etiquetado como jabón, pero está regulado como cosmético.\nRecursos",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "está regulado como cosmético.\nRecursos",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/es-un-cosmetico-un-medicamento-o-ambos-o-es-jabon"
  },
  {
    "text": "FDA has the legal authority to inspect cosmetic establishments as well as cosmetics offered for import. Here are resources to learn more about FDA inspection of cosmetics.\nSection 704 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to conduct inspections of cosmetic firms at reasonable times, in a reasonable manner, and without prior notice in order to assure compliance with the applicable laws and regulations, to determine whether cosmetics are safe and properly labeled, a",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/inspection-cosmetics"
  },
  {
    "text": "the applicable laws and regulations, to determine whether cosmetics are safe and properly labeled, and to identify possible health risks and other violations of the law.\nA number of factors affect how FDA determines that an inspection of a cosmetic establishment may be warranted. These factors may include--but are not limited to--the type of products, the significance of consumer or trade complaints received, the company's compliance history, FDA surveillance and compliance initiatives, and agen",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/inspection-cosmetics"
  },
  {
    "text": "ts received, the company's compliance history, FDA surveillance and compliance initiatives, and agency resources.\nSome things to know about inspections:\nUnder the FD&C Act, imported cosmetic products must comply with all the regulatory requirements that apply to domestic products (FD&C Act, section 201(b). They are subject to examination and/or sampling through U.S. Customs and Border Protection at the time of entry. Foreign cosmetics that appear to be adulterated or misbranded (FD&C Act, sectio",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/inspection-cosmetics"
  },
  {
    "text": "t the time of entry. Foreign cosmetics that appear to be adulterated or misbranded (FD&C Act, sections 601 and 602) may be refused entry into the United States. Shipments found not to comply with U.S. laws and regulations are subject to detention. They must be brought into compliance, destroyed, or re-exported (FD&C Act, section 801). Not all imported products are examined at the time of entry. Those not examined, however, are still subject to all the legal requirements of the laws we enforce.\nR",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/inspection-cosmetics"
  },
  {
    "text": "ose not examined, however, are still subject to all the legal requirements of the laws we enforce.\nRelated Resources:",
    "url": "https://www.fda.gov/cosmetics/compliance-enforcement/inspection-cosmetics"
  },
  {
    "text": "The FDA has received questions about 1,4-dioxane, a contaminant that may occur in trace amounts in certain cosmetics. The following information is from responses to those questions, scientific literature, and other public sources.\nThe compound 1,4-dioxane is a trace contaminant in some cosmetic products. It is not used as an ingredient in cosmetics, but may be present in extremely small amounts in some cosmetics. 1,4-dioxane forms as a byproduct during the manufacturing process of certain cosmet",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "some cosmetics. 1,4-dioxane forms as a byproduct during the manufacturing process of certain cosmetic ingredients. These ingredients include certain detergents, foaming agents, emulsifiers and solvents identifiable by the prefix, word, or syllables \"PEG,\" \"Polyethylene,\" \"Polyethylene glycol,\" \"Polyoxyethylene,\" \"-eth-,\" or \"-oxynol-.\"\n1,4-dioxane is a potential human carcinogen. A 2016 report by the Department of Health and Human Services National Toxicology Program (NTP) found that 1,4-dioxan",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "the Department of Health and Human Services National Toxicology Program (NTP) found that 1,4-dioxane is “reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals,” although the data available from human epidemiological studies are not adequate to evaluate the relationship between human cancer and exposure to 1,4-dioxane. The U.S. Environmental Protection Agency (EPA) has classified 1,4-dioxane as “likely to be carcinoge",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "The U.S. Environmental Protection Agency (EPA) has classified 1,4-dioxane as “likely to be carcinogenic to humans,” based on a finding of sufficient evidence of carcinogenicity in animals intentionally exposed to 1,4-dioxane but inadequate evidence of carcinogenicity in humans.\nThe FDA has not independently conducted a hazard identification and risk assessment concerning exposure to 1,4-dioxane as a contaminant in cosmetic products. However, two recent international scientific studies of trace c",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "a contaminant in cosmetic products. However, two recent international scientific studies of trace contamination levels of 1,4-dioxane in cosmetics (by the International Cooperation on Cosmetics Regulations (ICCR, an international group of regulatory authorities from the United States, the European Union, Japan, Canada, and Brazil), and by the European Commission Scientific Committee on Consumer Safety (SCCS)), have examined this issue. The ICCR work group determined that all of the levels repor",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "afety (SCCS)), have examined this issue. The ICCR work group determined that all of the levels reported in the recent literature are within acceptable margins of exposure based on available safety assessments from Canada, Europe, and Japan [1].  In an independent risk assessment, SCCS concluded that 1,4-dioxane amounts in cosmetic products are considered safe for consumers at trace levels of ≤10 ppm [2].\nThe FDA periodically monitors the levels of 1,4-dioxane in cosmetics products and we have ob",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "pm [2].\nThe FDA periodically monitors the levels of 1,4-dioxane in cosmetics products and we have observed that changes made in the manufacturing process have resulted in a significant decline over time in the levels of this contaminant in these products.\nThe FDA also conducted skin absorption studies, which showed that 1,4-dioxane can penetrate animal and human skin when applied in certain preparations, such as lotions. However, further research by the FDA determined that 1,4-dioxane evaporates",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "ations, such as lotions. However, further research by the FDA determined that 1,4-dioxane evaporates readily, further diminishing the already small amount available for skin absorption, even in products that remain on the skin for hours [3].\nThe FDA has periodically monitored specific levels of 1,4-dioxane in cosmetic products since the late 1970s. From 1981 to 1997, we conducted 10 surveys on the amount of 1,4-dioxane in finished cosmetic products. Although these surveys examined a limited numb",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "amount of 1,4-dioxane in finished cosmetic products. Although these surveys examined a limited number of samples, the number of products containing levels of 1-4-dioxane greater than 10 parts per million (ppm) declined over this period. In 1981, we found an average of 50 (ppm) 1,4-dioxane in finished cosmetic products, with a range of 2-279 ppm, and in 1997, we found an average of 19 ppm, with a range of 6-34 ppm [4]. In 2008, FDA conducted an 11th survey using a new analytical method with a de",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "range of 6-34 ppm [4]. In 2008, FDA conducted an 11th survey using a new analytical method with a detection limit of 1 ppm. Results from this survey found about 6% of the products were between 1-5 ppm, about 6% were between 5-10 ppm, about 8% were between 10-12 ppm (the highest level detected was 11.6 ppm), and did not detect any 1,4-dioxane in the majority (80%) of the products [5]).\n\nIn 2018, the FDA conducted a survey for 1,4-dioxane in 82 randomly selected cosmetic products marketed towards",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "e FDA conducted a survey for 1,4-dioxane in 82 randomly selected cosmetic products marketed towards children that contain ingredients associated with 1,4 dioxane contamination. Only 2 of the 82 products tested (approximately 2%) had levels of 1,4-dioxane above 10 ppm. Unlike earlier surveys, this survey looked only at products marketed to children and used a newer more sensitive detection method, making comparison to earlier results unreliable.\nSince the 1980s we have recommended that manufactur",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "making comparison to earlier results unreliable.\nSince the 1980s we have recommended that manufacturers use the “vacuum stripping” technique, as a way of reducing 1,4-dioxane [6].\nThe FDA will continue to monitor information about 1,4-dioxane and its levels in cosmetics. If the FDA were to determine that a health hazard exists, it would advise the industry and the public, and would consider appropriate actions for protecting the health and welfare of consumers.\nFor more on the subject of cosmeti",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "riate actions for protecting the health and welfare of consumers.\nFor more on the subject of cosmetic safety and the law, see FDA Authority Over Cosmetics and the cosmetics provisions of the Federal Food, Drug, and Cosmetic Act.\n[1] ICCR report: “Considerations on Acceptable Trace Level of 1,4-Dioxane in Cosmetic Products,” available on U.S. FDA, “1,4-Dioxane in Cosmetics: A Manufacturing Byproduct”\n[2] Scientific Opinion on The Report of the ICCR Working Group: Considerations on Acceptable Trac",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "t”\n[2] Scientific Opinion on The Report of the ICCR Working Group: Considerations on Acceptable Trace Level of 1,4-Dioxane in Cosmetic Products,” 15 December 2015, SCCS/1570/15\n[3] Robert L. Bronaugh, \"Percutaneous Absorption of Cosmetic Ingredients,\" in Principles of Cosmetics for the Dermatologist, Philip Frost, M.D., and Steven Horwitz, M.D., Eds. St. Louis: The C.V. Mosby Company, 1982\n[4] Roderick E. Black, Fred J. Hurley and Donald C. Havery, “Occurrence of 1,4-Dioxane in Cosmetic Raw Mate",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "erick E. Black, Fred J. Hurley and Donald C. Havery, “Occurrence of 1,4-Dioxane in Cosmetic Raw Materials and Finished Cosmetic Products,” Journal of AOAC International, 84 (3), 2001, pp. 666-667\n[5] Hardy J. Chou, Perry G. Wang, Wanlong Zhou, and Alexander J. Krynitsky, “Determination of 1,4-Dioxane in Cosmetic Products.”  Poster session presented at 124th AOAC Annual Meeting; 2010 Sept. 26-29; Orlando, Fl\n[6] Wenninger, J.A. (1980) Drug Cosmet. Ind. 127, 62, 64, 68-69, 117-118; FDA “Cosmetic H",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "rlando, Fl\n[6] Wenninger, J.A. (1980) Drug Cosmet. Ind. 127, 62, 64, 68-69, 117-118; FDA “Cosmetic Handbook” 1983, 1991, 1994.\nChemical Name: 1,4-Dioxane\nIUPAC International Chemical Identifier: InChI=1/C4H8O2/c1-2-6-4-3-5-1/h1-4H2\nJanuary 29, 2019. This information is current. It is updated only when necessary.",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/14-dioxane-cosmetics-manufacturing-byproduct"
  },
  {
    "text": "Available in PDF (316KB)\nThe Cosmetics Labeling Guide provides step-by-step help with cosmetic labeling, with examples and answers to questions  manufacturers often ask about labeling requirements under U.S. laws and related regulations.\nOn this page:\nFederal Food, Drug, and Cosmetic Act of 1938, as amended\nTo protect consumers from unsafe or deceptively labeled or packaged products by prohibiting the movement in interstate commerce of adulterated or misbranded food, drugs, devices, and cosmetic",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "the movement in interstate commerce of adulterated or misbranded food, drugs, devices, and cosmetics.\n21 U.S.C. 321-392\nThe cosmetics marketed in the United States, whether they are manufactured here or are imported from abroad, must comply with the labeling requirements of the Federal Food, Drug, and Cosmetic (FD&C) Act, the Fair Packaging and Labeling (FP&L) Act, and the regulations published by the Food and Drug Administration under the Authority of these two laws.\nThe FD&C Act was enacted b",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "y the Food and Drug Administration under the Authority of these two laws.\nThe FD&C Act was enacted by Congress to protect consumers from unsafe or deceptively labeled or packaged products by prohibiting the movement in interstate commerce of adulterated or misbranded food, drug devices and cosmetics.\nback to top\nFair Packaging and Labeling Act\nTo ensure that packages and their labels provide consumers with accurate information about the quantity of contents and facilitate value comparisons.\n15 U",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "mers with accurate information about the quantity of contents and facilitate value comparisons.\n15 U.S.C. 1451-1460\nThe FP&L Act was passed by Congress to ensure that packages and their labels provide consumers with accurate information about the quantity of contents and facilitate value comparisons.\nFederal Food, Drug, and Cosmetic Act\nThe FD&C Act prohibits the marketing of cosmetics that are adulterated or misbranded as well as their adulteration or misbranding while in interstate commerce.\nS",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ulterated or misbranded as well as their adulteration or misbranding while in interstate commerce.\nSec. 301, FD&C Act\nThe FD&C Act prohibits the marketing of cosmetics that are adulterated or misbranded as well as their adulteration or misbranding while in interstate commerce.\nA cosmetic is considered misbranded if.....\nSec. 602, FD&C Act\nSec. 602 of the FD&C Act defines the conditions which cause a cosmetic to be deemed misbranded.\nFactors Determining Whether Labeling Is Misleading\nSec. 201(n),",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "a cosmetic to be deemed misbranded.\nFactors Determining Whether Labeling Is Misleading\nSec. 201(n), FD&C Act\n21 CFR 1.21\nLabeling may be considered misleading not only because a label statement is deceptive but also because a material fact is not revealed on a label.\nA fact may be material in light of a statement made on a label or because certain consequences may result from the recommended use of a product.\nWhat is a cosmetic?\nA cosmetic is a product, except soap, intended to be applied to th",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "of a product.\nWhat is a cosmetic?\nA cosmetic is a product, except soap, intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance.\nSec. 201(i) FD&C Act\nAs defined in section 201(i) of the FD&C Act, a cosmetic is a product, except soap, intended to be applied to the human body for cleansing, beautifying, promoting attractiveness or altering the appearance.\nIn short, one may say that a cosmetic is a product intended to exert a physica",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ering the appearance.\nIn short, one may say that a cosmetic is a product intended to exert a physical, and not a physiological, effect on the human body.\nThe raw materials used as ingredients of cosmetic products are by law also cosmetics.\nIn section 701.20 of Title 21 of the Code of Federal Regulations [21 CFR 701.20], the Food and Drug Administration (FDA) defines the term \"soap\" as a product in which the non-volatile portion consists principally of an alkali salt of fatty acids, i.e., the tra",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "which the non-volatile portion consists principally of an alkali salt of fatty acids, i.e., the traditional composition of soap; the product is labeled as soap; and the label statements refer only to cleansing. If cosmetic claims, e.g., moisturizing, deodorizing, skin softening etc., are made on a label, the product is a cosmetic. Synthetic detergent bars are also considered cosmetics, although they may be labeled as \"soap.\"\nback to top\n\"Intended use\" within the meaning of the FD&C Act is deter",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "hey may be labeled as \"soap.\"\nback to top\n\"Intended use\" within the meaning of the FD&C Act is determined from its label or labeling.\nSenate Report No. 493\n73d Cong. 2d Sess. (1934)\nU.S. Courts of Appeals Decisions\nAccording to Senate Report No. 493 and court decisions, the term \"intended\" in the legal definition of the term \"cosmetic\" or in other definitions means, with respect to the use of a product, its directed or prescribed use as determined from the statements made on a product's label or",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "oduct, its directed or prescribed use as determined from the statements made on a product's label or labeling.\nThe courts, in deciding whether a product is a \"cosmetic\", a \"drug\", or both a \"drug\" and a \"cosmetic\", have relied principally on the consumer's perception of the meaning of a label statement and less so on the interpretation of the meaning of a label statement by the labeler or a regulatory agency.\nWhen is a cosmetic also a drug?\nA cosmetic is also a drug when it is intended to cleans",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "tory agency.\nWhen is a cosmetic also a drug?\nA cosmetic is also a drug when it is intended to cleanse, beautify or promote attractiveness as well as treat or prevent disease or otherwise affect the structure or any function of the human body.\nSec. 201(g) and (i), FD&C Act\nSec. 509, FD&C Act\nA cosmetic is legally also a drug if it is intended to exert a physical as well as a physiological effect because the FD&C Act defines in section 201(g) the term \"drug\" to mean, among other things, \"articles",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "cause the FD&C Act defines in section 201(g) the term \"drug\" to mean, among other things, \"articles intended for use in the ... cure, mitigation, treatment, or prevention of disease ... and ... articles ... intended to affect the structure or any function of the body ...\"\nSection 509 of the FD&C Act provides that the categories of \"drug\" and \"cosmetic\" are not mutually exclusive.\nWhat is a consumer commodity?\nA product customarily distributed for retail sale for use by consumers or for the perfo",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "r commodity?\nA product customarily distributed for retail sale for use by consumers or for the performance of services at home and usually consumed during such use.\nSec. 10(a), FP&L Act.\nA cosmetic is legally also a drug if it is intended to exert a physical as well as a physiological effect because the FD&C Act defines in section 201(g) the term \"drug\" to mean, among other things, \"articles intended for use in the ... cure, mitigation, treatment, or prevention of disease ... and ... articles ..",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ded for use in the ... cure, mitigation, treatment, or prevention of disease ... and ... articles ... intended to affect the structure or any function of the body ...\"\nSection 509 of the FD&C Act provides that the categories of \"drug\" and \"cosmetic\" are not mutually exclusive.\nPackage\nA container or wrapping, other than a shipping container or wrapping, in which a consumer commodity is delivered or displayed to retail purchasers.\nSec. 10(b), FP&L Act\n21 CFR 1.20\nThe term package is defined in th",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "r displayed to retail purchasers.\nSec. 10(b), FP&L Act\n21 CFR 1.20\nThe term package is defined in the Fair Packaging and Labeling Act [sec. 10(b)] and the Code of Federal Regulations [21 CFR 1.20].\nEssentially, the \"package\" is the outer container of a product as, for example, a box or folding carton. However, the \"package\" can also be the immediate container, e.g., bottle, jar or aerosol can that holds the product if the immediate container is not displayed in a box or folding carton.\nLabel\nA w",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "holds the product if the immediate container is not displayed in a box or folding carton.\nLabel\nA written, printed or graphic display of information...\nSec. 201(k), FD&C Act.\nSec. 10(c), FP&L Act\n21 CFR 1.3(b)\nThe term \"label\" is defined in the FD&C Act and the FP&L Act. The definitions differ in that under the FD&C Act definition a label is \"a display of written, printed or graphic matter upon the immediate container,\" and under the FP&L Act definition \"written, printed or graphic matter affix",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "he immediate container,\" and under the FP&L Act definition \"written, printed or graphic matter affixed to any consumer commodity or affixed to or appearing upon a package containing any consumer commodity.\"\nOne may say that the term \"label\" applies in the first instance to the information appearing directly on the immediate container and in the second instance to information attached to the immediate container and directly on or attached to the outer container if so packaged.\nThe FD&C Act, howev",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ate container and directly on or attached to the outer container if so packaged.\nThe FD&C Act, however, requires in sec 201(k) that any information required to appear on the label of the immediate container shall also appear on the outside container of the retail package or is legible through the outside container.\nLabeling\nAll labels and other written, printed or graphic material on or accompanying a product in interstate commerce or held for sale\nSec. 201(m), FD&C Act\n21 CFR 1.3(a)\nThe FD&C Ac",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ng a product in interstate commerce or held for sale\nSec. 201(m), FD&C Act\n21 CFR 1.3(a)\nThe FD&C Act defines in sec. 201(m) \"labeling\" to mean \"all labels and other written, printed or graphic matter on or accompanying such article.\"\nThis includes labels, inserts, risers, display packs, leaflets, promotional literature or any other written or printed information distributed with a product.\nPrincipal Display Panel\nThe part of a label that the consumer sees or examines when displayed for retail s",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "pal Display Panel\nThe part of a label that the consumer sees or examines when displayed for retail sale\nSec. 10(t), FP&L Act\n21 CFR 701.10\nA label may consist of more than one panel. It may consist of a front panel, side panels and a back panel. Back and side panels are generally called information panels.\nThe FP&L Act also defines for consumer commodities, or packages containing a consumer commodity, the term \"principal display panel,\" otherwise known for short as PDP.\nThe \"principal display pa",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ity, the term \"principal display panel,\" otherwise known for short as PDP.\nThe \"principal display panel\" is that part of a panel that is most likely to be shown or examined under customary conditions of display for retail sale. Usually, it is the front panel of the label of the outer package.\nback to top\nPlacement and Size of Principal Display Panel\nLocation\nSize\nMultiple PDPs\n\nExceptions\n\nDecorative containers\nCompacts or pencils\nContainers of 1/4 av. oz. or 1/8 fl. oz. capacity\nDisplay cards\n2",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ive containers\nCompacts or pencils\nContainers of 1/4 av. oz. or 1/8 fl. oz. capacity\nDisplay cards\n21 CFR 701.10 and 701.13(e)\nAs mentioned before, the PDP is that part of the label that is most likely to be shown or examined under customary conditions for retail sale.\nRegulations [21 CFR 701.10] published by the FDA require that the PDP be large enough to accommodate all required label information with clarity and conspicuousness.\nIf a package bears more than one PDP, the information required t",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "n with clarity and conspicuousness.\nIf a package bears more than one PDP, the information required to be placed on the PDP must be duplicated on all PDPs.\nFor the purpose of assuring uniform type size for declaring a product's net quantity of contents, the size of the surface area bearing the PDP, and not the size of the PDP itself, is the determining factor. The area of the PDP is for a:\nRectangular package: One entire side.\nCylindrical package: 40% of height x circumference.\nAny other shape of",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "lar package: One entire side.\nCylindrical package: 40% of height x circumference.\nAny other shape of container: 40% of total container surface, excluding top, bottom, neck, shoulder, flanges.\nThe PDP of a \"boudoir-type\" or decorative cosmetic container, e.g., cartridge, pill box, compact or special variety, and those containing 1/4 oz or less may be a tear-away tag or tape affixed to the container [21 CFR 701.13(e)(1)]. It may also be the display panel of a card to which the immediate container",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "[21 CFR 701.13(e)(1)]. It may also be the display panel of a card to which the immediate container is affixed [21 CFR 701.13(e)(2)].\nPlacement of Information on Labels\nOuter Container\n(Or Label of Single Container Product)\nPrincipal Display Panel:\nName of product\nIdentity\n§ 740.10 warning\nNet quantity of contents\nInformation Panels:\nDirections for safe use\nWarnings\nName and place of business\nIngredient declaration\nAny other required information\nThe information above must appear on the label of",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "edient declaration\nAny other required information\nThe information above must appear on the label of the outer container which usually is a box, folding carton, wrapper etc. holding the inner (immediate) container. The immediate container holding the cosmetic product also is the outer container if it is not displayed in a box, folding carton etc.\nPlease note that only the label of an outer container has a PDP.\nStatement of the brand name of the product is not a regulatory requirement under the FD",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "r has a PDP.\nStatement of the brand name of the product is not a regulatory requirement under the FD&C or FP&L Act.\nback to top\nPlacement of Information on Labels\nInner Container (If Packaged in an Outer Container)\nFront Panel\nInformation Panels\n\nDirections for safe use\n\nWarnings\nName of Product\nName and Place of Business\n\nNet Quantity of Contents\n\nAny Other Required Information\nThe information above must appear on the label of the inner (immediate) container holding the cosmetic product. The in",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ove must appear on the label of the inner (immediate) container holding the cosmetic product. The inner container is packaged and displayed in a non-transparent box, folding carton etc. If the outer container is removed and the product displayed for sale without it, the label of the immediate container becomes a label of an outer container.\nForm of Stating Required Information\nSection 602(c) of the FD&C deems a cosmetic misbranded if any word, statement, or other label or labeling information re",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "e FD&C deems a cosmetic misbranded if any word, statement, or other label or labeling information required by law or regulation is not placed on the label or labeling with such prominence and conspicuousness that it is likely to be read, or if it is not stated in such terms that it is likely to be understood by ordinary individuals.\nProminence and Conspicuousness\nPanel display at purchase\nPanel size\nStyle and size of letters\nBackground contrast\nObscuring designs, vignettes\n21 CFR 701.2\nRegulatio",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ze\nStyle and size of letters\nBackground contrast\nObscuring designs, vignettes\n21 CFR 701.2\nRegulations [21 CFR 701.2] published by the FDA offer detailed information on how to comply with the requirement for prominent and conspicuous placement of information on cosmetic labels or labeling.\nPanel display: The required information must be on a panel which is presented or displayed under customary conditions of purchase. This eliminates placement of required information on a bottom panel of a cosme",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "nditions of purchase. This eliminates placement of required information on a bottom panel of a cosmetic unless it is very small and customarily picked up by hand where inspected for possible purchase.\nPanel Size: The label must be large enough to provide sufficient space for prominent display of the required information.\nStyle and Size of Letters: The type must be of such size, and at least of the required minimum size, and of such style that the required label statements are easily readable.\nBa",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "required minimum size, and of such style that the required label statements are easily readable.\nBackground Contrast: The contrast must be sufficient to make the required label statements conspicuous and easily readable.\nObscuring Designs, Vignettes: The required statements must not be obscured by vignettes or other designs or by crowding with other printed or graphic matter.\nback to top\nLanguage\nEnglish language statements\nForeign language statements\n21 CFR 701.2(b)\nEnglish Language Statements",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "English language statements\nForeign language statements\n21 CFR 701.2(b)\nEnglish Language Statements: All label or labeling statements required by law or regulation must be in the English language. Products distributed solely in Puerto Rico or a Territory where the predominant language is one other than English, may state the required label information in the predominant language in place of English.\nForeign Language Statements: If the label contains any foreign language representation, all stat",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "sh.\nForeign Language Statements: If the label contains any foreign language representation, all statements required by regulation must also appear on the label in the foreign language. If labeling bears foreign language representations, the required statements must appear on the label or other labeling as required in English.\nback to top\nType Size\nIngredients: 1/16\", 1/32\" (Labeling surface, less than 12 sq. in.)\nNet Contents:\n1/16\" (PDP less than 5 sq. in.)\n1/8\" (PDP 5-25 sq. in.)\n3/16\" (PDP 25",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "than 12 sq. in.)\nNet Contents:\n1/16\" (PDP less than 5 sq. in.)\n1/8\" (PDP 5-25 sq. in.)\n3/16\" (PDP 25-100 sq. in.)\nWarning: 1/16\"\nAll Others: Reasonably related to panel size\n21 CFR 701.2(a) (b), 701.3(b),\n\t701.11(c), 701.13(i), 740.2(b)\nIngredient Declaration: Generally, in letters not less than 1/16\" in height [21 CFR 701.3(b)]. If surface area available to bear label (excludes surfaces with decorative relief, sculptured surfaces) is less than 12 square inches, letter height may be not less tha",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "rative relief, sculptured surfaces) is less than 12 square inches, letter height may be not less than 1/32\" [21 CFR 701.3(p)].\nNet Contents Declaration on PDP: Minimum letter height determined by the area of the PDP. In the case of \"boudoir-type\" containers, including decorative cosmetic containers of the cartridge, pill box, compact or pencil type, and cosmetics of 1/4 oz. or less capacity, the type size is determined by the total dimensions of the container. If the container is mounted on a di",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ype size is determined by the total dimensions of the container. If the container is mounted on a display card, the display panel determines the letter height [21 CFR 701.13(e) and (i)].\nWarning Statements: Type size no less than 1/16\" unless smaller size established by regulation [21 CFR 740.2].\nLetter Height: The lower case letter \"o\" or equivalent when upper and lower case letters are used [21 CFR 701.13(h)].\nback to top\nIdentity Labeling\nCommon or usual name\nDescriptive name\nFanciful name\nIl",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "CFR 701.13(h)].\nback to top\nIdentity Labeling\nCommon or usual name\nDescriptive name\nFanciful name\nIllustration\nProminence\nPlacement\nSec. 10(t), FP&L Act\n21 CFR 701.11\nSec. 4 of the FP&L Act [21 U.S.C. 14554] requires that a consumer commodity bear a statement of identity. Regulations [21 CFR 701.11] published by the FDA require that the identity statement appear on the PDP.\nThe identity of the commodity may be expressed in terms of the common or usual name of the cosmetic, a descriptive name, or",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "modity may be expressed in terms of the common or usual name of the cosmetic, a descriptive name, or when the nature of the cosmetic is obvious, a fanciful name. It may also be expressed in form of an illustration.\nThe identity statement must be in bold type and in a size reasonably related to the most prominent printed matter, which is usually the name of the cosmetic. It must be in lines generally parallel to the base on which the product rests when displayed at retail.\nback to top\nName and Pl",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ly parallel to the base on which the product rests when displayed at retail.\nback to top\nName and Place of Business\nCorporate name\nManufactured for...\nDistributed by...\nAddress\nPrincipal place of business\n21 CFR 701.12\nThe name and business address appearing on the label may be those of the manufacturer, packer or distributor.\nIf the name and address is not that of the manufacturer, the name must be preceded by phrases such as \"Manufactured for ...\", \"Distributed by ...\", or other appropriate wo",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "be preceded by phrases such as \"Manufactured for ...\", \"Distributed by ...\", or other appropriate wording.\nThe name of the firm must be the corporate name, and the address may be that of the principal place of business. Stating also the name of a corporation's particular division is optional.\nThe business address must include the street address, name of the city and state, and the ZIP code. The street address may be omitted if the firm is listed in a current city or telephone directory.\nThe Tari",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "reet address may be omitted if the firm is listed in a current city or telephone directory.\nThe Tariff Act of 1930 requires that imported products state on the label the English Name of the country of origin.\nback to top\nQuantity of Contents\nLocation on Package          § 701.13 (e) and (f)(2)\nOn PDP\nOn information panel\nProminence                          § 701.13 (f) and (f)(1)\nPlacement\nSpacing\nConspicuousness                 § 701.13 (h) and (i)\nContract\nLetter height\nAspect ration\nType size",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "Conspicuousness                 § 701.13 (h) and (i)\nContract\nLetter height\nAspect ration\nType size\nLocation: If the cosmetic is sold at retail in an outer container, the net contents statement must appear (1) within the bottom 30% of the PDP of the outer container, generally parallel in line to the base on which the package rests, and (2) on an information panel of the inner container. The bottom location requirement is waived for PDPs of 5 square inches or less.\nThe PDP may be a tear-away tag",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "m location requirement is waived for PDPs of 5 square inches or less.\nThe PDP may be a tear-away tag or tape affixed to a decorative container or to a container of less than 1/4 oz., or it may be the panel of a display card to which the container is affixed.\nProminence: The declaration must be a distinct item, separated from other printed matter by a space equal to at least the height of the lettering used in the declaration and twice the width of the letter \"N\".\nConspicuousness: The print must",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ring used in the declaration and twice the width of the letter \"N\".\nConspicuousness: The print must be easily legible bold face type in distinct contract to background and other matter on the package. The letter height must be at least that of the lower case letter \"o\", and the aspect ratio of height to width must not exceed 3:1.\nThe type size, as determined by the area of the PDP must be at least 1/16 in. if PDP area 5 sq. in., 1/8 in. if PDP area > 5 to 25 sq. In., 3/16 in. if PDP area > 25 to",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "1/16 in. if PDP area 5 sq. in., 1/8 in. if PDP area > 5 to 25 sq. In., 3/16 in. if PDP area > 25 to 100 sq. in., and 1/4 in. if PDP area > 100 sq. in.\nback to top\nExemptions from Net Contents Declaration\nCosmetics of less than 1/4 av. oz. or 1/8 fl. oz.\nOn display card\nIn outer container\n21 CFR 1.24\nCosmetics in packages containing less than 1/4 av. oz. or 1/8 fl. oz. are exempt from the net quantity of contents declaration if affixed to a properly labeled display card or sold at retail in a pr",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "tity of contents declaration if affixed to a properly labeled display card or sold at retail in a properly labeled outer container [21 CFR 1.24].\nWhen a cosmetic is required to bear net quantity of contents declarations on the inner and outer container, the declaration on the outer container must appear on the PDP; on the inner container, it may appear on an information panel other than the panel bearing the name of the product, i.e., the front panel.\nQuantity of Contents\nAccuracy§ 701.13 (g) an",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "bearing the name of the product, i.e., the front panel.\nQuantity of Contents\nAccuracy§ 701.13 (g) and (s)\nDeclaration by Product Consistency§ 701.13 (a)\nSystems of Measures and Weights§ 701.13(b) and (r)\nUnit Terms and Abbreviations§ 701.13 (j) (2) & (n)\nDual Form of Declaration701.13 (j) (1)\nDeclaration of Fraction§ 701.13 (d)\nExamples of Net Quantity Statements\n\"Net Wt. 6 Oz.\" or \"6 oz. Net Wt.\"\n\"Net Contents 6 fl. Oz.\" or \"Net 6 Fl. Oz.\" or \"6 Fl. Oz.\"\n\"Net Wt. 1/4 Oz.\" or \"Net Wt. 0.25 Oz.\"",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "\"Net Contents 6 fl. Oz.\" or \"Net 6 Fl. Oz.\" or \"6 Fl. Oz.\"\n\"Net Wt. 1/4 Oz.\" or \"Net Wt. 0.25 Oz.\"\n\"Net 1/8 Fl. Oz.\" or \"0.12 FL. Oz.\"\n\"Net Wt. 24 Oz. (1-1/2 Lb.)\" or \"Net Wt. 24 Oz. (1.5 Lb.)\"\n\"Net 56 Fl. Oz. (1 Qt. 1 Pt. 8 Fl. Oz.)\" or \"... (1 Qt. 1-1/2 Pt.)\" or \"... (1 Qt. 1.5 Pt.)\"\nAccuracy: The net quantity of contents (net contents) declaration must accurately reveal the quantity of cosmetic in the container in terms of weight, volume, measure, numerical count, or combinations of count an",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "c in the container in terms of weight, volume, measure, numerical count, or combinations of count and weight, volume or measure. Reasonable variations due to loss or gain of moisture, or deviations in good manufacturing practice, are acceptable. In case of an aerosol product, the net contents statement must express the net quantity of contents expelled.\nProduct Consistency: Unless there is a firmly established, general consumer usage or trade custom to the contrary, the statement must be in term",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "y established, general consumer usage or trade custom to the contrary, the statement must be in terms of fluid measure if the cosmetic is liquid and in terms of weight if the cosmetic is solid, semi-solid, viscous, or a mixture of solid and liquid. Fluid measures must express the volume at 68°F (20°C). The customary net contents declaration for aerosol products is in terms of weight.\nSystems: Weight is expressed in terms of avoirdupois pound and ounce. Fluid measures are expressed in terms of th",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ht is expressed in terms of avoirdupois pound and ounce. Fluid measures are expressed in terms of the U.S. gallon, quart, pint and fluid ounce. Net contents may additionally be stated also in the metric system.\nUnit Terms: The term \"net weight\" or \"net wt.\" must be used in conjunction with a weight statement, and the term \"net contents,\" \"net\" or nothing must be used in connection with a liquid statement.\nAdditional abbreviations are for: weight - wt., fluid - fl., gallon - gal., quart - qt., pi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "atement.\nAdditional abbreviations are for: weight - wt., fluid - fl., gallon - gal., quart - qt., pint - pt., ounce - oz., pound - lb.\nIn case of a weight ounce statement, the term \"oz.\" is sufficient. A fluid ounce is expressed as \"fl. oz.\"\nExamples:\nNet wt. 4 av. oz.\nNet contents 4 fl. oz.\n4 av. oz. net wt.\n4 oz. net wt.\nNet 4 fl. oz.\n4 fl. oz.\nDual Declaration: If the net weight exceeds one pound but is less than 4 pounds, the net contents statement must reveal the total number of ounces foll",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "nd but is less than 4 pounds, the net contents statement must reveal the total number of ounces followed, in parenthesis, by the number of pounds and ounces or by the number of pounds and fraction thereof. Fluid measures exceeding one pint, but being less than one gallon, must be expressed in terms of the total number of fluid ounces followed, in parenthesis, by the number of quarts, pints and ounces or by the fractions of the quart or pint.\nExamples:\nNet Wt. 24 oz. (1 lb. 8 oz.)\nNet Wt. 24 oz.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ces or by the fractions of the quart or pint.\nExamples:\nNet Wt. 24 oz. (1 lb. 8 oz.)\nNet Wt. 24 oz. (1 - 1/2 lb.)\nNet Wt. 24 oz. (1.5 lb.)\n56 fl. oz. (1 qt. 1 pt. 8 fl. oz.)\n56 fl. oz. (1 qt. 1-1/2 pt.)\n56 fl. oz. (1 qt. 1.5 pt.)\n56 fl. oz. (1-3/4 qt.)\nDeclaration of fractions: Fractions may be expressed in terms of common fractions ranging from 1/2 to 1/32 or as decimal fractions of no more than two significant numbers.\nQuantity of Contents\nOn Principal Display Panel\n\"Economy Size\" or \"Budget S",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "two significant numbers.\nQuantity of Contents\nOn Principal Display Panel\n\"Economy Size\" or \"Budget Size\"\n\"Giant Pint\" or \"Full Quart\"\n\"Net 6 Fl. Oz.\" and \"Six Applications\"\n\"Net 6 Fl. Oz.\" and \"6 Bottles of 1 Fl. Oz. Each\"\nOn Information Panel\nAny non-deceptive supplemental statement\n21 CFR 1.31 and 701.13 (g)\nEconomy Size: Representations of this type are permitted if the firm offers at least one other packaged size of the same brand, only one is labeled \"economy size,\" and the unit price of th",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "other packaged size of the same brand, only one is labeled \"economy size,\" and the unit price of the package so labeled is substantially (at least 5%) reduced compared to that of the other package.\nGiant Pint, Full Quart: Supplemental statements describing the net quantity of contents are permitted on panels other than the PDP. However, these statements must not be deceptive or exaggerate the amount present in the package.\nSix Applications: Declarations by numerical count or linear or area meas",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "unt present in the package.\nSix Applications: Declarations by numerical count or linear or area measure may be augmented by statements of weight or size of individual units or total weight or measure to give accurate information. These are not regarded as separate statements and must appear on the PDP.\nCosmetic Kit: If a package contains the integral components making up a kit and delivers the components in the manner of an application as, for example, a home permanent wave kit, the net contents",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ponents in the manner of an application as, for example, a home permanent wave kit, the net contents declaration may be stated in terms of the number of applications as per given instructions [21 CFR 701.13 (g) (2)].\nCosmetic Warning Statements\nGeneral Requirement:\nProminence\nPlacement\nSpacing\nConspicuousness\nContrast\nType size\n21 CFR 740 (1) and (2)\nRegulations require that \"[the label of a cosmetic product shall bear a warning statement whenever necessary or appropriate to prevent a health haz",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "tic product shall bear a warning statement whenever necessary or appropriate to prevent a health hazard that may be associated with the product\" [21 CFR 740(1)]. A cosmetic not bearing a necessary warning statement may be considered misbranded under sec. 602(a) of the FD&C Act because it fails to reveal a fact \"material ... with respect to consequences which may result from the use of the article\" [sec 201(n), FD&C Act].\nProminence: A warning statement must appear on the label prominently and co",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "[sec 201(n), FD&C Act].\nProminence: A warning statement must appear on the label prominently and conspicuously as compared to other words, statements or designs so that it is likely to be read by ordinary consumers at the time of purchase and use.\nConspicuousness: The lettering must be in bold type on contrasting background and may in no case be less than 1/16 inch in height.\nback to top\nCosmetics With Unsubstantiated Safety\nWarning--The safety of this product has not been determined.\n21 CFR 74",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "s With Unsubstantiated Safety\nWarning--The safety of this product has not been determined.\n21 CFR 740.10\nA cosmetic is considered misbranded if its safety has not adequately been substantiated, and it does not bear the following conspicuous statement on the PDP:\nWarning - The safety of this product has not been determined.\nThe safety of a cosmetic may be considered adequately substantiated if experts qualified by scientific training and experience can reasonably conclude from the available toxic",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "rts qualified by scientific training and experience can reasonably conclude from the available toxicological and other test data, chemical composition, and other pertinent information that the product is not injurious to consumers under conditions of customary use and reasonably foreseeable conditions of misuse.\nThe safety of a cosmetic can adequately be substantiated by:\na. Reliance on available toxicological test data on its ingredients and on similar products, and\nb. Performance of additional",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "toxicological test data on its ingredients and on similar products, and\nb. Performance of additional toxicological and other testing appropriate in the light of the existing data.\nEven if the safety of each ingredient has been substantiated, there usually still is at least some toxicological testing needed with the formulated product to assure adequate safety substantiation.\nCosmetic Aerosols\nWarning--Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not store at",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ing--Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not store at temperature above 120°F. Keep out of reach of children.\n21 CFR 740.11 (a)\nThe label of a cosmetic packaged in a self-pressurized container and intended to be expelled from the package under pressure must bear the warning stated below.\nThe words \"Avoid spraying in eyes\" may be omitted if the product is not expelled as a spray. Example: Aerosol shave cream.\nThe word \"puncture\" may be replaced by th",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "is not expelled as a spray. Example: Aerosol shave cream.\nThe word \"puncture\" may be replaced by the word \"break\" if the product is packaged in a glass container.\nIf the product is intended for use by children, the phrase \"except under adult supervision\" may be added at the end of the last sentence of the warning.\nCosmetic Aerosols\nWarning--Use only as directed. Intentional misues by deliberately concentrating and inhaling the contents can be harmful or fatal.\n21 CFR 740.11 (b)\nIf the propellan",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "concentrating and inhaling the contents can be harmful or fatal.\n21 CFR 740.11 (b)\nIf the propellant of a cosmetic packaged in a self-pressurized container consists in whole or in part of a halocarbon or hydrocarbon, the label must bear a second warning as stated below.\nThis second warning is not required for the following products:\n1.Aerosol foam or cream products containing less than 10% propellant.\n2.Products which do not expel the propellant at the time of use. Examples: products with built",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "lant.\n2.Products which do not expel the propellant at the time of use. Examples: products with built-in piston barrier or propellant bag.\n3.Metered spray products of less than 2 oz. net contents.\n4.Aerosol products of less than 1/2 oz. net contents.\nFeminine Deodorant Sprays\nCaution--For external use only. Spray at least 8 inches from skin. Do not apply to broken, irritated, or itching skin. Persistent, unusual odor or discharge may indicate conditions for which a physician should be consulted.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "stent, unusual odor or discharge may indicate conditions for which a physician should be consulted. Discontinue use immediately if rash, irritation, or discomfort develops.\n21 CFR 740.12\nA feminine deodorant spray which, for the purpose of this regulation, is defined as \"any spray deodorant product whose labeling represents or suggests that the product is for use in the female genital area or for use all over the body\" must bear the caution stated below.\nIf the expelled product does not contain",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "use all over the body\" must bear the caution stated below.\nIf the expelled product does not contain a liquefied halocarbon or hydrocarbon propellant, the sentence \"Spray at least 8 inches from skin\" may be omitted.\nThe regulation further states that the use of the word \"hygiene\" or \"hygienic\" or similar words renders any such product misbranded.\nFoaming Detergent Bath Products\nCaution--Use only as directed. Excessive use of prolonged exposure may cause irritation to skin and urinary tract. Disco",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "directed. Excessive use of prolonged exposure may cause irritation to skin and urinary tract. Discontinue use if rash, redness or itching occurs. Consult your physician if irritation persists. Keep out of reach of children.\n21 CFR 740.17\nA foaming detergent bath product--also known as bubble bath product--is, for the purpose of this regulation, defined as \"any product intended to be added to a bath for the purpose of producing foam that contains a surface-active agent serving as a detergent or",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "th for the purpose of producing foam that contains a surface-active agent serving as a detergent or foaming ingredient.\"\nThe caution stated above is required on the label of any foaming detergent bath product which is not clearly labeled as intended for use exclusively by adults. The following are two examples of label statements identifying a product as intended for use exclusively by adults: \"Keep out of reach of children\" and \"For adult use only.\"\nIf the bubble bath product is intended for us",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ep out of reach of children\" and \"For adult use only.\"\nIf the bubble bath product is intended for use by children, the phrase \"Keep out of reach of children\" may be expanded to further read \"except under adult supervision.\"\nThe regulation further requires that the label \"Shall bear adequate directions for safe use\" of the product.\nCosmetic Ingredient Labeling\nDeclaration of ingredients except flavor, fragrance, and trade secret ingredients in descending order of predominance\n21 CFR 701.3\nCosmeti",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "or, fragrance, and trade secret ingredients in descending order of predominance\n21 CFR 701.3\nCosmetic ingredient labeling became an issue in the early 1970s. Guidelines for ingredient labeling were published in mid-1972. Regulations were proposed in early 1973. After publication of two final regulations, stays of final regulations, terminations of stays, and lengthy court proceedings challenging the legality of the published regulations, the requirement for cosmetic ingredient labeling became fu",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "he legality of the published regulations, the requirement for cosmetic ingredient labeling became fully effective in early 1977.\nThe regulations requiring the declaration of cosmetic ingredients were published under the authority of the FP&L Act [secs. 5(c) and 6(a); 15 U.S.C. 1454 and 1455] and FD&C Act [sec. 701(e); 21 U.S.C. 371(e)].\nSince the FP&L Act applies only to consumer commodities and their packages as defined in the Act, cosmetic ingredient declarations are required only on the label",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "heir packages as defined in the Act, cosmetic ingredient declarations are required only on the label of the outer container of cosmetics customarily sold at retail or used in the performance of services conducted within the households. It does not apply, for example, to products used at professional establishments or samples distributed free of charge, unless such products are customarily also sold at retail, even if they were labeled \"For professional use only.\"\nThe ingredients must be declared",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "d at retail, even if they were labeled \"For professional use only.\"\nThe ingredients must be declared in descending order of predominance. Exceptions to this requirement are discussed later.\nback to top\nProminence of Ingredient Declaration\nProminent and conspicuous to render it easy to be read and understood by ordinary individuals under normal conditions of purchase\nLetter Height\n1/16 inch\nException:\n\t\t\tIf total available labeling surface area is less than 12 sq. in.\n1/32 inch\nInformation panel",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "on:\n\t\t\tIf total available labeling surface area is less than 12 sq. in.\n1/32 inch\nInformation panel\n\nFirmly affixed tag, tape, or card\n\n21 CFR 701.3(b) and (p)\nThe ingredient declaration may appear on any information panel of the package which is the outer container in form of a folding carton, box, wrapper etc. if the immediate container is so packaged, or which is the jar, bottle, box etc. if the immediate container is not packaged in an outer container. It may also appear on a tag, tape or ca",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "e immediate container is not packaged in an outer container. It may also appear on a tag, tape or card firmly affixed to a decorative or small size container.\nProminence: The declaration must appear with prominence and conspicuousness so that it is likely to be read and understood (read with ease) by ordinary individuals under normal conditions of purchase. The letters must not be obscured by design, vignettes, background or crowding.\nType Size: Not less than 1/16 inch in height. It may be not l",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "gn, vignettes, background or crowding.\nType Size: Not less than 1/16 inch in height. It may be not less than 1/32 inch in height if the total surface area available to bear labeling (which excludes bottom, shoulder, neck, flange, decorative or sculptured surfaces) is less than 12 square inches.\nThe type size consisting of upper and lower case letters is determined by the height of the lower case letter \"o\".\nThe ingredient declaration may appear on any information panel of the package which is th",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "etter \"o\".\nThe ingredient declaration may appear on any information panel of the package which is the outer container in form of a folding carton, box, wrapper etc. if the immediate container is so packaged, or which is the jar, bottle, box etc. if the immediate container is not packaged in an outer container. It may also appear on a tag, tape or card firmly affixed to a decorative or small size container.\nProminence: The declaration must appear with prominence and conspicuousness so that it is",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ontainer.\nProminence: The declaration must appear with prominence and conspicuousness so that it is likely to be read and understood (read with ease) by ordinary individuals under normal conditions of purchase. The letters must not be obscured by design, vignettes, background or crowding.\nType Size: Not less than 1/16 inch in height. It may be not less than 1/32 inch in height if the total surface area available to bear labeling (which excludes bottom, shoulder, neck, flange, decorative or sculp",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "area available to bear labeling (which excludes bottom, shoulder, neck, flange, decorative or sculptured surfaces) is less than 12 square inches.\nThe type size consisting of upper and lower case letters is determined by the height of the lower case letter \"o\".\nback to top\nIdentification of Ingredients by Name\nThe name established by the commissioner as specified in § 701.30.\nThe name adopted for the ingredient as listed in:\n(a) CTFA Cosmetic Ingredient Dictionary\n\t(b) United States Pharmacopeia",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "the ingredient as listed in:\n(a) CTFA Cosmetic Ingredient Dictionary\n\t(b) United States Pharmacopeia\n\t(c) National Formulary\n\t(d) Food Chemical Codex\n\t(e) USAN and the USP Dictionary of Drug Names\nThe name generally recognized by consumers\nThe chemical or technical name or description\n21 CFR 701.3(c)\nSection 701.3(c) requires that an ingredient be identified by the name established by the Commissioner for the purpose of cosmetic ingredient labeling or, in the absence of a name established by the",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "oner for the purpose of cosmetic ingredient labeling or, in the absence of a name established by the Commissioner, the name adopted for that ingredient in the editions and supplements of the compendia listed below.\nThe Commissioner may establish a name as petitioned or propose such a name on his own initiative. See section 701.3(e). The names specified by the Commissioner are listed in section 701.30.\nThe currently recognized edition of the CTFA (Cosmetic, Toiletry and Fragrance Association, Inc",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": ".30.\nThe currently recognized edition of the CTFA (Cosmetic, Toiletry and Fragrance Association, Inc.) Cosmetic Ingredient Dictionary is the second edition published in 1977. This edition is recognized only in part, i.e., not all names listed in the second edition have been adopted.\nThe third edition of the CTFA Cosmetic Ingredient Dictionary published in 1982 and the Supplement published in 1985 have not yet been recognized. However, FDA has informed the CTFA that the agency will not take regul",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "have not yet been recognized. However, FDA has informed the CTFA that the agency will not take regulatory action against products labeled in accordance with these editions while their review is in progress.\nThe compendia are listed in the descending order by which they must be utilized for identification of an ingredient name. If none lists a name for an ingredient, the name generally recognized by consumers, or the chemical or technical name or description, must be used.\nback to top\nOrder of In",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "y consumers, or the chemical or technical name or description, must be used.\nback to top\nOrder of Ingredient Declaration\nDescending order of predominance\nExceptions...\nActive drug ingredients\nIngredients with less than 1% concentration\nColor additives\n\"And other ingredients\"\n21 CFR 701.3(a), (d), (f) (2), (f) (3)\nThe ingredients must be listed in descending order of predominance. However, there are a few exceptions to this requirement.\n1. If the cosmetic is also a drug, section 502(c) of the FD&",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "e a few exceptions to this requirement.\n1. If the cosmetic is also a drug, section 502(c) of the FD&C Act requires that the active drug ingredient(s) be declared before declaration of the cosmetic ingredients. A declaration, thus, would read as follows: \"Active Ingredient: ... (Name of drug ingredient). Other (or Cosmetic) Ingredients: ... (Names of cosmetic ingredients in descending order).\" [§ 701.3(d)]\n2. Ingredients present at a concentration not exceeding 1% may be listed in any order after",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "01.3(d)]\n2. Ingredients present at a concentration not exceeding 1% may be listed in any order after the listing of the ingredients present at more than 1% in descending order of predominance. [§ 701.3(f)(2)]\n3. Color additives of any concentration may be listed in any order after the listing of the ingredients which are not color additives [§ 701.3(f)(3)].\n4. The name of an ingredient accepted by FDA in accordance with the procedure established in § 720.8 as a trade secret need not be disclosed",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "FDA in accordance with the procedure established in § 720.8 as a trade secret need not be disclosed on the label. In lieu of declaring the name of that ingredient, the phrase \"and other ingredients\" may be used at the end of the ingredient declaration [§ 701.3(a)].\nback to top\nOrder of Predominance\nLipstick\n\nIncorrect Label Copy:\nCaster Oil (58)\nBeeswax (6.5)\nCandelilla Wax (6.5)\nCarnauba Wax (3)\nLanolin (8)\nOzokerite (2)\nPropylene Glycol (and) BHA\n(And) Propyl Gallate\n(And) Citric Acid (1.3)\nT",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "Lanolin (8)\nOzokerite (2)\nPropylene Glycol (and) BHA\n(And) Propyl Gallate\n(And) Citric Acid (1.3)\nTitanium Dioxide (2)\nD&C Red No. 21 (2)\nD&C Red No. 6 Barium Lake (4)\nD&C Yellow No. 5 Aluminum Lake (5)\nFragrance (0.5)\nCorrect Label Copy:\nCastor Oil\nLanolin\nBeeswax\nCandelilla Wax\nCarnauba Wax\nOzokerite\nPropylene Glycol\nBHA\nPropyl Gallate\nCitric Acid\nFragrance\nTitanium Dioxide\nD&C Red No. 21\nD&C Red No. 6 Barium Lake\nD&C Yellow No. 5 Aluminum Lake\nIn this example, the correct ingredient declarat",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ed No. 6 Barium Lake\nD&C Yellow No. 5 Aluminum Lake\nIn this example, the correct ingredient declaration lists castor oil (58), lanolin (8), candelilla wax (6.5), carnauba wax (3), and ozokerite (2) in descending order of predominance. The concentrations (which need not be declared by regulation) are provided in parentheses.\nThe compounds of the proprietary antioxidant mixture dissolved in propylene glycol must be integrated into the product formulation and declared individually in order of decre",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "e glycol must be integrated into the product formulation and declared individually in order of decreasing predominance without the term \"(and).\"\nThe color additives titanium dioxide (2) etc. may be declared in any order after the other ingredients.\nDeclaration of Color Additives and Ingredients Present at One Percent or Less\nPressed Powder\nLabel Declaration:\nTalc (75)\nKaolin (7.5)\nZinc Stearate (5)\nTitanium Dioxide (5)\nMineral Oil (3)\nIron Oxides (2.5)\nIsopropyl Myristate (0.9)\nLanolin Oil (0.5)",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": ")\nTitanium Dioxide (5)\nMineral Oil (3)\nIron Oxides (2.5)\nIsopropyl Myristate (0.9)\nLanolin Oil (0.5)\nLanolin (0.2)\nFragrance (0.1)\nUltramarine Blue (0.05)\nAlternate Declaration:\nTalc\nKaolin\nZinc Stearate\nMineral Oil\nLanolin\nIsopropyl Myristate\nFragrance\nLanolin Oil\nTitanium Dioxide\nUltramarine Blue\nIron Oxides\nThe hypothetical pressed powder formulation portrayed in this example illustrates the two options for the listing of ingredients.\nOn the left side, the ingredients are listed in descending",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "o options for the listing of ingredients.\nOn the left side, the ingredients are listed in descending order of predominance according to § 701.3(2).\nOn the right side, the ingredients are listed according to § 701.3(f)(1), (2), and (3), i.e., ingredients other than colors present at a concentration exceeding 1% in descending order or predominance, followed by ingredients other than colors present at 1% or less in any order, followed by colors present at any concentration listed in any order.\nDecl",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "t 1% or less in any order, followed by colors present at any concentration listed in any order.\nDeclaration of Fragrance and Flavor Ingredients\nFragrance\nFlavor\nFragrance and flavor\n21 CFR 701.3(a)\nFragrance and flavor compounds may be declared in descending order of predominance as \"fragrance\" and \"flavor.\" If a fragrance compound also serves as a flavor, it must be declared as \"flavor and fragrance.\"\nThe components (ingredient) of a fragrance or flavor may also be declared individually by thei",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "nce.\"\nThe components (ingredient) of a fragrance or flavor may also be declared individually by their appropriate label names.\nThe ingredient or mixture of ingredients acting as a masking agent, i.e., covering the undesirable off-odor of a product without adding a discernable odor to it, may be declared by their individual name(s) or as \"fragrance\" (in lieu of a better designation). A masking agent present in a product at an insignificant level may be considered an incidental ingredient under §",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "t present in a product at an insignificant level may be considered an incidental ingredient under § 701.3(1)(2)(iii) in which case it need not be declared on the label.\nback to top\nDeclaration of Trade Secret Ingredients\nBy the Phrase \"And Other Ingredients\"\nIf accepted by FDA as exempt from public disclosure pursuant to the procedure of § 720.8.\n21 CFR 701.3(a)\nThe FP&L Act states in section 5(c)(3)(B) [15 U.S.C. 1454(c)(3)(B)] that \"nothing ... shall be deemed to require that any trade secret",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "(3)(B) [15 U.S.C. 1454(c)(3)(B)] that \"nothing ... shall be deemed to require that any trade secret be divulged.\" Accordingly, the cosmetic ingredient labeling regulation does not require the declaration of the identity of an ingredient FDA has accepted as exempt from public disclosure. In lieu of the declaration of the name of a confidential ingredient, the phrase \" and other ingredients\" may be used at the end of the ingredient declaration.\nThe policy the agency is following for processing req",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "used at the end of the ingredient declaration.\nThe policy the agency is following for processing requests for confidentiality of cosmetic ingredient identities has been codified under § 720.8.\nback to top\nWhat is a trade secret?\nA trade secret may consist of any formula, pattern, device or compilation of information which is used in one's business and which gives one an opportunity to obtain an advantage over competitors who do not know or use it.\n21 CFR 20.61\nThe question \"what is a trade secre",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "vantage over competitors who do not know or use it.\n21 CFR 20.61\nThe question \"what is a trade secret\" may be answered by restating the definition of the term \"trade secret\" as provided in § 20.61(a) of regulations published in 1974 for enforcement of the law commonly known as the \"Freedom of Information Act\" (the public information section of the Administrative Procedures Act; 5 U.S.C. 552).\nProcedure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nSubmission of inform",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "edure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nSubmission of information\nCosmetic formulation or raw material composition statement (Form 2512 OR 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of prior non-disclosure (§ 20.81)\n21 CFR 720.8\nThe first step in processing a request for trade secrecy, i.e., a request for exemption from label declaration, of the identity of a cosmetic ingredient is the submission to FDA of the following",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "abel declaration, of the identity of a cosmetic ingredient is the submission to FDA of the following information:\n(a) A semi-quantitative cosmetic formulation statement of the product in question on forms FD-2512 and 2512a.\n(b) A full statement of the factual and legal grounds for the request, including all data and other information on which the petitioner relies (as well as any information known to the petitioner that is unfavorable to petitioner's position).\nThe statement of factual grounds s",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "to the petitioner that is unfavorable to petitioner's position).\nThe statement of factual grounds should include scientific or technical data, reports, tests, and other relevant information that address the factors FDA considers in determining whether the identity of an ingredient qualifies as a trade secret. (The factors FDA considers are stated elsewhere.)\n(c) A statement that the identity of the ingredient in question has not previously been disclosed to anyone without appropriate safeguards",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "he ingredient in question has not previously been disclosed to anyone without appropriate safeguards for secrecy as further explained in § 20.81.\nback to top\nProcedure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nSubmission of Information\nCosmetic formulation or raw material composition statement (Form 2512 or 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of prior non-disclosure (§ 20.81).\nReview of data for adequacy\n21 CFR 720.8\nFDA",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "de secrecy\nStatement of prior non-disclosure (§ 20.81).\nReview of data for adequacy\n21 CFR 720.8\nFDA reviews the submitted information to determine whether the data are sufficient to permit a review of the merits of the request.\nA request that contains insufficient data to conduct a confidentiality review on the merits is returned and petitioner is advised about the additional information that is necessary to enable the agency to proceed with the review of the request.\nProcedure for Requesting E",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "necessary to enable the agency to proceed with the review of the request.\nProcedure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nSubmission of information\nCosmetic formulation of raw material composition statement (Form 2512 or 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of prior non-disclosure (§ 20.81)\nReview of data for adequacy\nTentative determination of trade secrecy\n21 CFR 720.8\nWhen the submitted information is sufficient to",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "entative determination of trade secrecy\n21 CFR 720.8\nWhen the submitted information is sufficient to permit a review of the merits of a request, FDA proceeds with the review.\nWhen the agency concurs with petitioner and decides that the ingredient identity is a trade secret, the request for exemption from label disclosure is granted. If FDA does not concur with petitioner, the agency tentatively denies the request. The person requesting trade secrecy is informed in writing of the agency's determi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "nies the request. The person requesting trade secrecy is informed in writing of the agency's determination. In case of a tentative denial, FDA informs petitioner of the grounds on which it relied in making this tentative determination.\nFactors Considered in Determining Trade Secret Status\n1. Is the information publicly known?\n(a) Prior public disclosure by petitioner\n(b) Public disclosure in the literature\n(c) Measures taken to guard secrecy\nWhen FDA reviews the merits of a confidentiality reque",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "iterature\n(c) Measures taken to guard secrecy\nWhen FDA reviews the merits of a confidentiality request and determines whether the identity of an ingredient qualifies as a trade secret, it considers the following three principal factors by seeking answers to the following three questions:\n1. Is the ingredient's identity and intended use publicly known?\n2. Does the intended use of the respective ingredient have value?\n3. Can the identity of the ingredient readily be acquired by legal means and its",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "redient have value?\n3. Can the identity of the ingredient readily be acquired by legal means and its intended use duplicated?\nThese questions are based on the factors considered in Comment B to section 757 of the Restatement of Torts in determining whether given information is a trade secret.\nSince the same factors are also being considered by FDA in determining whether the identity of an ingredient qualifies as a trade secret, a person requesting trade secrecy must address them factually and co",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "nt qualifies as a trade secret, a person requesting trade secrecy must address them factually and convincingly in the statement of grounds.\nAbsence of public knowledge of an ingredient's identity under conditions of intended use may be demonstrated by documenting the extent to which the information is known by employees or others in petitioner's business, the extent the information is publicly disclosed in pertinent literature, and the extent of measures taken by petitioner to guard the secrecy",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "closed in pertinent literature, and the extent of measures taken by petitioner to guard the secrecy of the information.\nFactors Considered in Determining Trade Secret Status\n2. Does the information have value?\n(a) Importance to the product\n(b) Product profitability\n(c) Future market performance of product\n(d) Effort and financial resources invested\nThe value of knowing the identity and intended use of the ingredient in question may be determined in terms of the importance of the ingredient to th",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "e of the ingredient in question may be determined in terms of the importance of the ingredient to the product formulation. It must be assumed that, to be of value, the ingredient significantly contributes to the claimed performance or other pertinent characteristics of the cosmetic and that a cosmetic not containing the claimed trade secret ingredient, or containing conventional substitutes in place of the respective ingredient, could not be expected to perform equally well or otherwise meet cer",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ce of the respective ingredient, could not be expected to perform equally well or otherwise meet certain requirements. Appropriate comparative testing of a cosmetic containing the trade secret ingredient, or one containing conventional substitutes, as well as testing of petitioner's cosmetic against competitor's cosmetic of the same use category may provide factual documentation to this effect and thus demonstrate the value of the information to petitioner. The value of the ingredient informatio",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "thus demonstrate the value of the information to petitioner. The value of the ingredient information may also be determined in terms of future market performance of a cosmetic or its profitability. However, this kind of value assessment is usually a difficult and inexact task and often provides little factual data to support a value assessment.\nDocumentation of the effort expended and financial resources invested in the development of the product formulation containing the ingredient in questio",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "esources invested in the development of the product formulation containing the ingredient in question and providing the claimed characteristics may further support a request for trade secrecy.\nFactors Considered in Determining Trade Secret Status\n3. Can the information readily be acquired or duplicated\nThe factor concerning the ease or difficulty with which the identity of the ingredient in question could properly be acquired or duplicated by others may be addressed by documenting an ingredient'",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "on could properly be acquired or duplicated by others may be addressed by documenting an ingredient's rare or unexpected use for the intended purpose in cosmetics of a particular product category or by demonstrating the complexity of the analytical methodology necessary to identify it.\nProcedure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nFinal determination of Trade Secrecy\nCosmetic formulation or raw material composition statement (Form 2512 OR 2513)\nStatement of",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "Secrecy\nCosmetic formulation or raw material composition statement (Form 2512 OR 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of prior non-disclosure (§ 20.81)\nReview of data for adequacy\nTentative determination of trade secrecy\nFinal determination of trade secrecy\n21 CFR 720.8\nWhen FDA tentatively decides to deny a request, the petitioner may withdraw the records for which FDA has tentatively denied a request for confidentiality. Petitioner may also submit, wi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "s for which FDA has tentatively denied a request for confidentiality. Petitioner may also submit, within 60 days from the date of receipt of the written notice of the tentative denial, additional relevant information and arguments and request that the agency reconsider its decision in light of both the additional material and the originally submitted information.\nIf the petitioner submits new data, the agency considers that material together with the initially submitted information and makes its",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": ", the agency considers that material together with the initially submitted information and makes its final determination. This constitutes final agency action. The petitioner is informed of the agency's final determination in writing.\nProcedure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nSubmission of Information\nCosmetic Formulation or Raw Material Composition Statement (Form 2512 OR 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ent (Form 2512 OR 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of prior non-disclosure (§ 20.81)\nReview of data for adequacy\nTentative determination of trade secrecy\nFinal determination of trade secrecy\nJudicial review under 5 U.S.C. Chapter 7\n21 CFR 720.8\nThe agency's final decision may be challenged in the courts under 5 U.S.C., Chapter 7. If suit is brought within 30 days after such determination, FDA will not disclose the records involved until the matter i",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "thin 30 days after such determination, FDA will not disclose the records involved until the matter is finally determined in the courts. If suit is not brought within 30 days and the petitioner does not withdraw the records for which a request for confidentiality has been denied, the records involved will be made part of FDA's files and will then be available to the public upon request.\nIt should be noted that until the agency has completed its determination that the identity of a cosmetic ingred",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "e noted that until the agency has completed its determination that the identity of a cosmetic ingredient is a trade secret, the cosmetic product in question may not bear the label statement \"and other ingredients\" in lieu of a declaration of the identity of the ingredient for which confidentiality has been requested. The phrase \"and other ingredients\" may be used on the label only after an ingredient is accepted by FDA as exempt from public disclosure or, when confidentiality has been denied, if",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ent is accepted by FDA as exempt from public disclosure or, when confidentiality has been denied, if suit is brought within 30 days after a final determination that the ingredient in question is not a trade secret.\nCosmetics That Are Also Drugs\nDeclaration\nThe established name of any active drug ingredient and the quantity, kind, and proportion of any alcohol, in compliance with Sec. 502(e) of the FD&C Act, as \"Active Ingredients\"\nThe remaining ingredients, in compliance with § 701.3, as \"Cosmet",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "FD&C Act, as \"Active Ingredients\"\nThe remaining ingredients, in compliance with § 701.3, as \"Cosmetic Ingredients\"\n21 CFR 701.3(d)\nA product intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance is a cosmetic. If this product claims to accomplish these deeds through physiological activity or by changing the structure of the skin, it is also a drug. The product categories \"drug\" and \"cosmetic\" are not mutually exclusive. This is",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "it is also a drug. The product categories \"drug\" and \"cosmetic\" are not mutually exclusive. This is recognized in sec. 509 of the FD&C Act.\nIf a cosmetic is also a drug, the label must list first the established name of the drug ingredient(s) and the quantity, kind and proportion of any alcohol, in compliance with sec. 502(e) of the FD&C Act, as \"Active Ingredients\" and then the remaining ingredients, in compliance with § 701.3(a) or (f), as \"Cosmetic Ingredients.\"\nback to top\nCosmetics That Ar",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ents, in compliance with § 701.3(a) or (f), as \"Cosmetic Ingredients.\"\nback to top\nCosmetics That Are Also Drugs\nAerosol Antiperspirant\nIncorrect Label Copy:\nsobutane\nSilicone Oil\nButane\nAluminum Chlorohydrate\nIsopropyl Myristate\nDenatured Alcohol\nPropane\nBentone 38\nCorrect Label Copy:\nActive Ingredient:\nAluminum Chlorohydrate\nCosmetic Ingredients:\nIsobutane\nCyclomethicone\nButane\nIsopropyl Myristate\nSD Alcohol 40\nPropane\nQuaternium 18 Hectorite\nThis hypothetical aerosol antiperspirant formulatio",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "te\nSD Alcohol 40\nPropane\nQuaternium 18 Hectorite\nThis hypothetical aerosol antiperspirant formulation illustrates on the right side the correct label declaration of the ingredients of a cosmetic which is also a drug.\nThe active drug ingredient aluminum chlorohydrate is identified as \"Active Ingredient\" in accordance with sec. 502(e) of the FD&C Act. The remaining ingredients may be identified as \"Cosmetic Ingredients\" as shown or as \"Other Ingredients.\"\nColor Additives Added Sometimes for Color",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "Cosmetic Ingredients\" as shown or as \"Other Ingredients.\"\nColor Additives Added Sometimes for Color Matching\nListed after the declaration of other color additives and after the phrase\"May contain\"\n21 CFR 701.3(g) (1)\nA color additive(s) that is added to a cosmetic during manufacture for the purpose of color matching may be declared on the label of each batch or lot even if not present in each.\nThe color additive sometimes added for color matching is listed after the declaration of other color ad",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "color additive sometimes added for color matching is listed after the declaration of other color additives, or at the end of the declaration, and after the phrase \"May Contain.\"\nback to top\nColor Additives Sometimes Added for Color Matching\nToilet Water\nIncorrect Label Copy:\nSD Alcohol 39C\nWater\nFragrance\nPropylene Glycol\nCetyl Lactate\nFD&C Red No. 40\nFD&C Blue No. 1\n\nCorrect Label Copy:\nSD Alcohol 39C\nWater\nFragrance\nPropylene Glycol\nCetyl Lactate\nFD&C Red No. 40\nFD&C Blue No. 1\nMay contain:\nD",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ol 39C\nWater\nFragrance\nPropylene Glycol\nCetyl Lactate\nFD&C Red No. 40\nFD&C Blue No. 1\nMay contain:\nD&C Yellow No. 10\nD&C Yellow No. 10 used for Color Adjustment\nThis hypothetical toilet water formulation in which D&C Yellow No. 10 is added to some batches for the purpose of color adjustment shows on the right side the correct label declaration of the color additive D&C Yellow No. 10.\nIncidental Ingredients\nDefinition:\nAny processing aid added and removed or converted to a declared ingredient\nor",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "gredients\nDefinition:\nAny processing aid added and removed or converted to a declared ingredient\nor\nAny ingredient of another ingredient or processing aid present at an insignificant level and having no technical or functional effect\nNeed not be declared\nIncidental ingredients need not be declared on the label.\nAn incidental ingredient is defined in § 701.3(1) as:\n1. A substance added during manufacture and removed from the cosmetic in accordance with good manufacturing practices before the cosm",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "acture and removed from the cosmetic in accordance with good manufacturing practices before the cosmetic is packaged in finished form. Example: Filter aid.\n2. A substance that is added during manufacture of a cosmetic, is converted to an ingredient declared on the label, and does not significantly increase the concentration of the declared ingredient. Example: Sodium hydroxide added to a sodium stearate and stearic acid-containing cosmetic.\n3. A substance added to a cosmetic during manufacture f",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "earate and stearic acid-containing cosmetic.\n3. A substance added to a cosmetic during manufacture for its technical effect in processing but present in the finished cosmetic at an insignificant level and not having any technical or functional effect in that cosmetic. Example: Defoaming agent.\n4. A substance added to a cosmetic as a component of a cosmetic ingredient and having no technical or functional effect in the finished cosmetic. Example: Preservative of a raw material added to a cosmetic",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ctional effect in the finished cosmetic. Example: Preservative of a raw material added to a cosmetic as an ingredient at a concentration which reduces the preservative to a level at which it is no longer effective.\nback to top\nMultiunit or Multicomponent Packages\nExamples:\nGift set of makeup assortment\nHair coloring kit or home permanent\nDeclaration:\nOn outside retail package only if components are not customarily sold individually.\n21 CFR 701.3 (q)\nThe ingredients of the units of cosmetics mark",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "e not customarily sold individually.\n21 CFR 701.3 (q)\nThe ingredients of the units of cosmetics marketed as multiunit or multicomponent packages must be declared on the label of the outside container. They must also be declared on the labels of the inside containers of the units if the inside containers are customarily separated from the outer container for individual retail sale.\nA MULTIUNIT package is a package which contains an assortment of similar or dissimilar products. Examples: A shade a",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "age is a package which contains an assortment of similar or dissimilar products. Examples: A shade assortment of eye shadows in an eye make-up kit or a gift set consisting of a lotion, powder and toilet water in a gift box.\nA MULTICOMPONENT package is \"a package which contains the integral components making up a complete kit, and which is designed to deliver the components in the manner of an application.\" See 21 CFR 701.13(g)(2). Examples: A hair coloring kit consisting of dye solution and hydr",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ication.\" See 21 CFR 701.13(g)(2). Examples: A hair coloring kit consisting of dye solution and hydrogen peroxide or a permanent wave set consisting of thioglycolate solution and sodium bromate solution.\nMultiunit Packages (Assortments in Same Package)\nDissimilar products\nSimilar products intended same use\nLabeling surface area\nLess than 12 square inches\nOver 12 square inches\nBranded shade lines\nSingle units and assortments\nFor the purpose of cosmetic ingredient labeling and to take advantage of",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ingle units and assortments\nFor the purpose of cosmetic ingredient labeling and to take advantage of provisions for consolidated ingredient listing in place of somtimes repetitive listing of ingredients unit by unit, a distinction must be made between packages containing:\n1. Dissimilar products. Example: Gift set containing a shave cream and an after shave lotion.\n2. Products of similar composition and intended for the same use in a package with a total surface area available for labeling of 12",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "n and intended for the same use in a package with a total surface area available for labeling of 12 square inches or more. Example: Two toilet waters of different fragrance or color in gift set.\n3. Products of similar composition and intended for the same use in a package with a total surface area available for labeling of less than 12 square inches. Example: Eye shadows of different color in a compact case.\n4. Products that are single units or assortments of a branded shade line. A branded shad",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "mpact case.\n4. Products that are single units or assortments of a branded shade line. A branded shade line is a series of products of similar composition, intended for the same use, and sharing a common label with the same brand name. Example: A shade line of lipsticks.\nAssortments of Dissimilar Products\nAlternate Declaration\nSingle composite list of color additives with statement that list pertains to all products\n21 CFR 701.3(h)\nThe package of an assortment of dissimilar products, i.e., a mult",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ns to all products\n21 CFR 701.3(h)\nThe package of an assortment of dissimilar products, i.e., a multiunit package, as, for example, a toilet water and a dusting powder in a gift box, may bear:\nA conventional ingredient declaration in which each ingredient of each product is identified under an appropriate product heading, or\nAn alternate ingredient declaration in which the color additives of all products of the assortment are integrated into a single composite list that indicates that the list p",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "roducts of the assortment are integrated into a single composite list that indicates that the list pertains to all products.\nPlease note that if the units of an assortment are customarily separated from the outer package for retail sale, the ingredients must also be declared on the label of each inside unit.\nback to top\nAssortments of Dissimilar Products\nToilet Water and Dusting Powder\nLabel Copy:\nToilet Water:\nSD Alcohol 40\nWater\nFragrance\nFD&C Red No. 40\nFD&C Blue No. 1\nDusting Powder:\nTalc\nKa",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "Toilet Water:\nSD Alcohol 40\nWater\nFragrance\nFD&C Red No. 40\nFD&C Blue No. 1\nDusting Powder:\nTalc\nKaolin\nFragrance\nD&C Red No 21 Aluminum Lake\nAlternate Label:\nToilet Water:\nSD Alcohol 40\nWater\nFragrance\n\nDusting Powder:\nTalc\nKaolin\nFragrance\nColor Additives Pertaining to Both Products:\nFD&C Red No. 40\nFD&C Blue No. 1\nD&C Red No. 21 Aluminum Lake\nThis example of a hypothetical assortment of dissimilar products consisting of a toilet water and a dusting powder illustrates on the right side the al",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ilar products consisting of a toilet water and a dusting powder illustrates on the right side the alternate ingredient labeling option in which all color additives are declared in a single composite list. The declaration advises that the color additives pertain to both products.\nIf, for example, Red 40 or Blue 1 were present in both products, they would have to be listed only once in the declaration.\nAssortments of Similar Products Intended for Same Use\nAvailable Labeling Surface Area Less Than",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "on.\nAssortments of Similar Products Intended for Same Use\nAvailable Labeling Surface Area Less Than 12 Square Inches\nAlternate Declaration\nIngredients common to all products listed in cumulative descending order of predominance (or according to paragraph (f)), and\nIngredients not common to all products identified by product in which used, and\nSingle composite list of all color additives without product identification\n21 CFR 701.3 (O) (1)\nAn assortment of products of similar composition and inten",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "oduct identification\n21 CFR 701.3 (O) (1)\nAn assortment of products of similar composition and intended for the same use in a package with a total surface area available for labeling of 12 square inches or more as, for example, two toilet waters of different fragrance or color in a gift set, may bear either:\nA conventional ingredient declaration in which the ingredients of each product are identified under appropriate product headings, listing either all the ingredients in descending order of pr",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ied under appropriate product headings, listing either all the ingredients in descending order of predominance according to § 701.3(a) or listing the ingredients according to § 701.3(f), declaring first in descending order the ingredients other than colors present at concentrations exceeding 1%, followed in any order by the ingredients other than color present at concentrations of 1% or less, followed in any order by the color additives present at any concentration, or\nAn alternate ingredient de",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "owed in any order by the color additives present at any concentration, or\nAn alternate ingredient declaration, listing:\n1. The ingredients other than colors common to all products in cumulative descending order of predominance according to § 701.3(a), or according to § 701.3(f) [permitting listing of ingredients present at 1% or less in any order], followed by\n2. The ingredients other than color not common to all products, identified by the products in which they are present, followed by\n3. The",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ot common to all products, identified by the products in which they are present, followed by\n3. The color additives of all products without identification of products in which they are present.\nback to top\nAssortments of Similar Products Intended for Same Use\nAvailable Labeling Surface Area Less Than 12 Square Inches\nAlternate Declaration\nSingle list of all ingredients in cumulative descending order of predominance\nor\nSingle list of all ingredients according to paragraph (f)\nAn assortment of pro",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "er of predominance\nor\nSingle list of all ingredients according to paragraph (f)\nAn assortment of products of similar composition and intended for the same use in a package with a total surface area available for labeling of less than 12 square inches as, for example, several eye shadows in a compact, may bear either:\nA conventional ingredient declaration in which the ingredients of each product are identified under appropriate product headings, listing either all the ingredients in descending or",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "e identified under appropriate product headings, listing either all the ingredients in descending order or according to § 701.3(a) or listing the ingredients according to § 701.3(f), declaring first in descending order the ingredients other than colors present at concentrations exceeding 1%, followed in any order by the ingredients other than color present at concentrations of 1% or less, followed in any order by the color additives present at any concentration,\nor\nAn alternate ingredient declar",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "in any order by the color additives present at any concentration,\nor\nAn alternate ingredient declaration listing the ingredients of all products in a single integrated list in cumulative descending order of predominance according to § 701.3(a), or cumulatively according to § 701.3(f).\nAssortments of Similar Products\nEye Shadow--Two Shades\nAlternate Labels\nLabel Copy\nLabeling Area 12 Sq. In. or More\nLabeling Area Less Than 12 Sq. In.\nBlue, Pearly Shade:\nTalc\nZinc Stearate\nKaolin\nBentonite\nMinera",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "re\nLabeling Area Less Than 12 Sq. In.\nBlue, Pearly Shade:\nTalc\nZinc Stearate\nKaolin\nBentonite\nMineral Oil\nBismuth Oxychloride\nTitanium Dioxide\nUltramarine Blue\nUltramarine Violet\nGreen Shade:\nTalc\nZinc Stearate\nKaolin\nMineral Oil\nLanolin\nTitanium Dioxide\nUltramarine Green\nChromium Hydroxide Green\nTalc\nZinc Stearate\nKaolin\nMineral Oil\nBentonite in Blue Shade\nLanolin in Green Shade\nBismuth Oxychloride\nTitanium Dioxide\nUltramarine Blue\nUltramarine Violet\nUltramarine Green\nChromium Hydroxide Green\nT",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "de\nTitanium Dioxide\nUltramarine Blue\nUltramarine Violet\nUltramarine Green\nChromium Hydroxide Green\nTalc\nZinc Stearate\nKaolin\nBentonite\nMineral Oil\nLanolin\nBismuth Oxychloride\nTitanium Dioxide\nUltramarine Blue\nUltramarine Violet\nUltramarine Green\nChromium Hydroxide Green\n21 CFR 701.3 (o) (2)\nThis example of an assortment consisting of two similar hypothetical eye shadow formulations demonstrates the optional ingredient declarations for packages with a total surface area available for labeling of",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "e optional ingredient declarations for packages with a total surface area available for labeling of 12 square inches or more (center) and for packages with a total surface area available for labeling of less than 12 square inches (right side).\nOn the left side are shown two conventional ingredient declarations, each representing one shade.\nIn the center is shown the integrated ingredient declaration for the two shades in the package with 12 square inches or more of available labeling area. Note",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "on for the two shades in the package with 12 square inches or more of available labeling area. Note that the ingredients other than color not common to all products are listed after the ingredients that are common and are identified by the products in which they are used. (Bentonite in Blue Shade, Lanolin in Green Shade.)\nOn the right side is shown the integrated ingredient declaration for the two shades in the package with less than 12 square inches of available labeling area. Note that the ing",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "shades in the package with less than 12 square inches of available labeling area. Note that the ingredients not common to all formulations need not be identified by the products in which they are used.\nBranded Shade Lines\nand\nBranded Shade Line Assortments\nDefinition:\nIndividually packaged, or assortments of eye or facial makeup cosmetics or nail enamels bearing the same name\n21 CFR 701.3 (g) (2) and (o) (3)\n(g) (2) and (o) (4)\nAccording to §§ 701.3(g)(2) and (o)(3), a branded shade line may be",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "and (o) (3)\n(g) (2) and (o) (4)\nAccording to §§ 701.3(g)(2) and (o)(3), a branded shade line may be defined as a line of individually packaged eye or facial make-up cosmetics or nail enamels bearing a label that is shared with other products, i.e., bearing the same product name. Example: A line of lipsticks with the same brand name.\nAccording to §§ 701.3(g)(2) and (o)4), a branded shade line assortment may be defined as several assortments of eye or facial make-up cosmetics or nail enamels in p",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "rtment may be defined as several assortments of eye or facial make-up cosmetics or nail enamels in packages bearing the same label. Example: Several compacts with the same name and label, each containing several eye shadows.\nAccording to 701.3(g)(2) and (o)(4), a branded shade line assortment may be defined as several assortments of eye or facial make-up cosmetics or nail enamels in packages bearing the same label. Example: Several compacts with the same name and label, each containing several e",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ng the same label. Example: Several compacts with the same name and label, each containing several eye shadows.\nback to top\nBranded Shade Lines\nand\nBranded Shade Line Assortments\nAlternate Declaration\nSingle ingredient declaration for all branded shades listing ...\nIngredients common to all products, in cumulative descending order of predominance\nIngredients not common, identified by product in which used\nColor additives common to all products, in any order\nColor additives not common, preceded b",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "ich used\nColor additives common to all products, in any order\nColor additives not common, preceded by \"May contain\"\n21 CFR 701.3 (g) (2) and (o) (3)\n(g) (2) and (o) (4)\nBranded shade lines and branded shade line assortments may bear either:\nA conventional ingredient declaration for each product in which the ingredients of each product are identified in descending order of predominance according to § 701.3(a) or, alternately, according to § 701.3(f) [in the case of an assortment the ingredients m",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "§ 701.3(a) or, alternately, according to § 701.3(f) [in the case of an assortment the ingredients may be declared cumulatively in a single list for each assortment according to §§ 701.3(a) or (f)]\nor\nAn alternate ingredient declaration listing all ingredients for all branded shades in the cumulative order shown below. In this case, each shade of a branded shade line or each package of a branded shade line assortment bears the same ingredient declaration.\nBranded Shade Lines and Branded Shade Li",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "hade line assortment bears the same ingredient declaration.\nBranded Shade Lines and Branded Shade Line Assortments\nLipstick - Cherry Red\nIncorrect Label Copy:\nCastor Oil\nIsopropyl Myristate\nBeeswax\nCandelilla Wax\nOleyl Alcohol\nOzokerite\nSorbitan Trioleate\nMay contain:\nMica (and) Titanium Dioxide (and) Iron Oxides\nD&C Red No. 21\nD&C Orange No. 5\nD&C Red No. 6 Barium Lake\nD&C Red No. 7 Calcium Lake\nD&C Red No. 27 Aluminum Lake\nD&C Orange No. 5 Aluminum Lake\nD&C Yellow No. 10 Aluminum Lake\nCorrect",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "D&C Red No. 27 Aluminum Lake\nD&C Orange No. 5 Aluminum Lake\nD&C Yellow No. 10 Aluminum Lake\nCorrect Label Copy:\nCastor Oil\nIsopropyl Myristate\nBeeswax\nCandelilla Wax\nOleyl Alcohol\nOzokerite\nSorbitan Trioleate in Pearl Peach and Pearl Cherry Shades\nTitanium Dioxide\nD&C Red No. 21\nD&C Orange No. 5\nMay contain:\nMica\nIron Oxides\nD&C Red No. 6 Barium Lake\nD&C Red No. 7 Calcium Lake\nD&C Red No. 27 Aluminum Lake\nD&C Orange No. 5 Aluminum Lake\nD&C Yellow No. 10 Aluminum Lake\nThis example of a hypothetic",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "num Lake\nD&C Orange No. 5 Aluminum Lake\nD&C Yellow No. 10 Aluminum Lake\nThis example of a hypothetical shade of a line of lipsticks bearing the same brand name illustrates three common errors found in cosmetic ingredient declarations, namely:\n1. Proprietary mixtures of ingredients identified in the ingredient dictionary by a parenthetical \"(and)\" are often declared on the label as shown in the dictionary section listing chemical/trade names and their respective label names. The compounds of such",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "tionary section listing chemical/trade names and their respective label names. The compounds of such mixtures must be separated, the \"(and)\" omitted, and the components treated as individual ingredients for labeling purposes. See \"Mica (and) Titanium dioxide (and) Iron oxides.\"\n2. Many labels list all color additives of a shade line after the phrase \"May contain.\" The color additives common to all shades must be listed before \"May contain\", and only those not found in all shade formulations may",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "shades must be listed before \"May contain\", and only those not found in all shade formulations may be listed after \"May contain.\"\n3. The ingredients other than colors which are not included in all shade formulations must be identified as to the shades in which they are present.\nDirect Mail Cosmetics\nDefinition\nCosmetics ordered by and delivered to consumers through the mail without involvement of an intermediary sales agent\n21 CFR 701.3 (r)\nDirect mail cosmetics may utilize off-package ingredie",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "an intermediary sales agent\n21 CFR 701.3 (r)\nDirect mail cosmetics may utilize off-package ingredient labeling as an alternative to the declaration of ingredients on an information panel.\nFor the purpose of cosmetic ingredient labeling, direct mail cosmetics are defined as cosmetics ordered by mail and delivered to consumers through the mail without the involvement of an intermediary sales agent.\nCosmetics sold to consumers through \"door-to-door\" salespersons are not considered direct mail cosm",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "Cosmetics sold to consumers through \"door-to-door\" salespersons are not considered direct mail cosmetics even though they may be delivered to consumers directly by mail.\nback to top\nDirect Mail Cosmetics\nDeclaration on\nlabeling accompanying the mailed cosmetic\nor\nlabeling furnished to each consumer ordering cosmetics by mail\n21 CFR 701.3 (r)\nAs an alternative to the declaration of ingredients on an information panel, the declaration may appear in letters not less than 1/16 of an inch in height",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "an information panel, the declaration may appear in letters not less than 1/16 of an inch in height in:\nLabeling that accompanies and specifically relates to the cosmetic(s) mailed, e.g., a brochure, insert or written directions for safe use, or\nLabeling furnished to each consumer for personal use and from which cosmetics are ordered through the mail, e.g., a direct mail sales catalog or brochure.\nDirect Mail Cosmetics\nRequirements\nNotice in 3/16-inch lettering located or affixed to top, inside,",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "Direct Mail Cosmetics\nRequirements\nNotice in 3/16-inch lettering located or affixed to top, inside, or outside of package, stating:\nLocation of ingredient declaration\nAvailability on request through mail\nName and address of distributor\n21 CFR 701.3(r)\nIf the ingredients of cosmetics distributed to consumers by direct mail are made available through off-package labeling, the following requirement must be met:\n1. The package mailed to consumers must be accompanied by a notice in 3/16 of an inch l",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "must be met:\n1. The package mailed to consumers must be accompanied by a notice in 3/16 of an inch lettering informing the consumer of the location of the ingredient declaration(s), of the name and address of the mail order distributor, and that a copy of the ingredient declaration(s) will be mailed to any person requesting it.\n2. The mail order distributor must promptly mail a copy of an ingredient declaration to any person requesting it.\n3. The notice in 3/16 of an inch lettering must be locat",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "nt declaration to any person requesting it.\n3. The notice in 3/16 of an inch lettering must be located on, or affixed to, the top of the package; or it must be inside the package on top of the contents or on the face of the platform surrounding and holding the product(s) and must be readily visible to the consumer on opening.\n4. The ingredient declarations must be conspicuous and presented in a way that the consumer can readily associate each ingredient declaration with each cosmetic.\nOff-packag",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "y that the consumer can readily associate each ingredient declaration with each cosmetic.\nOff-package Ingredient Labeling\nQualifying Conditions\n21 CFR 701.3(i)\nThe declaration of ingredients in labeling accompanying a cosmetic, i.e., off-package ingredient labeling, requires that:\n(1)The product is not enclosed in an outer container,\n(2)The total package surface area is less than 12 square inches, and\n(3)The products are held for sale in tightly compartmented trays or racks.\nThe ingredient decla",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "and\n(3)The products are held for sale in tightly compartmented trays or racks.\nThe ingredient declaration must be in letters not less than 1/16 of an inch in height and may appear on padded sheets, leaflets or similar labeling accompanying the product.\nProducts which are not eye or facial make-up cosmetics or nail enamels must be displayed for sale in tightly compartmented trays or racks of a display unit. The holder of the padded sheets or leaflets bearing the ingredient declaration(s) must be",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "play unit. The holder of the padded sheets or leaflets bearing the ingredient declaration(s) must be attached to the display unit.\nProducts which are eye or facial make-up cosmetics or nail enamels may be held for sale in tightly compartmented trays or racks located below the sales counter. The holder of the ingredient labeling must be attached to a display chart which bears samples of the product shades and is displayed to purchasers.\nback to top\nOff-package Ingredient Labeling\nHolder of Labeli",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "shades and is displayed to purchasers.\nback to top\nOff-package Ingredient Labeling\nHolder of Labeling\n1. Must bear the following statement visible after last list has been taken:\n\"Federal law requires ingredient list to be displayed here.\"\n21.CFR 701.3(j)\nAmong the various conditions described in §§ 701.3(j) and (k) that must be met if off-package ingredient labeling is utilized as an alternative to the declaration of ingredients on an information panel, the following deserve particular attenti",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "to the declaration of ingredients on an information panel, the following deserve particular attention:\n1. The display unit or chart must bear the statement \"Federal law requires ingredient lists to be displayed here\" in letters not less than 3/16 of an inch in height. This statement becomes conspicuous when the last ingredient list has been taken or may also be shown at all times adjacent to the holder of labeling bearing the ingredient declaration(s).\nOff-package Ingredient Labeling\nHolder of",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "holder of labeling bearing the ingredient declaration(s).\nOff-package Ingredient Labeling\nHolder of Labeling\n2. Padded sheets or leaflets must be attached to the display unit and be fully visible on the front\nor\npartially visible on the front and bear a notice in 3/16-inch lettering describing their location\nor\nlocated on the side only and bear the location notice.\n21 CFR 701.3 (j)\n2. The holder of off-package cosmetic ingredient labeling, e.g., padded sheets or leaflets, must be attached to the",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "f off-package cosmetic ingredient labeling, e.g., padded sheets or leaflets, must be attached to the display unit or chart so that the labeling is in front of the display unit or chart and can be read in full by a purchaser facing the display under customary conditions of retail sale.\nAs an alternative to full display of off-package ingredient labeling, the labeling may also be on the side of the display unit or chart, but not at the top, back or bottom, in which case it must be accompanied by a",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "display unit or chart, but not at the top, back or bottom, in which case it must be accompanied by a conspicuous notice in 3/16 of an inch lettering on the front of the display unit, describing the location of the off-package labeling and stating \"Federal law requires ingredient lists to be displayed here.\"\nAdditional Requirements\n1. Leaflets must bear declarations of all products sold with display unit or chart.\n2. Leaflets must be identical.\n21 CFR 701.3 (k)\nThe following additional conditions",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "y unit or chart.\n2. Leaflets must be identical.\n21 CFR 701.3 (k)\nThe following additional conditions must be met to comply with the requirements for off-package ingredient labeling of cosmetics:\n1. The padded sheets or leaflets attached to the display unit or chart must declare the ingredients of all products sold with the display.\n2. The padded sheets or leaflets must be identical.\nAdditional Requirements\n3. Leaflets and displays must be shipped together.\n4. Leaflets must be sufficient in numbe",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "uirements\n3. Leaflets and displays must be shipped together.\n4. Leaflets must be sufficient in number and replaced with refills with replacement instructions to retailer.\n21 CFR 701.3\n3. The number of copies of padded sheets or leaflets provided with each shipment of a cosmetic must be sufficient so that each purchaser may obtain a copy of an ingredient declaration. Further, the display units and replacement labeling must be accompanied by appropriate instructions to the retailer to assure that",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "replacement labeling must be accompanied by appropriate instructions to the retailer to assure that retailers display the padded sheets or leaflets.\n4. Shipments of refill items also must be accompanied by sufficient copies of ingredient declarations, and the container holding the refill items and the respective copies of ingredient declarations must not contain other cosmetic products.\nAdditional Requirements\n5. Label firm must send copy of ingredient declaration to requesting person.\n6. In cas",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "Requirements\n5. Label firm must send copy of ingredient declaration to requesting person.\n6. In case of formulation change, leaflet must declare both formulations.\n21 CFR 701.3\n5. The firm engaged in off-package cosmetic ingredient labeling must promptly mail a copy of the ingredient declaration to any person requesting it.\n6. In case of a formulation change, the new padded sheet or leaflet must be dated if not shipped together with the display unit or chart. If a padded sheet or leaflet is to",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "be dated if not shipped together with the display unit or chart. If a padded sheet or leaflet is to be used in conjunction with the old and the new formulations, it must bear both ingredient declarations, and the declarations must be identified in a way that the purchaser can determine which declaration pertains to which product. As an alternative, the padded sheet or leaflet bearing the two ingredient declarations may advise the purchaser that the formulation has been changed and that either de",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "dient declarations may advise the purchaser that the formulation has been changed and that either declaration may be applicable.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide"
  },
  {
    "text": "You may see fragrance products, such as “essential oils,” marketed with “aromatherapy” claims that they will treat health problems or improve well-being. Who regulates these products, and how? Find answers here:\nWhat's the \"intended use\"?\nUnder the law, how “aromatherapy” products are regulated depends mainly on how they are intended to be used.\nFDA determines a product’s intended use based on factors such as claims made in the labeling, on websites, and in advertising, as well as what consumers",
    "url": "https://www.fda.gov/cosmetics/products/aromatherapy"
  },
  {
    "text": "tors such as claims made in the labeling, on websites, and in advertising, as well as what consumers expect it to do. We also look at how a product is marketed, not just a word or phrase taken out of context. Finally, we make decisions on a case-by-case basis.\nIs it a cosmetic?\nIf a product is intended only to cleanse the body or to make a person more attractive, it’s a cosmetic. So, if a product such as a shower gel is intended only to cleanse the body, or a perfume or cologne is intended only",
    "url": "https://www.fda.gov/cosmetics/products/aromatherapy"
  },
  {
    "text": "such as a shower gel is intended only to cleanse the body, or a perfume or cologne is intended only to make a person smell good, it’s a cosmetic.\nThe law doesn’t require cosmetics to have FDA approval before they go on the market. But FDA can take action against a cosmetic on the market if we have reliable information showing that it is unsafe when consumers use it according to directions on the label, or in the customary or expected way, or if it is not labeled properly.\nTo learn more, see “FDA",
    "url": "https://www.fda.gov/cosmetics/products/aromatherapy"
  },
  {
    "text": "abel, or in the customary or expected way, or if it is not labeled properly.\nTo learn more, see “FDA Authority Over Cosmetics.”\nIs it a drug?\nIf a product is intended for a therapeutic use, such as treating or preventing disease, or to affect the structure or function of the body, it’s a drug. For example, claims that a product will relieve colic, ease pain, relax muscles, treat depression or anxiety, or help you sleep are drug claims.\nSuch claims are sometimes made for products such as soaps, l",
    "url": "https://www.fda.gov/cosmetics/products/aromatherapy"
  },
  {
    "text": "ety, or help you sleep are drug claims.\nSuch claims are sometimes made for products such as soaps, lotions, and massage oils containing “essential oils” and marketed as “aromatherapy.” The fact that a fragrance material or other ingredient comes from a plant doesn’t keep it from being regulated as a drug.\nUnder the law, drugs must meet requirements such as FDA approval for safety and effectiveness before they go on the market. To find out if a product marketed with drug claims is FDA-approved, c",
    "url": "https://www.fda.gov/cosmetics/products/aromatherapy"
  },
  {
    "text": "before they go on the market. To find out if a product marketed with drug claims is FDA-approved, contact FDA’s Center for Drug Evaluation and Research (CDER), at druginfo@fda.hhs.gov.\nTo learn more, see Drugs.\nIs it both a cosmetic and a drug?\nSome products are both cosmetics and drugs. For example, a baby lotion marketed with claims that it both moisturizes the baby’s skin and relieves colic would be both a cosmetic and a drug. Such products must meet the requirements for both cosmetics and d",
    "url": "https://www.fda.gov/cosmetics/products/aromatherapy"
  },
  {
    "text": "uld be both a cosmetic and a drug. Such products must meet the requirements for both cosmetics and drugs.\nTo learn more, see “Cosmetics Q&A: ‘Personal Care Products’” and “Is It a Cosmetic, a Drug, or Both? (or Is It Soap?).”\nIs it something else?\nSome fragrance products are regulated by the Consumer Product Safety Commission (CPSC). These include products such as air fresheners, scented candles, laundry detergents, and household cleansers.\nIf an “essential oil” or other fragrance is “natural” o",
    "url": "https://www.fda.gov/cosmetics/products/aromatherapy"
  },
  {
    "text": "laundry detergents, and household cleansers.\nIf an “essential oil” or other fragrance is “natural” or “organic,” doesn’t that mean it’s safe?\nSometimes people think that if an “essential oil” or other ingredient comes from a plant, it must be safe. But many plants contain materials that are toxic, irritating, or likely to cause allergic reactions when applied to the skin.\nFor example, cumin oil is safe in food, but can cause the skin to blister. Certain citrus oils used safely in food can also b",
    "url": "https://www.fda.gov/cosmetics/products/aromatherapy"
  },
  {
    "text": "safe in food, but can cause the skin to blister. Certain citrus oils used safely in food can also be harmful in cosmetics, particularly when applied to skin exposed to the sun.\nFDA doesn’t have regulations defining “natural” or “organic” for cosmetics. All cosmetic products and ingredients must meet the same safety requirement, regardless of their source. To learn more, see “’Organic’ Cosmetics” and “FDA’s Poisonous Plant Database.”\nWho regulates advertising claims?\nWhile FDA regulates labeling",
    "url": "https://www.fda.gov/cosmetics/products/aromatherapy"
  },
  {
    "text": "and “FDA’s Poisonous Plant Database.”\nWho regulates advertising claims?\nWhile FDA regulates labeling for cosmetics and drugs, advertising claims are regulated by the Federal Trade Commission.\nMore Resources:\nCosmetics Guidance & Regulation\nCosmetics Labeling\nFragrances in Cosmetics\nProducts & Ingredients\nSoaps & Lotions\nIs It a Cosmetic, a Drug, or Both? (Or Is It Soap?)",
    "url": "https://www.fda.gov/cosmetics/products/aromatherapy"
  },
  {
    "text": "English\nEn cas de réaction ou de problème avec un produit cosmétique, la première chose à faire est d’arrêter son utilisation et de contacter votre prestataire de soins de santé. La Food and Drug Administration (ci-après FDA ou nous) ne fournit pas de conseils d’ordre médical. En second lieu, il convient de signaler le problème à la FDA.\nDéposer une plainte concernant un produit cosmétique\nInformez la FDA dans les cas suivants :\nTypes de produits considérés comme des produits cosmétiques\nLes pro",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "z la FDA dans les cas suivants :\nTypes de produits considérés comme des produits cosmétiques\nLes produits cosmétiques se distinguent des produits pharmaceutiques et sont réglementés différemment par la FDA. Voici quelques exemples de produits cosmétiques :\nComment les consommateurs et les prestataires de soins de santé peuvent signaler un problème concernant des produits cosmétiques à la FDA\nSi vous êtes un consommateur ou un prestataire de soins de santé et que vous souhaitez déposer une plaint",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "us êtes un consommateur ou un prestataire de soins de santé et que vous souhaitez déposer une plainte ou signaler un événement indésirable (maladie, réaction allergique, éruption cutanée, irritation, cicatrice ou perte de cheveux) lié à un produit cosmétique, vous pouvez :\nMedWatchFood and Drug Administration5600 Fishers LaneRockville, MD 20852Fax : 800-332-0178 (numéro gratuit).\nComment les entreprises du secteur signalent les événements indésirables graves\nLa loi de 2022 sur la modernisation d",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "prises du secteur signalent les événements indésirables graves\nLa loi de 2022 sur la modernisation de la réglementation des produits cosmétiques (Modernization of Cosmetics Regulation Act of 2022) ou MoCRA, a été promulguée le 29 décembre 2022. Elle modifie le chapitre VI de la loi fédérale sur les aliments, les médicaments et les produits cosmétiques (Federal Food, Drug, and Cosmetic Act) et prévoit l'extension la plus importante de l'autorité de la FDA en matière de réglementation des produits",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "oit l'extension la plus importante de l'autorité de la FDA en matière de réglementation des produits cosmétiques depuis 1938.\nLa loi MoCRA exige qu'une personne responsable (voir définition ci-dessous) signale à la FDA, dans les 15 jours ouvrables, les événements indésirables graves (voir définition ci-dessous) liés à l'utilisation de produits cosmétiques aux États-Unis. La personne responsable doit inclure une copie de l’étiquette figurant sur ou à l’intérieur de l’emballage du produit cosmétiq",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "it inclure une copie de l’étiquette figurant sur ou à l’intérieur de l’emballage du produit cosmétique concerné. Si la personne responsable reçoit des informations médicales ou autres sur l'événement indésirable dans l'année qui suit la déclaration initiale à la FDA, elle doit soumettre ces nouvelles informations à la FDA dans les 15 jours ouvrables. La FDA aura également accès aux rapports d'événements indésirables lors d'une inspection.\nLes personnes responsables du secteur doivent obligatoire",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "ements indésirables lors d'une inspection.\nLes personnes responsables du secteur doivent obligatoirement soumettre des rapports d'événements indésirables graves (SAER) associés aux produits cosmétiques à l’aide du Formulaire FDA 3500A - Mandatory Reporting qui peut être téléchargé et rempli sur MedWatch : Le programme d'information sur la sécurité et de signalement des événements indésirables de la FDA - Obligatoire (PDF).\nVeuillez lire les instructions pour remplir le Formulaire FDA 3500A.\nSoum",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "a FDA - Obligatoire (PDF).\nVeuillez lire les instructions pour remplir le Formulaire FDA 3500A.\nSoumettre :\nà la FDA par e-mail à : CosmeticAERS@fda.hhs.gov ou par courrier postal à l’adresse suivante :\nFDA CDER Mail CenterAttn: Cosmetics MedWatch reportsWhite Oak Campus, Building 22, G020710903 New Hampshire Ave.Silver Spring, MD 20993\nLa FDA développe actuellement une procédure de soumission électronique des rapports obligatoires sur les effets indésirables des produits cosmétiques.\nBien que l",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "ctronique des rapports obligatoires sur les effets indésirables des produits cosmétiques.\nBien que la loi MoCRA n'exige pas que les personnes responsables du secteur soumettent à la FDA des rapports concernant les effets indésirables sans gravité des produits cosmétiques, vous pouvez les soumettre volontairement à l'aide du formulaire 3500A, en suivant la même procédure que celle décrite ci-dessus pour les rapports obligatoires sur les effets indésirables.\nTermes essentiels\nÉvénement indésirable",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "pour les rapports obligatoires sur les effets indésirables.\nTermes essentiels\nÉvénement indésirable grave : un événement indésirable qui :\n(A) a pour conséquence :\n(B) nécessite, sur la base d'un avis médical raisonnable, une intervention médicale ou chirurgicale pour prévenir une conséquence décrite au point (A) ci-dessus.\nPersonne responsable : la personne ou entité chargée de la fabrication, du conditionnement ou de la distribution d'un produit cosmétique dont le nom apparaît sur l'étiquette",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "u conditionnement ou de la distribution d'un produit cosmétique dont le nom apparaît sur l'étiquette de ce produit cosmétique conformément à la section 609(a) de la loi FD&C sur les aliments, les médicaments et les produits cosmétiques ou à la section 4(a) de la loi sur le conditionnement et l'étiquetage équitables (Fair Packaging and Labeling Act).",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/comment-deposer-une-plainte-concernant-un-produit-cosmetique"
  },
  {
    "text": "Information on recently posted and updated Web pages related to cosmetics, as well as meetings, conferences, and workshops.\nMeetings, Conferences & Workshops on Cosmetics\nCosmetics Guidance Documents\n\n\n\n\n\n\n\n\nSee Warning Letters Related to Cosmetics\nSUBSCRIBE",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events"
  },
  {
    "text": "Consumers may find information they need about cosmetics anywhere on FDA's Cosmetics Web pages. We've highlighted the items below because they are quick-reference resources that consumers often request.\nSUBSCRIBE",
    "url": "https://www.fda.gov/cosmetics/resources-you-cosmetics/resources-consumers-cosmetics"
  },
  {
    "text": "The Federal Food, Drug, and Cosmetic Act does not require cosmetic products and ingredients to be approved by FDA before they go on the market, except for color additives that are not intended for use as coal tar hair dyes. However, they must be safe for consumers under labeled or customary conditions of use. Companies and individuals who market cosmetics have a legal responsibility for the safety of their products and ingredients.\nThe resources listed below are related to cosmetic ingredients t",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products-ingredients/cosmetic-ingredients"
  },
  {
    "text": "of their products and ingredients.\nThe resources listed below are related to cosmetic ingredients that people often inquire about. For resources on cosmetic products, see Product Information.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products-ingredients/cosmetic-ingredients"
  },
  {
    "text": "Many products we use every day contain fragrances. Some of these products are regulated as cosmetics by FDA. Some belong to other product categories and are regulated differently, depending on how the product is intended to be used. Here is information about fragrances that people often ask about:\nHow to Know If a Fragrance Product Is Regulated as a Cosmetic\nIf a product is intended to be applied to a person’s body to make the person more attractive, it’s a cosmetic under the law. Here are some",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "to a person’s body to make the person more attractive, it’s a cosmetic under the law. Here are some examples of fragrance products that are regulated as cosmetics:\nFragrance ingredients are also commonly used in other products, such as shampoos, shower gels, shaving creams, and body lotions. Even some products labeled “unscented” may contain fragrance ingredients. This is because the manufacturer may add just enough fragrance to mask the unpleasant smell of other ingredients, without giving the",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "may add just enough fragrance to mask the unpleasant smell of other ingredients, without giving the product a noticeable scent.\nSome fragrance products that are applied to the body are intended for therapeutic uses, such as treating or preventing disease, or affecting the structure or function of the body. Products intended for this type of use are treated as drugs under the law, or sometimes as both cosmetics and drugs. Here are some examples of labeling statements that will cause a product con",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "oth cosmetics and drugs. Here are some examples of labeling statements that will cause a product containing fragrances to be treated as a drug:\nMany other products that may contain fragrance ingredients, but are not applied to the body, are regulated by the Consumer Product Safety Commission. Here are some examples:\nStatements on labels, marketing claims, consumer expectations, and even some ingredients may determine a product’s intended use. To learn more about the differences, including the di",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "dients may determine a product’s intended use. To learn more about the differences, including the different requirements, see \"Is it a Cosmetic, a Drug, or Both? (or Is It a Soap).\"\n“Essential Oils” and “Aromatherapy”\nThere is no regulatory definition for “essential oils,” although people commonly use the term to refer to certain oils extracted from plants. The law treats Ingredients from plants the same as those from any other source.\nFor example, “essential oils” are commonly used in so-called",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "he same as those from any other source.\nFor example, “essential oils” are commonly used in so-called “aromatherapy” products. If an “aromatherapy” product is intended to treat or prevent disease, or to affect the structure or function of the body, it’s a drug. To learn more, see “Aromatherapy.”\nSimilarly, a massage oil intended to lubricate the skin is a cosmetic. But if claims are made that a massage oil relieves aches or relaxes muscles, apart from the action of the massage itself, it’s a drug",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "sage oil relieves aches or relaxes muscles, apart from the action of the massage itself, it’s a drug, or possibly both a cosmetic and a drug.\nSafety Requirements\nFragrance ingredients in cosmetics must meet the same requirement for safety as other cosmetic ingredients. The law does not require FDA approval before they go on the market, but they must be safe for consumers when they are used according to labeled directions, or as people customarily use them. Companies and individuals who manufactu",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "ng to labeled directions, or as people customarily use them. Companies and individuals who manufacture or market cosmetics have a legal responsibility for ensuring that their products are safe and properly labeled. To learn more, see “FDA Authority Over Cosmetics.”\nLabeling of Fragrance Ingredients\nIf a cosmetic is marketed on a retail basis to consumers, such as in stores, on the Internet, or person-to-person, it must have a list of ingredients. In most cases, each ingredient must be listed ind",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "son-to-person, it must have a list of ingredients. In most cases, each ingredient must be listed individually. But under U.S. regulations, fragrance and flavor ingredients can be listed simply as “Fragrance” or “Flavor.”\nHere’s why: FDA requires the list of ingredients under the Fair Packaging and Labeling ActExternal Link Disclaimer (FPLA). This law is not allowed to be used to force a company to tell “trade secrets.” Fragrance and flavor formulas are complex mixtures of many different natural",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "tell “trade secrets.” Fragrance and flavor formulas are complex mixtures of many different natural and synthetic chemical ingredients, and they are the kinds of cosmetic components that are most likely to be “trade secrets.” To learn more, see the regulation on cosmetic ingredient labeling and the Federal Register notice for this regulation, which addresses “trade secrets” and the FPLA.\nFragrance Allergies and Sensitivities\nSome individuals may be allergic or sensitive to certain ingredients in",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "Allergies and Sensitivities\nSome individuals may be allergic or sensitive to certain ingredients in cosmetics, food, or other products, even if those ingredients are safe for most people. Some components of fragrance formulas may have a potential to cause allergic reactions or sensitivities for some people.\nFDA does not have the same legal authority to require allergen labeling for cosmetics as for food.  So, if you are concerned about fragrance sensitivities, you may want to choose products th",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "or food.  So, if you are concerned about fragrance sensitivities, you may want to choose products that are fragrance free, and check the ingredient list carefully. If consumers have questions, they may choose to contact the manufacturer directly.\nPhthalates as Fragrance Ingredients\nPhthalates are a group of chemicals used in hundreds of products. The phthalate commonly used in fragrance products is diethyl phthalate, or DEP. DEP does not pose known risks for human health as it is currently used",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "s diethyl phthalate, or DEP. DEP does not pose known risks for human health as it is currently used in cosmetics and fragrances. To learn more, see “Phthalates and Cosmetic Products.”",
    "url": "https://www.fda.gov/cosmetics/ingredients/fragrances-cosmetics"
  },
  {
    "text": "On average people use 6 to 12 cosmetics products daily. Examples of some of these products include makeup, nail polishes, shaving cream and other grooming products, perfumes, face and body cleansers, haircare products, moisturizers, and other skincare products.\nThe Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is the most significant expansion of FDA’s authority to regulate cosmetics since the Federal Food, Drug, and Cosmetic (FD&C) Act was passed in 1938. This new law will help en",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "since the Federal Food, Drug, and Cosmetic (FD&C) Act was passed in 1938. This new law will help ensure the safety of cosmetic products many consumers use daily.\n\n\nAdverse Event: any health-related event associated with the use of a cosmetic product that is adverse\nFacility: any establishment (including an establishment of an importer) that manufactures or processes cosmetic products distributed in the United States\nResponsible Person: the manufacturer, packer, or distributor of a cosmetic prod",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "in the United States\nResponsible Person: the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product in accordance with section 609(a) of the FD&C Act or section 4(a) of the Fair Packaging and Labeling Act\nSerious Adverse Event: an adverse event that\nMoCRA provides new authorities to FDA including:\nRecords Access: If certain conditions are met, FDA can access and copy certain records related to a cosmetic product, including safety recor",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "e met, FDA can access and copy certain records related to a cosmetic product, including safety records.\nMandatory Recall Authority: If the agency determines that there is a reasonable probability that a cosmetic is adulterated or misbranded and the use of or exposure to the cosmetic will cause serious adverse health consequences or death, FDA has the authority to order a mandatory recall if the responsible person refuses to do so voluntarily.\nMoCRA establishes the following new requirements for",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "sponsible person refuses to do so voluntarily.\nMoCRA establishes the following new requirements for industry:\nAdverse Event Reporting: A responsible person is required to report serious adverse events associated with the use of cosmetic products in the United States to FDA within 15 business days. The responsible person must include a copy of the label on or within the retail packaging of such cosmetic product. If the responsible person receives medical or other information about the adverse eve",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "metic product. If the responsible person receives medical or other information about the adverse event within 1 year of the initial report to FDA, they must submit this new information to FDA within 15 business days. FDA will also have access to adverse event reports during an inspection.\nIt is mandatory for industry responsible persons to submit serious adverse event reports (SAER) for cosmetics by using the current Form FDA 3500A – Mandatory Reporting that is downloadable and fillable at MedWa",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "by using the current Form FDA 3500A – Mandatory Reporting that is downloadable and fillable at MedWatch: The FDA Safety Information and Adverse Event Reporting Program - Mandatory (PDF).\nPlease see the Instructions for Completing Form FDA 3500A. To learn more, see “How Industry Reports Serious Adverse Events” at How to Report a Cosmetic Product Related Complaint | FDA.\nFor more information about adverse events submitted to FDA, see FDA's Adverse Event Reporting System (FAERS) | FDA.\nFacility Reg",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "dverse events submitted to FDA, see FDA's Adverse Event Reporting System (FAERS) | FDA.\nFacility Registration: Manufacturers and processors must register their facilities with FDA and renew their registration every two years.\nProduct Listing: A responsible person must list each marketed cosmetic product with FDA, including product ingredients, and provide any updates annually.\n\nFor additional information, see Registration & Listing of Cosmetic Product Facilities and Products.\n\nSafety Substantiat",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "rmation, see Registration & Listing of Cosmetic Product Facilities and Products.\n\nSafety Substantiation: Companies and individuals who manufacture or market cosmetics have a responsibility to ensure the safety of their products. Neither the law nor FDA regulations require specific tests to demonstrate the safety of individual products or ingredients.\nMoCRA authorizes FDA to establish regulations for:\nMoCRA requires FDA to publish a report summarizing:\n\n\nMoCRA exempts certain small businesses fro",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "or:\nMoCRA requires FDA to publish a report summarizing:\n\n\nMoCRA exempts certain small businesses from GMP, registration, and product listing requirements.\nHowever, such exemptions do not apply to manufacturers or facilities that manufacture or process the following cosmetic products:\nExemptions also exist for certain products and facilities that are subject to requirements for drugs and devices.\n\n\nFDA hosted a webinar titled Modernization of Cosmetics Regulation Act of 2022 – Key Terms and Provi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "FDA hosted a webinar titled Modernization of Cosmetics Regulation Act of 2022 – Key Terms and ProvisionsExternal Link Disclaimer in April 2023. This stakeholder webinar provides an overview of the Modernization of Cosmetics Regulation Act of 2022.\nInquiries about MoCRA can be directed to QuestionsAboutMoCRA@fda.hhs.gov.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022"
  },
  {
    "text": "FDA often gets questions from both salon professionals and their clients about the safety of cosmetic products used in hair, nail, skin care, and spray tanning salons. Here is a list of resources people often ask for when they’re concerned about salon safety.\nInformation on hair dyes, straighteners, and more\nInformation on products such as nail polishes, extenders, and hardeners\nInformation on products used to cleanse and beautify the skin\nInformation on tanning products that are regulated as co",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/salon-professionals-fact-sheet"
  },
  {
    "text": "ducts used to cleanse and beautify the skin\nInformation on tanning products that are regulated as cosmetics\nRemember, sunlamps and tanning beds are not cosmetics. They are regulated by FDA’s Center for Devices and Radiological Health, and you will find information on them under Sunlamps and Sunlamp Products (Tanning Beds/Booths).\nLearn the rules you need to know if you make or market your own products. Find out about starting a cosmetics business, labeling, imports, and more.\nFDA does not have t",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/salon-professionals-fact-sheet"
  },
  {
    "text": "ucts. Find out about starting a cosmetics business, labeling, imports, and more.\nFDA does not have the authority to order a recall, but we do help firms make sure their recalls are effective, and we post information on product safety concerns.\nFDA has authority over cosmetic product safety, but other agencies regulate workplace safety.\nYour state and local licensing authorities also may have requirements, and you will need to contact them directly.",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/salon-professionals-fact-sheet"
  },
  {
    "text": "rements, and you will need to contact them directly.",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/salon-professionals-fact-sheet"
  },
  {
    "text": "The following information is intended to respond to some questions consumers and manufacturers commonly ask FDA about “organic” cosmetics.\nOn this page:\nAdditional Resources:\nNo. FDA regulates cosmetics under the authority of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling ActExternal Link Disclaimer (FPLA). The term “organic” is not defined in either of these laws or the regulations that FDA enforces under their authority.\nThe Agricultural Marketing Servi",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/organic-cosmetics"
  },
  {
    "text": "se laws or the regulations that FDA enforces under their authority.\nThe Agricultural Marketing Service of the U.S. Department of Agriculture (USDA) oversees the National Organic Program (NOP). The NOP regulations include a definition of “organic” and provide for certification that agricultural ingredients have been produced under conditions that would meet the definition. They also include labeling standards based on the percentage of organic ingredients in a product. For more information on \"or",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/organic-cosmetics"
  },
  {
    "text": "g standards based on the percentage of organic ingredients in a product. For more information on \"organic\" labeling for cosmetics, see the NOP publication, \"Cosmetics, Body Care Products, and Personal Care Products.\"\nYes. The USDA requirements for the use of the term “organic” are separate from the laws and regulations that FDA enforces for cosmetics. Cosmetic products labeled with organic claims must comply with both USDA regulations for the organic claim and FDA regulations for labeling and sa",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/organic-cosmetics"
  },
  {
    "text": "must comply with both USDA regulations for the organic claim and FDA regulations for labeling and safety requirements for cosmetics. Information on FDA’s regulation of cosmetics is available on our Cosmetics website.\nNo. An ingredient’s source does not determine its safety. For example, many plants, whether or not they are organically grown, contain substances that may be toxic or allergenic. For more on this subject, see FDA Poisonous Plant Database. Under the FD&C Act, all cosmetic products an",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/organic-cosmetics"
  },
  {
    "text": "more on this subject, see FDA Poisonous Plant Database. Under the FD&C Act, all cosmetic products and ingredients are subject to the same safety requirement: They must be safe for consumers under labeled or customary conditions of use (FD&C Act, section 601(a). Companies and individuals who market cosmetics have a legal responsibility to ensure that their products and ingredients are safe for the intended use.\nMarch 8, 2010; updated September 15, 2010. This document is current and is updated onl",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/organic-cosmetics"
  },
  {
    "text": "intended use.\nMarch 8, 2010; updated September 15, 2010. This document is current and is updated only when needed.",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/organic-cosmetics"
  },
  {
    "text": "English\nNan ka yon reyaksyon oswa pwoblèm avèk yon pwodwi kosmetik, premye etap la se sispann itilize pwodwi a epi kontakte founisè swen sante w la. Administrasyon Manje ak Medikaman (Food and Drug Administration (FDA, nou) pa bay konsèy medikal. Dezyèmman, rapòte pwoblèm nan bay FDA.\nRapòte yon plent pou pwodwi kosmetik\nDi FDA si w gen eksperyans\nKalite pwodwi yo konsidere kòm pwodwi kosmetik\nPwodwi kosmetik yo pa menm ak pwodwi medikal, epi FDA a reglemante yo yon fason diferan. Men kèk egzanp",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ki-jan-yo-rapote-yon-plent-ki-gen-rapo-ak-pwodwi-kosmetik"
  },
  {
    "text": "dwi kosmetik yo pa menm ak pwodwi medikal, epi FDA a reglemante yo yon fason diferan. Men kèk egzanp pwodwi kosmetik:\nKijan Konsomatè ak Pwofesyonèl Sante yo ka rapòte yon pwoblèm avèk pwodwi kosmetik bay FDA\nSi ou se yon konsomatè oswa yon pwofesyonèl sante ki vle rapòte yon plent oswa yon efè negatif (tankou yon maladi, reyaksyon alèjik, gratèl, iritasyon, sikatris, oswa pèt cheve) ki gen rapò ak yon pwodwi kosmetik, ou kapab:\nMedWatchAdministrasyon Manje ak Medikaman5600 Fishers LaneRockville",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ki-jan-yo-rapote-yon-plent-ki-gen-rapo-ak-pwodwi-kosmetik"
  },
  {
    "text": "k yon pwodwi kosmetik, ou kapab:\nMedWatchAdministrasyon Manje ak Medikaman5600 Fishers LaneRockville, MD 20852FAKS: 800-332-0178 (gratis).\nKijan Endistri a Rapòte Efè Negatif Grav yo\nLwa 2022 sou Modènizasyon Regleman Kosmetik yo (MoCRA) te adopte nan dat 29 Desanm 2022. MoCRA amande Chapit VI Lwa Federal sou Manje, Medikaman, ak Kosmetik epi li prevwa ekspansyon otorite FDA ki pi enpòtan an pou kontwole pwodwi kosmetik depi 1938.\nMoCRA mande pou moun ki responsab la (gade definisyon pi ba a) po",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ki-jan-yo-rapote-yon-plent-ki-gen-rapo-ak-pwodwi-kosmetik"
  },
  {
    "text": "ontwole pwodwi kosmetik depi 1938.\nMoCRA mande pou moun ki responsab la (gade definisyon pi ba a) pou rapòte efè negatif grav (gade definisyon pi ba a) ki asosye ak itilizasyon pwodwi kosmetik Ozetazini bay FDA, nan lespas 15 jou ouvrab. Moun ki responsab la dwe mete yon kopi etikèt la sou oswa nan anbalaj vant an detay pwodwi kosmetik sa yo. Si moun ki responsab la resevwa enfòmasyon medikal oswa lòt enfòmasyon sou efè negatif la nan lespas 1 ane apre rapò inisyal la bay FDA, li dwe soumèt nouv",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ki-jan-yo-rapote-yon-plent-ki-gen-rapo-ak-pwodwi-kosmetik"
  },
  {
    "text": "lòt enfòmasyon sou efè negatif la nan lespas 1 ane apre rapò inisyal la bay FDA, li dwe soumèt nouvo enfòmasyon sa a bay FDA nan lespas 15 jou ouvrab. FDA ap gen aksè a rapò sou efè negatif yo tou pandan yon enspeksyon.\nLi obligatwa pou moun ki responsab endistri yo itilize Fòmilè FDA 3500A pou soumèt rapò sou efè negatif grav (SAER) pou pwodwi kosmetik - Rapò obligatwa ki ka telechaje epi ranpli nan MedWatch: FDA Enfòmasyon sou Sekirite ak Pwogram Rapò sou efè negatif- Obligatwa (PDF).\nTanpri",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ki-jan-yo-rapote-yon-plent-ki-gen-rapo-ak-pwodwi-kosmetik"
  },
  {
    "text": "nan MedWatch: FDA Enfòmasyon sou Sekirite ak Pwogram Rapò sou efè negatif- Obligatwa (PDF).\nTanpri gade Enstriksyon pou Ranpli Fòmilè FDA 3500A.\nSoumèt:\nBay FDA atravè imel nan : CosmeticAERS@fda.hhs.gov oswa pa lapò bay:\nSant Kourye CDER FDAAtansyon: Rapò sou Komestik MedWatchWhite Oak Campus, Building 22, G020710903 New Hampshire Ave.Silver Spring, MD 20993\nFDA ap devlope yon pwosesis soumisyon elektwonik rapò sou efè negatif obligatwa pou pwodwi kosmetik.\nPandanke MoCRA pa egzije moun ki res",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ki-jan-yo-rapote-yon-plent-ki-gen-rapo-ak-pwodwi-kosmetik"
  },
  {
    "text": "elektwonik rapò sou efè negatif obligatwa pou pwodwi kosmetik.\nPandanke MoCRA pa egzije moun ki responsab endistri yo soumèt rapò sou efè negatif ki pa grav pou pwodwi kosmetik bay FDA, ou ka itilize Fòm 3500A pou soumèt rapò sou efè negatif ki pa grav volontèman, swiv menm pwosesis ki dekri pi wo a pou rapò obligatwa sou efè negatif.\nTèm Kle yo\nEfè Negatif Grav: yon efè negatif ki:\n(A) lakòz:\n(B) egzije, baze sou jijman medikal rezonab, yon entèvansyon medikal oswa chirijikal pou anpeche yon r",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ki-jan-yo-rapote-yon-plent-ki-gen-rapo-ak-pwodwi-kosmetik"
  },
  {
    "text": ") egzije, baze sou jijman medikal rezonab, yon entèvansyon medikal oswa chirijikal pou anpeche yon rezilta ki dekri nan (A) pi wo a.\nMoun ki Responsab: fabrikan, moun k ap anbale, oswa distribitè yon pwodwi kosmetik ki gen non ki parèt sou etikèt pwodwi kosmetik sa a an akò ak seksyon 609(a) Lwa FD&C oswa seksyon 4(a) Lwa sou anbalaj ak Etikèt Ekitab (Fair Packaging and Labeling Act) la.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/ki-jan-yo-rapote-yon-plent-ki-gen-rapo-ak-pwodwi-kosmetik"
  },
  {
    "text": "Back to Cosmetics & U.S. Law\nThe law does not require cosmetic products and ingredients, other than color additives, to have FDA approval before they go on the market, but there are laws and regulations that apply to cosmetics on the market in interstate commerce.\nThe two most important laws pertaining to cosmetics marketed in the United States are the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling Act (FPLA)External Link Disclaimer. FDA regulates cosmetics u",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "t) and the Fair Packaging and Labeling Act (FPLA)External Link Disclaimer. FDA regulates cosmetics under the authority of these laws.\nIn the United States, federal laws are enacted by Congress. In order to make the laws work on a day-to-day level, Congress authorizes certain government agencies. such as FDA, to create regulations. A change in FDA's legal authority over cosmetics would require Congress to change the law.\nThe FD&C Act defines cosmetics by their intended use, as \"articles intended",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "ress to change the law.\nThe FD&C Act defines cosmetics by their intended use, as \"articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance\" (FD&C Act, sec. 201(i)). Among the products included in this definition are skin moisturizers, perfumes, lipsticks, fingernail polishes, eye and facial makeup, cleansing shampoos, permanent waves, hair colors, an",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "ks, fingernail polishes, eye and facial makeup, cleansing shampoos, permanent waves, hair colors, and deodorants, as well as any substance intended for use as a component of a cosmetic product. It does not include soap. (To learn what products are considered \"soap\" for regulatory purposes, see \"Soap.\"\nBut, if the product is intended for a therapeutic use, such as treating or preventing disease, or to affect the structure or function of the body, it’s a drug (FD&C Act, 201(g)), or in some cases a",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "to affect the structure or function of the body, it’s a drug (FD&C Act, 201(g)), or in some cases a medical device (FD&C Act, 201(h)), even if it affects the appearance. Other “personal care products” may be regulated as dietary supplements or as consumer products. To learn more, see “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)” and “Cosmetics Q&A: Personal Care Products.”\nThe information presented here applies only to the regulation of products that are cosmetics as defined by the FD&C",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "presented here applies only to the regulation of products that are cosmetics as defined by the FD&C Act.\nback to top\nThe FD&C Act prohibits the marketing of adulterated or misbranded cosmetics in interstate commerce.\n“Adulteration” refers to violations involving product composition--whether they result from ingredients, contaminants, processing, packaging, or shipping and handling. Under the FD&C Act, a cosmetic is adulterated if--\n\"it bears or contains any poisonous or deleterious substance wh",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "Act, a cosmetic is adulterated if--\n\"it bears or contains any poisonous or deleterious substance which may render it injurious to users under the conditions of use prescribed in the labeling thereof, or under conditions of use as are customary and usual\" (with an exception made for coal-tar hair dyes);\n\"it consists in whole or in part of any filthy, putrid, or decomposed substance\";\n\"it has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with f",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health\";\n\"its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health\"; or\nexcept for coal-tar hair dyes, \"it is, or it bears or contains, a color additive which is unsafe within the meaning of section 721(a)\" of the FD&C Act. (FD&C Act, sec. 601)\n“Misbranding” re",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "unsafe within the meaning of section 721(a)\" of the FD&C Act. (FD&C Act, sec. 601)\n“Misbranding” refers to violations involving improperly labeled or deceptively packaged products. Under the FD&C Act, a cosmetic is misbranded if--\n\"its labeling is false or misleading in any particular\";\nits label does not include all required information. (An exemption may apply to cosmetics that are to be processed, labeled, or repacked at an establishment other than where they were originally processed or pac",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "sed, labeled, or repacked at an establishment other than where they were originally processed or packed; see Title 21, Code of Federal Regulations, section 701.9.)\nthe required information is not adequately prominent and conspicuous;\n\"its container is so made, formed, or filled as to be misleading\";\nit is a color additive, other than a hair dye, that does not conform to applicable regulations issued under section 721 of the FD&C Act; and\n\"its packaging or labeling is in violation of an applicabl",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "ed under section 721 of the FD&C Act; and\n\"its packaging or labeling is in violation of an applicable regulation issued pursuant to section 3 or 4 of the Poison Prevention Packaging Act of 1970.\" (FD&C Act, sec. 602)\nUnder the FD&C Act, a product also may be misbranded due to failure to provide material facts. This means, for example, any directions for safe use and warning statements needed to ensure a product's safe use.\nIn addition, under the authority of the FPLA, FDA requires a list of ingr",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "sure a product's safe use.\nIn addition, under the authority of the FPLA, FDA requires a list of ingredients for cosmetics marketed on a retail basis to consumers (Title 21, Code of Federal Regulations (CFR), section 701.3). Cosmetics that fail to comply with the FPLA are considered misbranded under the FD&C Act. (FPLA, section 1456) This requirement does not apply to cosmetics distributed solely for professional use, institutional use (such as in schools or the workplace), or as free samples or",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "or professional use, institutional use (such as in schools or the workplace), or as free samples or hotel amenities.\nFDA can take action against cosmetics on the market that are in violation of these laws, as well as companies and individuals who market such products.\nFDA's legal authority over cosmetics is different from our authority over other products we regulate, such as drugs, biologics, and medical devices. Under the law, cosmetic products and ingredients do not need FDA premarket approva",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "medical devices. Under the law, cosmetic products and ingredients do not need FDA premarket approval, with the exception of color additives. However, FDA can pursue enforcement action against products on the market that are not in compliance with the law, or against firms or individuals who violate the law.\nIn general, except for color additives and those ingredients that are prohibited or restricted by regulation, a manufacturer may use any ingredient in the formulation of a cosmetic, provided",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "cted by regulation, a manufacturer may use any ingredient in the formulation of a cosmetic, provided that--\nthe ingredient and the finished cosmetic are safe under labeled or customary conditions of use,\nthe product is properly labeled, and\nthe use of the ingredient does not otherwise cause the cosmetic to be adulterated or misbranded under the laws that FDA enforces.\nback to top\nCompanies and individuals who manufacture or market cosmetics have a legal responsibility to ensure the safety of the",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "ividuals who manufacture or market cosmetics have a legal responsibility to ensure the safety of their products. Neither the law nor FDA regulations require specific tests to demonstrate the safety of individual products or ingredients. The law also does not require cosmetic companies to share their safety information with FDA.\nFDA has consistently advised manufacturers to use whatever testing is necessary to ensure the safety of their products and ingredients. Firms may substantiate safety in a",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "necessary to ensure the safety of their products and ingredients. Firms may substantiate safety in a number of ways. FDA has stated that \"the safety of a product can be adequately substantiated through (a) reliance on already available toxicological test data on individual ingredients and on product formulations that are similar in composition to the particular cosmetic, and (b) performance of any additional toxicological and other tests that are appropriate in light of such existing data and in",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "additional toxicological and other tests that are appropriate in light of such existing data and information.\" (Federal Register, March 3, 1975, page 8916).\nIn addition, regulations prohibit or restrict the use of several ingredients in cosmetic products and require warning statements on the labels of certain types of cosmetics.\nback to top\nRecalls of cosmetics are voluntary actions taken by manufacturers or distributors to remove from the marketplace products that represent a hazard or gross d",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "facturers or distributors to remove from the marketplace products that represent a hazard or gross deception, or that are somehow defective (21 CFR 7.40(a). FDA is not authorized to order recalls of cosmetics, but we do monitor companies that conduct a product recall and may request a product recall if the firm is not willing to remove dangerous products from the market without FDA's written request. To learn more, see “FDA Recall Policy for Cosmetics.”\nFDA may take regulatory action if we have",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "st. To learn more, see “FDA Recall Policy for Cosmetics.”\nFDA may take regulatory action if we have reliable information indicating that a cosmetic is adulterated or misbranded. For example, FDA can pursue action through the Department of Justice in the federal court system to remove adulterated and misbranded cosmetics from the market. To prevent further shipment of an adulterated or misbranded product, FDA may request a federal district court to issue a restraining order against the manufactur",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "roduct, FDA may request a federal district court to issue a restraining order against the manufacturer or distributor of the violative cosmetic. Cosmetics that are not in compliance with the law may be subject to seizure. “Seizure” means that the government takes possession of property from someone who has violated the law, or is suspected of doing so. FDA also may initiate criminal action against a person violating the law.\nIn addition, FDA works closely with U.S. Customs and Border Protection",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "a person violating the law.\nIn addition, FDA works closely with U.S. Customs and Border Protection to monitor imports. Under section 801(a) of the FD&C Act, imported cosmetics are subject to review by FDA at the time of entry through U.S. Customs. Products that do not comply with FDA laws and regulations are subject to refusal of admission into the United States. They must be brought into compliance (if possible), destroyed, or re-exported. FDA does not inspect every shipment of cosmetics that",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "nce (if possible), destroyed, or re-exported. FDA does not inspect every shipment of cosmetics that comes into this country, but imported cosmetics are still subject to the laws we enforce, even if they are not inspected upon entry. To learn more, see “Information for Cosmetics Importers.”\nFDA takes regulatory action based upon agency priorities, consistent with public health concerns and available resources.\nback to top\nFDA can and does inspect cosmetic manufacturing facilities to assure cosmet",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "e resources.\nback to top\nFDA can and does inspect cosmetic manufacturing facilities to assure cosmetic product safety and determine whether cosmetics are adulterated or misbranded under the FD&C Act or FPLA.\nAlthough FD&C Act does not subject cosmetics to premarket approval by FDA, we do collect samples for examination and analysis as part of cosmetic facility inspections, import inspections, and follow-up to complaints of adverse events associated with their use. FDA may also conduct research o",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "follow-up to complaints of adverse events associated with their use. FDA may also conduct research on cosmetic products and ingredients to address safety concerns.\nFDA does not function as a private testing laboratory, and in order to avoid even the perception of conflict of interest, we do not recommend private laboratories to consumers or manufacturers for sample analysis.\nUnder the law, manufacturers are not required to register their cosmetic establishments or file their product formulations",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "turers are not required to register their cosmetic establishments or file their product formulations with FDA, and no registration number is required to import cosmetics into the United States.\nHowever, we encourage cosmetic firms to participate in FDA's Voluntary Cosmetic Registration Program (VCRP) using the online registration system. Cosmetic manufacturers, distributors, and packers can file information on their products that are currently being marketed to consumers in the United States and",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "nformation on their products that are currently being marketed to consumers in the United States and register their manufacturing and/or packaging facility locations in the VCRP database. To learn more and access this program, see Voluntary Cosmetic Registration Program (VCRP).\nMarch 3, 2005; updated August 3, 2013\nback to top",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "Frequently requested resources for cosmetics manufacturers, packers, and distributors, large and small, are listed on this page.\nColor Additives:\nSUBSCRIBE",
    "url": "https://www.fda.gov/cosmetics/resources-you-cosmetics/resources-industry-cosmetics"
  },
  {
    "text": "FDA sometimes receives questions from consumers and industry, asking about shelf life and expiration dates for cosmetics. Here are answers to some common questions on this subject.\nA product’s “shelf life” generally means the length of time you can expect a product to look and act as expected and to stay safe for use. This length of time varies, depending on the type of product, how it is used, and how it is stored.\nOver time, cosmetics start to degrade or break down for a number of reasons. Her",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/shelf-life-and-expiration-dating-cosmetics"
  },
  {
    "text": "d how it is stored.\nOver time, cosmetics start to degrade or break down for a number of reasons. Here are some common ones:\nEye-area cosmetics tend to have shorter shelf lives than other products, which may cause eye infections that can be serious. Manufacturers usually recommend discarding mascara two to four months after purchase. That’s because each time a person uses mascara, it’s exposed to bacteria and fungi.\nThere are no U.S. laws or regulations that require cosmetics to have specific she",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/shelf-life-and-expiration-dating-cosmetics"
  },
  {
    "text": "acteria and fungi.\nThere are no U.S. laws or regulations that require cosmetics to have specific shelf lives or have expiration dates on their labels. However, manufacturers are responsible for making sure their products are safe.  FDA considers determining a product’s shelf life to be part of the manufacturer’s responsibility.\nNot all “personal care products” are regulated as cosmetics. Some, such as sunscreen products and acne treatments, are drugs under the law. Some, such as makeup and moist",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/shelf-life-and-expiration-dating-cosmetics"
  },
  {
    "text": "h as sunscreen products and acne treatments, are drugs under the law. Some, such as makeup and moisturizers that are also sunscreens, with “SPF” labeling, are regulated as both cosmetics and drugs.\nDrugs, including those that are both drugs and cosmetics, must be tested for stability (see the regulations at 21 CFR 211) and are required to have expiration dates printed on the labels. Manufacturers must make sure their drug products are safe and effective until their expiration dates.\nTo learn mor",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/shelf-life-and-expiration-dating-cosmetics"
  },
  {
    "text": "must make sure their drug products are safe and effective until their expiration dates.\nTo learn more, see “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?).”\nBased on inspections of cosmetics manufacturers, FDA is aware that some companies test products by exposing samples to different temperatures and humidity levels, to see how different conditions affect the products. This helps determine how long a product will stay safe and usable under normal conditions. Some companies also track how l",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/shelf-life-and-expiration-dating-cosmetics"
  },
  {
    "text": "ow long a product will stay safe and usable under normal conditions. Some companies also track how long their products have been on store shelves and alert stores when it is time to discard them.\nHowever, the law does not require cosmetics companies to share testing and tracking information with FDA. If you would like to know how a company tests cosmetic shelf life and keeps track of products on the market, you will need to contact the company.\nHow long you can use a cosmetic safely also depends",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/shelf-life-and-expiration-dating-cosmetics"
  },
  {
    "text": "he market, you will need to contact the company.\nHow long you can use a cosmetic safely also depends on you. Here are tips to help keep your cosmetics safe:",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/shelf-life-and-expiration-dating-cosmetics"
  },
  {
    "text": "On this page:\nThere are important differences between definitions and requirements for cosmetic products and drugs in the United States, and these differences vary among countries worldwide.  Some products regulated as cosmetics in Europe, for instance, are regulated as drugs in the United States. Sunscreens are a case in point. There also are differences regarding prohibited and restricted ingredients, particularly color additives. In addition, like in the United States, some countries may requ",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "ients, particularly color additives. In addition, like in the United States, some countries may require cosmetic companies to register their establishments and list products and ingredients with the government.\nImported cosmetics must comply with the same U.S. laws and regulations that apply to those produced domestically.\nWith the passage of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), the most significant expansion of FDA’s authority to regulate cosmetics since the Federal Fo",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "MoCRA), the most significant expansion of FDA’s authority to regulate cosmetics since the Federal Food, Drug, and Cosmetic (FD&C) Act was passed in 1938, FDA has new authorities to help ensure the safety of cosmetic products many consumers use daily. MoCRA provides new authorities to FDA including records access and mandatory recall authority. MoCRA also establishes new requirements for industry concerning adverse event reporting, facility registration and product listing, and safety substantiat",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "oncerning adverse event reporting, facility registration and product listing, and safety substantiation. MoCRA further requires FDA to establish regulations for Good Manufacturing Practices for facilities that manufacture or process cosmetic products; fragrance allergen labeling requirements; and standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products.\nThe Federal Food, Drug & Cosmetic Act (FD&C Act) defines “cosmetic” in Section 201(i) as \"articl",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "ts.\nThe Federal Food, Drug & Cosmetic Act (FD&C Act) defines “cosmetic” in Section 201(i) as \"articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance.\" MoCRA amends the FD&C Act to include “cosmetic product,” which is defined as “a preparation of cosmetic ingredients with a qualitatively and quantitatively set composition for use in a finished produ",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "etic ingredients with a qualitatively and quantitatively set composition for use in a finished product” [FD&C Act, sec. 361].\nIncluded in these definitions are products consumers use, such as skin moisturizers, perfumes, lipsticks, fingernail polishes, and eye and facial makeup preparations. To learn more, see Cosmetic Product Categories and Codes.\nThe FD&C Act defines drugs as \"articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease...and articles (othe",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "for use in the diagnosis, cure, mitigation, treatment, or prevention of disease...and articles (other than food) intended to affect the structure or any function of the body of man or other animals.\" Over-the-counter (OTC) drugs are drugs that can be purchased without a doctor's prescription.\nCertain claims may cause a product to qualify as a drug, even if the product is marketed as if it were a cosmetic. Such claims establish the product as a drug because the intended use is to treat or prevent",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "osmetic. Such claims establish the product as a drug because the intended use is to treat or prevent disease or otherwise affect the structure or functions of the human body. Some examples are claims that products will restore hair growth, reduce cellulite, treat varicose veins, or revitalize cells.\nOTC drugs are often marketed side by side with cosmetics, and some products qualify both as cosmetics and as OTC drugs. This may happen when a product has more than one intended use. For example, an",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "cs and as OTC drugs. This may happen when a product has more than one intended use. For example, an anti-dandruff shampoo is both a cosmetic and a drug. It is a cosmetic, since its intended use is to cleanse the hair, and it is also a drug, because its intended use is to treat dandruff. Other cosmetic/drug products include some toothpastes that contain fluoride or make anti-caries or anti-gingivitis claims, deodorants that are also antiperspirants, and moisturizers and makeup marketed with sun-p",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "is claims, deodorants that are also antiperspirants, and moisturizers and makeup marketed with sun-protection claims.\nFDA does not pre-approve cosmetic products or ingredients, with the important exception of some color additives. However, cosmetic firms are responsible for marketing safe, properly labeled products; using no prohibited ingredients; and adhering to limits on restricted ingredients. To learn more, see Prohibited & Restricted Ingredients in Cosmetics.\nBefore marketing a product con",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "To learn more, see Prohibited & Restricted Ingredients in Cosmetics.\nBefore marketing a product containing a color additive in the United States, it is essential to determine whether the additive is approved for its intended use. Many color additives must be certified for purity in FDA labs if they are to be used legally in a product marketed in the United States. To learn more, see Color Additives Permitted for Use in Cosmetics.\nAlthough U.S. FDA regulations do not specify any particular testi",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "es Permitted for Use in Cosmetics.\nAlthough U.S. FDA regulations do not specify any particular testing regimens for cosmetic products or ingredients, cosmetics firms, even before MoCRA, have been responsible for marketing safe products.  In addition, MoCRA explicitly requires that a responsible person for a cosmetic product shall ensure, and maintain records supporting, that there is adequate substantiation of safety of their cosmetic product. To learn more, see Product Testing of Cosmetics.\nMoC",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "tantiation of safety of their cosmetic product. To learn more, see Product Testing of Cosmetics.\nMoCRA provided new authorities to FDA including:\nResponsible person means the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product in accordance with section 609(a) of the FD&C Act or section 4(a) of the Fair Packaging and Labeling Act.\nTo learn more, see Registration & Listing of Cosmetic Product Facilities and Products.",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "learn more, see Registration & Listing of Cosmetic Product Facilities and Products.",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/cosmetics-us-law"
  },
  {
    "text": "While FDA can’t give medical advice, here is information on cosmetic safety that may be useful for doctors, nurses, physicians’ assistants, and other caregivers.\nSUBSCRIBE",
    "url": "https://www.fda.gov/cosmetics/resources-you-cosmetics/resources-health-professionals-cosmetics"
  },
  {
    "text": "The information below is an overview of regulatory requirements for cosmetics, with an emphasis on those that affect labeling.\nOn this page:\nCosmetics marketed in the United States, whether manufactured here or imported from abroad, must be in compliance with the provisions of the Federal Food, Drug, and Cosmetic Act (FD&C Act), Fair Packaging and Labeling Act (FP&L Act) 15 USC Ch. 39; 16 CFR Chapter 1 Subchapter E, and the regulations published under the authority of these laws.\nThe regulations",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "ter 1 Subchapter E, and the regulations published under the authority of these laws.\nThe regulations published by the Food and Drug Administration (FDA) are all codified in Title 21, Code of Federal Regulations (21 CFR). The regulations related to cosmetics are stated at 21 CFR, parts 700 to 740 (21 CFR 700 to 740). The color additive regulations that apply to cosmetics are found at 21 CFR 73, 74, 81 and 82.\nThe FD&C Act defines cosmetics as articles intended to be applied to the human body for",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "81 and 82.\nThe FD&C Act defines cosmetics as articles intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance without affecting the body's structure or functions. Included in this definition are products such as skin creams, lotions, perfumes, lipsticks, fingernail polishes, eye and facial make-up preparations, shampoos, permanent waves, hair colors, toothpastes, deodorants, and any material intended for use as a component of a c",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "waves, hair colors, toothpastes, deodorants, and any material intended for use as a component of a cosmetic product. Soap products consisting primarily of an alkali salt of fatty acid and making no label claim other than cleansing of the human body are not considered cosmetics under the law.\nProducts that are cosmetics but are also intended to treat or prevent disease, or affect the structure or functions of the human body, are considered also drugs and must comply with both the drug and cosmeti",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "unctions of the human body, are considered also drugs and must comply with both the drug and cosmetic provisions of the law. Examples of products which are drugs as well as cosmetics are anticaries toothpastes (e.g., \"fluoride\" toothpastes), suntanning preparations intended to protect against sunburn, antiperspirants that are also deodorants, and antidandruff shampoos.\nMost currently marketed cosmetics which are also drugs are over-the-counter drugs. Several are new drugs for which safety and ef",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "etics which are also drugs are over-the-counter drugs. Several are new drugs for which safety and effectiveness had to be proved to the agency before they could be marketed. A new drug is a drug which is not generally recognized by experts as safe and effective under the conditions of intended use or which has become so recognized but has not been used to a material extent or for a material time under such conditions.\nThe regulatory requirements for drugs are more extensive than the requirements",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "nder such conditions.\nThe regulatory requirements for drugs are more extensive than the requirements applicable to cosmetics. For example, the FD&C Act requires that drug manufacturers register every year with the FDA and update their lists of all manufactured drugs twice annually. Additionally, drugs must be manufactured in accordance with current good manufacturing practice regulations as codified at 21 CFR 210 and 211.\nFor additional information, refer to Is It a Cosmetic, a Drug, or Both? (O",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "ed at 21 CFR 210 and 211.\nFor additional information, refer to Is It a Cosmetic, a Drug, or Both? (Or Is It Soap)?\nThe FD&C Act prohibits the distribution of cosmetics which are adulterated or misbranded. A cosmetic is considered adulterated if it contains a substance which may make the product harmful to consumers under customary conditions of use; if it contains a filthy, putrid, or decomposed substance; if it is manufactured or held under insanitary conditions whereby it may have become conta",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "ubstance; if it is manufactured or held under insanitary conditions whereby it may have become contaminated with filth, or may have become harmful to consumers; or if it is not a hair dye and it contains a non-permitted color additive. Coal-tar hair dyes bearing on the label the caution statement prescribed by law and that give \"patch-test\" instructions are exempted from the adulteration provision even if they are irritating to the skin or are otherwise harmful to the human body. Eyelash and eye",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "even if they are irritating to the skin or are otherwise harmful to the human body. Eyelash and eyebrow dyes are not included in this exemption. All dyes used in eyelash and eyebrow dye products must be approved by the FDA for such use.\nA cosmetic is misbranded if its labeling is false or misleading, if it does not bear the required labeling information, or if the container is made or filled in a deceptive manner. For additional information, see Key Legal Concepts: \"Interstate Commerce,\" \"Adult",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "deceptive manner. For additional information, see Key Legal Concepts: \"Interstate Commerce,\" \"Adulterated,\" and \"Misbranded.\"\nThe cosmetics distributed in the United States must comply with the labeling regulations published by the FDA under the authority of the FD&C Act and the FP&L Act. Labeling means all labels and other written, printed or graphic matter on or accompanying a product. The label statements required under the authority of the FD&C Act must appear on the inside as well as any o",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "l statements required under the authority of the FD&C Act must appear on the inside as well as any outside container or wrapper. FP&L Act requirements, e.g., ingredient labeling and statement of the net quantity of contents on the principal display panel, only apply to the label of the outer container. The labeling requirements are codified at 21 CFR 701 and 740. Cosmetics bearing false or misleading label statements or otherwise not labeled in accordance with these requirements may be considere",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "ing label statements or otherwise not labeled in accordance with these requirements may be considered misbranded and may be subject to regulatory action.\nThe principal display panel, i.e., the part of the label most likely displayed or examined under customary conditions of display for sale (21 CFR 701.10), must state the name of the product, identify by descriptive name or illustration the nature or use of the product, and bear an accurate statement of the net quantity of contents of the cosmet",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "or use of the product, and bear an accurate statement of the net quantity of contents of the cosmetic in the package in terms of weight, measure, numerical count, or a combination of numerical count and weight or measure. The declaration must be distinct, placed in the bottom area of the panel in line generally parallel to the base on which the package rests, and in a type size commensurate with the size of the container as prescribed by regulation. The net quantity of contents statement of a s",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "the size of the container as prescribed by regulation. The net quantity of contents statement of a solid, semisolid or viscous cosmetic must be in terms of the avoirdupois pound and ounce, and a statement of liquid measure must be in terms of the U.S. gallon of 231 cubic inches and the quart, pint, and fluid ounce subdivisions thereof. If the net quantity of contents is one pound or one pint or more, it must be expressed in ounces, followed in parenthesis () by a declaration of the largest whole",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "re, it must be expressed in ounces, followed in parenthesis () by a declaration of the largest whole units (i.e., pounds and ounces or quarts and pints and ounces). The net quantity of contents may additionally be stated in terms of the metric system of weights or measures.\nThe name and place of business of the firm marketing the product must be stated on an information panel of the label (21 CFR 701.12). The address must state the street address, city, state, and zip code. If a firm is listed i",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "701.12). The address must state the street address, city, state, and zip code. If a firm is listed in a current city or telephone directory, the street address may be omitted. If the distributor is not the manufacturer or packer, this fact must be stated on the label by the qualifying phrase \"Manufactured for ......\" or \"Distributed by ......\" or similar, appropriate wording.\nThe Tariff Act of 1930 requires that all imported articles state on the label the English name of the country of origin.",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "0 requires that all imported articles state on the label the English name of the country of origin.\nCosmetics produced or distributed for retail sale to consumers for their personal care are required to bear an ingredient declaration (21 CFR 701.3). Cosmetics not customarily distributed for retail sale, e.g., hair preparations or make-up products used by professionals on customers at their establishments and skin cleansing or emollient creams used by persons at their places of work, are exempt f",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "shments and skin cleansing or emollient creams used by persons at their places of work, are exempt from this requirement provided these products are not also sold to consumers at professional establishments or workplaces for their consumption at home.\nThe ingredient declaration must be conspicuous so that it is likely to be read at the time of purchase. It may appear on any information panel of the package, i.e., the folding carton, box wrapping if the immediate container is so packaged, and may",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "e package, i.e., the folding carton, box wrapping if the immediate container is so packaged, and may also appear on a firmly affixed tag, tape or card. The letters must not be less than 1/16 of an inch in height (21 CFR 701.3 (b)). If the total package surface available to bear labeling is less than 12 square inches, the letters must not be less than 1/32 of an inch in height (21 CFR 701.3(p)). Off-package ingredient labeling is permitted if the cosmetic is held in tightly compartmented trays or",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "f-package ingredient labeling is permitted if the cosmetic is held in tightly compartmented trays or racks, it is not enclosed in a folding carton, and the package surface area is less than 12 square inches (21 CFR 701.3(i)).\nThe ingredients must be declared in descending order of predominance. Color additives (21 CFR 701.3(f)(3)) and ingredients present at one percent or less (21 CFR 701.3(f)(2)) may be declared without regard for predominance. The ingredients must be identified by the names es",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "may be declared without regard for predominance. The ingredients must be identified by the names established or adopted by regulation (21 CFR 701.3(c)); those accepted by the FDA as exempt from public disclosure may be stated as \"and other ingredients\" (21 CFR 701.3(a)).\nCosmetics which are also drugs must first identify the drug ingredient(s) as \"active ingredient(s)\" before listing the cosmetic ingredients (21 CFR 701.3(d)).\nAll label statements required by regulation must be in the English l",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "ingredients (21 CFR 701.3(d)).\nAll label statements required by regulation must be in the English language and must be placed on the label or labeling with such prominence and conspicuousness that they are readily noticed and understood by consumers under customary conditions of purchase (21 CFR 701.2).\nCosmetics which may be hazardous to consumers when misused must bear appropriate label warnings and adequate directions for safe use. The statements must be prominent and conspicuous. Some cosme",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "s and adequate directions for safe use. The statements must be prominent and conspicuous. Some cosmetics must bear label warnings or cautions prescribed by regulation (21 CFR 740). Cosmetics in self-pressurized containers (aerosol products), feminine deodorant sprays, and children's bubble bath products are examples of products requiring such statements.\nAlthough the FD&C Act does not require that cosmetic manufacturers or marketers test their products for safety, the FDA strongly urges cosmetic",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "cosmetic manufacturers or marketers test their products for safety, the FDA strongly urges cosmetic manufacturers to conduct whatever toxicological or other tests are appropriate to substantiate the safety of their cosmetics. If the safety of a cosmetic is not adequately substantiated, the product may be considered misbranded and may be subject to regulatory action unless the label bears the following statement: Warning--The safety of this product has not been determined. Sec. 21 CFR 740.10.\nLi",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "owing statement: Warning--The safety of this product has not been determined. Sec. 21 CFR 740.10.\nLiquid oral hygiene products (e.g., mouthwashes, fresheners) and all cosmetic vaginal products (e.g., douches, tablets) must be packaged in tamper-resistant packages when sold at retail. A package is considered tamper resistant if it has an indicator or barrier to entry (e.g., shrink or tape seal, sealed carton, tube or pouch, aerosol container) which, if breached or missing, alerts a consumer that",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "led carton, tube or pouch, aerosol container) which, if breached or missing, alerts a consumer that tampering has occurred. The indicator must be distinctive by design (breakable cap, blister) or appearance (logo, vignette, other illustration) to preclude substitution. The tamper-resistant feature may involve the immediate or outer container or both. The package must also bear a prominently placed statement alerting the consumer to the tamper-resistant feature. This statement must remain unaffec",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "statement alerting the consumer to the tamper-resistant feature. This statement must remain unaffected if the tamper-resistant feature is breached or missing. Sec. 21 CFR 700.25.\nFor enforcement of the law, the FDA may conduct examinations and investigations of products, inspect establishments in which products are manufactured or held, and seize adulterated (harmful) or misbranded (incorrectly or deceptively labeled or filled) cosmetics. Adulterated or misbranded foreign products may be refuse",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "r deceptively labeled or filled) cosmetics. Adulterated or misbranded foreign products may be refused entry into the United States. To prevent further shipment of an adulterated or misbranded product, the agency may request a federal district court to issue a restraining order against the manufacturer or distributor of the violative cosmetic. The FDA may also initiate criminal action against a person violating the law. Examples of products seized in recent years are nail preparations containing",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "son violating the law. Examples of products seized in recent years are nail preparations containing methyl methacrylate or formaldehyde, various eyebrow and eyelash dye products containing prohibited coal-tar dyes, and products contaminated with harmful microorganisms. For further information, see FDA Authority Over Cosmetics.",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/summary-labeling-requirements"
  },
  {
    "text": "The Federal Food, Drug and Cosmetic Act prohibits the introduction or delivery for introduction into interstate commerce of cosmetics that are adulterated or misbranded (Sec. 301).\nA cosmetic may be deemed adulterated (Sec. 601) for essentially four reasons, namely:\nA cosmetic may be deemed misbranded (Sec. 602) for reasons of:\nTo determine whether cosmetic firms manufacture, hold or deliver for introduction into interstate commerce cosmetics that are adulterated or misbranded, and to prevent th",
    "url": "https://www.fda.gov/cosmetics/guidance-documents/good-manufacturing-practice-gmp-guidelinesinspection-checklist"
  },
  {
    "text": "ntroduction into interstate commerce cosmetics that are adulterated or misbranded, and to prevent these and other practices violating Sec. 301 of the FD&C Act, the law gives the agency the authority to enter the establishments of such firms and inspect their facilities as well as all pertinent equipment, finished and unfinished materials, containers and labeling therein. See Sec. 704(a) of the FD&C Act.\nRigorous adherence to good manufacturing practice minimizes the risk of adulteration or misbr",
    "url": "https://www.fda.gov/cosmetics/guidance-documents/good-manufacturing-practice-gmp-guidelinesinspection-checklist"
  },
  {
    "text": "C Act.\nRigorous adherence to good manufacturing practice minimizes the risk of adulteration or misbranding of cosmetics. The following cosmetic establishment instructions, excerpted from FDA's Inspection Operations Manual, may serve as guidelines for effective self-inspection. A good inspection score means that an establishment follows good manufacturing practice.\nFor important information on international approaches to Good Manufacturing Practice, please refer to International Cooperation on Co",
    "url": "https://www.fda.gov/cosmetics/guidance-documents/good-manufacturing-practice-gmp-guidelinesinspection-checklist"
  },
  {
    "text": "rnational approaches to Good Manufacturing Practice, please refer to International Cooperation on Cosmetic Regulation Outcome of MeetingExternal Link Disclaimer, September 26-28, 2007.",
    "url": "https://www.fda.gov/cosmetics/guidance-documents/good-manufacturing-practice-gmp-guidelinesinspection-checklist"
  },
  {
    "text": "FAQs Main Page\nFDA-regulated does not mean FDA-approved. FDA does not have the legal authority to approve cosmetics before they go on the market, although we do approve color additives used in them (except coal tar hair dyes).\nHowever, under the law, cosmetics must not be \"adulterated\" or \"misbranded.\" For example, they must be safe for consumers when used according to directions on the label, or in the customary or expected way, and they must be properly labeled. Companies and individuals who m",
    "url": "https://www.fda.gov/cosmetics/consumers/cosmetics-qa-why-are-cosmetics-not-fda-approved"
  },
  {
    "text": "in the customary or expected way, and they must be properly labeled. Companies and individuals who market cosmetics have a legal responsibility for the safety and labeling of their products.\nFDA can take action against a cosmetic on the market if we have reliable information showing that it is adulterated or misbranded. FDA takes action within our legal authority, based on public health priorities and available resources.\nTo learn more, see\n\nFDA Basics Cosmetics PageExternal Link Disclaimer",
    "url": "https://www.fda.gov/cosmetics/consumers/cosmetics-qa-why-are-cosmetics-not-fda-approved"
  },
  {
    "text": "and available resources.\nTo learn more, see\n\nFDA Basics Cosmetics PageExternal Link Disclaimer",
    "url": "https://www.fda.gov/cosmetics/consumers/cosmetics-qa-why-are-cosmetics-not-fda-approved"
  },
  {
    "text": "Cosmetics manufacturers and distributors may need to work with government agencies other than FDA. Here is a list of agencies you may need to know about, and why:\nFDA has entered into Memoranda of Understanding (MOU) with a number of other entities in government, academia, and elsewhere to define lines of authority or responsibility or to clarify cooperative procedures. The intent of an MOU is to improve consumer protection through more effective use of collective resources and to eliminate dupl",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/cosmetics-resources-other-government-agencies"
  },
  {
    "text": "improve consumer protection through more effective use of collective resources and to eliminate duplication of activities.\nMore Resources",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/cosmetics-resources-other-government-agencies"
  },
  {
    "text": "Arabic (عربي)Chinese Simplified (简体中文)French (Français)Haitian Creole (Kreyòl ayisyen)Korean (한국인)Spanish (Español)Tagalog (Tagalog)\nIn the case of a reaction or problem with a cosmetic product, the first step is to stop using the product and contact your healthcare provider. Food and Drug Administration (FDA, we) does not provide medical advice. Secondly, report the problem to FDA.\nReport a Cosmetic Product Complaint\nCosmetic products are not the same as drug products, and they are regulated di",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-product-related-complaint"
  },
  {
    "text": "tic Product Complaint\nCosmetic products are not the same as drug products, and they are regulated differently by the FDA. Here are some examples of cosmetic products:\nIf you are a consumer or health professional who wants to report a complaint or adverse event (such as an illness, allergic reaction, rash, irritation, scarring, or hair loss) related to a cosmetic product, you can:\nComplete a paper MedWatch Consumer Voluntary Reporting Form and mail or fax the form to FDA:\nMedWatchFood and Drug Ad",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-product-related-complaint"
  },
  {
    "text": "MedWatch Consumer Voluntary Reporting Form and mail or fax the form to FDA:\nMedWatchFood and Drug Administration5600 Fishers LaneRockville, MD 20852FAX: 800-332-0178 (toll-free).\nThe Modernization of Cosmetics Regulation Act of 2022 (MoCRA) was enacted on December 29, 2022. MoCRA amends Chapter VI of the Federal Food, Drug, and Cosmetic Act and provides for the most significant expansion of FDA authority to regulate cosmetics since 1938.\nMoCRA requires a responsible person (see definition below)",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-product-related-complaint"
  },
  {
    "text": "thority to regulate cosmetics since 1938.\nMoCRA requires a responsible person (see definition below) to report serious adverse events (see definition below) associated with the use of cosmetic products in the United States to FDA, within 15 business days. The responsible person must include a copy of the label on or within the retail packaging of such cosmetic product. If the responsible person receives medical or other information about the adverse event within 1 year of the initial report to F",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-product-related-complaint"
  },
  {
    "text": "ceives medical or other information about the adverse event within 1 year of the initial report to FDA, they must submit this new information to FDA within 15 business days. FDA will also have access to adverse event reports during an inspection.\nIt is mandatory for industry responsible persons to submit serious adverse event reports (SAER) for cosmetic products by using the current Form FDA 3500A - Mandatory Reporting that is downloadable and fillable at MedWatch: The FDA Safety Information and",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-product-related-complaint"
  },
  {
    "text": "- Mandatory Reporting that is downloadable and fillable at MedWatch: The FDA Safety Information and Adverse Event Reporting Program - Mandatory (PDF).\nPlease see the Instructions for Completing Form FDA 3500A.\nSubmit:\nto FDA via email at: CosmeticAERS@fda.hhs.gov or by mail to:\nFDA CDER Mail CenterAttn: Cosmetics MedWatch reportsWhite Oak Campus, Building 22, G020710903 New Hampshire Ave.Silver Spring, MD 20993\nFDA is developing a process for submitting electronic mandatory adverse event report",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-product-related-complaint"
  },
  {
    "text": "pring, MD 20993\nFDA is developing a process for submitting electronic mandatory adverse event reports for cosmetic products.\nWhile MoCRA does not require industry responsible persons to submit non-serious adverse event reports for cosmetic products to FDA, you may submit non-serious adverse event reports voluntarily using Form 3500A, following the same process described above for mandatory adverse event reports.\nSerious Adverse Event: an adverse event that:\n(A) results in:\n(B) requires, based on",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-product-related-complaint"
  },
  {
    "text": "event reports.\nSerious Adverse Event: an adverse event that:\n(A) results in:\n(B) requires, based on reasonable medical judgment, a medical or surgical intervention to prevent an outcome described in (A) above.\nResponsible Person: the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product in accordance with section 609(a) of the FD&C Act or section 4(a) of the Fair Packaging and Labeling Act.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-product-related-complaint"
  },
  {
    "text": "or section 4(a) of the Fair Packaging and Labeling Act.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-product-related-complaint"
  },
  {
    "text": "This section contains information on compliance with and enforcement of laws and related FDA regulations for cosmetics.\nIf you’ve experienced a bad reaction to a cosmetic product, FDA wants to know. You can report a problem with a cosmetic product to FDA by using the contact information at How to Report a Cosmetic Product Related Complaint | FDA.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement"
  },
  {
    "text": "FAQs Main Page\nThe Federal Food, Drug, and Cosmetic Act does not specifically require the use of animals in testing cosmetics for safety, nor does it subject cosmetics to FDA premarket approval. However, FDA has consistently advised cosmetic manufacturers to employ whatever testing is appropriate and effective for substantiating the safety of their products. It remains the responsibility of the manufacturer to substantiate the safety of both ingredients and finished cosmetic products prior to ma",
    "url": "https://www.fda.gov/cosmetics/consumers/cosmetics-safety-qa-animal-testing"
  },
  {
    "text": "nufacturer to substantiate the safety of both ingredients and finished cosmetic products prior to marketing.\nAnimal testing by manufacturers seeking to market new products may be used to establish product safety. In some cases, after considering available alternatives, companies may determine that animal testing is necessary to assure the safety of a product or ingredient.\nFDA supports the development and use of alternatives to whole-animal testing as well as adherence to the most humane methods",
    "url": "https://www.fda.gov/cosmetics/consumers/cosmetics-safety-qa-animal-testing"
  },
  {
    "text": "ment and use of alternatives to whole-animal testing as well as adherence to the most humane methods available within the limits of scientific capability when animals are used for testing the safety of cosmetic products. We will continue to be a strong advocate of methodologies for the refinement, reduction, and replacement of animal tests with alternative methodologies that do not employ the use of animals.\nTo learn more, see Animal Testing & Cosmetics.\nMore Resources:",
    "url": "https://www.fda.gov/cosmetics/consumers/cosmetics-safety-qa-animal-testing"
  },
  {
    "text": "of animals.\nTo learn more, see Animal Testing & Cosmetics.\nMore Resources:",
    "url": "https://www.fda.gov/cosmetics/consumers/cosmetics-safety-qa-animal-testing"
  },
  {
    "text": "Available in PDF (316KB)\nThe Cosmetics Labeling Guide provides step-by-step help with cosmetic labeling, with examples and answers to questions  manufacturers often ask about labeling requirements under U.S. laws and related regulations.\nOn this page:\nFederal Food, Drug, and Cosmetic Act of 1938, as amended\nTo protect consumers from unsafe or deceptively labeled or packaged products by prohibiting the movement in interstate commerce of adulterated or misbranded food, drugs, devices, and cosmetic",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "the movement in interstate commerce of adulterated or misbranded food, drugs, devices, and cosmetics.\n21 U.S.C. 321-392\nThe cosmetics marketed in the United States, whether they are manufactured here or are imported from abroad, must comply with the labeling requirements of the Federal Food, Drug, and Cosmetic (FD&C) Act, the Fair Packaging and Labeling (FP&L) Act, and the regulations published by the Food and Drug Administration under the Authority of these two laws.\nThe FD&C Act was enacted b",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "y the Food and Drug Administration under the Authority of these two laws.\nThe FD&C Act was enacted by Congress to protect consumers from unsafe or deceptively labeled or packaged products by prohibiting the movement in interstate commerce of adulterated or misbranded food, drug devices and cosmetics.\nback to top\nFair Packaging and Labeling Act\nTo ensure that packages and their labels provide consumers with accurate information about the quantity of contents and facilitate value comparisons.\n15 U",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "mers with accurate information about the quantity of contents and facilitate value comparisons.\n15 U.S.C. 1451-1460\nThe FP&L Act was passed by Congress to ensure that packages and their labels provide consumers with accurate information about the quantity of contents and facilitate value comparisons.\nFederal Food, Drug, and Cosmetic Act\nThe FD&C Act prohibits the marketing of cosmetics that are adulterated or misbranded as well as their adulteration or misbranding while in interstate commerce.\nS",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ulterated or misbranded as well as their adulteration or misbranding while in interstate commerce.\nSec. 301, FD&C Act\nThe FD&C Act prohibits the marketing of cosmetics that are adulterated or misbranded as well as their adulteration or misbranding while in interstate commerce.\nA cosmetic is considered misbranded if.....\nSec. 602, FD&C Act\nSec. 602 of the FD&C Act defines the conditions which cause a cosmetic to be deemed misbranded.\nFactors Determining Whether Labeling Is Misleading\nSec. 201(n),",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "a cosmetic to be deemed misbranded.\nFactors Determining Whether Labeling Is Misleading\nSec. 201(n), FD&C Act\n21 CFR 1.21\nLabeling may be considered misleading not only because a label statement is deceptive but also because a material fact is not revealed on a label.\nA fact may be material in light of a statement made on a label or because certain consequences may result from the recommended use of a product.\nWhat is a cosmetic?\nA cosmetic is a product, except soap, intended to be applied to th",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "of a product.\nWhat is a cosmetic?\nA cosmetic is a product, except soap, intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance.\nSec. 201(i) FD&C Act\nAs defined in section 201(i) of the FD&C Act, a cosmetic is a product, except soap, intended to be applied to the human body for cleansing, beautifying, promoting attractiveness or altering the appearance.\nIn short, one may say that a cosmetic is a product intended to exert a physica",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ering the appearance.\nIn short, one may say that a cosmetic is a product intended to exert a physical, and not a physiological, effect on the human body.\nThe raw materials used as ingredients of cosmetic products are by law also cosmetics.\nIn section 701.20 of Title 21 of the Code of Federal Regulations [21 CFR 701.20], the Food and Drug Administration (FDA) defines the term \"soap\" as a product in which the non-volatile portion consists principally of an alkali salt of fatty acids, i.e., the tra",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "which the non-volatile portion consists principally of an alkali salt of fatty acids, i.e., the traditional composition of soap; the product is labeled as soap; and the label statements refer only to cleansing. If cosmetic claims, e.g., moisturizing, deodorizing, skin softening etc., are made on a label, the product is a cosmetic. Synthetic detergent bars are also considered cosmetics, although they may be labeled as \"soap.\"\nback to top\n\"Intended use\" within the meaning of the FD&C Act is deter",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "hey may be labeled as \"soap.\"\nback to top\n\"Intended use\" within the meaning of the FD&C Act is determined from its label or labeling.\nSenate Report No. 493\n73d Cong. 2d Sess. (1934)\nU.S. Courts of Appeals Decisions\nAccording to Senate Report No. 493 and court decisions, the term \"intended\" in the legal definition of the term \"cosmetic\" or in other definitions means, with respect to the use of a product, its directed or prescribed use as determined from the statements made on a product's label or",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "oduct, its directed or prescribed use as determined from the statements made on a product's label or labeling.\nThe courts, in deciding whether a product is a \"cosmetic\", a \"drug\", or both a \"drug\" and a \"cosmetic\", have relied principally on the consumer's perception of the meaning of a label statement and less so on the interpretation of the meaning of a label statement by the labeler or a regulatory agency.\nWhen is a cosmetic also a drug?\nA cosmetic is also a drug when it is intended to cleans",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "tory agency.\nWhen is a cosmetic also a drug?\nA cosmetic is also a drug when it is intended to cleanse, beautify or promote attractiveness as well as treat or prevent disease or otherwise affect the structure or any function of the human body.\nSec. 201(g) and (i), FD&C Act\nSec. 509, FD&C Act\nA cosmetic is legally also a drug if it is intended to exert a physical as well as a physiological effect because the FD&C Act defines in section 201(g) the term \"drug\" to mean, among other things, \"articles",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "cause the FD&C Act defines in section 201(g) the term \"drug\" to mean, among other things, \"articles intended for use in the ... cure, mitigation, treatment, or prevention of disease ... and ... articles ... intended to affect the structure or any function of the body ...\"\nSection 509 of the FD&C Act provides that the categories of \"drug\" and \"cosmetic\" are not mutually exclusive.\nWhat is a consumer commodity?\nA product customarily distributed for retail sale for use by consumers or for the perfo",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "r commodity?\nA product customarily distributed for retail sale for use by consumers or for the performance of services at home and usually consumed during such use.\nSec. 10(a), FP&L Act.\nA cosmetic is legally also a drug if it is intended to exert a physical as well as a physiological effect because the FD&C Act defines in section 201(g) the term \"drug\" to mean, among other things, \"articles intended for use in the ... cure, mitigation, treatment, or prevention of disease ... and ... articles ..",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ded for use in the ... cure, mitigation, treatment, or prevention of disease ... and ... articles ... intended to affect the structure or any function of the body ...\"\nSection 509 of the FD&C Act provides that the categories of \"drug\" and \"cosmetic\" are not mutually exclusive.\nPackage\nA container or wrapping, other than a shipping container or wrapping, in which a consumer commodity is delivered or displayed to retail purchasers.\nSec. 10(b), FP&L Act\n21 CFR 1.20\nThe term package is defined in th",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "r displayed to retail purchasers.\nSec. 10(b), FP&L Act\n21 CFR 1.20\nThe term package is defined in the Fair Packaging and Labeling Act [sec. 10(b)] and the Code of Federal Regulations [21 CFR 1.20].\nEssentially, the \"package\" is the outer container of a product as, for example, a box or folding carton. However, the \"package\" can also be the immediate container, e.g., bottle, jar or aerosol can that holds the product if the immediate container is not displayed in a box or folding carton.\nLabel\nA w",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "holds the product if the immediate container is not displayed in a box or folding carton.\nLabel\nA written, printed or graphic display of information...\nSec. 201(k), FD&C Act.\nSec. 10(c), FP&L Act\n21 CFR 1.3(b)\nThe term \"label\" is defined in the FD&C Act and the FP&L Act. The definitions differ in that under the FD&C Act definition a label is \"a display of written, printed or graphic matter upon the immediate container,\" and under the FP&L Act definition \"written, printed or graphic matter affix",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "he immediate container,\" and under the FP&L Act definition \"written, printed or graphic matter affixed to any consumer commodity or affixed to or appearing upon a package containing any consumer commodity.\"\nOne may say that the term \"label\" applies in the first instance to the information appearing directly on the immediate container and in the second instance to information attached to the immediate container and directly on or attached to the outer container if so packaged.\nThe FD&C Act, howev",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ate container and directly on or attached to the outer container if so packaged.\nThe FD&C Act, however, requires in sec 201(k) that any information required to appear on the label of the immediate container shall also appear on the outside container of the retail package or is legible through the outside container.\nLabeling\nAll labels and other written, printed or graphic material on or accompanying a product in interstate commerce or held for sale\nSec. 201(m), FD&C Act\n21 CFR 1.3(a)\nThe FD&C Ac",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ng a product in interstate commerce or held for sale\nSec. 201(m), FD&C Act\n21 CFR 1.3(a)\nThe FD&C Act defines in sec. 201(m) \"labeling\" to mean \"all labels and other written, printed or graphic matter on or accompanying such article.\"\nThis includes labels, inserts, risers, display packs, leaflets, promotional literature or any other written or printed information distributed with a product.\nPrincipal Display Panel\nThe part of a label that the consumer sees or examines when displayed for retail s",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "pal Display Panel\nThe part of a label that the consumer sees or examines when displayed for retail sale\nSec. 10(t), FP&L Act\n21 CFR 701.10\nA label may consist of more than one panel. It may consist of a front panel, side panels and a back panel. Back and side panels are generally called information panels.\nThe FP&L Act also defines for consumer commodities, or packages containing a consumer commodity, the term \"principal display panel,\" otherwise known for short as PDP.\nThe \"principal display pa",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ity, the term \"principal display panel,\" otherwise known for short as PDP.\nThe \"principal display panel\" is that part of a panel that is most likely to be shown or examined under customary conditions of display for retail sale. Usually, it is the front panel of the label of the outer package.\nback to top\nPlacement and Size of Principal Display Panel\nLocation\nSize\nMultiple PDPs\n\nExceptions\n\nDecorative containers\nCompacts or pencils\nContainers of 1/4 av. oz. or 1/8 fl. oz. capacity\nDisplay cards\n2",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ive containers\nCompacts or pencils\nContainers of 1/4 av. oz. or 1/8 fl. oz. capacity\nDisplay cards\n21 CFR 701.10 and 701.13(e)\nAs mentioned before, the PDP is that part of the label that is most likely to be shown or examined under customary conditions for retail sale.\nRegulations [21 CFR 701.10] published by the FDA require that the PDP be large enough to accommodate all required label information with clarity and conspicuousness.\nIf a package bears more than one PDP, the information required t",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "n with clarity and conspicuousness.\nIf a package bears more than one PDP, the information required to be placed on the PDP must be duplicated on all PDPs.\nFor the purpose of assuring uniform type size for declaring a product's net quantity of contents, the size of the surface area bearing the PDP, and not the size of the PDP itself, is the determining factor. The area of the PDP is for a:\nRectangular package: One entire side.\nCylindrical package: 40% of height x circumference.\nAny other shape of",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "lar package: One entire side.\nCylindrical package: 40% of height x circumference.\nAny other shape of container: 40% of total container surface, excluding top, bottom, neck, shoulder, flanges.\nThe PDP of a \"boudoir-type\" or decorative cosmetic container, e.g., cartridge, pill box, compact or special variety, and those containing 1/4 oz or less may be a tear-away tag or tape affixed to the container [21 CFR 701.13(e)(1)]. It may also be the display panel of a card to which the immediate container",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "[21 CFR 701.13(e)(1)]. It may also be the display panel of a card to which the immediate container is affixed [21 CFR 701.13(e)(2)].\nPlacement of Information on Labels\nOuter Container\n(Or Label of Single Container Product)\nPrincipal Display Panel:\nName of product\nIdentity\n§ 740.10 warning\nNet quantity of contents\nInformation Panels:\nDirections for safe use\nWarnings\nName and place of business\nIngredient declaration\nAny other required information\nThe information above must appear on the label of",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "edient declaration\nAny other required information\nThe information above must appear on the label of the outer container which usually is a box, folding carton, wrapper etc. holding the inner (immediate) container. The immediate container holding the cosmetic product also is the outer container if it is not displayed in a box, folding carton etc.\nPlease note that only the label of an outer container has a PDP.\nStatement of the brand name of the product is not a regulatory requirement under the FD",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "r has a PDP.\nStatement of the brand name of the product is not a regulatory requirement under the FD&C or FP&L Act.\nback to top\nPlacement of Information on Labels\nInner Container (If Packaged in an Outer Container)\nFront Panel\nInformation Panels\n\nDirections for safe use\n\nWarnings\nName of Product\nName and Place of Business\n\nNet Quantity of Contents\n\nAny Other Required Information\nThe information above must appear on the label of the inner (immediate) container holding the cosmetic product. The in",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ove must appear on the label of the inner (immediate) container holding the cosmetic product. The inner container is packaged and displayed in a non-transparent box, folding carton etc. If the outer container is removed and the product displayed for sale without it, the label of the immediate container becomes a label of an outer container.\nForm of Stating Required Information\nSection 602(c) of the FD&C deems a cosmetic misbranded if any word, statement, or other label or labeling information re",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "e FD&C deems a cosmetic misbranded if any word, statement, or other label or labeling information required by law or regulation is not placed on the label or labeling with such prominence and conspicuousness that it is likely to be read, or if it is not stated in such terms that it is likely to be understood by ordinary individuals.\nProminence and Conspicuousness\nPanel display at purchase\nPanel size\nStyle and size of letters\nBackground contrast\nObscuring designs, vignettes\n21 CFR 701.2\nRegulatio",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ze\nStyle and size of letters\nBackground contrast\nObscuring designs, vignettes\n21 CFR 701.2\nRegulations [21 CFR 701.2] published by the FDA offer detailed information on how to comply with the requirement for prominent and conspicuous placement of information on cosmetic labels or labeling.\nPanel display: The required information must be on a panel which is presented or displayed under customary conditions of purchase. This eliminates placement of required information on a bottom panel of a cosme",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "nditions of purchase. This eliminates placement of required information on a bottom panel of a cosmetic unless it is very small and customarily picked up by hand where inspected for possible purchase.\nPanel Size: The label must be large enough to provide sufficient space for prominent display of the required information.\nStyle and Size of Letters: The type must be of such size, and at least of the required minimum size, and of such style that the required label statements are easily readable.\nBa",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "required minimum size, and of such style that the required label statements are easily readable.\nBackground Contrast: The contrast must be sufficient to make the required label statements conspicuous and easily readable.\nObscuring Designs, Vignettes: The required statements must not be obscured by vignettes or other designs or by crowding with other printed or graphic matter.\nback to top\nLanguage\nEnglish language statements\nForeign language statements\n21 CFR 701.2(b)\nEnglish Language Statements",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "English language statements\nForeign language statements\n21 CFR 701.2(b)\nEnglish Language Statements: All label or labeling statements required by law or regulation must be in the English language. Products distributed solely in Puerto Rico or a Territory where the predominant language is one other than English, may state the required label information in the predominant language in place of English.\nForeign Language Statements: If the label contains any foreign language representation, all stat",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "sh.\nForeign Language Statements: If the label contains any foreign language representation, all statements required by regulation must also appear on the label in the foreign language. If labeling bears foreign language representations, the required statements must appear on the label or other labeling as required in English.\nback to top\nType Size\nIngredients: 1/16\", 1/32\" (Labeling surface, less than 12 sq. in.)\nNet Contents:\n1/16\" (PDP less than 5 sq. in.)\n1/8\" (PDP 5-25 sq. in.)\n3/16\" (PDP 25",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "than 12 sq. in.)\nNet Contents:\n1/16\" (PDP less than 5 sq. in.)\n1/8\" (PDP 5-25 sq. in.)\n3/16\" (PDP 25-100 sq. in.)\nWarning: 1/16\"\nAll Others: Reasonably related to panel size\n21 CFR 701.2(a) (b), 701.3(b),\n\t701.11(c), 701.13(i), 740.2(b)\nIngredient Declaration: Generally, in letters not less than 1/16\" in height [21 CFR 701.3(b)]. If surface area available to bear label (excludes surfaces with decorative relief, sculptured surfaces) is less than 12 square inches, letter height may be not less tha",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "rative relief, sculptured surfaces) is less than 12 square inches, letter height may be not less than 1/32\" [21 CFR 701.3(p)].\nNet Contents Declaration on PDP: Minimum letter height determined by the area of the PDP. In the case of \"boudoir-type\" containers, including decorative cosmetic containers of the cartridge, pill box, compact or pencil type, and cosmetics of 1/4 oz. or less capacity, the type size is determined by the total dimensions of the container. If the container is mounted on a di",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ype size is determined by the total dimensions of the container. If the container is mounted on a display card, the display panel determines the letter height [21 CFR 701.13(e) and (i)].\nWarning Statements: Type size no less than 1/16\" unless smaller size established by regulation [21 CFR 740.2].\nLetter Height: The lower case letter \"o\" or equivalent when upper and lower case letters are used [21 CFR 701.13(h)].\nback to top\nIdentity Labeling\nCommon or usual name\nDescriptive name\nFanciful name\nIl",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "CFR 701.13(h)].\nback to top\nIdentity Labeling\nCommon or usual name\nDescriptive name\nFanciful name\nIllustration\nProminence\nPlacement\nSec. 10(t), FP&L Act\n21 CFR 701.11\nSec. 4 of the FP&L Act [21 U.S.C. 14554] requires that a consumer commodity bear a statement of identity. Regulations [21 CFR 701.11] published by the FDA require that the identity statement appear on the PDP.\nThe identity of the commodity may be expressed in terms of the common or usual name of the cosmetic, a descriptive name, or",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "modity may be expressed in terms of the common or usual name of the cosmetic, a descriptive name, or when the nature of the cosmetic is obvious, a fanciful name. It may also be expressed in form of an illustration.\nThe identity statement must be in bold type and in a size reasonably related to the most prominent printed matter, which is usually the name of the cosmetic. It must be in lines generally parallel to the base on which the product rests when displayed at retail.\nback to top\nName and Pl",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ly parallel to the base on which the product rests when displayed at retail.\nback to top\nName and Place of Business\nCorporate name\nManufactured for...\nDistributed by...\nAddress\nPrincipal place of business\n21 CFR 701.12\nThe name and business address appearing on the label may be those of the manufacturer, packer or distributor.\nIf the name and address is not that of the manufacturer, the name must be preceded by phrases such as \"Manufactured for ...\", \"Distributed by ...\", or other appropriate wo",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "be preceded by phrases such as \"Manufactured for ...\", \"Distributed by ...\", or other appropriate wording.\nThe name of the firm must be the corporate name, and the address may be that of the principal place of business. Stating also the name of a corporation's particular division is optional.\nThe business address must include the street address, name of the city and state, and the ZIP code. The street address may be omitted if the firm is listed in a current city or telephone directory.\nThe Tari",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "reet address may be omitted if the firm is listed in a current city or telephone directory.\nThe Tariff Act of 1930 requires that imported products state on the label the English Name of the country of origin.\nback to top\nQuantity of Contents\nLocation on Package          § 701.13 (e) and (f)(2)\nOn PDP\nOn information panel\nProminence                          § 701.13 (f) and (f)(1)\nPlacement\nSpacing\nConspicuousness                 § 701.13 (h) and (i)\nContract\nLetter height\nAspect ration\nType size",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "Conspicuousness                 § 701.13 (h) and (i)\nContract\nLetter height\nAspect ration\nType size\nLocation: If the cosmetic is sold at retail in an outer container, the net contents statement must appear (1) within the bottom 30% of the PDP of the outer container, generally parallel in line to the base on which the package rests, and (2) on an information panel of the inner container. The bottom location requirement is waived for PDPs of 5 square inches or less.\nThe PDP may be a tear-away tag",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "m location requirement is waived for PDPs of 5 square inches or less.\nThe PDP may be a tear-away tag or tape affixed to a decorative container or to a container of less than 1/4 oz., or it may be the panel of a display card to which the container is affixed.\nProminence: The declaration must be a distinct item, separated from other printed matter by a space equal to at least the height of the lettering used in the declaration and twice the width of the letter \"N\".\nConspicuousness: The print must",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ring used in the declaration and twice the width of the letter \"N\".\nConspicuousness: The print must be easily legible bold face type in distinct contract to background and other matter on the package. The letter height must be at least that of the lower case letter \"o\", and the aspect ratio of height to width must not exceed 3:1.\nThe type size, as determined by the area of the PDP must be at least 1/16 in. if PDP area 5 sq. in., 1/8 in. if PDP area > 5 to 25 sq. In., 3/16 in. if PDP area > 25 to",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "1/16 in. if PDP area 5 sq. in., 1/8 in. if PDP area > 5 to 25 sq. In., 3/16 in. if PDP area > 25 to 100 sq. in., and 1/4 in. if PDP area > 100 sq. in.\nback to top\nExemptions from Net Contents Declaration\nCosmetics of less than 1/4 av. oz. or 1/8 fl. oz.\nOn display card\nIn outer container\n21 CFR 1.24\nCosmetics in packages containing less than 1/4 av. oz. or 1/8 fl. oz. are exempt from the net quantity of contents declaration if affixed to a properly labeled display card or sold at retail in a pr",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "tity of contents declaration if affixed to a properly labeled display card or sold at retail in a properly labeled outer container [21 CFR 1.24].\nWhen a cosmetic is required to bear net quantity of contents declarations on the inner and outer container, the declaration on the outer container must appear on the PDP; on the inner container, it may appear on an information panel other than the panel bearing the name of the product, i.e., the front panel.\nQuantity of Contents\nAccuracy§ 701.13 (g) an",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "bearing the name of the product, i.e., the front panel.\nQuantity of Contents\nAccuracy§ 701.13 (g) and (s)\nDeclaration by Product Consistency§ 701.13 (a)\nSystems of Measures and Weights§ 701.13(b) and (r)\nUnit Terms and Abbreviations§ 701.13 (j) (2) & (n)\nDual Form of Declaration701.13 (j) (1)\nDeclaration of Fraction§ 701.13 (d)\nExamples of Net Quantity Statements\n\"Net Wt. 6 Oz.\" or \"6 oz. Net Wt.\"\n\"Net Contents 6 fl. Oz.\" or \"Net 6 Fl. Oz.\" or \"6 Fl. Oz.\"\n\"Net Wt. 1/4 Oz.\" or \"Net Wt. 0.25 Oz.\"",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "\"Net Contents 6 fl. Oz.\" or \"Net 6 Fl. Oz.\" or \"6 Fl. Oz.\"\n\"Net Wt. 1/4 Oz.\" or \"Net Wt. 0.25 Oz.\"\n\"Net 1/8 Fl. Oz.\" or \"0.12 FL. Oz.\"\n\"Net Wt. 24 Oz. (1-1/2 Lb.)\" or \"Net Wt. 24 Oz. (1.5 Lb.)\"\n\"Net 56 Fl. Oz. (1 Qt. 1 Pt. 8 Fl. Oz.)\" or \"... (1 Qt. 1-1/2 Pt.)\" or \"... (1 Qt. 1.5 Pt.)\"\nAccuracy: The net quantity of contents (net contents) declaration must accurately reveal the quantity of cosmetic in the container in terms of weight, volume, measure, numerical count, or combinations of count an",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "c in the container in terms of weight, volume, measure, numerical count, or combinations of count and weight, volume or measure. Reasonable variations due to loss or gain of moisture, or deviations in good manufacturing practice, are acceptable. In case of an aerosol product, the net contents statement must express the net quantity of contents expelled.\nProduct Consistency: Unless there is a firmly established, general consumer usage or trade custom to the contrary, the statement must be in term",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "y established, general consumer usage or trade custom to the contrary, the statement must be in terms of fluid measure if the cosmetic is liquid and in terms of weight if the cosmetic is solid, semi-solid, viscous, or a mixture of solid and liquid. Fluid measures must express the volume at 68°F (20°C). The customary net contents declaration for aerosol products is in terms of weight.\nSystems: Weight is expressed in terms of avoirdupois pound and ounce. Fluid measures are expressed in terms of th",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ht is expressed in terms of avoirdupois pound and ounce. Fluid measures are expressed in terms of the U.S. gallon, quart, pint and fluid ounce. Net contents may additionally be stated also in the metric system.\nUnit Terms: The term \"net weight\" or \"net wt.\" must be used in conjunction with a weight statement, and the term \"net contents,\" \"net\" or nothing must be used in connection with a liquid statement.\nAdditional abbreviations are for: weight - wt., fluid - fl., gallon - gal., quart - qt., pi",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "atement.\nAdditional abbreviations are for: weight - wt., fluid - fl., gallon - gal., quart - qt., pint - pt., ounce - oz., pound - lb.\nIn case of a weight ounce statement, the term \"oz.\" is sufficient. A fluid ounce is expressed as \"fl. oz.\"\nExamples:\nNet wt. 4 av. oz.\nNet contents 4 fl. oz.\n4 av. oz. net wt.\n4 oz. net wt.\nNet 4 fl. oz.\n4 fl. oz.\nDual Declaration: If the net weight exceeds one pound but is less than 4 pounds, the net contents statement must reveal the total number of ounces foll",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "nd but is less than 4 pounds, the net contents statement must reveal the total number of ounces followed, in parenthesis, by the number of pounds and ounces or by the number of pounds and fraction thereof. Fluid measures exceeding one pint, but being less than one gallon, must be expressed in terms of the total number of fluid ounces followed, in parenthesis, by the number of quarts, pints and ounces or by the fractions of the quart or pint.\nExamples:\nNet Wt. 24 oz. (1 lb. 8 oz.)\nNet Wt. 24 oz.",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ces or by the fractions of the quart or pint.\nExamples:\nNet Wt. 24 oz. (1 lb. 8 oz.)\nNet Wt. 24 oz. (1 - 1/2 lb.)\nNet Wt. 24 oz. (1.5 lb.)\n56 fl. oz. (1 qt. 1 pt. 8 fl. oz.)\n56 fl. oz. (1 qt. 1-1/2 pt.)\n56 fl. oz. (1 qt. 1.5 pt.)\n56 fl. oz. (1-3/4 qt.)\nDeclaration of fractions: Fractions may be expressed in terms of common fractions ranging from 1/2 to 1/32 or as decimal fractions of no more than two significant numbers.\nQuantity of Contents\nOn Principal Display Panel\n\"Economy Size\" or \"Budget S",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "two significant numbers.\nQuantity of Contents\nOn Principal Display Panel\n\"Economy Size\" or \"Budget Size\"\n\"Giant Pint\" or \"Full Quart\"\n\"Net 6 Fl. Oz.\" and \"Six Applications\"\n\"Net 6 Fl. Oz.\" and \"6 Bottles of 1 Fl. Oz. Each\"\nOn Information Panel\nAny non-deceptive supplemental statement\n21 CFR 1.31 and 701.13 (g)\nEconomy Size: Representations of this type are permitted if the firm offers at least one other packaged size of the same brand, only one is labeled \"economy size,\" and the unit price of th",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "other packaged size of the same brand, only one is labeled \"economy size,\" and the unit price of the package so labeled is substantially (at least 5%) reduced compared to that of the other package.\nGiant Pint, Full Quart: Supplemental statements describing the net quantity of contents are permitted on panels other than the PDP. However, these statements must not be deceptive or exaggerate the amount present in the package.\nSix Applications: Declarations by numerical count or linear or area meas",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "unt present in the package.\nSix Applications: Declarations by numerical count or linear or area measure may be augmented by statements of weight or size of individual units or total weight or measure to give accurate information. These are not regarded as separate statements and must appear on the PDP.\nCosmetic Kit: If a package contains the integral components making up a kit and delivers the components in the manner of an application as, for example, a home permanent wave kit, the net contents",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ponents in the manner of an application as, for example, a home permanent wave kit, the net contents declaration may be stated in terms of the number of applications as per given instructions [21 CFR 701.13 (g) (2)].\nCosmetic Warning Statements\nGeneral Requirement:\nProminence\nPlacement\nSpacing\nConspicuousness\nContrast\nType size\n21 CFR 740 (1) and (2)\nRegulations require that \"[the label of a cosmetic product shall bear a warning statement whenever necessary or appropriate to prevent a health haz",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "tic product shall bear a warning statement whenever necessary or appropriate to prevent a health hazard that may be associated with the product\" [21 CFR 740(1)]. A cosmetic not bearing a necessary warning statement may be considered misbranded under sec. 602(a) of the FD&C Act because it fails to reveal a fact \"material ... with respect to consequences which may result from the use of the article\" [sec 201(n), FD&C Act].\nProminence: A warning statement must appear on the label prominently and co",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "[sec 201(n), FD&C Act].\nProminence: A warning statement must appear on the label prominently and conspicuously as compared to other words, statements or designs so that it is likely to be read by ordinary consumers at the time of purchase and use.\nConspicuousness: The lettering must be in bold type on contrasting background and may in no case be less than 1/16 inch in height.\nback to top\nCosmetics With Unsubstantiated Safety\nWarning--The safety of this product has not been determined.\n21 CFR 74",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "s With Unsubstantiated Safety\nWarning--The safety of this product has not been determined.\n21 CFR 740.10\nA cosmetic is considered misbranded if its safety has not adequately been substantiated, and it does not bear the following conspicuous statement on the PDP:\nWarning - The safety of this product has not been determined.\nThe safety of a cosmetic may be considered adequately substantiated if experts qualified by scientific training and experience can reasonably conclude from the available toxic",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "rts qualified by scientific training and experience can reasonably conclude from the available toxicological and other test data, chemical composition, and other pertinent information that the product is not injurious to consumers under conditions of customary use and reasonably foreseeable conditions of misuse.\nThe safety of a cosmetic can adequately be substantiated by:\na. Reliance on available toxicological test data on its ingredients and on similar products, and\nb. Performance of additional",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "toxicological test data on its ingredients and on similar products, and\nb. Performance of additional toxicological and other testing appropriate in the light of the existing data.\nEven if the safety of each ingredient has been substantiated, there usually still is at least some toxicological testing needed with the formulated product to assure adequate safety substantiation.\nCosmetic Aerosols\nWarning--Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not store at",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ing--Avoid spraying in eyes. Contents under pressure. Do not puncture or incinerate. Do not store at temperature above 120°F. Keep out of reach of children.\n21 CFR 740.11 (a)\nThe label of a cosmetic packaged in a self-pressurized container and intended to be expelled from the package under pressure must bear the warning stated below.\nThe words \"Avoid spraying in eyes\" may be omitted if the product is not expelled as a spray. Example: Aerosol shave cream.\nThe word \"puncture\" may be replaced by th",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "is not expelled as a spray. Example: Aerosol shave cream.\nThe word \"puncture\" may be replaced by the word \"break\" if the product is packaged in a glass container.\nIf the product is intended for use by children, the phrase \"except under adult supervision\" may be added at the end of the last sentence of the warning.\nCosmetic Aerosols\nWarning--Use only as directed. Intentional misues by deliberately concentrating and inhaling the contents can be harmful or fatal.\n21 CFR 740.11 (b)\nIf the propellan",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "concentrating and inhaling the contents can be harmful or fatal.\n21 CFR 740.11 (b)\nIf the propellant of a cosmetic packaged in a self-pressurized container consists in whole or in part of a halocarbon or hydrocarbon, the label must bear a second warning as stated below.\nThis second warning is not required for the following products:\n1.Aerosol foam or cream products containing less than 10% propellant.\n2.Products which do not expel the propellant at the time of use. Examples: products with built",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "lant.\n2.Products which do not expel the propellant at the time of use. Examples: products with built-in piston barrier or propellant bag.\n3.Metered spray products of less than 2 oz. net contents.\n4.Aerosol products of less than 1/2 oz. net contents.\nFeminine Deodorant Sprays\nCaution--For external use only. Spray at least 8 inches from skin. Do not apply to broken, irritated, or itching skin. Persistent, unusual odor or discharge may indicate conditions for which a physician should be consulted.",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "stent, unusual odor or discharge may indicate conditions for which a physician should be consulted. Discontinue use immediately if rash, irritation, or discomfort develops.\n21 CFR 740.12\nA feminine deodorant spray which, for the purpose of this regulation, is defined as \"any spray deodorant product whose labeling represents or suggests that the product is for use in the female genital area or for use all over the body\" must bear the caution stated below.\nIf the expelled product does not contain",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "use all over the body\" must bear the caution stated below.\nIf the expelled product does not contain a liquefied halocarbon or hydrocarbon propellant, the sentence \"Spray at least 8 inches from skin\" may be omitted.\nThe regulation further states that the use of the word \"hygiene\" or \"hygienic\" or similar words renders any such product misbranded.\nFoaming Detergent Bath Products\nCaution--Use only as directed. Excessive use of prolonged exposure may cause irritation to skin and urinary tract. Disco",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "directed. Excessive use of prolonged exposure may cause irritation to skin and urinary tract. Discontinue use if rash, redness or itching occurs. Consult your physician if irritation persists. Keep out of reach of children.\n21 CFR 740.17\nA foaming detergent bath product--also known as bubble bath product--is, for the purpose of this regulation, defined as \"any product intended to be added to a bath for the purpose of producing foam that contains a surface-active agent serving as a detergent or",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "th for the purpose of producing foam that contains a surface-active agent serving as a detergent or foaming ingredient.\"\nThe caution stated above is required on the label of any foaming detergent bath product which is not clearly labeled as intended for use exclusively by adults. The following are two examples of label statements identifying a product as intended for use exclusively by adults: \"Keep out of reach of children\" and \"For adult use only.\"\nIf the bubble bath product is intended for us",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ep out of reach of children\" and \"For adult use only.\"\nIf the bubble bath product is intended for use by children, the phrase \"Keep out of reach of children\" may be expanded to further read \"except under adult supervision.\"\nThe regulation further requires that the label \"Shall bear adequate directions for safe use\" of the product.\nCosmetic Ingredient Labeling\nDeclaration of ingredients except flavor, fragrance, and trade secret ingredients in descending order of predominance\n21 CFR 701.3\nCosmeti",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "or, fragrance, and trade secret ingredients in descending order of predominance\n21 CFR 701.3\nCosmetic ingredient labeling became an issue in the early 1970s. Guidelines for ingredient labeling were published in mid-1972. Regulations were proposed in early 1973. After publication of two final regulations, stays of final regulations, terminations of stays, and lengthy court proceedings challenging the legality of the published regulations, the requirement for cosmetic ingredient labeling became fu",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "he legality of the published regulations, the requirement for cosmetic ingredient labeling became fully effective in early 1977.\nThe regulations requiring the declaration of cosmetic ingredients were published under the authority of the FP&L Act [secs. 5(c) and 6(a); 15 U.S.C. 1454 and 1455] and FD&C Act [sec. 701(e); 21 U.S.C. 371(e)].\nSince the FP&L Act applies only to consumer commodities and their packages as defined in the Act, cosmetic ingredient declarations are required only on the label",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "heir packages as defined in the Act, cosmetic ingredient declarations are required only on the label of the outer container of cosmetics customarily sold at retail or used in the performance of services conducted within the households. It does not apply, for example, to products used at professional establishments or samples distributed free of charge, unless such products are customarily also sold at retail, even if they were labeled \"For professional use only.\"\nThe ingredients must be declared",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "d at retail, even if they were labeled \"For professional use only.\"\nThe ingredients must be declared in descending order of predominance. Exceptions to this requirement are discussed later.\nback to top\nProminence of Ingredient Declaration\nProminent and conspicuous to render it easy to be read and understood by ordinary individuals under normal conditions of purchase\nLetter Height\n1/16 inch\nException:\n\t\t\tIf total available labeling surface area is less than 12 sq. in.\n1/32 inch\nInformation panel",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "on:\n\t\t\tIf total available labeling surface area is less than 12 sq. in.\n1/32 inch\nInformation panel\n\nFirmly affixed tag, tape, or card\n\n21 CFR 701.3(b) and (p)\nThe ingredient declaration may appear on any information panel of the package which is the outer container in form of a folding carton, box, wrapper etc. if the immediate container is so packaged, or which is the jar, bottle, box etc. if the immediate container is not packaged in an outer container. It may also appear on a tag, tape or ca",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "e immediate container is not packaged in an outer container. It may also appear on a tag, tape or card firmly affixed to a decorative or small size container.\nProminence: The declaration must appear with prominence and conspicuousness so that it is likely to be read and understood (read with ease) by ordinary individuals under normal conditions of purchase. The letters must not be obscured by design, vignettes, background or crowding.\nType Size: Not less than 1/16 inch in height. It may be not l",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "gn, vignettes, background or crowding.\nType Size: Not less than 1/16 inch in height. It may be not less than 1/32 inch in height if the total surface area available to bear labeling (which excludes bottom, shoulder, neck, flange, decorative or sculptured surfaces) is less than 12 square inches.\nThe type size consisting of upper and lower case letters is determined by the height of the lower case letter \"o\".\nThe ingredient declaration may appear on any information panel of the package which is th",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "etter \"o\".\nThe ingredient declaration may appear on any information panel of the package which is the outer container in form of a folding carton, box, wrapper etc. if the immediate container is so packaged, or which is the jar, bottle, box etc. if the immediate container is not packaged in an outer container. It may also appear on a tag, tape or card firmly affixed to a decorative or small size container.\nProminence: The declaration must appear with prominence and conspicuousness so that it is",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ontainer.\nProminence: The declaration must appear with prominence and conspicuousness so that it is likely to be read and understood (read with ease) by ordinary individuals under normal conditions of purchase. The letters must not be obscured by design, vignettes, background or crowding.\nType Size: Not less than 1/16 inch in height. It may be not less than 1/32 inch in height if the total surface area available to bear labeling (which excludes bottom, shoulder, neck, flange, decorative or sculp",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "area available to bear labeling (which excludes bottom, shoulder, neck, flange, decorative or sculptured surfaces) is less than 12 square inches.\nThe type size consisting of upper and lower case letters is determined by the height of the lower case letter \"o\".\nback to top\nIdentification of Ingredients by Name\nThe name established by the commissioner as specified in § 701.30.\nThe name adopted for the ingredient as listed in:\n(a) CTFA Cosmetic Ingredient Dictionary\n\t(b) United States Pharmacopeia",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "the ingredient as listed in:\n(a) CTFA Cosmetic Ingredient Dictionary\n\t(b) United States Pharmacopeia\n\t(c) National Formulary\n\t(d) Food Chemical Codex\n\t(e) USAN and the USP Dictionary of Drug Names\nThe name generally recognized by consumers\nThe chemical or technical name or description\n21 CFR 701.3(c)\nSection 701.3(c) requires that an ingredient be identified by the name established by the Commissioner for the purpose of cosmetic ingredient labeling or, in the absence of a name established by the",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "oner for the purpose of cosmetic ingredient labeling or, in the absence of a name established by the Commissioner, the name adopted for that ingredient in the editions and supplements of the compendia listed below.\nThe Commissioner may establish a name as petitioned or propose such a name on his own initiative. See section 701.3(e). The names specified by the Commissioner are listed in section 701.30.\nThe currently recognized edition of the CTFA (Cosmetic, Toiletry and Fragrance Association, Inc",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": ".30.\nThe currently recognized edition of the CTFA (Cosmetic, Toiletry and Fragrance Association, Inc.) Cosmetic Ingredient Dictionary is the second edition published in 1977. This edition is recognized only in part, i.e., not all names listed in the second edition have been adopted.\nThe third edition of the CTFA Cosmetic Ingredient Dictionary published in 1982 and the Supplement published in 1985 have not yet been recognized. However, FDA has informed the CTFA that the agency will not take regul",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "have not yet been recognized. However, FDA has informed the CTFA that the agency will not take regulatory action against products labeled in accordance with these editions while their review is in progress.\nThe compendia are listed in the descending order by which they must be utilized for identification of an ingredient name. If none lists a name for an ingredient, the name generally recognized by consumers, or the chemical or technical name or description, must be used.\nback to top\nOrder of In",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "y consumers, or the chemical or technical name or description, must be used.\nback to top\nOrder of Ingredient Declaration\nDescending order of predominance\nExceptions...\nActive drug ingredients\nIngredients with less than 1% concentration\nColor additives\n\"And other ingredients\"\n21 CFR 701.3(a), (d), (f) (2), (f) (3)\nThe ingredients must be listed in descending order of predominance. However, there are a few exceptions to this requirement.\n1. If the cosmetic is also a drug, section 502(c) of the FD&",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "e a few exceptions to this requirement.\n1. If the cosmetic is also a drug, section 502(c) of the FD&C Act requires that the active drug ingredient(s) be declared before declaration of the cosmetic ingredients. A declaration, thus, would read as follows: \"Active Ingredient: ... (Name of drug ingredient). Other (or Cosmetic) Ingredients: ... (Names of cosmetic ingredients in descending order).\" [§ 701.3(d)]\n2. Ingredients present at a concentration not exceeding 1% may be listed in any order after",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "01.3(d)]\n2. Ingredients present at a concentration not exceeding 1% may be listed in any order after the listing of the ingredients present at more than 1% in descending order of predominance. [§ 701.3(f)(2)]\n3. Color additives of any concentration may be listed in any order after the listing of the ingredients which are not color additives [§ 701.3(f)(3)].\n4. The name of an ingredient accepted by FDA in accordance with the procedure established in § 720.8 as a trade secret need not be disclosed",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "FDA in accordance with the procedure established in § 720.8 as a trade secret need not be disclosed on the label. In lieu of declaring the name of that ingredient, the phrase \"and other ingredients\" may be used at the end of the ingredient declaration [§ 701.3(a)].\nback to top\nOrder of Predominance\nLipstick\n\nIncorrect Label Copy:\nCaster Oil (58)\nBeeswax (6.5)\nCandelilla Wax (6.5)\nCarnauba Wax (3)\nLanolin (8)\nOzokerite (2)\nPropylene Glycol (and) BHA\n(And) Propyl Gallate\n(And) Citric Acid (1.3)\nT",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "Lanolin (8)\nOzokerite (2)\nPropylene Glycol (and) BHA\n(And) Propyl Gallate\n(And) Citric Acid (1.3)\nTitanium Dioxide (2)\nD&C Red No. 21 (2)\nD&C Red No. 6 Barium Lake (4)\nD&C Yellow No. 5 Aluminum Lake (5)\nFragrance (0.5)\nCorrect Label Copy:\nCastor Oil\nLanolin\nBeeswax\nCandelilla Wax\nCarnauba Wax\nOzokerite\nPropylene Glycol\nBHA\nPropyl Gallate\nCitric Acid\nFragrance\nTitanium Dioxide\nD&C Red No. 21\nD&C Red No. 6 Barium Lake\nD&C Yellow No. 5 Aluminum Lake\nIn this example, the correct ingredient declarat",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ed No. 6 Barium Lake\nD&C Yellow No. 5 Aluminum Lake\nIn this example, the correct ingredient declaration lists castor oil (58), lanolin (8), candelilla wax (6.5), carnauba wax (3), and ozokerite (2) in descending order of predominance. The concentrations (which need not be declared by regulation) are provided in parentheses.\nThe compounds of the proprietary antioxidant mixture dissolved in propylene glycol must be integrated into the product formulation and declared individually in order of decre",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "e glycol must be integrated into the product formulation and declared individually in order of decreasing predominance without the term \"(and).\"\nThe color additives titanium dioxide (2) etc. may be declared in any order after the other ingredients.\nDeclaration of Color Additives and Ingredients Present at One Percent or Less\nPressed Powder\nLabel Declaration:\nTalc (75)\nKaolin (7.5)\nZinc Stearate (5)\nTitanium Dioxide (5)\nMineral Oil (3)\nIron Oxides (2.5)\nIsopropyl Myristate (0.9)\nLanolin Oil (0.5)",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": ")\nTitanium Dioxide (5)\nMineral Oil (3)\nIron Oxides (2.5)\nIsopropyl Myristate (0.9)\nLanolin Oil (0.5)\nLanolin (0.2)\nFragrance (0.1)\nUltramarine Blue (0.05)\nAlternate Declaration:\nTalc\nKaolin\nZinc Stearate\nMineral Oil\nLanolin\nIsopropyl Myristate\nFragrance\nLanolin Oil\nTitanium Dioxide\nUltramarine Blue\nIron Oxides\nThe hypothetical pressed powder formulation portrayed in this example illustrates the two options for the listing of ingredients.\nOn the left side, the ingredients are listed in descending",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "o options for the listing of ingredients.\nOn the left side, the ingredients are listed in descending order of predominance according to § 701.3(2).\nOn the right side, the ingredients are listed according to § 701.3(f)(1), (2), and (3), i.e., ingredients other than colors present at a concentration exceeding 1% in descending order or predominance, followed by ingredients other than colors present at 1% or less in any order, followed by colors present at any concentration listed in any order.\nDecl",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "t 1% or less in any order, followed by colors present at any concentration listed in any order.\nDeclaration of Fragrance and Flavor Ingredients\nFragrance\nFlavor\nFragrance and flavor\n21 CFR 701.3(a)\nFragrance and flavor compounds may be declared in descending order of predominance as \"fragrance\" and \"flavor.\" If a fragrance compound also serves as a flavor, it must be declared as \"flavor and fragrance.\"\nThe components (ingredient) of a fragrance or flavor may also be declared individually by thei",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "nce.\"\nThe components (ingredient) of a fragrance or flavor may also be declared individually by their appropriate label names.\nThe ingredient or mixture of ingredients acting as a masking agent, i.e., covering the undesirable off-odor of a product without adding a discernable odor to it, may be declared by their individual name(s) or as \"fragrance\" (in lieu of a better designation). A masking agent present in a product at an insignificant level may be considered an incidental ingredient under §",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "t present in a product at an insignificant level may be considered an incidental ingredient under § 701.3(1)(2)(iii) in which case it need not be declared on the label.\nback to top\nDeclaration of Trade Secret Ingredients\nBy the Phrase \"And Other Ingredients\"\nIf accepted by FDA as exempt from public disclosure pursuant to the procedure of § 720.8.\n21 CFR 701.3(a)\nThe FP&L Act states in section 5(c)(3)(B) [15 U.S.C. 1454(c)(3)(B)] that \"nothing ... shall be deemed to require that any trade secret",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "(3)(B) [15 U.S.C. 1454(c)(3)(B)] that \"nothing ... shall be deemed to require that any trade secret be divulged.\" Accordingly, the cosmetic ingredient labeling regulation does not require the declaration of the identity of an ingredient FDA has accepted as exempt from public disclosure. In lieu of the declaration of the name of a confidential ingredient, the phrase \" and other ingredients\" may be used at the end of the ingredient declaration.\nThe policy the agency is following for processing req",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "used at the end of the ingredient declaration.\nThe policy the agency is following for processing requests for confidentiality of cosmetic ingredient identities has been codified under § 720.8.\nback to top\nWhat is a trade secret?\nA trade secret may consist of any formula, pattern, device or compilation of information which is used in one's business and which gives one an opportunity to obtain an advantage over competitors who do not know or use it.\n21 CFR 20.61\nThe question \"what is a trade secre",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "vantage over competitors who do not know or use it.\n21 CFR 20.61\nThe question \"what is a trade secret\" may be answered by restating the definition of the term \"trade secret\" as provided in § 20.61(a) of regulations published in 1974 for enforcement of the law commonly known as the \"Freedom of Information Act\" (the public information section of the Administrative Procedures Act; 5 U.S.C. 552).\nProcedure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nSubmission of inform",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "edure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nSubmission of information\nCosmetic formulation or raw material composition statement (Form 2512 OR 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of prior non-disclosure (§ 20.81)\n21 CFR 720.8\nThe first step in processing a request for trade secrecy, i.e., a request for exemption from label declaration, of the identity of a cosmetic ingredient is the submission to FDA of the following",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "abel declaration, of the identity of a cosmetic ingredient is the submission to FDA of the following information:\n(a) A semi-quantitative cosmetic formulation statement of the product in question on forms FD-2512 and 2512a.\n(b) A full statement of the factual and legal grounds for the request, including all data and other information on which the petitioner relies (as well as any information known to the petitioner that is unfavorable to petitioner's position).\nThe statement of factual grounds s",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "to the petitioner that is unfavorable to petitioner's position).\nThe statement of factual grounds should include scientific or technical data, reports, tests, and other relevant information that address the factors FDA considers in determining whether the identity of an ingredient qualifies as a trade secret. (The factors FDA considers are stated elsewhere.)\n(c) A statement that the identity of the ingredient in question has not previously been disclosed to anyone without appropriate safeguards",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "he ingredient in question has not previously been disclosed to anyone without appropriate safeguards for secrecy as further explained in § 20.81.\nback to top\nProcedure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nSubmission of Information\nCosmetic formulation or raw material composition statement (Form 2512 or 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of prior non-disclosure (§ 20.81).\nReview of data for adequacy\n21 CFR 720.8\nFDA",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "de secrecy\nStatement of prior non-disclosure (§ 20.81).\nReview of data for adequacy\n21 CFR 720.8\nFDA reviews the submitted information to determine whether the data are sufficient to permit a review of the merits of the request.\nA request that contains insufficient data to conduct a confidentiality review on the merits is returned and petitioner is advised about the additional information that is necessary to enable the agency to proceed with the review of the request.\nProcedure for Requesting E",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "necessary to enable the agency to proceed with the review of the request.\nProcedure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nSubmission of information\nCosmetic formulation of raw material composition statement (Form 2512 or 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of prior non-disclosure (§ 20.81)\nReview of data for adequacy\nTentative determination of trade secrecy\n21 CFR 720.8\nWhen the submitted information is sufficient to",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "entative determination of trade secrecy\n21 CFR 720.8\nWhen the submitted information is sufficient to permit a review of the merits of a request, FDA proceeds with the review.\nWhen the agency concurs with petitioner and decides that the ingredient identity is a trade secret, the request for exemption from label disclosure is granted. If FDA does not concur with petitioner, the agency tentatively denies the request. The person requesting trade secrecy is informed in writing of the agency's determi",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "nies the request. The person requesting trade secrecy is informed in writing of the agency's determination. In case of a tentative denial, FDA informs petitioner of the grounds on which it relied in making this tentative determination.\nFactors Considered in Determining Trade Secret Status\n1. Is the information publicly known?\n(a) Prior public disclosure by petitioner\n(b) Public disclosure in the literature\n(c) Measures taken to guard secrecy\nWhen FDA reviews the merits of a confidentiality reque",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "iterature\n(c) Measures taken to guard secrecy\nWhen FDA reviews the merits of a confidentiality request and determines whether the identity of an ingredient qualifies as a trade secret, it considers the following three principal factors by seeking answers to the following three questions:\n1. Is the ingredient's identity and intended use publicly known?\n2. Does the intended use of the respective ingredient have value?\n3. Can the identity of the ingredient readily be acquired by legal means and its",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "redient have value?\n3. Can the identity of the ingredient readily be acquired by legal means and its intended use duplicated?\nThese questions are based on the factors considered in Comment B to section 757 of the Restatement of Torts in determining whether given information is a trade secret.\nSince the same factors are also being considered by FDA in determining whether the identity of an ingredient qualifies as a trade secret, a person requesting trade secrecy must address them factually and co",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "nt qualifies as a trade secret, a person requesting trade secrecy must address them factually and convincingly in the statement of grounds.\nAbsence of public knowledge of an ingredient's identity under conditions of intended use may be demonstrated by documenting the extent to which the information is known by employees or others in petitioner's business, the extent the information is publicly disclosed in pertinent literature, and the extent of measures taken by petitioner to guard the secrecy",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "closed in pertinent literature, and the extent of measures taken by petitioner to guard the secrecy of the information.\nFactors Considered in Determining Trade Secret Status\n2. Does the information have value?\n(a) Importance to the product\n(b) Product profitability\n(c) Future market performance of product\n(d) Effort and financial resources invested\nThe value of knowing the identity and intended use of the ingredient in question may be determined in terms of the importance of the ingredient to th",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "e of the ingredient in question may be determined in terms of the importance of the ingredient to the product formulation. It must be assumed that, to be of value, the ingredient significantly contributes to the claimed performance or other pertinent characteristics of the cosmetic and that a cosmetic not containing the claimed trade secret ingredient, or containing conventional substitutes in place of the respective ingredient, could not be expected to perform equally well or otherwise meet cer",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ce of the respective ingredient, could not be expected to perform equally well or otherwise meet certain requirements. Appropriate comparative testing of a cosmetic containing the trade secret ingredient, or one containing conventional substitutes, as well as testing of petitioner's cosmetic against competitor's cosmetic of the same use category may provide factual documentation to this effect and thus demonstrate the value of the information to petitioner. The value of the ingredient informatio",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "thus demonstrate the value of the information to petitioner. The value of the ingredient information may also be determined in terms of future market performance of a cosmetic or its profitability. However, this kind of value assessment is usually a difficult and inexact task and often provides little factual data to support a value assessment.\nDocumentation of the effort expended and financial resources invested in the development of the product formulation containing the ingredient in questio",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "esources invested in the development of the product formulation containing the ingredient in question and providing the claimed characteristics may further support a request for trade secrecy.\nFactors Considered in Determining Trade Secret Status\n3. Can the information readily be acquired or duplicated\nThe factor concerning the ease or difficulty with which the identity of the ingredient in question could properly be acquired or duplicated by others may be addressed by documenting an ingredient'",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "on could properly be acquired or duplicated by others may be addressed by documenting an ingredient's rare or unexpected use for the intended purpose in cosmetics of a particular product category or by demonstrating the complexity of the analytical methodology necessary to identify it.\nProcedure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nFinal determination of Trade Secrecy\nCosmetic formulation or raw material composition statement (Form 2512 OR 2513)\nStatement of",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "Secrecy\nCosmetic formulation or raw material composition statement (Form 2512 OR 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of prior non-disclosure (§ 20.81)\nReview of data for adequacy\nTentative determination of trade secrecy\nFinal determination of trade secrecy\n21 CFR 720.8\nWhen FDA tentatively decides to deny a request, the petitioner may withdraw the records for which FDA has tentatively denied a request for confidentiality. Petitioner may also submit, wi",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "s for which FDA has tentatively denied a request for confidentiality. Petitioner may also submit, within 60 days from the date of receipt of the written notice of the tentative denial, additional relevant information and arguments and request that the agency reconsider its decision in light of both the additional material and the originally submitted information.\nIf the petitioner submits new data, the agency considers that material together with the initially submitted information and makes its",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": ", the agency considers that material together with the initially submitted information and makes its final determination. This constitutes final agency action. The petitioner is informed of the agency's final determination in writing.\nProcedure for Requesting Exemption of an Ingredient Identity From Public Disclosure\nSubmission of Information\nCosmetic Formulation or Raw Material Composition Statement (Form 2512 OR 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ent (Form 2512 OR 2513)\nStatement of factual and legal grounds justifying trade secrecy\nStatement of prior non-disclosure (§ 20.81)\nReview of data for adequacy\nTentative determination of trade secrecy\nFinal determination of trade secrecy\nJudicial review under 5 U.S.C. Chapter 7\n21 CFR 720.8\nThe agency's final decision may be challenged in the courts under 5 U.S.C., Chapter 7. If suit is brought within 30 days after such determination, FDA will not disclose the records involved until the matter i",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "thin 30 days after such determination, FDA will not disclose the records involved until the matter is finally determined in the courts. If suit is not brought within 30 days and the petitioner does not withdraw the records for which a request for confidentiality has been denied, the records involved will be made part of FDA's files and will then be available to the public upon request.\nIt should be noted that until the agency has completed its determination that the identity of a cosmetic ingred",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "e noted that until the agency has completed its determination that the identity of a cosmetic ingredient is a trade secret, the cosmetic product in question may not bear the label statement \"and other ingredients\" in lieu of a declaration of the identity of the ingredient for which confidentiality has been requested. The phrase \"and other ingredients\" may be used on the label only after an ingredient is accepted by FDA as exempt from public disclosure or, when confidentiality has been denied, if",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ent is accepted by FDA as exempt from public disclosure or, when confidentiality has been denied, if suit is brought within 30 days after a final determination that the ingredient in question is not a trade secret.\nCosmetics That Are Also Drugs\nDeclaration\nThe established name of any active drug ingredient and the quantity, kind, and proportion of any alcohol, in compliance with Sec. 502(e) of the FD&C Act, as \"Active Ingredients\"\nThe remaining ingredients, in compliance with § 701.3, as \"Cosmet",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "FD&C Act, as \"Active Ingredients\"\nThe remaining ingredients, in compliance with § 701.3, as \"Cosmetic Ingredients\"\n21 CFR 701.3(d)\nA product intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance is a cosmetic. If this product claims to accomplish these deeds through physiological activity or by changing the structure of the skin, it is also a drug. The product categories \"drug\" and \"cosmetic\" are not mutually exclusive. This is",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "it is also a drug. The product categories \"drug\" and \"cosmetic\" are not mutually exclusive. This is recognized in sec. 509 of the FD&C Act.\nIf a cosmetic is also a drug, the label must list first the established name of the drug ingredient(s) and the quantity, kind and proportion of any alcohol, in compliance with sec. 502(e) of the FD&C Act, as \"Active Ingredients\" and then the remaining ingredients, in compliance with § 701.3(a) or (f), as \"Cosmetic Ingredients.\"\nback to top\nCosmetics That Ar",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ents, in compliance with § 701.3(a) or (f), as \"Cosmetic Ingredients.\"\nback to top\nCosmetics That Are Also Drugs\nAerosol Antiperspirant\nIncorrect Label Copy:\nsobutane\nSilicone Oil\nButane\nAluminum Chlorohydrate\nIsopropyl Myristate\nDenatured Alcohol\nPropane\nBentone 38\nCorrect Label Copy:\nActive Ingredient:\nAluminum Chlorohydrate\nCosmetic Ingredients:\nIsobutane\nCyclomethicone\nButane\nIsopropyl Myristate\nSD Alcohol 40\nPropane\nQuaternium 18 Hectorite\nThis hypothetical aerosol antiperspirant formulatio",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "te\nSD Alcohol 40\nPropane\nQuaternium 18 Hectorite\nThis hypothetical aerosol antiperspirant formulation illustrates on the right side the correct label declaration of the ingredients of a cosmetic which is also a drug.\nThe active drug ingredient aluminum chlorohydrate is identified as \"Active Ingredient\" in accordance with sec. 502(e) of the FD&C Act. The remaining ingredients may be identified as \"Cosmetic Ingredients\" as shown or as \"Other Ingredients.\"\nColor Additives Added Sometimes for Color",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "Cosmetic Ingredients\" as shown or as \"Other Ingredients.\"\nColor Additives Added Sometimes for Color Matching\nListed after the declaration of other color additives and after the phrase\"May contain\"\n21 CFR 701.3(g) (1)\nA color additive(s) that is added to a cosmetic during manufacture for the purpose of color matching may be declared on the label of each batch or lot even if not present in each.\nThe color additive sometimes added for color matching is listed after the declaration of other color ad",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "color additive sometimes added for color matching is listed after the declaration of other color additives, or at the end of the declaration, and after the phrase \"May Contain.\"\nback to top\nColor Additives Sometimes Added for Color Matching\nToilet Water\nIncorrect Label Copy:\nSD Alcohol 39C\nWater\nFragrance\nPropylene Glycol\nCetyl Lactate\nFD&C Red No. 40\nFD&C Blue No. 1\n\nCorrect Label Copy:\nSD Alcohol 39C\nWater\nFragrance\nPropylene Glycol\nCetyl Lactate\nFD&C Red No. 40\nFD&C Blue No. 1\nMay contain:\nD",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ol 39C\nWater\nFragrance\nPropylene Glycol\nCetyl Lactate\nFD&C Red No. 40\nFD&C Blue No. 1\nMay contain:\nD&C Yellow No. 10\nD&C Yellow No. 10 used for Color Adjustment\nThis hypothetical toilet water formulation in which D&C Yellow No. 10 is added to some batches for the purpose of color adjustment shows on the right side the correct label declaration of the color additive D&C Yellow No. 10.\nIncidental Ingredients\nDefinition:\nAny processing aid added and removed or converted to a declared ingredient\nor",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "gredients\nDefinition:\nAny processing aid added and removed or converted to a declared ingredient\nor\nAny ingredient of another ingredient or processing aid present at an insignificant level and having no technical or functional effect\nNeed not be declared\nIncidental ingredients need not be declared on the label.\nAn incidental ingredient is defined in § 701.3(1) as:\n1. A substance added during manufacture and removed from the cosmetic in accordance with good manufacturing practices before the cosm",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "acture and removed from the cosmetic in accordance with good manufacturing practices before the cosmetic is packaged in finished form. Example: Filter aid.\n2. A substance that is added during manufacture of a cosmetic, is converted to an ingredient declared on the label, and does not significantly increase the concentration of the declared ingredient. Example: Sodium hydroxide added to a sodium stearate and stearic acid-containing cosmetic.\n3. A substance added to a cosmetic during manufacture f",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "earate and stearic acid-containing cosmetic.\n3. A substance added to a cosmetic during manufacture for its technical effect in processing but present in the finished cosmetic at an insignificant level and not having any technical or functional effect in that cosmetic. Example: Defoaming agent.\n4. A substance added to a cosmetic as a component of a cosmetic ingredient and having no technical or functional effect in the finished cosmetic. Example: Preservative of a raw material added to a cosmetic",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ctional effect in the finished cosmetic. Example: Preservative of a raw material added to a cosmetic as an ingredient at a concentration which reduces the preservative to a level at which it is no longer effective.\nback to top\nMultiunit or Multicomponent Packages\nExamples:\nGift set of makeup assortment\nHair coloring kit or home permanent\nDeclaration:\nOn outside retail package only if components are not customarily sold individually.\n21 CFR 701.3 (q)\nThe ingredients of the units of cosmetics mark",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "e not customarily sold individually.\n21 CFR 701.3 (q)\nThe ingredients of the units of cosmetics marketed as multiunit or multicomponent packages must be declared on the label of the outside container. They must also be declared on the labels of the inside containers of the units if the inside containers are customarily separated from the outer container for individual retail sale.\nA MULTIUNIT package is a package which contains an assortment of similar or dissimilar products. Examples: A shade a",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "age is a package which contains an assortment of similar or dissimilar products. Examples: A shade assortment of eye shadows in an eye make-up kit or a gift set consisting of a lotion, powder and toilet water in a gift box.\nA MULTICOMPONENT package is \"a package which contains the integral components making up a complete kit, and which is designed to deliver the components in the manner of an application.\" See 21 CFR 701.13(g)(2). Examples: A hair coloring kit consisting of dye solution and hydr",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ication.\" See 21 CFR 701.13(g)(2). Examples: A hair coloring kit consisting of dye solution and hydrogen peroxide or a permanent wave set consisting of thioglycolate solution and sodium bromate solution.\nMultiunit Packages (Assortments in Same Package)\nDissimilar products\nSimilar products intended same use\nLabeling surface area\nLess than 12 square inches\nOver 12 square inches\nBranded shade lines\nSingle units and assortments\nFor the purpose of cosmetic ingredient labeling and to take advantage of",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ingle units and assortments\nFor the purpose of cosmetic ingredient labeling and to take advantage of provisions for consolidated ingredient listing in place of somtimes repetitive listing of ingredients unit by unit, a distinction must be made between packages containing:\n1. Dissimilar products. Example: Gift set containing a shave cream and an after shave lotion.\n2. Products of similar composition and intended for the same use in a package with a total surface area available for labeling of 12",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "n and intended for the same use in a package with a total surface area available for labeling of 12 square inches or more. Example: Two toilet waters of different fragrance or color in gift set.\n3. Products of similar composition and intended for the same use in a package with a total surface area available for labeling of less than 12 square inches. Example: Eye shadows of different color in a compact case.\n4. Products that are single units or assortments of a branded shade line. A branded shad",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "mpact case.\n4. Products that are single units or assortments of a branded shade line. A branded shade line is a series of products of similar composition, intended for the same use, and sharing a common label with the same brand name. Example: A shade line of lipsticks.\nAssortments of Dissimilar Products\nAlternate Declaration\nSingle composite list of color additives with statement that list pertains to all products\n21 CFR 701.3(h)\nThe package of an assortment of dissimilar products, i.e., a mult",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ns to all products\n21 CFR 701.3(h)\nThe package of an assortment of dissimilar products, i.e., a multiunit package, as, for example, a toilet water and a dusting powder in a gift box, may bear:\nA conventional ingredient declaration in which each ingredient of each product is identified under an appropriate product heading, or\nAn alternate ingredient declaration in which the color additives of all products of the assortment are integrated into a single composite list that indicates that the list p",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "roducts of the assortment are integrated into a single composite list that indicates that the list pertains to all products.\nPlease note that if the units of an assortment are customarily separated from the outer package for retail sale, the ingredients must also be declared on the label of each inside unit.\nback to top\nAssortments of Dissimilar Products\nToilet Water and Dusting Powder\nLabel Copy:\nToilet Water:\nSD Alcohol 40\nWater\nFragrance\nFD&C Red No. 40\nFD&C Blue No. 1\nDusting Powder:\nTalc\nKa",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "Toilet Water:\nSD Alcohol 40\nWater\nFragrance\nFD&C Red No. 40\nFD&C Blue No. 1\nDusting Powder:\nTalc\nKaolin\nFragrance\nD&C Red No 21 Aluminum Lake\nAlternate Label:\nToilet Water:\nSD Alcohol 40\nWater\nFragrance\n\nDusting Powder:\nTalc\nKaolin\nFragrance\nColor Additives Pertaining to Both Products:\nFD&C Red No. 40\nFD&C Blue No. 1\nD&C Red No. 21 Aluminum Lake\nThis example of a hypothetical assortment of dissimilar products consisting of a toilet water and a dusting powder illustrates on the right side the al",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ilar products consisting of a toilet water and a dusting powder illustrates on the right side the alternate ingredient labeling option in which all color additives are declared in a single composite list. The declaration advises that the color additives pertain to both products.\nIf, for example, Red 40 or Blue 1 were present in both products, they would have to be listed only once in the declaration.\nAssortments of Similar Products Intended for Same Use\nAvailable Labeling Surface Area Less Than",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "on.\nAssortments of Similar Products Intended for Same Use\nAvailable Labeling Surface Area Less Than 12 Square Inches\nAlternate Declaration\nIngredients common to all products listed in cumulative descending order of predominance (or according to paragraph (f)), and\nIngredients not common to all products identified by product in which used, and\nSingle composite list of all color additives without product identification\n21 CFR 701.3 (O) (1)\nAn assortment of products of similar composition and inten",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "oduct identification\n21 CFR 701.3 (O) (1)\nAn assortment of products of similar composition and intended for the same use in a package with a total surface area available for labeling of 12 square inches or more as, for example, two toilet waters of different fragrance or color in a gift set, may bear either:\nA conventional ingredient declaration in which the ingredients of each product are identified under appropriate product headings, listing either all the ingredients in descending order of pr",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ied under appropriate product headings, listing either all the ingredients in descending order of predominance according to § 701.3(a) or listing the ingredients according to § 701.3(f), declaring first in descending order the ingredients other than colors present at concentrations exceeding 1%, followed in any order by the ingredients other than color present at concentrations of 1% or less, followed in any order by the color additives present at any concentration, or\nAn alternate ingredient de",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "owed in any order by the color additives present at any concentration, or\nAn alternate ingredient declaration, listing:\n1. The ingredients other than colors common to all products in cumulative descending order of predominance according to § 701.3(a), or according to § 701.3(f) [permitting listing of ingredients present at 1% or less in any order], followed by\n2. The ingredients other than color not common to all products, identified by the products in which they are present, followed by\n3. The",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ot common to all products, identified by the products in which they are present, followed by\n3. The color additives of all products without identification of products in which they are present.\nback to top\nAssortments of Similar Products Intended for Same Use\nAvailable Labeling Surface Area Less Than 12 Square Inches\nAlternate Declaration\nSingle list of all ingredients in cumulative descending order of predominance\nor\nSingle list of all ingredients according to paragraph (f)\nAn assortment of pro",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "er of predominance\nor\nSingle list of all ingredients according to paragraph (f)\nAn assortment of products of similar composition and intended for the same use in a package with a total surface area available for labeling of less than 12 square inches as, for example, several eye shadows in a compact, may bear either:\nA conventional ingredient declaration in which the ingredients of each product are identified under appropriate product headings, listing either all the ingredients in descending or",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "e identified under appropriate product headings, listing either all the ingredients in descending order or according to § 701.3(a) or listing the ingredients according to § 701.3(f), declaring first in descending order the ingredients other than colors present at concentrations exceeding 1%, followed in any order by the ingredients other than color present at concentrations of 1% or less, followed in any order by the color additives present at any concentration,\nor\nAn alternate ingredient declar",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "in any order by the color additives present at any concentration,\nor\nAn alternate ingredient declaration listing the ingredients of all products in a single integrated list in cumulative descending order of predominance according to § 701.3(a), or cumulatively according to § 701.3(f).\nAssortments of Similar Products\nEye Shadow--Two Shades\nAlternate Labels\nLabel Copy\nLabeling Area 12 Sq. In. or More\nLabeling Area Less Than 12 Sq. In.\nBlue, Pearly Shade:\nTalc\nZinc Stearate\nKaolin\nBentonite\nMinera",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "re\nLabeling Area Less Than 12 Sq. In.\nBlue, Pearly Shade:\nTalc\nZinc Stearate\nKaolin\nBentonite\nMineral Oil\nBismuth Oxychloride\nTitanium Dioxide\nUltramarine Blue\nUltramarine Violet\nGreen Shade:\nTalc\nZinc Stearate\nKaolin\nMineral Oil\nLanolin\nTitanium Dioxide\nUltramarine Green\nChromium Hydroxide Green\nTalc\nZinc Stearate\nKaolin\nMineral Oil\nBentonite in Blue Shade\nLanolin in Green Shade\nBismuth Oxychloride\nTitanium Dioxide\nUltramarine Blue\nUltramarine Violet\nUltramarine Green\nChromium Hydroxide Green\nT",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "de\nTitanium Dioxide\nUltramarine Blue\nUltramarine Violet\nUltramarine Green\nChromium Hydroxide Green\nTalc\nZinc Stearate\nKaolin\nBentonite\nMineral Oil\nLanolin\nBismuth Oxychloride\nTitanium Dioxide\nUltramarine Blue\nUltramarine Violet\nUltramarine Green\nChromium Hydroxide Green\n21 CFR 701.3 (o) (2)\nThis example of an assortment consisting of two similar hypothetical eye shadow formulations demonstrates the optional ingredient declarations for packages with a total surface area available for labeling of",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "e optional ingredient declarations for packages with a total surface area available for labeling of 12 square inches or more (center) and for packages with a total surface area available for labeling of less than 12 square inches (right side).\nOn the left side are shown two conventional ingredient declarations, each representing one shade.\nIn the center is shown the integrated ingredient declaration for the two shades in the package with 12 square inches or more of available labeling area. Note",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "on for the two shades in the package with 12 square inches or more of available labeling area. Note that the ingredients other than color not common to all products are listed after the ingredients that are common and are identified by the products in which they are used. (Bentonite in Blue Shade, Lanolin in Green Shade.)\nOn the right side is shown the integrated ingredient declaration for the two shades in the package with less than 12 square inches of available labeling area. Note that the ing",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "shades in the package with less than 12 square inches of available labeling area. Note that the ingredients not common to all formulations need not be identified by the products in which they are used.\nBranded Shade Lines\nand\nBranded Shade Line Assortments\nDefinition:\nIndividually packaged, or assortments of eye or facial makeup cosmetics or nail enamels bearing the same name\n21 CFR 701.3 (g) (2) and (o) (3)\n(g) (2) and (o) (4)\nAccording to §§ 701.3(g)(2) and (o)(3), a branded shade line may be",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "and (o) (3)\n(g) (2) and (o) (4)\nAccording to §§ 701.3(g)(2) and (o)(3), a branded shade line may be defined as a line of individually packaged eye or facial make-up cosmetics or nail enamels bearing a label that is shared with other products, i.e., bearing the same product name. Example: A line of lipsticks with the same brand name.\nAccording to §§ 701.3(g)(2) and (o)4), a branded shade line assortment may be defined as several assortments of eye or facial make-up cosmetics or nail enamels in p",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "rtment may be defined as several assortments of eye or facial make-up cosmetics or nail enamels in packages bearing the same label. Example: Several compacts with the same name and label, each containing several eye shadows.\nAccording to 701.3(g)(2) and (o)(4), a branded shade line assortment may be defined as several assortments of eye or facial make-up cosmetics or nail enamels in packages bearing the same label. Example: Several compacts with the same name and label, each containing several e",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ng the same label. Example: Several compacts with the same name and label, each containing several eye shadows.\nback to top\nBranded Shade Lines\nand\nBranded Shade Line Assortments\nAlternate Declaration\nSingle ingredient declaration for all branded shades listing ...\nIngredients common to all products, in cumulative descending order of predominance\nIngredients not common, identified by product in which used\nColor additives common to all products, in any order\nColor additives not common, preceded b",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "ich used\nColor additives common to all products, in any order\nColor additives not common, preceded by \"May contain\"\n21 CFR 701.3 (g) (2) and (o) (3)\n(g) (2) and (o) (4)\nBranded shade lines and branded shade line assortments may bear either:\nA conventional ingredient declaration for each product in which the ingredients of each product are identified in descending order of predominance according to § 701.3(a) or, alternately, according to § 701.3(f) [in the case of an assortment the ingredients m",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "§ 701.3(a) or, alternately, according to § 701.3(f) [in the case of an assortment the ingredients may be declared cumulatively in a single list for each assortment according to §§ 701.3(a) or (f)]\nor\nAn alternate ingredient declaration listing all ingredients for all branded shades in the cumulative order shown below. In this case, each shade of a branded shade line or each package of a branded shade line assortment bears the same ingredient declaration.\nBranded Shade Lines and Branded Shade Li",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "hade line assortment bears the same ingredient declaration.\nBranded Shade Lines and Branded Shade Line Assortments\nLipstick - Cherry Red\nIncorrect Label Copy:\nCastor Oil\nIsopropyl Myristate\nBeeswax\nCandelilla Wax\nOleyl Alcohol\nOzokerite\nSorbitan Trioleate\nMay contain:\nMica (and) Titanium Dioxide (and) Iron Oxides\nD&C Red No. 21\nD&C Orange No. 5\nD&C Red No. 6 Barium Lake\nD&C Red No. 7 Calcium Lake\nD&C Red No. 27 Aluminum Lake\nD&C Orange No. 5 Aluminum Lake\nD&C Yellow No. 10 Aluminum Lake\nCorrect",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "D&C Red No. 27 Aluminum Lake\nD&C Orange No. 5 Aluminum Lake\nD&C Yellow No. 10 Aluminum Lake\nCorrect Label Copy:\nCastor Oil\nIsopropyl Myristate\nBeeswax\nCandelilla Wax\nOleyl Alcohol\nOzokerite\nSorbitan Trioleate in Pearl Peach and Pearl Cherry Shades\nTitanium Dioxide\nD&C Red No. 21\nD&C Orange No. 5\nMay contain:\nMica\nIron Oxides\nD&C Red No. 6 Barium Lake\nD&C Red No. 7 Calcium Lake\nD&C Red No. 27 Aluminum Lake\nD&C Orange No. 5 Aluminum Lake\nD&C Yellow No. 10 Aluminum Lake\nThis example of a hypothetic",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "num Lake\nD&C Orange No. 5 Aluminum Lake\nD&C Yellow No. 10 Aluminum Lake\nThis example of a hypothetical shade of a line of lipsticks bearing the same brand name illustrates three common errors found in cosmetic ingredient declarations, namely:\n1. Proprietary mixtures of ingredients identified in the ingredient dictionary by a parenthetical \"(and)\" are often declared on the label as shown in the dictionary section listing chemical/trade names and their respective label names. The compounds of such",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "tionary section listing chemical/trade names and their respective label names. The compounds of such mixtures must be separated, the \"(and)\" omitted, and the components treated as individual ingredients for labeling purposes. See \"Mica (and) Titanium dioxide (and) Iron oxides.\"\n2. Many labels list all color additives of a shade line after the phrase \"May contain.\" The color additives common to all shades must be listed before \"May contain\", and only those not found in all shade formulations may",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "shades must be listed before \"May contain\", and only those not found in all shade formulations may be listed after \"May contain.\"\n3. The ingredients other than colors which are not included in all shade formulations must be identified as to the shades in which they are present.\nDirect Mail Cosmetics\nDefinition\nCosmetics ordered by and delivered to consumers through the mail without involvement of an intermediary sales agent\n21 CFR 701.3 (r)\nDirect mail cosmetics may utilize off-package ingredie",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "an intermediary sales agent\n21 CFR 701.3 (r)\nDirect mail cosmetics may utilize off-package ingredient labeling as an alternative to the declaration of ingredients on an information panel.\nFor the purpose of cosmetic ingredient labeling, direct mail cosmetics are defined as cosmetics ordered by mail and delivered to consumers through the mail without the involvement of an intermediary sales agent.\nCosmetics sold to consumers through \"door-to-door\" salespersons are not considered direct mail cosm",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "Cosmetics sold to consumers through \"door-to-door\" salespersons are not considered direct mail cosmetics even though they may be delivered to consumers directly by mail.\nback to top\nDirect Mail Cosmetics\nDeclaration on\nlabeling accompanying the mailed cosmetic\nor\nlabeling furnished to each consumer ordering cosmetics by mail\n21 CFR 701.3 (r)\nAs an alternative to the declaration of ingredients on an information panel, the declaration may appear in letters not less than 1/16 of an inch in height",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "an information panel, the declaration may appear in letters not less than 1/16 of an inch in height in:\nLabeling that accompanies and specifically relates to the cosmetic(s) mailed, e.g., a brochure, insert or written directions for safe use, or\nLabeling furnished to each consumer for personal use and from which cosmetics are ordered through the mail, e.g., a direct mail sales catalog or brochure.\nDirect Mail Cosmetics\nRequirements\nNotice in 3/16-inch lettering located or affixed to top, inside,",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "Direct Mail Cosmetics\nRequirements\nNotice in 3/16-inch lettering located or affixed to top, inside, or outside of package, stating:\nLocation of ingredient declaration\nAvailability on request through mail\nName and address of distributor\n21 CFR 701.3(r)\nIf the ingredients of cosmetics distributed to consumers by direct mail are made available through off-package labeling, the following requirement must be met:\n1. The package mailed to consumers must be accompanied by a notice in 3/16 of an inch l",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "must be met:\n1. The package mailed to consumers must be accompanied by a notice in 3/16 of an inch lettering informing the consumer of the location of the ingredient declaration(s), of the name and address of the mail order distributor, and that a copy of the ingredient declaration(s) will be mailed to any person requesting it.\n2. The mail order distributor must promptly mail a copy of an ingredient declaration to any person requesting it.\n3. The notice in 3/16 of an inch lettering must be locat",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "nt declaration to any person requesting it.\n3. The notice in 3/16 of an inch lettering must be located on, or affixed to, the top of the package; or it must be inside the package on top of the contents or on the face of the platform surrounding and holding the product(s) and must be readily visible to the consumer on opening.\n4. The ingredient declarations must be conspicuous and presented in a way that the consumer can readily associate each ingredient declaration with each cosmetic.\nOff-packag",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "y that the consumer can readily associate each ingredient declaration with each cosmetic.\nOff-package Ingredient Labeling\nQualifying Conditions\n21 CFR 701.3(i)\nThe declaration of ingredients in labeling accompanying a cosmetic, i.e., off-package ingredient labeling, requires that:\n(1)The product is not enclosed in an outer container,\n(2)The total package surface area is less than 12 square inches, and\n(3)The products are held for sale in tightly compartmented trays or racks.\nThe ingredient decla",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "and\n(3)The products are held for sale in tightly compartmented trays or racks.\nThe ingredient declaration must be in letters not less than 1/16 of an inch in height and may appear on padded sheets, leaflets or similar labeling accompanying the product.\nProducts which are not eye or facial make-up cosmetics or nail enamels must be displayed for sale in tightly compartmented trays or racks of a display unit. The holder of the padded sheets or leaflets bearing the ingredient declaration(s) must be",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "play unit. The holder of the padded sheets or leaflets bearing the ingredient declaration(s) must be attached to the display unit.\nProducts which are eye or facial make-up cosmetics or nail enamels may be held for sale in tightly compartmented trays or racks located below the sales counter. The holder of the ingredient labeling must be attached to a display chart which bears samples of the product shades and is displayed to purchasers.\nback to top\nOff-package Ingredient Labeling\nHolder of Labeli",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "shades and is displayed to purchasers.\nback to top\nOff-package Ingredient Labeling\nHolder of Labeling\n1. Must bear the following statement visible after last list has been taken:\n\"Federal law requires ingredient list to be displayed here.\"\n21.CFR 701.3(j)\nAmong the various conditions described in §§ 701.3(j) and (k) that must be met if off-package ingredient labeling is utilized as an alternative to the declaration of ingredients on an information panel, the following deserve particular attenti",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "to the declaration of ingredients on an information panel, the following deserve particular attention:\n1. The display unit or chart must bear the statement \"Federal law requires ingredient lists to be displayed here\" in letters not less than 3/16 of an inch in height. This statement becomes conspicuous when the last ingredient list has been taken or may also be shown at all times adjacent to the holder of labeling bearing the ingredient declaration(s).\nOff-package Ingredient Labeling\nHolder of",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "holder of labeling bearing the ingredient declaration(s).\nOff-package Ingredient Labeling\nHolder of Labeling\n2. Padded sheets or leaflets must be attached to the display unit and be fully visible on the front\nor\npartially visible on the front and bear a notice in 3/16-inch lettering describing their location\nor\nlocated on the side only and bear the location notice.\n21 CFR 701.3 (j)\n2. The holder of off-package cosmetic ingredient labeling, e.g., padded sheets or leaflets, must be attached to the",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "f off-package cosmetic ingredient labeling, e.g., padded sheets or leaflets, must be attached to the display unit or chart so that the labeling is in front of the display unit or chart and can be read in full by a purchaser facing the display under customary conditions of retail sale.\nAs an alternative to full display of off-package ingredient labeling, the labeling may also be on the side of the display unit or chart, but not at the top, back or bottom, in which case it must be accompanied by a",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "display unit or chart, but not at the top, back or bottom, in which case it must be accompanied by a conspicuous notice in 3/16 of an inch lettering on the front of the display unit, describing the location of the off-package labeling and stating \"Federal law requires ingredient lists to be displayed here.\"\nAdditional Requirements\n1. Leaflets must bear declarations of all products sold with display unit or chart.\n2. Leaflets must be identical.\n21 CFR 701.3 (k)\nThe following additional conditions",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "y unit or chart.\n2. Leaflets must be identical.\n21 CFR 701.3 (k)\nThe following additional conditions must be met to comply with the requirements for off-package ingredient labeling of cosmetics:\n1. The padded sheets or leaflets attached to the display unit or chart must declare the ingredients of all products sold with the display.\n2. The padded sheets or leaflets must be identical.\nAdditional Requirements\n3. Leaflets and displays must be shipped together.\n4. Leaflets must be sufficient in numbe",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "uirements\n3. Leaflets and displays must be shipped together.\n4. Leaflets must be sufficient in number and replaced with refills with replacement instructions to retailer.\n21 CFR 701.3\n3. The number of copies of padded sheets or leaflets provided with each shipment of a cosmetic must be sufficient so that each purchaser may obtain a copy of an ingredient declaration. Further, the display units and replacement labeling must be accompanied by appropriate instructions to the retailer to assure that",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "replacement labeling must be accompanied by appropriate instructions to the retailer to assure that retailers display the padded sheets or leaflets.\n4. Shipments of refill items also must be accompanied by sufficient copies of ingredient declarations, and the container holding the refill items and the respective copies of ingredient declarations must not contain other cosmetic products.\nAdditional Requirements\n5. Label firm must send copy of ingredient declaration to requesting person.\n6. In cas",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "Requirements\n5. Label firm must send copy of ingredient declaration to requesting person.\n6. In case of formulation change, leaflet must declare both formulations.\n21 CFR 701.3\n5. The firm engaged in off-package cosmetic ingredient labeling must promptly mail a copy of the ingredient declaration to any person requesting it.\n6. In case of a formulation change, the new padded sheet or leaflet must be dated if not shipped together with the display unit or chart. If a padded sheet or leaflet is to",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "be dated if not shipped together with the display unit or chart. If a padded sheet or leaflet is to be used in conjunction with the old and the new formulations, it must bear both ingredient declarations, and the declarations must be identified in a way that the purchaser can determine which declaration pertains to which product. As an alternative, the padded sheet or leaflet bearing the two ingredient declarations may advise the purchaser that the formulation has been changed and that either de",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "dient declarations may advise the purchaser that the formulation has been changed and that either declaration may be applicable.",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/cosmetic-labeling-guide"
  },
  {
    "text": "We've listed resources on cosmetic safety and regulation that may be especially useful to students and teachers. If you don't find what you're looking for here, please visit our Cosmetics main page.\nSUBSCRIBE",
    "url": "https://www.fda.gov/cosmetics/resources-you-cosmetics/resources-students-teachers-cosmetics"
  },
  {
    "text": "This section contains information related to the laws and regulations FDA enforces, as well as Federal Register notices that consumers and manufacturers often ask for.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-guidance-regulation/cosmetics-laws-regulations"
  },
  {
    "text": "FDA often receives questions from soap makers about how their products are regulated. Here is information to help small-scale soap producers understand the laws and regulations they need to know about.\nHow are traditional soaps and synthetic detergents different?\nOrdinary soap is made by combining fats or oils and an alkali, such as lye. The fats and oils, which may be from animal, vegetable, or mineral sources, are degraded into free fatty acids, which then combine with the alkali to form crude",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/frequently-asked-questions-soap"
  },
  {
    "text": "ineral sources, are degraded into free fatty acids, which then combine with the alkali to form crude soap. The alkali reacts with the oils, turning what starts out as liquid into blocks of soap. When made properly, no lye remains in the finished product. In the past, people commonly made their own soap using animal fats and lye that had been extracted from wood ashes.\nToday there are very few true soaps on the market. Most body cleansers, both liquid and solid, are synthetic detergent products.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/frequently-asked-questions-soap"
  },
  {
    "text": "soaps on the market. Most body cleansers, both liquid and solid, are synthetic detergent products. Detergent cleansers are popular because they make suds easily in water and don't form gummy deposits. Many of these detergent products are marketed as \"soap\" but are not true soap according to the regulatory definition of the word.\nWhat’s FDA's regulatory definition of soap (21 CFR 701.20)?\nFDA’s regulatory definition of soap includes the following three conditions; all three conditions must be me",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/frequently-asked-questions-soap"
  },
  {
    "text": "gulatory definition of soap includes the following three conditions; all three conditions must be met to be a soap under FDA’s regulatory definition:\nHow are different “soap” products regulated?\nWhat if my ingredients are “natural” or “organic”?\nTo learn more, see Product Testing of Cosmetics. To learn more about “organic” requirements, see ‘Organic’ Cosmetics and the National Organic Program (USDA).",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/frequently-asked-questions-soap"
  },
  {
    "text": "A).",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/frequently-asked-questions-soap"
  },
  {
    "text": "At-a-Glance information on popular topics, including:\nMore Resources for Consumers\nQuick-reference links for industry members, including:\nMore Resources for Industry\nMore Resources for Health Professionals\nResources for Students & Teachers\nInformación con Cosméticos en Español\nSUBSCRIBE",
    "url": "https://www.fda.gov/cosmetics/resources-you-cosmetics"
  },
  {
    "text": "The regulations listed below are the authoritative resource for cosmetic labeling requirements. The links to the sections of Title 21 of the Code of Federal Regulations (21 CFR) will take you from FDA's website to the Electronic Code of Federal Regulations, maintained by the U.S. Government Printing Office.\nMore Resources:",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/labeling-regulations-cfr-title-21-part-701"
  },
  {
    "text": "English\n화장품과 관련해서 신체 반응이 발생하거나 이상을 발견한 경우, 가장 먼저 할 일은 해당 화장품의 사용을 중지하고 의료인에게 연락하는 것입니다. 식품의약국(Food and Drug Administration, FDA)은 의학적 조언을 제공하지 않습니다. 그 다음에는 FDA에 문제를 신고합니다.\n화장품 관련 불만 사항 신고\n다음과 같은 일이 있을 경우 FDA에 신고합니다\n화장품으로 간주되는 제품 유형\n화장품은 의약품과 같지 않으므로 FDA의 규제가 다르게 적용됩니다. 화장품의 예는 다음과 같습니다.\n소비자와 의료인이 화장품 관련 문제를 FDA에 신고하는 방법\n화장품과 관련된 불만 사항 또는 이상반응(몸이 아픔, 알레르기 반응, 발진, 자극, 흉터, 탈모)을 신고하고자 하는 소비자 또는 의료인이라면 다음과 같이 할 수 있습니다.\nMedWatchFood and Drug Administration5600 Fishers LaneRockville, MD 20852팩스: 800-33",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/hwajangpum-gwanlyeon-bulman-sahang-singo-bangbeob"
  },
  {
    "text": "다음과 같이 할 수 있습니다.\nMedWatchFood and Drug Administration5600 Fishers LaneRockville, MD 20852팩스: 800-332-0178(무료)\n업계 관계자가 심각한 이상반응을 신고하는 방법\n2022년 화장품 규제 현대화법(Modernization of Cosmetics Regulation Act of 2022, MoCRA)이 2022년 12월 29일 제정되었습니다. MoCRA는 연방 식품, 의약품 및 화장품법(Federal Food, Drug, and Cosmetic Act, FD&C Act) 6장을 개정하였으며, 1938년 이후 화장품에 대한 FDA의 규제 권한을 가장 크게 확장했습니다.\nMoCRA는 신고 의무자(뒤에 정의됨)가 미국 내 화장품 사용과 관련된 심각한 이상반응(뒤에 정의됨)을 15영업일 이내에 FDA에 신고하도록 규정합니다. 신고 의무자는 그 화장품의 용기 또는 포장 속에 있는 라벨의 사본을 첨부해야 합니다. 신",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/hwajangpum-gwanlyeon-bulman-sahang-singo-bangbeob"
  },
  {
    "text": "관련된 심각한 이상반응(뒤에 정의됨)을 15영업일 이내에 FDA에 신고하도록 규정합니다. 신고 의무자는 그 화장품의 용기 또는 포장 속에 있는 라벨의 사본을 첨부해야 합니다. 신고 의무자가 FDA 첫 신고 후 1년 내로 그 이상반응에 대한 의학적 정보 또는 기타 정보를 입수할 경우, 이 새로운 정보를 15영업일 이내에 FDA에 제출해야 합니다. 또 FDA는 점검 시 이상반응 신고를 열람할 수 있습니다.\n업계 내 신고 의무자는 화장품에 대한 심각한 이상반응 보고서(Serious Adverse Event Reports, SAER)를 최신 양식 FDA 3500A - 의무적 신고(Form FDA 3500A - Mandatory Reporting)를 사용해서 신고할 의무가 있습니다. 이 양식은 다음 링크에서 다운로드하고 작성할 수 있습니다. MedWatch: FDA 안전 정보 및 이상반응 신고 프로그램 - 의무(FDA Safety Information and Adverse Event Rep",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/hwajangpum-gwanlyeon-bulman-sahang-singo-bangbeob"
  },
  {
    "text": "드하고 작성할 수 있습니다. MedWatch: FDA 안전 정보 및 이상반응 신고 프로그램 - 의무(FDA Safety Information and Adverse Event Reporting Program - Mandatory) (PDF).\n양식 FDA 3500A 작성 안내를 참고하십시오.\n제출:\nFDA에 이메일을 CosmeticAERS@fda.hhs.gov로 보내거나 다음 주소로 우편으로 보냅니다.\nFDA CDER Mail CenterAttn: Cosmetics MedWatch reportsWhite Oak Campus, Building 22, G020710903 New Hampshire Ave.Silver Spring, MD 20993\nFDA는 화장품 이상반응의 의무적 신고를 전자적으로 제출하는 절차를 마련 중입니다.\nMoCRA는 업계 내 신고 의무자가 심각하지 않은 화장품 이상반응을 FDA에 신고하도록 규정하지 않습니다. 그러나 양식 3500A를 사용해 의무적 신고와 똑같은 절",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/hwajangpum-gwanlyeon-bulman-sahang-singo-bangbeob"
  },
  {
    "text": "마련 중입니다.\nMoCRA는 업계 내 신고 의무자가 심각하지 않은 화장품 이상반응을 FDA에 신고하도록 규정하지 않습니다. 그러나 양식 3500A를 사용해 의무적 신고와 똑같은 절차를 거쳐서, 심각하지 않은 이상반응을 자진 신고할 수 있습니다.\n주요 용어\n심각한 이상반응: 다음과 같은 이상반응\n(A) 다음과 같은 결과를 초래함:\n(B) 합리적인 의학적 판단에 비추어볼 때 (A)의 결과를 예방하기 위해 의료 중재 또는 시술이 필요함.\n신고 의무자: 연방 식품, 의약품 및 화장품법 섹션 609(a) 또는 공정포장라벨법(Fair Packaging and Labeling Act) 섹션 4(a)에 따라 화장품 라벨에 이름이 표기된 제조사, 포장 회사, 판매 회사.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/hwajangpum-gwanlyeon-bulman-sahang-singo-bangbeob"
  },
  {
    "text": "Consumers and manufacturers sometimes ask about the use of animals for testing cosmetics. The following information addresses the legal requirement for cosmetic safety and FDA policy on developing alternative methods.\nFDA is responsible for assuring that cosmetics are safe and properly labeled. This mission is accomplished through enforcement of the Federal Food, Drug, and Cosmetic Act (FD&C Act), related statutes, and regulations promulgated under these laws.\nThe FD&C Act does not specifically",
    "url": "https://www.fda.gov/cosmetics/product-testing/animal-testing-cosmetics"
  },
  {
    "text": "related statutes, and regulations promulgated under these laws.\nThe FD&C Act does not specifically require the use of animals in testing cosmetics for safety, nor does the Act subject cosmetics to FDA premarket approval. However, the agency has consistently advised cosmetic manufacturers to employ whatever testing is appropriate and effective for substantiating the safety of their products. It remains the responsibility of the manufacturer to substantiate the safety of both ingredients and fini",
    "url": "https://www.fda.gov/cosmetics/product-testing/animal-testing-cosmetics"
  },
  {
    "text": "mains the responsibility of the manufacturer to substantiate the safety of both ingredients and finished cosmetic products prior to marketing.\nAnimal testing by manufacturers seeking to market new products may be used to establish product safety. In some cases, after considering available alternatives, companies may determine that animal testing is necessary to assure the safety of a product or ingredient. FDA supports and adheres to the provisions of applicable laws, regulations, and policies g",
    "url": "https://www.fda.gov/cosmetics/product-testing/animal-testing-cosmetics"
  },
  {
    "text": "gredient. FDA supports and adheres to the provisions of applicable laws, regulations, and policies governing animal testing, including the Animal Welfare Act and the Public Health Service Policy of Humane Care and Use of Laboratory Animals. Moreover, in all cases where animal testing is used, FDA advocates that research and testing derive the maximum amount of useful scientific information from the minimum number of animals and employ the most humane methods available within the limits of scient",
    "url": "https://www.fda.gov/cosmetics/product-testing/animal-testing-cosmetics"
  },
  {
    "text": "e minimum number of animals and employ the most humane methods available within the limits of scientific capability.\nWe also believe that prior to use of animals, consideration should be given to the use of scientifically valid alternative methods to whole-animal testing. In 1997, FDA joined with thirteen other Federal agencies in forming the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). ICCVAM and its supporting center, the National Toxicology Program Int",
    "url": "https://www.fda.gov/cosmetics/product-testing/animal-testing-cosmetics"
  },
  {
    "text": "Alternative Methods (ICCVAM). ICCVAM and its supporting center, the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), coordinate the development, validation, acceptance, and harmonization of alternative toxicological test methods throughout the U.S. Federal Government. To learn more, visit the ICCVAM and NICEATM websites.\nFDA supports the development and use of alternatives to whole-animal testing as well as adherence to the most h",
    "url": "https://www.fda.gov/cosmetics/product-testing/animal-testing-cosmetics"
  },
  {
    "text": "s the development and use of alternatives to whole-animal testing as well as adherence to the most humane methods available within the limits of scientific capability when animals are used for testing the safety of cosmetic products. We will continue to be a strong advocate of methodologies for the refinement, reduction, and replacement of animal tests with alternative methodologies that do not employ the use of animals.\nMore Resources from FDA:\nResources from Other U.S. Government Agencies:\nRes",
    "url": "https://www.fda.gov/cosmetics/product-testing/animal-testing-cosmetics"
  },
  {
    "text": "ploy the use of animals.\nMore Resources from FDA:\nResources from Other U.S. Government Agencies:\nResources from the International Cooperation on Cosmetics Regulation (ICCR):\nMay 31, 1999; Updated April 5, 2006. This information is current. It is updated only when needed.",
    "url": "https://www.fda.gov/cosmetics/product-testing/animal-testing-cosmetics"
  },
  {
    "text": "FAQs Main Page\nPeople often use the term \"personal care products\" to refer to a wide variety of items that we commonly find in the health and beauty departments of drug and department stores. These products may fall into a number of different categories under the law.\nThe law does not recognize any such category as \"cosmeceuticals.\" If a product has drug properties, it must meet the requirements for drugs.\nTo learn more, see",
    "url": "https://www.fda.gov/cosmetics/consumers/cosmetics-safety-qa-personal-care-products"
  },
  {
    "text": "or drugs.\nTo learn more, see",
    "url": "https://www.fda.gov/cosmetics/consumers/cosmetics-safety-qa-personal-care-products"
  },
  {
    "text": "FDA has the legal authority to inspect cosmetic establishments as well as cosmetics offered for import. Here are resources to learn more about FDA inspection of cosmetics.\nSection 704 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to conduct inspections of cosmetic firms at reasonable times, in a reasonable manner, and without prior notice in order to assure compliance with the applicable laws and regulations, to determine whether cosmetics are safe and properly labeled, a",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/inspection-cosmetics"
  },
  {
    "text": "the applicable laws and regulations, to determine whether cosmetics are safe and properly labeled, and to identify possible health risks and other violations of the law.\nA number of factors affect how FDA determines that an inspection of a cosmetic establishment may be warranted. These factors may include--but are not limited to--the type of products, the significance of consumer or trade complaints received, the company's compliance history, FDA surveillance and compliance initiatives, and agen",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/inspection-cosmetics"
  },
  {
    "text": "ts received, the company's compliance history, FDA surveillance and compliance initiatives, and agency resources.\nSome things to know about inspections:\nUnder the FD&C Act, imported cosmetic products must comply with all the regulatory requirements that apply to domestic products (FD&C Act, section 201(b). They are subject to examination and/or sampling through U.S. Customs and Border Protection at the time of entry. Foreign cosmetics that appear to be adulterated or misbranded (FD&C Act, sectio",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/inspection-cosmetics"
  },
  {
    "text": "t the time of entry. Foreign cosmetics that appear to be adulterated or misbranded (FD&C Act, sections 601 and 602) may be refused entry into the United States. Shipments found not to comply with U.S. laws and regulations are subject to detention. They must be brought into compliance, destroyed, or re-exported (FD&C Act, section 801). Not all imported products are examined at the time of entry. Those not examined, however, are still subject to all the legal requirements of the laws we enforce.\nR",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/inspection-cosmetics"
  },
  {
    "text": "ose not examined, however, are still subject to all the legal requirements of the laws we enforce.\nRelated Resources:",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/inspection-cosmetics"
  },
  {
    "text": "Back to Cosmetics & U.S. Law\nThe law does not require cosmetic products and ingredients, other than color additives, to have FDA approval before they go on the market, but there are laws and regulations that apply to cosmetics on the market in interstate commerce.\nThe two most important laws pertaining to cosmetics marketed in the United States are the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling Act (FPLA)External Link Disclaimer. FDA regulates cosmetics u",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "t) and the Fair Packaging and Labeling Act (FPLA)External Link Disclaimer. FDA regulates cosmetics under the authority of these laws.\nIn the United States, federal laws are enacted by Congress. In order to make the laws work on a day-to-day level, Congress authorizes certain government agencies. such as FDA, to create regulations. A change in FDA's legal authority over cosmetics would require Congress to change the law.\nThe FD&C Act defines cosmetics by their intended use, as \"articles intended",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "ress to change the law.\nThe FD&C Act defines cosmetics by their intended use, as \"articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance\" (FD&C Act, sec. 201(i)). Among the products included in this definition are skin moisturizers, perfumes, lipsticks, fingernail polishes, eye and facial makeup, cleansing shampoos, permanent waves, hair colors, an",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "ks, fingernail polishes, eye and facial makeup, cleansing shampoos, permanent waves, hair colors, and deodorants, as well as any substance intended for use as a component of a cosmetic product. It does not include soap. (To learn what products are considered \"soap\" for regulatory purposes, see \"Soap.\"\nBut, if the product is intended for a therapeutic use, such as treating or preventing disease, or to affect the structure or function of the body, it’s a drug (FD&C Act, 201(g)), or in some cases a",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "to affect the structure or function of the body, it’s a drug (FD&C Act, 201(g)), or in some cases a medical device (FD&C Act, 201(h)), even if it affects the appearance. Other “personal care products” may be regulated as dietary supplements or as consumer products. To learn more, see “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)” and “Cosmetics Q&A: Personal Care Products.”\nThe information presented here applies only to the regulation of products that are cosmetics as defined by the FD&C",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "presented here applies only to the regulation of products that are cosmetics as defined by the FD&C Act.\nback to top\nThe FD&C Act prohibits the marketing of adulterated or misbranded cosmetics in interstate commerce.\n“Adulteration” refers to violations involving product composition--whether they result from ingredients, contaminants, processing, packaging, or shipping and handling. Under the FD&C Act, a cosmetic is adulterated if--\n\"it bears or contains any poisonous or deleterious substance wh",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "Act, a cosmetic is adulterated if--\n\"it bears or contains any poisonous or deleterious substance which may render it injurious to users under the conditions of use prescribed in the labeling thereof, or under conditions of use as are customary and usual\" (with an exception made for coal-tar hair dyes);\n\"it consists in whole or in part of any filthy, putrid, or decomposed substance\";\n\"it has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with f",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health\";\n\"its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health\"; or\nexcept for coal-tar hair dyes, \"it is, or it bears or contains, a color additive which is unsafe within the meaning of section 721(a)\" of the FD&C Act. (FD&C Act, sec. 601)\n“Misbranding” re",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "unsafe within the meaning of section 721(a)\" of the FD&C Act. (FD&C Act, sec. 601)\n“Misbranding” refers to violations involving improperly labeled or deceptively packaged products. Under the FD&C Act, a cosmetic is misbranded if--\n\"its labeling is false or misleading in any particular\";\nits label does not include all required information. (An exemption may apply to cosmetics that are to be processed, labeled, or repacked at an establishment other than where they were originally processed or pac",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "sed, labeled, or repacked at an establishment other than where they were originally processed or packed; see Title 21, Code of Federal Regulations, section 701.9.)\nthe required information is not adequately prominent and conspicuous;\n\"its container is so made, formed, or filled as to be misleading\";\nit is a color additive, other than a hair dye, that does not conform to applicable regulations issued under section 721 of the FD&C Act; and\n\"its packaging or labeling is in violation of an applicabl",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "ed under section 721 of the FD&C Act; and\n\"its packaging or labeling is in violation of an applicable regulation issued pursuant to section 3 or 4 of the Poison Prevention Packaging Act of 1970.\" (FD&C Act, sec. 602)\nUnder the FD&C Act, a product also may be misbranded due to failure to provide material facts. This means, for example, any directions for safe use and warning statements needed to ensure a product's safe use.\nIn addition, under the authority of the FPLA, FDA requires a list of ingr",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "sure a product's safe use.\nIn addition, under the authority of the FPLA, FDA requires a list of ingredients for cosmetics marketed on a retail basis to consumers (Title 21, Code of Federal Regulations (CFR), section 701.3). Cosmetics that fail to comply with the FPLA are considered misbranded under the FD&C Act. (FPLA, section 1456) This requirement does not apply to cosmetics distributed solely for professional use, institutional use (such as in schools or the workplace), or as free samples or",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "or professional use, institutional use (such as in schools or the workplace), or as free samples or hotel amenities.\nFDA can take action against cosmetics on the market that are in violation of these laws, as well as companies and individuals who market such products.\nFDA's legal authority over cosmetics is different from our authority over other products we regulate, such as drugs, biologics, and medical devices. Under the law, cosmetic products and ingredients do not need FDA premarket approva",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "medical devices. Under the law, cosmetic products and ingredients do not need FDA premarket approval, with the exception of color additives. However, FDA can pursue enforcement action against products on the market that are not in compliance with the law, or against firms or individuals who violate the law.\nIn general, except for color additives and those ingredients that are prohibited or restricted by regulation, a manufacturer may use any ingredient in the formulation of a cosmetic, provided",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "cted by regulation, a manufacturer may use any ingredient in the formulation of a cosmetic, provided that--\nthe ingredient and the finished cosmetic are safe under labeled or customary conditions of use,\nthe product is properly labeled, and\nthe use of the ingredient does not otherwise cause the cosmetic to be adulterated or misbranded under the laws that FDA enforces.\nback to top\nCompanies and individuals who manufacture or market cosmetics have a legal responsibility to ensure the safety of the",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "ividuals who manufacture or market cosmetics have a legal responsibility to ensure the safety of their products. Neither the law nor FDA regulations require specific tests to demonstrate the safety of individual products or ingredients. The law also does not require cosmetic companies to share their safety information with FDA.\nFDA has consistently advised manufacturers to use whatever testing is necessary to ensure the safety of their products and ingredients. Firms may substantiate safety in a",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "necessary to ensure the safety of their products and ingredients. Firms may substantiate safety in a number of ways. FDA has stated that \"the safety of a product can be adequately substantiated through (a) reliance on already available toxicological test data on individual ingredients and on product formulations that are similar in composition to the particular cosmetic, and (b) performance of any additional toxicological and other tests that are appropriate in light of such existing data and in",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "additional toxicological and other tests that are appropriate in light of such existing data and information.\" (Federal Register, March 3, 1975, page 8916).\nIn addition, regulations prohibit or restrict the use of several ingredients in cosmetic products and require warning statements on the labels of certain types of cosmetics.\nback to top\nRecalls of cosmetics are voluntary actions taken by manufacturers or distributors to remove from the marketplace products that represent a hazard or gross d",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "facturers or distributors to remove from the marketplace products that represent a hazard or gross deception, or that are somehow defective (21 CFR 7.40(a). FDA is not authorized to order recalls of cosmetics, but we do monitor companies that conduct a product recall and may request a product recall if the firm is not willing to remove dangerous products from the market without FDA's written request. To learn more, see “FDA Recall Policy for Cosmetics.”\nFDA may take regulatory action if we have",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "st. To learn more, see “FDA Recall Policy for Cosmetics.”\nFDA may take regulatory action if we have reliable information indicating that a cosmetic is adulterated or misbranded. For example, FDA can pursue action through the Department of Justice in the federal court system to remove adulterated and misbranded cosmetics from the market. To prevent further shipment of an adulterated or misbranded product, FDA may request a federal district court to issue a restraining order against the manufactur",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "roduct, FDA may request a federal district court to issue a restraining order against the manufacturer or distributor of the violative cosmetic. Cosmetics that are not in compliance with the law may be subject to seizure. “Seizure” means that the government takes possession of property from someone who has violated the law, or is suspected of doing so. FDA also may initiate criminal action against a person violating the law.\nIn addition, FDA works closely with U.S. Customs and Border Protection",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "a person violating the law.\nIn addition, FDA works closely with U.S. Customs and Border Protection to monitor imports. Under section 801(a) of the FD&C Act, imported cosmetics are subject to review by FDA at the time of entry through U.S. Customs. Products that do not comply with FDA laws and regulations are subject to refusal of admission into the United States. They must be brought into compliance (if possible), destroyed, or re-exported. FDA does not inspect every shipment of cosmetics that",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "nce (if possible), destroyed, or re-exported. FDA does not inspect every shipment of cosmetics that comes into this country, but imported cosmetics are still subject to the laws we enforce, even if they are not inspected upon entry. To learn more, see “Information for Cosmetics Importers.”\nFDA takes regulatory action based upon agency priorities, consistent with public health concerns and available resources.\nback to top\nFDA can and does inspect cosmetic manufacturing facilities to assure cosmet",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "e resources.\nback to top\nFDA can and does inspect cosmetic manufacturing facilities to assure cosmetic product safety and determine whether cosmetics are adulterated or misbranded under the FD&C Act or FPLA.\nAlthough FD&C Act does not subject cosmetics to premarket approval by FDA, we do collect samples for examination and analysis as part of cosmetic facility inspections, import inspections, and follow-up to complaints of adverse events associated with their use. FDA may also conduct research o",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "follow-up to complaints of adverse events associated with their use. FDA may also conduct research on cosmetic products and ingredients to address safety concerns.\nFDA does not function as a private testing laboratory, and in order to avoid even the perception of conflict of interest, we do not recommend private laboratories to consumers or manufacturers for sample analysis.\nUnder the law, manufacturers are not required to register their cosmetic establishments or file their product formulations",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "turers are not required to register their cosmetic establishments or file their product formulations with FDA, and no registration number is required to import cosmetics into the United States.\nHowever, we encourage cosmetic firms to participate in FDA's Voluntary Cosmetic Registration Program (VCRP) using the online registration system. Cosmetic manufacturers, distributors, and packers can file information on their products that are currently being marketed to consumers in the United States and",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "nformation on their products that are currently being marketed to consumers in the United States and register their manufacturing and/or packaging facility locations in the VCRP database. To learn more and access this program, see Voluntary Cosmetic Registration Program (VCRP).\nMarch 3, 2005; updated August 3, 2013\nback to top",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated"
  },
  {
    "text": "Soaps & Lotions Main Page\nSome products are marketed with claims that they will make people look younger. But are these products cosmetics? It depends.\nUnder the law, cosmetics must be safe when consumers use them according to product labeling, or the way in which the products are customarily used. But the law does not require cosmetics to be approved by FDA before they go on the market. Drugs, however, must have FDA approval for both safety and effectiveness before they go on the market. Simila",
    "url": "https://www.fda.gov/cosmetics/products/wrinkle-treatments-and-other-anti-aging-products"
  },
  {
    "text": "wever, must have FDA approval for both safety and effectiveness before they go on the market. Similarly, medical devices must go through FDA’s clearance process.\nFDA is concerned about drug claims made for products marketed as cosmetics, such as skin care products with anti-wrinkle or anti-aging claims that involve supposed effects on the structure or function of the skin.\nWhere to learn more:\nRegulation and Enforcement\nFederal Trade Commission Action on L’Oréal Anti-aging Claims for Génifique a",
    "url": "https://www.fda.gov/cosmetics/products/wrinkle-treatments-and-other-anti-aging-products"
  },
  {
    "text": "ulation and Enforcement\nFederal Trade Commission Action on L’Oréal Anti-aging Claims for Génifique and Youth Code\nProducts and Ingredients\nOutside of FDA",
    "url": "https://www.fda.gov/cosmetics/products/wrinkle-treatments-and-other-anti-aging-products"
  },
  {
    "text": "English\nEn caso de una reacción o un problema con un producto cosmético, el primer paso es dejar de usar el producto y ponerse en contacto con su proveedor de atención médica. La Administración de Alimentos y Medicamentos (FDA, por sus siglas en inglés) no proporciona asesoramiento médico al respecto. En segundo lugar, debe notificar el problema a la FDA.\nPresentar una queja sobre un producto cosmético\nNotifique a la FDA en los siguientes casos:\nTipos de productos que se consideran cosméticos\nLo",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "ético\nNotifique a la FDA en los siguientes casos:\nTipos de productos que se consideran cosméticos\nLos productos cosméticos no son lo mismo que los productos farmacológicos y están regulados de manera diferente por la FDA. A continuación, especificamos algunos ejemplos de productos cosméticos:\nCómo pueden los consumidores y los profesionales de la salud denunciar un problema con los productos cosméticos ante la FDA\nSi usted es un consumidor o profesional de la salud que desea presentar una queja",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "ticos ante la FDA\nSi usted es un consumidor o profesional de la salud que desea presentar una queja o denunciar un evento adverso (como una enfermedad, reacción alérgica, erupción, irritación, cicatrización o caída del cabello) relacionado con un producto cosmético, puede proceder de la siguiente manera:\nMedWatchFood and Drug Administration5600 Fishers LaneRockville, MD 20852FAX: 800-332-0178 (línea gratuita).\nCómo notifica la industria de eventos adversos graves\nEl 29 de diciembre de 2022 se pr",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "ea gratuita).\nCómo notifica la industria de eventos adversos graves\nEl 29 de diciembre de 2022 se promulgó la Ley de Modernización de la Regulación de Cosméticos (MoCRA, por sus siglas en inglés).  La MoCRA enmienda el capítulo VI de la Ley Federal de Alimentos, Medicamentos y Cosméticos (FFDCA, por sus siglas en inglés) y prevé la expansión más significativa de la autoridad de la FDA en la regulación de cosméticos desde 1938.\nMoCRA exige que una persona responsable (vea la definición que aparec",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "ción de cosméticos desde 1938.\nMoCRA exige que una persona responsable (vea la definición que aparece más adelante) informe a la FDA sobre eventos adversos graves (vea la definición que aparece más adelante) asociados con el uso de productos cosméticos en los Estados Unidos, dentro de un plazo de 15 días hábiles. La persona responsable deberá incluir una copia de la etiqueta en o dentro del embalaje minorista de dicho producto cosmético. Si la persona responsable recibe información médica o de o",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "je minorista de dicho producto cosmético. Si la persona responsable recibe información médica o de otro tipo sobre el evento adverso dentro de los doce (12) meses posteriores al envío del reporte inicial a la FDA, deberá enviar esta nueva información a la FDA dentro de los 15 días hábiles desde su recepción. La FDA también tendrá acceso a reportes de eventos adversos durante una inspección.\nEs obligatorio que las personas responsables de la industria presenten reportes de eventos adversos graves",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "igatorio que las personas responsables de la industria presenten reportes de eventos adversos graves de productos cosméticos utilizando el formulario FDA 3500A de denuncia obligatoria vigente que se puede descargar y llenar en MedWatch: Formulario de denuncia obligatoria del Programa de Información de Seguridad y Notificación de Eventos Adversos de la FDA (PDF).\nConsulte las Instrucciones para Completar el Formulario FDA 3500A.\nPresente a la FDA los siguientes documentos:\nEnvíe esta documentació",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "pletar el Formulario FDA 3500A.\nPresente a la FDA los siguientes documentos:\nEnvíe esta documentación por correo electrónico a CosmeticAERS@fda.hhs.gov o por correo postal a la siguiente dirección:\nFDA CDER Mail CenterAttn: Cosmetics MedWatch ReportsWhite Oak Campus, Building 22, G020710903 New Hampshire Ave.Silver Spring, MD 20993\nLa FDA está desarrollando un proceso para presentar reportes electrónicos obligatorios de eventos adversos para productos cosméticos.\nSi bien MoCRA no exige que las p",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "rónicos obligatorios de eventos adversos para productos cosméticos.\nSi bien MoCRA no exige que las personas responsables de la industria presenten reportes de eventos adversos no graves de productos cosméticos a la FDA, usted sí puede presentarlos de manera voluntaria utilizando el Formulario 3500A y siguiendo el mismo proceso descrito anteriormente para la presentación de reportes de eventos adversos obligatorios.\nTérminos clave\nEvento adverso grave: un evento adverso que\n(A) produce, como cons",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "rsos obligatorios.\nTérminos clave\nEvento adverso grave: un evento adverso que\n(A) produce, como consecuencia, los siguientes resultados:\n(B) exige, según el criterio médico, una intervención médica o quirúrgica para prevenir algunos de los resultados descritos en el punto (A) anterior.\nPersona responsable: el fabricante, envasador o distribuidor de un producto cosmético cuyo nombre aparece en la etiqueta de dicho producto cosmético de acuerdo con el artículo 609, inciso a), de la FFDCA o el artí",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "tiqueta de dicho producto cosmético de acuerdo con el artículo 609, inciso a), de la FFDCA o el artículo 4, inciso a), de la Ley de Embalaje y Etiquetado Justos (FPLA, por sus siglas en inglés).",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/como-presentar-una-queja-relacionada-con-un-producto-cosmetico"
  },
  {
    "text": "En Español (Spanish)\nFrançais (French)\n한국어 (Korean)\n中文 (Simplified Chinese)\n英語 (Traditional Chinese)\nNOTE on antibacterial soaps: For the latest information, see FDA issues final rule on safety and effectiveness of antibacterial soaps.\nWhether a product is a cosmetic or a drug under the law is determined by a product's intended use. Different laws and regulations apply to each type of product. Firms sometimes violate the law by marketing a cosmetic with a drug claim or by marketing a drug as if",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ms sometimes violate the law by marketing a cosmetic with a drug claim or by marketing a drug as if it were a cosmetic, without adhering to requirements for drugs.\nHow does the law define a cosmetic?\nThe Federal Food, Drug, and Cosmetic Act (FD&C Act) defines cosmetics as \"articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance\" [FD&C Act, sec. 201(",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "r cleansing, beautifying, promoting attractiveness, or altering the appearance\" [FD&C Act, sec. 201(i)]. Among the products included in this definition are skin moisturizers, perfumes, lipsticks, fingernail polishes, makeup, cleansing shampoos, permanent waves, hair colors, and deodorants, as well as any substance intended for use as a component of a cosmetic product.\nThe Modernization of Cosmetics Regulation Act of 2022 (MoCRA) amended the FD&C Act to include “cosmetic product” which is defined",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "s Regulation Act of 2022 (MoCRA) amended the FD&C Act to include “cosmetic product” which is defined as “a preparation of cosmetic ingredients with a qualitatively and quantitatively set composition for use in a finished product” [FD&C Act, sec. 361]. This new term applies to these amendments of the FD&C Act.\nHow does the law define a drug?\nThe FD&C Act defines drugs, in part, by their intended use, as \"articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of dis",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "e, as \"articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease\" and \"articles (other than food) intended to affect the structure or any function of the body of man or other animals\" [FD&C Act, sec. 201(g)(1)].\nHow can a product be both a cosmetic and a drug?\nSome products meet the definitions of both cosmetics and drugs. This may happen when a product has more than one intended use. For example, an antidandruff shampoo is a cosmetic because its intended",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "more than one intended use. For example, an antidandruff shampoo is a cosmetic because its intended use is to cleanse the hair, and it is also a drug because its intended use is to treat dandruff. Among other cosmetic/drug combinations are toothpastes with claims to freshen breath and cleanse the teeth that contain fluoride. Similarly, deodorants that are also antiperspirants, and moisturizers and makeup marketed with sun-protection claims are cosmetic/drug products. Such products must comply wi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "makeup marketed with sun-protection claims are cosmetic/drug products. Such products must comply with the requirements for both cosmetics and drugs.\nWhat about \"cosmeceuticals\"?\nThe FD&C Act does not recognize any such category as \"cosmeceuticals.\" A product can be a drug, a cosmetic, or a combination of both, but the term \"cosmeceutical\" has no meaning under the law.\nHow is a product's intended use established?\nIntended use may be established in a number of ways. The following are some example",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "use established?\nIntended use may be established in a number of ways. The following are some examples:\nThis principle also holds true for \"essential oils.\" For example, a fragrance marketed for promoting attractiveness is a cosmetic. But a fragrance marketed with certain \"aromatherapy\" claims, such as assertions that the scent will help the consumer sleep or quit smoking, meets the definition of a drug because of its intended use. Similarly, a massage oil that is simply intended to lubricate the",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "drug because of its intended use. Similarly, a massage oil that is simply intended to lubricate the skin and impart fragrance is a cosmetic, but if the product is intended for a therapeutic use, such as relieving muscle pain, it's a drug.\nHow are the laws and regulations different for cosmetics and drugs?\nThe following information is not a complete description of cosmetic or drug laws and regulations. It is intended only to alert you to some important differences and similarities between the la",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ions. It is intended only to alert you to some important differences and similarities between the laws and regulations for cosmetics and drugs in the areas of approval, good manufacturing practice, registration, and labeling. Questions regarding laws and regulations for drugs should be directed to FDA's Center for Drug Evaluation and Research (CDER).\nHow are approval requirements different?\nUnder the FD&C Act, cosmetic products and ingredients, with the exception of color additives, do not requi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "the FD&C Act, cosmetic products and ingredients, with the exception of color additives, do not require FDA approval before they go on the market. Drugs, however, must generally either receive premarket approval by FDA through the New Drug Application (NDA) process or conform to a \"monograph\" for a particular drug category, as established by FDA's Over-the-Counter (OTC) Drug Review. These monographs specify conditions whereby OTC drug ingredients are generally recognized as safe and effective (GR",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "s specify conditions whereby OTC drug ingredients are generally recognized as safe and effective (GRASE), and not misbranded. Certain OTC drugs may remain on the market without an NDA approval until a monograph for its class of drugs is finalized as a regulation. However, once FDA has made a final determination on the status of an OTC drug category, such products must either be the subject of an approved NDA [FD&C Act, sec. 505(a) and (b)], or comply with the appropriate monograph for an OTC dru",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "pproved NDA [FD&C Act, sec. 505(a) and (b)], or comply with the appropriate monograph for an OTC drug.\nWhat do these terms mean?\nYou can find information on FDA's website, under Development and Approval Process (Drugs), especially How Drugs Are Developed and Approved. If you still have questions about NDAs and OTC monographs, or any other aspect of drug regulation, please contact CDER. You can also contact CDER's Small Business and Industry Assistance at CDERSBIA@fda.hhs.gov or, for general drug",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "o contact CDER's Small Business and Industry Assistance at CDERSBIA@fda.hhs.gov or, for general drug-related inquiries, CDER's Division of Drug Information at druginfo@fda.hhs.gov.\nDo cosmetics and drugs have different good manufacturing practice requirements?\nAt the present time, FDA has Draft Guidance for Industry: Cosmetic Good Manufacturing Practices to assist industry and other stakeholders in identifying the standards and issues that can affect the quality of cosmetic products. MoCRA amend",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "n identifying the standards and issues that can affect the quality of cosmetic products. MoCRA amended the FD&C Act to require that FDA will establish good manufacturing practice (GMP) requirements for facilities that manufacture or process cosmetic products distributed in the United States. Under MoCRA, FDA is required to establish these cosmetic GMP regulations not later than December 29, 2025. The law will require strict adherence by industry to these GMP requirements, with certain exemptions",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "The law will require strict adherence by industry to these GMP requirements, with certain exemptions. Cosmetics products that fail to follow these GMP requirements will be adulterated [FD&C Act, sec. 601(f)]. These regulations are intended to protect the public health and ensure that cosmetic products are not adulterated or misbranded.\nRegarding drugs, the law requires strict adherence to GMP requirements for drugs, and there are regulations specifying minimum current GMP requirements for drugs",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "irements for drugs, and there are regulations specifying minimum current GMP requirements for drugs [Title 21 of the Code of Federal Regulations (CFR), parts 210 and 211]. Drugs that fail to follow GMP requirements are considered to be adulterated [FD&C Act, sec. 501(a)(2)(B)].\nHow are registration requirements different?\nUnder MoCRA, cosmetic product facility registration and cosmetic product listing are now mandatory with certain exemptions for small businesses. Learn more at Registration & Li",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ting are now mandatory with certain exemptions for small businesses. Learn more at Registration & Listing of Cosmetic Product Facilities and Products. Likewise, it is also mandatory for drug firms to register their establishments and list their drug products with FDA [FD&C Act, sec. 510; 21 CFR 207]. See Drug Registration and Listing System (DRLS and eDRLS).\nHow are labeling requirements different?\nA cosmetic product must be labeled according to cosmetic labeling regulations. See Cosmetic Labeli",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "?\nA cosmetic product must be labeled according to cosmetic labeling regulations. See Cosmetic Labeling for guidance on cosmetic labeling and links to the regulations related to cosmetic labeling.\nOTC drugs must be labeled according to OTC drug regulations, including the \"Drug Facts\" labeling, as described in 21 CFR 201.66 Combination OTC drug/cosmetic products must have combination OTC drug/cosmetic labeling. For example, the drug ingredients must be listed alphabetically as \"Active Ingredients,",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ic labeling. For example, the drug ingredients must be listed alphabetically as \"Active Ingredients,\" followed by cosmetic ingredients, listed in descending order of predominance as \"Inactive Ingredients.\"\nWhat if it's \"soap\"?\nSoap is a category that needs special explanation. That's because the regulatory definition of \"soap\" is different from the way in which people commonly use the word. Products that meet the definition of \"soap\" are exempt from the provisions of the FD&C Act because-even th",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ts that meet the definition of \"soap\" are exempt from the provisions of the FD&C Act because-even though Section 201(i)(1) of the act includes \"articles...for cleansing\" in the definition of a cosmetic-Section 201(i)(2) excludes soap from the definition of a cosmetic.\nHow does FDA define \"soap\"?\nNot every product marketed as soap meets FDA's definition of the term. FDA interprets the term \"soap\" to apply only when\nProducts that meet this definition of soap are regulated by the Consumer Product S",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "o apply only when\nProducts that meet this definition of soap are regulated by the Consumer Product Safety Commission (CPSC), not by FDA. Please direct questions about these products, such as safety and labeling requirements, to CPSC.\nIf a cleanser does not meet all of the criteria for soap...\nIf a product intended to cleanse the human body does not meet all the criteria for soap, as listed above, it is either a cosmetic or a drug. For example:\nIf a product:\nit is regulated as a cosmetic. Example",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "it is either a cosmetic or a drug. For example:\nIf a product:\nit is regulated as a cosmetic. Examples of cosmetic uses include making the user more attractive, by acting as a deodorant, imparting fragrance to the user, or moisturizing the skin.\nIf a product:\nit is regulated as a drug, or possibly both a drug and a cosmetic. Examples include antibacterial cleansers and cleansers that are also intended to treat acne.\nIf a product:\nit may be identified in labeling as soap, but it is regulated as a",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ded to treat acne.\nIf a product:\nit may be identified in labeling as soap, but it is regulated as a cosmetic.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "The following information is intended to respond to some questions consumers and manufacturers commonly ask FDA about “organic” cosmetics.\nOn this page:\nAdditional Resources:\nNo. FDA regulates cosmetics under the authority of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling ActExternal Link Disclaimer (FPLA). The term “organic” is not defined in either of these laws or the regulations that FDA enforces under their authority.\nThe Agricultural Marketing Servi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-claims/organic-cosmetics"
  },
  {
    "text": "se laws or the regulations that FDA enforces under their authority.\nThe Agricultural Marketing Service of the U.S. Department of Agriculture (USDA) oversees the National Organic Program (NOP). The NOP regulations include a definition of “organic” and provide for certification that agricultural ingredients have been produced under conditions that would meet the definition. They also include labeling standards based on the percentage of organic ingredients in a product. For more information on \"or",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-claims/organic-cosmetics"
  },
  {
    "text": "g standards based on the percentage of organic ingredients in a product. For more information on \"organic\" labeling for cosmetics, see the NOP publication, \"Cosmetics, Body Care Products, and Personal Care Products.\"\nYes. The USDA requirements for the use of the term “organic” are separate from the laws and regulations that FDA enforces for cosmetics. Cosmetic products labeled with organic claims must comply with both USDA regulations for the organic claim and FDA regulations for labeling and sa",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-claims/organic-cosmetics"
  },
  {
    "text": "must comply with both USDA regulations for the organic claim and FDA regulations for labeling and safety requirements for cosmetics. Information on FDA’s regulation of cosmetics is available on our Cosmetics website.\nNo. An ingredient’s source does not determine its safety. For example, many plants, whether or not they are organically grown, contain substances that may be toxic or allergenic. For more on this subject, see FDA Poisonous Plant Database. Under the FD&C Act, all cosmetic products an",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-claims/organic-cosmetics"
  },
  {
    "text": "more on this subject, see FDA Poisonous Plant Database. Under the FD&C Act, all cosmetic products and ingredients are subject to the same safety requirement: They must be safe for consumers under labeled or customary conditions of use (FD&C Act, section 601(a). Companies and individuals who market cosmetics have a legal responsibility to ensure that their products and ingredients are safe for the intended use.\nMarch 8, 2010; updated September 15, 2010. This document is current and is updated onl",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-claims/organic-cosmetics"
  },
  {
    "text": "intended use.\nMarch 8, 2010; updated September 15, 2010. This document is current and is updated only when needed.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-claims/organic-cosmetics"
  },
  {
    "text": "A continuación aparece una lista de información y recursos disponibles en publicaciones relacionadas con cosméticos. Estas publicaciones fueron producidas por la Oficina de la Salud de la Mujer (Office of Women’s Health/OWH) de la Administración de Alimentos y Medicamentos (Food and Drug Administration/FDA).",
    "url": "https://www.fda.gov/cosmetics/resources-you-cosmetics/informacion-con-cosmeticos-en-espanol"
  },
  {
    "text": "Cosmetics are required to be safe when consumers use them according to directions in the labeling, or in the customary or expected way. Product testing is just one of the things a manufacturer might do to ensure the safety of a cosmetic product. Sometimes FDA conducts testing when we are investigating possible safety problems with a product or as part of our research program. FDA resources on cosmetic product testing are valuable to consumers and industry alike.\nFDA does not have the legal autho",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research/product-testing-cosmetics"
  },
  {
    "text": "etic product testing are valuable to consumers and industry alike.\nFDA does not have the legal authority to approve cosmetic products and ingredients (other than color additives) before they go on the market. We also do not have a list of tests required for any particular cosmetic product or ingredient. However, a manufacturer or distributor of a cosmetic is legally responsible for ensuring that a marketed product is safe when consumers use it according to the directions in the labeling or in th",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research/product-testing-cosmetics"
  },
  {
    "text": "marketed product is safe when consumers use it according to the directions in the labeling or in the customary or expected way. FDA can take action against the manufacturer of a cosmetic on the market if we have reliable information to show that a cosmetic does not meet the legal requirement for safety.\nThe law treats color additives differently. Unlike other cosmetic ingredients, color additives, other than coloring materials used in coal-tar hair dyes, must be approved by FDA for the specific",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research/product-testing-cosmetics"
  },
  {
    "text": ", other than coloring materials used in coal-tar hair dyes, must be approved by FDA for the specific intended use before they are permitted in any cosmetic.\nManufacturers can use safety data that is already available on individual ingredients and on products with similar formulations. Here are some examples:\nThe Cosmetic Ingredient Review (CIR) websiteExternal Link Disclaimer  has information on the safety of cosmetic ingredients that they have reviewed. (CIR is an industry-funded panel of scien",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research/product-testing-cosmetics"
  },
  {
    "text": "he safety of cosmetic ingredients that they have reviewed. (CIR is an industry-funded panel of scientific and medical experts who review the safety of cosmetic ingredients. FDA participates in CIR meetings, but does not vote, and we may agree or disagree with CIR conclusions. However, we do take CIR reviews into consideration when we evaluate cosmetic ingredient safety.)\nManufacturers may also need to do toxicological testing to fill in any gaps in the information that’s available. Toxicology or",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research/product-testing-cosmetics"
  },
  {
    "text": "d to do toxicological testing to fill in any gaps in the information that’s available. Toxicology or other testing methods may be necessary to determine the safety of each ingredient and the finished product. Animal testing is not a specific requirement for marketing a cosmetic; however, it’s important for all testing to be scientifically sound.\nAs a government agency, FDA does not provide referrals for private testing labs.\nCosmetics do not have to be sterile, but they must not contain any harm",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research/product-testing-cosmetics"
  },
  {
    "text": "ls for private testing labs.\nCosmetics do not have to be sterile, but they must not contain any harmful microorganisms, and the number of aerobic microorganisms per gram must be low. To learn more, see “Microbiological Methods for Cosmetics.”\nMany factors can affect how a product may become contaminated, including use by consumers, such as dipping one’s fingers into a jar. If a manufacturer does not have the technical expertise to determine the best way to ensure that a product is protected from",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research/product-testing-cosmetics"
  },
  {
    "text": "ot have the technical expertise to determine the best way to ensure that a product is protected from contamination, the company may want to work with a consultant.\nChoosing ingredients from sources the manufacturer considers “organic” or “natural” is no guarantee that they are safe. Manufacturers are still responsible for making sure their products are safe when used according to the directions in the labeling, or in the customary or expected way. Some testing may still be needed.\nFor related in",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research/product-testing-cosmetics"
  },
  {
    "text": "the labeling, or in the customary or expected way. Some testing may still be needed.\nFor related information, see \"Organic\" Cosmetics.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research/product-testing-cosmetics"
  },
  {
    "text": "December 26, 2024\nFDA announces a proposed rule to establish and require established testing methods to detect and identify asbestos in talc-containing cosmetic products.\nThis proposed rule, if finalized, will help protect consumers who use talc-containing cosmetic products from harmful exposure to asbestos. This proposal is part of the agency's work to fulfill the requirements of section 3505 of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).\nApril 5, 2024\nFDA announces the rele",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).\nApril 5, 2024\nFDA announces the release of the data from the agency’s 2023 testing of talc-containing cosmetic products from asbestos.\n\nTalc is an ingredient used in many cosmetic products, from baby powder to blush. From time to time, FDA has received questions about its safety and whether talc contains harmful contaminants, such as asbestos.\nUnder the Federal Food, Drug and Cosmetic Act (FD&C Act), cosmetic products and ingredient",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "asbestos.\nUnder the Federal Food, Drug and Cosmetic Act (FD&C Act), cosmetic products and ingredients, with the exception of color additives, do not have to undergo FDA review or approval before they go on the market. Cosmetic products must be properly labeled, and they must be safe for use by consumers under labeled or customary conditions of use.\nFDA monitors for potential safety problems with cosmetic products on the market and takes action when needed to protect public health. Before we can",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "osmetic products on the market and takes action when needed to protect public health. Before we can take such action against a cosmetic product, we need sound scientific data to show that it is harmful under its intended use. Learn more about FDA's Authority Over Cosmetics.\nTalc is a naturally occurring mineral, mined from the earth, composed of magnesium, silicon, oxygen, and hydrogen. Chemically, talc is a hydrous magnesium silicate with a chemical formula of Mg3Si4O10(OH)2.\nTalc has many uses",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": ", talc is a hydrous magnesium silicate with a chemical formula of Mg3Si4O10(OH)2.\nTalc has many uses in cosmetic products and other personal care products. For example, it may be used to absorb moisture, to prevent caking, to make facial makeup opaque, or to improve the feel of a product.\nPublished scientific literature going back to the 1960s has suggested a possible association between the use of powders containing talc in the genital area and the incidence of ovarian cancer. However, these st",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "f powders containing talc in the genital area and the incidence of ovarian cancer. However, these studies have not conclusively demonstrated such a link, or if such a link existed, what risk factors might be involved. More research is needed to confirm if there is a link or not. In addition, questions about the potential contamination of talc with asbestos have been raised since the 1970s.\nBoth talc and asbestos are naturally occurring minerals that may be found in close proximity in the earth.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "lc and asbestos are naturally occurring minerals that may be found in close proximity in the earth. Asbestos is also a naturally occurring silicate mineral, but with a different crystal structure. Unlike talc, asbestos is a known carcinogen when inhaled. There is the potential for contamination of talc with asbestos and therefore, it is important to select talc mining sites carefully and take steps to test the ore sufficiently.\nThe FDA has continued its testing for asbestos contamination in talc",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "s to test the ore sufficiently.\nThe FDA has continued its testing for asbestos contamination in talc-containing cosmetic products. The products were selected based on various factors including, type of talc-containing cosmetic product, price range, popular products on social media and in advertisements, products marketed to children, and products marketed to women of color and, if any, third party reports of potential asbestos contamination. Testing of samples was conducted by AMA Analytical Ser",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "reports of potential asbestos contamination. Testing of samples was conducted by AMA Analytical Services, Inc. (AMA) on behalf of the FDA. Samples were analyzed using polarized light microscopy (PLM) and transmission electron microscopy (TEM). For additional information, see:\nThe summary table, “FDA Summary of Results from Testing of Official Samples of Talc-Containing Cosmetics for Asbestiform Fibers completed by AMA Laboratories in 2023” provides details for each of the talc-containing cosmet",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "ibers completed by AMA Laboratories in 2023” provides details for each of the talc-containing cosmetic products that were analyzed in this survey, including product distributor/manufacturer, brand, product name, batch/lot #, FDA Sample ID #, and the findings from the testing.\n\n2022 Testing of Talc-Containing Cosmetics for Asbestos\nThe FDA has continued its testing for asbestos contamination in talc-containing cosmetics.  The products were selected based on various factors including, type of talc",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "c-containing cosmetics.  The products were selected based on various factors including, type of talc-containing cosmetic product, price range, popular products on social media and in advertisements, products marketed to children, and products marketed to women of color. Testing of samples was conducted by AMA Analytical Services, Inc. (AMA) on behalf of the FDA. Samples were analyzed using polarized light microscopy (PLM) and transmission electron microscopy (TEM). For additional information, se",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "ed light microscopy (PLM) and transmission electron microscopy (TEM). For additional information, see:\nThe summary table, “FDA Summary of Results from Testing of Official Samples of Talc-Containing Cosmetics for Asbestiform Fibers completed by AMA Laboratories in 2022” provides details for each of the talc-containing cosmetics that were analyzed in this survey, including product distributor/manufacturer, brand, product name, batch/lot #, FDA Sample ID #, and the findings from the testing.\nWhite",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "cturer, brand, product name, batch/lot #, FDA Sample ID #, and the findings from the testing.\nWhite Paper on Talc Testing Methods Released. On January 13, 2022, the FDA announced the release of a white paper and technical appendices on testing methods for asbestos in cosmetic products containing talc.\n2021 Testing of Talc-Containing Cosmetics for Asbestos\nThe products tested in 2021 were selected based on various factors including, type of talc-containing cosmetic product, price range, popular p",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "based on various factors including, type of talc-containing cosmetic product, price range, popular products on social media and in advertisements, products marketed to children, and, if any, third party reports of potential asbestos contamination. Testing of samples was conducted by AMA Analytical Services, Inc. (AMA) on behalf of the FDA. Samples were analyzed using PLM and TEM methods. For additional information, see:\nThe summary table, “FDA Summary of Results from Testing of Official Samples",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "ional information, see:\nThe summary table, “FDA Summary of Results from Testing of Official Samples of Talc-Containing Cosmetics of Asbestiform Fibers completed by AMA Laboratories in 2021” provides details for each of the talc-containing cosmetics that were analyzed in this survey, including product distributor/manufacturer, brand, product name, batch/lot #, FDA Sample ID #, and the findings from the testing.\n2019 Talc Testing Results Released. FDA release data from a year-long sampling assignm",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "the testing.\n2019 Talc Testing Results Released. FDA release data from a year-long sampling assignment of testing talc-containing cosmetic products for the presence of asbestos. The FDA sampled cosmetic products following reports of asbestos contamination in talc-containing cosmetics. Testing of the samples was conducted on behalf of the FDA by the Occupational Safety and Health Administration (OSHA) and AMA. The summary table, “FDA Summary of Results from Testing of Official Samples of Talc-Co",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "SHA) and AMA. The summary table, “FDA Summary of Results from Testing of Official Samples of Talc-Containing Cosmetics of Asbestiform Fibers by AMA Laboratories During FY19\" provides details for each of the talc-containing cosmetics that were analyzed in this survey. For additional information, see:\nPublic Meeting on Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc. On February 4, 2020, the FDA opened a public docket and held a public meeting to discuss and obtain scien",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "bruary 4, 2020, the FDA opened a public docket and held a public meeting to discuss and obtain scientific data and information on topics related to cosmetic products with talc as an ingredient, specifically, testing methodologies, terminology, and criteria that could be applied to characterize and measure asbestos and other potentially harmful elongate mineral particles (EMPs) that may be present as contaminants in such products. The FDA made available, as part of the meeting materials, an  Exec",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "as contaminants in such products. The FDA made available, as part of the meeting materials, an  Executive Summary titled “Preliminary Recommendations on Testing Methods for Asbestos in Talc and Consumer Products Containing Talc” by the IWGACP. Neither the Executive Summary nor any of the presentations at the public meeting by members of the IWGACP, represent proposed or preliminary recommendations or policies of the FDA or any other federal agency. The Executive Summary and related presentations",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "or policies of the FDA or any other federal agency. The Executive Summary and related presentations at the public meeting were meant solely to solicit scientific feedback on the issues raised and should not be used for any other purpose. The FDA and members of the IWGACP continue to evaluate the science and comments submitted to the docket. The FDA does not have any recommendations at this time. Should the FDA decide to develop recommendations with respect to standards or testing methods for as",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "Should the FDA decide to develop recommendations with respect to standards or testing methods for asbestos in talc, as a result of the information it received as part of the public meeting and comments to the public docket or otherwise, it would issue draft guidance for public comment. Likewise, the FDA would propose any related regulations through a public notice and comment process.\nWarning to Consumers. On October 18, 2019, the FDA updated a Safety Alert and issued a Constituent Update warnin",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "onsumers. On October 18, 2019, the FDA updated a Safety Alert and issued a Constituent Update warning consumers not to use certain cosmetic products tested positive for asbestos.\nJoint Institute for Food Safety and Applied Nutrition (JIFSAN) Scientific/Technical Meeting. On November 28, 2018, the FDA and other government agency representatives attended a scientific and technical symposium designed to provide a forum for scientists to share their knowledge and experience in testing methods for an",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "to provide a forum for scientists to share their knowledge and experience in testing methods for analysis of talc, developing criteria used for fiber identification, and interpreting data. For the full transcripts from the symposium, see:\nFormation of an Interagency Working Group on Asbestos in Consumer Products in the Fall of 2018. The purpose of this government work group is to develop recommendations on topics related to testing methodologies, terminology, and criteria for data interpretatio",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "dations on topics related to testing methodologies, terminology, and criteria for data interpretation that can be applied to characterize mineral fibers present as contaminants in consumer products.\nFDA's Talc Survey of 2009-2010. The FDA contracted with AMA to conduct a laboratory talc survey, which ran from September 28, 2009 to September 27, 2010. AMA analyzed the samples using PLM and  TEM methods. The survey found no asbestos fibers or structures in any of the samples of cosmetic-grade raw",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "hods. The survey found no asbestos fibers or structures in any of the samples of cosmetic-grade raw material talc or cosmetic products containing talc. The results were limited, however, by the fact that only four of nine talc suppliers submitted samples and by the number of products tested. For these reasons, while the FDA found these results informative, they did not prove that most or all talc or talc-containing cosmetic products marketed in the United States at that time were likely to be fr",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "or talc-containing cosmetic products marketed in the United States at that time were likely to be free of asbestos contamination. The tables found in the FDA Summary of Results from Testing of Official Samples of Talc-Containing Cosmetics of Asbestiform Fibers by AMA Laboratories During 2009-2010 provided details for each of the cosmetic-grade raw material talc samples and cosmetic products containing talc that were analyzed in this survey.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "ning talc that were analyzed in this survey.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredients/talc"
  },
  {
    "text": "Here are questions consumers frequently ask about cosmetic safety and regulation, with quick answers and links to resources where you can learn more:",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-faqs"
  },
  {
    "text": "FDA issues regulations to implement its statutory authority. The regulations can create binding obligations and have the force of law. Here are links to the regulations related to cosmetics, from Title 21 of the Code of Federal Regulations (21 CFR):",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/regulations-related-cosmetics"
  },
  {
    "text": "The tables below are provided as a supplement to the information in the Summary of Color Additives Listed for Use in the United States in Food, Drugs, Cosmetics, and Medical Devices. They are intended for quick reference to help in determining which color additives may be used in different types of cosmetics, as provided for in Title 21 of the Code of Federal Regulations (CFR), Subpart C of Part 73 (Listing of Color Additives Exempt from Certification), Subpart C of Part 74 (Listing of Color Add",
    "url": "https://www.fda.gov/cosmetics/ingredient-names/color-additives-permitted-use-cosmetics"
  },
  {
    "text": "3 (Listing of Color Additives Exempt from Certification), Subpart C of Part 74 (Listing of Color Additives Subject to Certification), and Subparts B, C, and D of Part 82 (Listing of Certified Provisionally Listed Colors and Specifications).\nFor additional information on the permitted use, specifications, and restrictions that apply to each color additive, please refer to the appropriate listing regulation, using the links provided in the tables. For more information on the use of color additives",
    "url": "https://www.fda.gov/cosmetics/ingredient-names/color-additives-permitted-use-cosmetics"
  },
  {
    "text": "gulation, using the links provided in the tables. For more information on the use of color additives in cosmetics in general, please see Color Additives and Cosmetics.\nColor Additives That Are Exempt from Certification and Permitted for Use in Cosmetics (21 CFR Part 73 Subpart C—Cosmetics)\nColor Additives That Are Subject to Certification and Permitted for Use in Cosmetics*\nIncludes Straight Colors and Lakes\n(21 CFR Part 74 Subpart C—Cosmetics and 21 CFR Part 82 Subparts B, C, and D)\n*Includes s",
    "url": "https://www.fda.gov/cosmetics/ingredient-names/color-additives-permitted-use-cosmetics"
  },
  {
    "text": "s and Lakes\n(21 CFR Part 74 Subpart C—Cosmetics and 21 CFR Part 82 Subparts B, C, and D)\n*Includes straight colors and lakes\n**Excludes lakes except where noted. Only aluminum lakes on alumina are permitted for designated lakes.\nApril 30, 2008; Updated June 20, 2008 and February 22, 2010. This information is current. It is updated only when necessary.",
    "url": "https://www.fda.gov/cosmetics/ingredient-names/color-additives-permitted-use-cosmetics"
  },
  {
    "text": "Many people may be unaware of the lead poisoning risk, in adults and children, from an avoidable source: traditional eye cosmetics containing kohl, kajal, al-kahal, surma, tiro, tozali, or kwalli.\nThe following information is intended to answer questions people may ask about these products and their dangers:\nKohl, kajal, al-Kahal, surma, tiro, tozali, and kwalli often contain high levels of lead. For example, lead, usually in the form of lead sulfide, sometimes accounts for more than half the we",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/kohl-kajal-al-kahal-surma-tiro-tozali-or-kwalli-any-name-beware-lead-poisoning"
  },
  {
    "text": "For example, lead, usually in the form of lead sulfide, sometimes accounts for more than half the weight of kohl products. Kohl products may also contain a variety of other materials, such as aluminum, antimony, carbon, iron, and zinc compounds, as well as camphor and menthol.[1, 2, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14] A tiro product linked to lead poisoning in an infant was found to consist of 82.6% lead.[15]\nThe risks associated with exposure to lead are especially serious for children. Among th",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/kohl-kajal-al-kahal-surma-tiro-tozali-or-kwalli-any-name-beware-lead-poisoning"
  },
  {
    "text": "% lead.[15]\nThe risks associated with exposure to lead are especially serious for children. Among the effects associated with high levels of lead exposure are anemia, kidney problems, and neurological damage that may include seizures, coma, and death. Even at relatively low levels, chronic exposure to lead may lead to learning and behavior problems. The Centers for Disease Control (CDC) has set a blood lead level of 5 micrograms per deciliter (µg/dL) in children as the reference level at which C",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/kohl-kajal-al-kahal-surma-tiro-tozali-or-kwalli-any-name-beware-lead-poisoning"
  },
  {
    "text": "blood lead level of 5 micrograms per deciliter (µg/dL) in children as the reference level at which CDC recommends initiating public health actions (see CDC information under \"Lead\").\nYes. FDA is aware of instances of kohl-related lead poisoning in children in the U.S. A number of studies have shown that children exposed to kohl and similar products have increased levels of lead in their blood.[3, 4, 9, 11, 15]\nIn some cultures, it is common for parents to apply these products to the eyes of infa",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/kohl-kajal-al-kahal-surma-tiro-tozali-or-kwalli-any-name-beware-lead-poisoning"
  },
  {
    "text": "4, 9, 11, 15]\nIn some cultures, it is common for parents to apply these products to the eyes of infants and children. Infants of mothers who use these products sometimes have elevated levels of lead in their blood.[9, 11] Also, some people traditionally paint a newborn's umbilical stump with kohl powder, supposedly for medicinal reasons.[3, 4]\nUnlike some sources of exposure to lead, this one is easily avoidable by not using kohl and similar products on your children or yourself, and keeping the",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/kohl-kajal-al-kahal-surma-tiro-tozali-or-kwalli-any-name-beware-lead-poisoning"
  },
  {
    "text": "asily avoidable by not using kohl and similar products on your children or yourself, and keeping them out of your home.\nHere are two important steps to take against exposure to kohl and similar products:\nYou will receive further recommendations based on the results of your laboratory tests.\nNo. Here’s why:\nFDA has identified kohl, kajal, surma, and similar materials as illegal color additives as defined in the law (Federal Food, Drug and Cosmetic Act, section 201(t)). Under this law, color addit",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/kohl-kajal-al-kahal-surma-tiro-tozali-or-kwalli-any-name-beware-lead-poisoning"
  },
  {
    "text": "efined in the law (Federal Food, Drug and Cosmetic Act, section 201(t)). Under this law, color additives must be approved by FDA and listed in the color additive regulations before they are allowed in cosmetics or any other FDA-regulated products. To be FDA-approved, they must be safe for the intended use.\nNone of these materials have been approved by FDA and listed in the color additive regulations. This means that their use in cosmetics or any other FDA-regulated products is against the law. T",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/kohl-kajal-al-kahal-surma-tiro-tozali-or-kwalli-any-name-beware-lead-poisoning"
  },
  {
    "text": "ns. This means that their use in cosmetics or any other FDA-regulated products is against the law. To learn more, see \"Color Additives and Cosmetics.\"\nFDA has an import Alert in effect for eye area cosmetics that declare kohl, kajal, or surma on their labels, not only because they appear to contain high levels of lead, but also because of other labeling violations. For example, some of these products have been falsely labeled as having \"FDA approval.\" Such products are subject to detention and r",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/kohl-kajal-al-kahal-surma-tiro-tozali-or-kwalli-any-name-beware-lead-poisoning"
  },
  {
    "text": "cts have been falsely labeled as having \"FDA approval.\" Such products are subject to detention and refusal of admission at U.S. ports of entry.\nThese products have been popular in much of the world since ancient times, particularly in parts of Africa, the Middle East, Pakistan, and India. Kohl and similar products now sometimes appear in specialty markets catering to individuals from the above regions. More recently, tiro, tozali, and kwalli products have come from Nigeria.[15] Despite being ill",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/kohl-kajal-al-kahal-surma-tiro-tozali-or-kwalli-any-name-beware-lead-poisoning"
  },
  {
    "text": "ions. More recently, tiro, tozali, and kwalli products have come from Nigeria.[15] Despite being illegal in the United States, these products may be imported by individual users, for example, in personal luggage. These products also have been sold by mail order on some websites.\nOne useful resource is the Lead Poisoning Prevention Program at the Centers for Disease Control and Prevention.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/kohl-kajal-al-kahal-surma-tiro-tozali-or-kwalli-any-name-beware-lead-poisoning"
  },
  {
    "text": "FAQs Main Page\nHypoallergenic cosmetics are products that manufacturers claim produce fewer allergic reactions than other cosmetic products. Consumers with hypersensitive skin, and even those with \"normal\" skin, may be led to believe that these products will be gentler to their skin than non-hypoallergenic cosmetics.\nThere are no Federal standards or definitions that govern the use of the term \"hypoallergenic.\" The term means whatever a particular company wants it to mean. Manufacturers of cosme",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-safety-qa-hypoallergenic"
  },
  {
    "text": "poallergenic.\" The term means whatever a particular company wants it to mean. Manufacturers of cosmetics labeled as hypoallergenic are not required to submit substantiation of their hypoallergenicity claims to FDA.\nThe term \"hypoallergenic\" may have considerable market value in promoting cosmetic products to consumers on a retail basis, but dermatologists say it has very little meaning.\nTo learn more, see Hypoallergenic Cosmetics.\nMore Resources:",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-safety-qa-hypoallergenic"
  },
  {
    "text": "ore, see Hypoallergenic Cosmetics.\nMore Resources:",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-safety-qa-hypoallergenic"
  },
  {
    "text": "The warning statement that FDA requires on tanning products that do not contain sunscreen is important for both consumers and manufacturers.\nAll suntanning preparations that do not contain sunscreen ingredients are required to carry the following warning statement on the label:\n\"Warning--This product does not contain a sunscreen and does not protect against sunburn. Repeated exposure of unprotected skin while tanning may increase the risk of skin aging, skin cancer, and other harmful effects to",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/required-warning-statement-tanning-products-without-sunscreen"
  },
  {
    "text": "d skin while tanning may increase the risk of skin aging, skin cancer, and other harmful effects to the skin even if you do not burn.\" (Title 21 of the Code of Federal Regulations, Section 740.19)\nFDA is requiring this warning statement so that consumers are fully informed that such products do not provide protection from the sun.\nThe term \"suntanning preparations\" includes gels, creams, liquids, and other topical products that are intended to provide cosmetic effects on the skin while tanning t",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/required-warning-statement-tanning-products-without-sunscreen"
  },
  {
    "text": "and other topical products that are intended to provide cosmetic effects on the skin while tanning through exposure to ultraviolet (UV) radiation (such as moisturizing or conditioning products) or to give the appearance of a tan by imparting color to the skin through the application of approved color additives, such as dihydroxyacetone, without the need for exposure to UV radiation.\nBecause such products include those sold for use at the beach or for use in tanning salons, consumers are strongly",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/required-warning-statement-tanning-products-without-sunscreen"
  },
  {
    "text": "roducts include those sold for use at the beach or for use in tanning salons, consumers are strongly encouraged to read carefully the labeling of all tanning products to determine whether or not they provide protection against the harmful effects of UV radiation.\nThis required warning was published in the rulemaking for over-the-counter sunscreen drug products in the Federal Register May 21, 1999. The regulation became effective May 22, 2000.\nMore Resources:",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/required-warning-statement-tanning-products-without-sunscreen"
  },
  {
    "text": "The regulation became effective May 22, 2000.\nMore Resources:",
    "url": "https://www.fda.gov/cosmetics/labeling-regulations/required-warning-statement-tanning-products-without-sunscreen"
  },
  {
    "text": "Bovine spongiform encephalopathy, or BSE, is a progressive neurological disorder of cattle. The resources below provide safety and regulatory information on BSE and cosmetics, as well as other FDA-regulated products.",
    "url": "https://www.fda.gov/cosmetics/potential-contaminants/bovine-spongiform-encephalopathy-bse-and-cosmetics"
  },
  {
    "text": "FDA sometimes receives questions about the safe use of cosmetics during pregnancy.  If you are pregnant and have concerns about cosmetic products or ingredients, contact your health care provider. While FDA can’t give medical advice, we can provide some general safety information.\nOn This Page:\nIt’s important to know that the law does not require cosmetic products or ingredients to have FDA approval before they go on the market. However, cosmetics must be safe when consumers use them according t",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-pregnancy"
  },
  {
    "text": "al before they go on the market. However, cosmetics must be safe when consumers use them according to product labeling, or as the products are customarily used.\nCompanies and individuals who manufacture or market cosmetics are legally responsible for making sure their products are safe. FDA can take action against an unsafe cosmetic that doesn’t comply with the law, but first we need reliable information showing that it is unsafe when people use it as intended.\nThe law treats color additives dif",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-pregnancy"
  },
  {
    "text": "rmation showing that it is unsafe when people use it as intended.\nThe law treats color additives differently. Color additives must be approved by FDA before they are used in cosmetics or other FDA-regulated products. Some must even be from batches certified in FDA’s own labs.\nThe law also makes a special exception for coal tar hair dyes, which include most permanent, semi-permanent, and temporary hair dyes on the market. FDA cannot take action against a coal-tar hair dye if it has this statement",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-pregnancy"
  },
  {
    "text": "hair dyes on the market. FDA cannot take action against a coal-tar hair dye if it has this statement on the label—\n”Caution  - This product contains ingredients which may cause skin irritation on certain individuals and a preliminary test according to accompanying directions should first be made. This product must not be used for dyeing the eyelashes or eyebrows; to do so may cause blindness.”\n—along with instructions for doing a skin test.\nFDA monitors the safety of cosmetics in several ways. F",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-pregnancy"
  },
  {
    "text": "ong with instructions for doing a skin test.\nFDA monitors the safety of cosmetics in several ways. For example, FDA periodically buys cosmetics and analyzes them, especially if we are aware of a potential problem. FDA scientists keep up with the latest research and FDA conducts its own research as well.  We also evaluate reports of problems that are sent to us by consumers who have had bad reactions, to watch for trends that will tell us if a particular product may require action on FDA’s part.",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-pregnancy"
  },
  {
    "text": "ns, to watch for trends that will tell us if a particular product may require action on FDA’s part.\nWhen we look into the safety of a cosmetic product or ingredient on the market, we consider factors such as how it is used and who is likely to use it. This includes whether there are likely to be safety concerns when women use the product during pregnancy. When we identify a safety problem, we let the public know and take action against the product. To learn more, see “How FDA Evaluates Regulated",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-pregnancy"
  },
  {
    "text": "the public know and take action against the product. To learn more, see “How FDA Evaluates Regulated Products: CosmeticsExternal Link Disclaimer.”\nCosmetics must be labeled properly. For example, they must have any directions for use and any warnings needed to make sure consumers use the product safely.\nAlso, cosmetics marketed on a retail basis to consumers, such as in stores or person to person, must have a list of ingredients on the label. For cosmetics sold by mail order, including online, t",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-pregnancy"
  },
  {
    "text": "must have a list of ingredients on the label. For cosmetics sold by mail order, including online, this list must be on the label, in a catalog, on a website, enclosed with the shipment, or sent separately when the consumer asks for it. This list lets consumers know if a product contains ingredients they want to avoid.\nNot all “personal care products,” including those you might use during and after pregnancy, are cosmetics. For example, a product that’s intended to affect the structure or functi",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-pregnancy"
  },
  {
    "text": "r pregnancy, are cosmetics. For example, a product that’s intended to affect the structure or function of your body, or to treat or prevent disease, is regulated as a drug, or sometimes both a cosmetic and a drug. This is true even if it affects how you look. Stretch mark treatments, creams for treating irritated or cracked nipples, sunscreens, antiperspirants, and treatments for dandruff and acne are some common examples.\nGenerally, non-prescription drugs must conform to special regulations, ca",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-pregnancy"
  },
  {
    "text": "are some common examples.\nGenerally, non-prescription drugs must conform to special regulations, called \"monographs,\" for their product category or be approved by FDA before they go on the market.\nTo learn more, see “Cosmetics Q&A: Personal Care Products.”",
    "url": "https://www.fda.gov/cosmetics/resources-consumers-cosmetics/cosmetics-pregnancy"
  },
  {
    "text": "The FDA held a virtual listening session on June 1, 2023.\nThe purpose of the listening session was to consult cosmetics manufacturers, including smaller businesses, contract manufacturers, consumer organizations, and other experts to inform FDA’s efforts in developing regulations to establish good manufacturing practices (GMPs) for facilities that manufacture, or process cosmetic products distributed in the United States.\nTo facilitate input, the FDA developed a series of topics covering the typ",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/public-meeting-good-manufacturing-practices-cosmetic-products-06012023"
  },
  {
    "text": "ted in the United States.\nTo facilitate input, the FDA developed a series of topics covering the types of information that we are interested in obtaining:\nTopics Related to Good Manufacturing Practices\nTopics Related to Economic Impact\nYou may submit written/electronic comments starting April 27, 2023. The deadline to submit comments is July 3, 2023.\nSubmit comments electronically on https://www.regulations.gov/ to Docket No. FDA-2023-N-1466.\nAdditional information on commenting is available in",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/public-meeting-good-manufacturing-practices-cosmetic-products-06012023"
  },
  {
    "text": "egulations.gov/ to Docket No. FDA-2023-N-1466.\nAdditional information on commenting is available in the Federal Register notice.\nSubscribe to Cosmetics News",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/public-meeting-good-manufacturing-practices-cosmetic-products-06012023"
  },
  {
    "text": "November 8, 2023\nFDA issued guidance on its intent to delay enforcement of the requirements for cosmetic product facility registration and cosmetic product listing requirements under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) for six months to help ensure that industry has sufficient time to submit such facility registration and product listing information.\nNovember 1, 2023\nFDA is providing an update on ongoing activities related to the new cosmetic product facility registrat",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "is providing an update on ongoing activities related to the new cosmetic product facility registration and cosmetic product listing mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).\nOctober 13, 2023\nFDA has published a Structured Product Labeling (SPL) Implementation Guide with Validation Procedures. Cosmetics product facility registrations and product listings are now included within the SPL framework.\nSeptember 15, 2023\nFDA is seeking comments on its newly developed d",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "cluded within the SPL framework.\nSeptember 15, 2023\nFDA is seeking comments on its newly developed draft electronic submission portal (Cosmetics Direct) and paper forms (Forms FDA 5066 and 5067).\nCosmetics Direct includes the required registration and listing submission information from the paper forms in a standard electronic format. This will help the respondent organize their registration and listing submission to include the information needed for FDA and will give the respondent access to t",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "isting submission to include the information needed for FDA and will give the respondent access to their previous Cosmetic Direct registrations and listing submissions.\nFDA strongly encourages electronic submissions to facilitate efficiency and timeliness of data submission and management for the agency. Respondents that prefer to submit paper registrations and listings will still have the option to do so.\nDraft screenshots of the electronic system are available below for review and comments. Fo",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "to do so.\nDraft screenshots of the electronic system are available below for review and comments. For more information, see the Federal Register Notice and Registration & Listing of Cosmetic Product Facilities and Products.\n\nAugust 7, 2023\nThe U.S. Food and Drug Administration, today, issued draft guidance on cosmetic product facility registrations and product listings, as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).\nWhen finalized, the draft guidance will assist st",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "ation of Cosmetics Regulation Act of 2022 (MoCRA).\nWhen finalized, the draft guidance will assist stakeholders with cosmetic product facility registration and product listing submissions to FDA, by describing who is responsible for making the registration and listing submissions, what information to include, how to submit, and when to submit, as well as certain exemptions to the registration and listing requirements.\nMoCRA provided new authorities to FDA including:\nResponsible person means the m",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "isting requirements.\nMoCRA provided new authorities to FDA including:\nResponsible person means the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product in accordance with section 609(a) of the FD&C Act or section 4(a) of the Fair Packaging and Labeling Act.\nExemptions:\nMoCRA exempts certain small businesses from facility registration and product listing requirements.\nHowever, such exemptions do not apply to facilities that manufactur",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "nd product listing requirements.\nHowever, such exemptions do not apply to facilities that manufacture or process, or responsible persons for, the following cosmetic products:\nExemptions also exist for certain products and facilities that are subject to requirements for drugs and devices.\nIn March 2023, FDA issued a Constituent Update FDA Has Stopped Accepting Submissions to the Voluntary Cosmetic Registration Program (VCRP) as a result of the facility registration and product listing authorities",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "Registration Program (VCRP) as a result of the facility registration and product listing authorities mandated by MoCRA.\nThe draft guidance also contains information about a new electronic registration and listing submission portal. FDA intends to make the new electronic submission portal available in October 2023. FDA strongly encourages electronic submissions to facilitate efficiency and timeliness of data submission and management for the agency. FDA is also developing a paper form as an alter",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "ss of data submission and management for the agency. FDA is also developing a paper form as an alternative submission tool to the electronic submission portal.\nAs described in the draft guidance, FDA intends to use the FDA Establishment Identifier (FEI) as the required facility registration number. To facilitate the registration process, the owner or operator of a facility will need to obtain an FEI number before submitting the facility registration. To determine if an entity already has an FEI",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "EI number before submitting the facility registration. To determine if an entity already has an FEI number, please refer to the FEI Search Portal. If your firm does not have an FEI number assigned by FDA, see How can I request an FEI? at FEI Search Portal (fda.gov).\nThe responsible person will need to obtain the relevant facility registration (FEI) number(s) for each facility where their cosmetic products are manufactured or processed, because the facility registration number(s) is required for",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "products are manufactured or processed, because the facility registration number(s) is required for the product listing submission. If the facility is a small business that is exempt from registration and has no facility registration number, then facility name/address can be provided instead for the product listing.\nStakeholders should plan to register and list well in advance of the December 29, 2023, statutory deadline.\nIn addition, FDA is soliciting applications from members of the cosmetic p",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "2023, statutory deadline.\nIn addition, FDA is soliciting applications from members of the cosmetic product industry interested in participating in a voluntary pilot program to conduct User Acceptance Testing (UAT) to help evaluate a potential new electronic submissions portal for cosmetic product facility registration and listing. This electronic submission portal is being implemented pursuant to MoCRA. FDA plans to accept up to nine participants for the pilot program. The pilot program is inten",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "MoCRA. FDA plans to accept up to nine participants for the pilot program. The pilot program is intended to provide input to inform evaluation of this new electronic submission portal. For more information, please refer to: Federal Register Notice: Pilot Program for Cosmetic Product Facility Registration and Listing Electronic Submissions User Acceptance Testing.\nTo Submit Comments on the Draft Guidance:\nComments on the draft guidance should be submitted by 9/7/2023. You may submit electronic com",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "dance:\nComments on the draft guidance should be submitted by 9/7/2023. You may submit electronic comments to Regulations.gov. All written comments should be identified with the docket number FDA-2023-D-1716 and title of the guidance document.\nSUBSCRIBE",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-draft-guidance-registration-and-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "This section contains information on laws and regulations that FDA enforces, as well as guidance for industry and Federal Register documents.\nFDA enforces laws enacted by Congress and issues regulations as authorized by Congress to implement its statutory authority. The regulations can create binding obligations and have the force of law. Links to laws and regulations that FDA enforces, as well as related overviews and reference materials are posted in this section.\nGuidance documents represent",
    "url": "https://www.fda.gov/cosmetics/cosmetics-guidance-regulation"
  },
  {
    "text": "related overviews and reference materials are posted in this section.\nGuidance documents represent FDA’s current thinking on a topic. They do not create or confer any rights for or on any person and do not operate to bind FDA or the public. Manufacturers can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. Links to Federal Register documents, including notices and final rules, are also posted in this section.\nLinks to information",
    "url": "https://www.fda.gov/cosmetics/cosmetics-guidance-regulation"
  },
  {
    "text": "documents, including notices and final rules, are also posted in this section.\nLinks to information and resources for the cosmetics industry",
    "url": "https://www.fda.gov/cosmetics/cosmetics-guidance-regulation"
  },
  {
    "text": "FDA scientists conduct cosmetic safety research and stay abreast of research by scientists elsewhere, because any action FDA takes on cosmetic safety must be based on reliable information.\nUnder U.S. law, cosmetic products and ingredients do not need FDA approval before they go on the market. The one exception is color additives (other than coloring materials used in coal-tar hair dyes), which must be approved for their intended use. Companies and individuals who market cosmetics have a legal re",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research"
  },
  {
    "text": "t be approved for their intended use. Companies and individuals who market cosmetics have a legal responsibility to ensure the safety of their products. In order to take action for safety reasons against a cosmetic on the market, we need reliable information showing that it is unsafe when consumers use it according to the directions in the labeling or in the customary or expected way.\nIn this section, you will find:",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research"
  },
  {
    "text": "ion, you will find:",
    "url": "https://www.fda.gov/cosmetics/cosmetics-science-research"
  },
  {
    "text": "English\nSakaling may reaksiyon o problema sa produktong cosmetic, ang unang hakbang ay ang paghinto sa paggamit ng produkto at kontakin ang iyong tagapagkaloob ng pangangalaga sa kalusugan. Hindi nagbibigay ang Food and Drug Administration (FDA, kami) ng medikal na payo. Pangalawa, isumbong ang problema sa FDA.\nMagsumbong ng Reklamo sa Produktong Cosmetic\nSabihin sa FDA Kung Makaranas Ka\nMga Klase ng Produkto na Itinuturing na Produktong Cosmetic\nAng mga produktong cosmetic ay hindi pareho sa mg",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "ng Produkto na Itinuturing na Produktong Cosmetic\nAng mga produktong cosmetic ay hindi pareho sa mga produktong gamot, at iba ang pagreregula sa kanila ng FDA. Narito ang ilang mga halimbawa ng mga produktong cosmetic:\nPaano Makakapagsumbong ang Mga Mamimili at Pangkalusugang Propesyonal ng Problema sa Mga Produktong Cosmetic sa FDA\nKung ikaw ay mamimili o propesyonal sa kalusugan na gustong magsumbong ng reklamo o mga salungat na kaganapan (tulad ng pagkakasakit, allergic na reaksiyon, pamaman",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "umbong ng reklamo o mga salungat na kaganapan (tulad ng pagkakasakit, allergic na reaksiyon, pamamantal, iritasyon, pagpepeklat, o pagkawala ng buhok) na kaugnay ng produktong cosmetic, maaari kang:\nMedWatchFood and Drug Administration5600 Fishers LaneRockville, MD 20852FAX: 800-332-0178 (toll-free).\nPaano Nag-uulat ang Industriya ng Mga Malalang Salungat na Kaganapan\nIpinatupad ang 2022 na Batas ng Regulasyon sa Modernisasyon ng Cosmetics o Modernization of Cosmetics Regulation Act of 2022 (MoC",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "ng Regulasyon sa Modernisasyon ng Cosmetics o Modernization of Cosmetics Regulation Act of 2022 (MoCRA) noong Disyembre 29, 2022. Inaamyendahan ng MoCRA ang Chapter VI ng Batas Pederal ng Pagkain, Gamot at Cosmetic o Federal Food, Drug, and Cosmetic Act at naglalaan para sa pinakamakabuluhang pagpapalawak ng awtoridad ng FDA para iregula ang cosmetics mula 1938.\nInaatasan ng MoCRA ang responsableng tao (tingnan ang kahulugan sa ibaba) para isumbong ang mga malalang salungat na kaganapan (tingnan",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "g tao (tingnan ang kahulugan sa ibaba) para isumbong ang mga malalang salungat na kaganapan (tingnan ang kahulugan sa ibaba) na kaugnay ng paggamit ng mga produktong cosmetic sa Estados Unidos sa FDA, sa loob ng 15 araw ng negosyo. Ang responsableng tao ay dapat magsama ng kopya ng label sa o sa loob ng retail na pakete ng nasabing cosmetic na produkto. Kung makatanggap ang responsableng tao ng medikal o ibang impormasyon tungkol sa salungat na kaganapan sa loob ng 1 taon ng inisyal na ulat sa F",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "dikal o ibang impormasyon tungkol sa salungat na kaganapan sa loob ng 1 taon ng inisyal na ulat sa FDA, dapat silang magsumite ng bagong impormasyong ito sa FDA sa loob ng 15 araw ng negosyo. Magkakaroon din ang FDA ng access sa mga pagsusumbong ng salungat na kaganapan sa panahon ng inspeksiyon.\nMandatoryo para sa taong responsible sa industriya na magsumite ng mga pagsumbong sa malalang salungat na kaganapan (SAER) para sa mga produktong cosmetic sa pamamagitan ng paggamit ng kasalukuyang Form",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "na kaganapan (SAER) para sa mga produktong cosmetic sa pamamagitan ng paggamit ng kasalukuyang Form FDA 3500A - Mandatory Reporting na maaaring i-download at punan sa MedWatch: The FDA Safety Information and Adverse Event Reporting Program - Mandatory (PDF).\nPakitingnan ang Instructions for Completing Form FDA 3500A.\nIsumite:\nsa FDA sa pamamagitan ng email sa: CosmeticAERS@fda.hhs.gov o sa pamamagitan ng mail sa:\nFDA CDER Mail CenterAttn: Cosmetics MedWatch reportsWhite Oak Campus, Building 22,",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "gitan ng mail sa:\nFDA CDER Mail CenterAttn: Cosmetics MedWatch reportsWhite Oak Campus, Building 22, G020710903 New Hampshire Ave.Silver Spring, MD 20993\nGumagawa ang FDA ng proseso sa pagsumite ng electronic na mandatoryong mga ulat ng salungat na kaganapan para sa mga produktong cosmetic.\nHabang hindi inaatasan ng MoCRA ang mga taong responsible sa industriya na magsumite ng mga ulat ng hindi-malalang salungat na kaganapan para sa mga produktong cosmetic sa FDA, maaari kang boluntaryong magsum",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "lalang salungat na kaganapan para sa mga produktong cosmetic sa FDA, maaari kang boluntaryong magsumite ng mga ulat ng hindi-malalang salungat na kaganapan gamit ang Form 3500A, kasunod ang parehong prosesong nakalarawan sa itaas para sa mga mandatoryong ulat ng salungat na kaganapan.\nMga Pangunahing Termino\nMalalang Salungat na Kaganapan: isang salungat na kaganapan na:\n(A) nagreresulta sa:\n(B) nangangailangan, batay sa makatwirang medikal na paghatol, ng isang medikal o operasyon na interbensy",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "angangailangan, batay sa makatwirang medikal na paghatol, ng isang medikal o operasyon na interbensyon upang maiwasan ang isang kinalabasan na inilarawan sa (A) sa itaas.\nResponsableng Tao: ang manufacturer, tagapakete, o distributor ng isang produktong cosmetic na ang pangalan ay makikita sa label ng naturang produktong cosmetic alinsunod sa seksyon 609(a) ng FD&C Act o seksyon 4(a) ng Fair Packaging and Labeling Act.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "ging and Labeling Act.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/paano-isumbong-ang-reklamong-kaugnay-sa-cosmetic-na-produkto"
  },
  {
    "text": "Under U.S. law, cosmetic products and ingredients do not need FDA approval before they go on the market. The one exception is color additives (other than coloring materials used in coal-tar hair dyes), which must be approved for their intended use. Companies and individuals who market cosmetics have a legal responsibility to ensure the safety of their products. In order to take action for safety reasons against a cosmetic on the market, we need reliable information showing that it is unsafe when",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products-ingredients/cosmetic-products"
  },
  {
    "text": "easons against a cosmetic on the market, we need reliable information showing that it is unsafe when consumers use it according to the directions in the labeling or in the customary or expected way.\nThe resources listed below are related to cosmetic products that people often inquire about. For resources on cosmetic ingredients, see Cosmetic Ingredients.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products-ingredients/cosmetic-products"
  },
  {
    "text": "The Warning Letters appearing below illustrate an important legal distinction, the difference between a cosmetic and a drug under the Federal Food, Drug, and Cosmetic Act (FD&C Act).\nUnder the FD&C Act, a product intended to diagnose, mitigate, treat, or prevent disease, or to affect the structure or function of the body is classified as a drug (FD&C Act, Section 201(g)). If such a product is not generally recognized by qualified experts as safe and effective when used as labeled, it is a “new d",
    "url": "https://www.fda.gov/cosmetics/warning-letters/warning-letters-address-drug-claims-made-products-marketed-cosmetics"
  },
  {
    "text": "generally recognized by qualified experts as safe and effective when used as labeled, it is a “new drug” (FD&C Act, Section 201(p)) and requires an approved New Drug Application to be marketed legally in the United States (FD&C Act, Section 505(a)). FDA issued Warning Letters to the following firms, citing drug claims associated with topical skin care, hair care, and eyelash/eyebrow preparations, noted on both product labeling and Web sites. Some examples of the drug claims cited are acne treatm",
    "url": "https://www.fda.gov/cosmetics/warning-letters/warning-letters-address-drug-claims-made-products-marketed-cosmetics"
  },
  {
    "text": "noted on both product labeling and Web sites. Some examples of the drug claims cited are acne treatment, cellulite reduction, stretch mark reduction, wrinkle removal, dandruff treatment, hair restoration, and eyelash growth.",
    "url": "https://www.fda.gov/cosmetics/warning-letters/warning-letters-address-drug-claims-made-products-marketed-cosmetics"
  },
  {
    "text": "En Español (Spanish)\nFrançais (French)\n한국어 (Korean)\n中文 (Simplified Chinese)\n英語 (Traditional Chinese)\nNOTE on antibacterial soaps: For the latest information, see FDA issues final rule on safety and effectiveness of antibacterial soaps.\nWhether a product is a cosmetic or a drug under the law is determined by a product's intended use. Different laws and regulations apply to each type of product. Firms sometimes violate the law by marketing a cosmetic with a drug claim or by marketing a drug as if",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ms sometimes violate the law by marketing a cosmetic with a drug claim or by marketing a drug as if it were a cosmetic, without adhering to requirements for drugs.\nHow does the law define a cosmetic?\nThe Federal Food, Drug, and Cosmetic Act (FD&C Act) defines cosmetics as \"articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance\" [FD&C Act, sec. 201(",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "r cleansing, beautifying, promoting attractiveness, or altering the appearance\" [FD&C Act, sec. 201(i)]. Among the products included in this definition are skin moisturizers, perfumes, lipsticks, fingernail polishes, makeup, cleansing shampoos, permanent waves, hair colors, and deodorants, as well as any substance intended for use as a component of a cosmetic product.\nThe Modernization of Cosmetics Regulation Act of 2022 (MoCRA) amended the FD&C Act to include “cosmetic product” which is defined",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "s Regulation Act of 2022 (MoCRA) amended the FD&C Act to include “cosmetic product” which is defined as “a preparation of cosmetic ingredients with a qualitatively and quantitatively set composition for use in a finished product” [FD&C Act, sec. 361]. This new term applies to these amendments of the FD&C Act.\nHow does the law define a drug?\nThe FD&C Act defines drugs, in part, by their intended use, as \"articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of dis",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "e, as \"articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease\" and \"articles (other than food) intended to affect the structure or any function of the body of man or other animals\" [FD&C Act, sec. 201(g)(1)].\nHow can a product be both a cosmetic and a drug?\nSome products meet the definitions of both cosmetics and drugs. This may happen when a product has more than one intended use. For example, an antidandruff shampoo is a cosmetic because its intended",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "more than one intended use. For example, an antidandruff shampoo is a cosmetic because its intended use is to cleanse the hair, and it is also a drug because its intended use is to treat dandruff. Among other cosmetic/drug combinations are toothpastes with claims to freshen breath and cleanse the teeth that contain fluoride. Similarly, deodorants that are also antiperspirants, and moisturizers and makeup marketed with sun-protection claims are cosmetic/drug products. Such products must comply wi",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "makeup marketed with sun-protection claims are cosmetic/drug products. Such products must comply with the requirements for both cosmetics and drugs.\nWhat about \"cosmeceuticals\"?\nThe FD&C Act does not recognize any such category as \"cosmeceuticals.\" A product can be a drug, a cosmetic, or a combination of both, but the term \"cosmeceutical\" has no meaning under the law.\nHow is a product's intended use established?\nIntended use may be established in a number of ways. The following are some example",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "use established?\nIntended use may be established in a number of ways. The following are some examples:\nThis principle also holds true for \"essential oils.\" For example, a fragrance marketed for promoting attractiveness is a cosmetic. But a fragrance marketed with certain \"aromatherapy\" claims, such as assertions that the scent will help the consumer sleep or quit smoking, meets the definition of a drug because of its intended use. Similarly, a massage oil that is simply intended to lubricate the",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "drug because of its intended use. Similarly, a massage oil that is simply intended to lubricate the skin and impart fragrance is a cosmetic, but if the product is intended for a therapeutic use, such as relieving muscle pain, it's a drug.\nHow are the laws and regulations different for cosmetics and drugs?\nThe following information is not a complete description of cosmetic or drug laws and regulations. It is intended only to alert you to some important differences and similarities between the la",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ions. It is intended only to alert you to some important differences and similarities between the laws and regulations for cosmetics and drugs in the areas of approval, good manufacturing practice, registration, and labeling. Questions regarding laws and regulations for drugs should be directed to FDA's Center for Drug Evaluation and Research (CDER).\nHow are approval requirements different?\nUnder the FD&C Act, cosmetic products and ingredients, with the exception of color additives, do not requi",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "the FD&C Act, cosmetic products and ingredients, with the exception of color additives, do not require FDA approval before they go on the market. Drugs, however, must generally either receive premarket approval by FDA through the New Drug Application (NDA) process or conform to a \"monograph\" for a particular drug category, as established by FDA's Over-the-Counter (OTC) Drug Review. These monographs specify conditions whereby OTC drug ingredients are generally recognized as safe and effective (GR",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "s specify conditions whereby OTC drug ingredients are generally recognized as safe and effective (GRASE), and not misbranded. Certain OTC drugs may remain on the market without an NDA approval until a monograph for its class of drugs is finalized as a regulation. However, once FDA has made a final determination on the status of an OTC drug category, such products must either be the subject of an approved NDA [FD&C Act, sec. 505(a) and (b)], or comply with the appropriate monograph for an OTC dru",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "pproved NDA [FD&C Act, sec. 505(a) and (b)], or comply with the appropriate monograph for an OTC drug.\nWhat do these terms mean?\nYou can find information on FDA's website, under Development and Approval Process (Drugs), especially How Drugs Are Developed and Approved. If you still have questions about NDAs and OTC monographs, or any other aspect of drug regulation, please contact CDER. You can also contact CDER's Small Business and Industry Assistance at CDERSBIA@fda.hhs.gov or, for general drug",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "o contact CDER's Small Business and Industry Assistance at CDERSBIA@fda.hhs.gov or, for general drug-related inquiries, CDER's Division of Drug Information at druginfo@fda.hhs.gov.\nDo cosmetics and drugs have different good manufacturing practice requirements?\nAt the present time, FDA has Draft Guidance for Industry: Cosmetic Good Manufacturing Practices to assist industry and other stakeholders in identifying the standards and issues that can affect the quality of cosmetic products. MoCRA amend",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "n identifying the standards and issues that can affect the quality of cosmetic products. MoCRA amended the FD&C Act to require that FDA will establish good manufacturing practice (GMP) requirements for facilities that manufacture or process cosmetic products distributed in the United States. Under MoCRA, FDA is required to establish these cosmetic GMP regulations not later than December 29, 2025. The law will require strict adherence by industry to these GMP requirements, with certain exemptions",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "The law will require strict adherence by industry to these GMP requirements, with certain exemptions. Cosmetics products that fail to follow these GMP requirements will be adulterated [FD&C Act, sec. 601(f)]. These regulations are intended to protect the public health and ensure that cosmetic products are not adulterated or misbranded.\nRegarding drugs, the law requires strict adherence to GMP requirements for drugs, and there are regulations specifying minimum current GMP requirements for drugs",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "irements for drugs, and there are regulations specifying minimum current GMP requirements for drugs [Title 21 of the Code of Federal Regulations (CFR), parts 210 and 211]. Drugs that fail to follow GMP requirements are considered to be adulterated [FD&C Act, sec. 501(a)(2)(B)].\nHow are registration requirements different?\nUnder MoCRA, cosmetic product facility registration and cosmetic product listing are now mandatory with certain exemptions for small businesses. Learn more at Registration & Li",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ting are now mandatory with certain exemptions for small businesses. Learn more at Registration & Listing of Cosmetic Product Facilities and Products. Likewise, it is also mandatory for drug firms to register their establishments and list their drug products with FDA [FD&C Act, sec. 510; 21 CFR 207]. See Drug Registration and Listing System (DRLS and eDRLS).\nHow are labeling requirements different?\nA cosmetic product must be labeled according to cosmetic labeling regulations. See Cosmetic Labeli",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "?\nA cosmetic product must be labeled according to cosmetic labeling regulations. See Cosmetic Labeling for guidance on cosmetic labeling and links to the regulations related to cosmetic labeling.\nOTC drugs must be labeled according to OTC drug regulations, including the \"Drug Facts\" labeling, as described in 21 CFR 201.66 Combination OTC drug/cosmetic products must have combination OTC drug/cosmetic labeling. For example, the drug ingredients must be listed alphabetically as \"Active Ingredients,",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ic labeling. For example, the drug ingredients must be listed alphabetically as \"Active Ingredients,\" followed by cosmetic ingredients, listed in descending order of predominance as \"Inactive Ingredients.\"\nWhat if it's \"soap\"?\nSoap is a category that needs special explanation. That's because the regulatory definition of \"soap\" is different from the way in which people commonly use the word. Products that meet the definition of \"soap\" are exempt from the provisions of the FD&C Act because-even th",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ts that meet the definition of \"soap\" are exempt from the provisions of the FD&C Act because-even though Section 201(i)(1) of the act includes \"articles...for cleansing\" in the definition of a cosmetic-Section 201(i)(2) excludes soap from the definition of a cosmetic.\nHow does FDA define \"soap\"?\nNot every product marketed as soap meets FDA's definition of the term. FDA interprets the term \"soap\" to apply only when\nProducts that meet this definition of soap are regulated by the Consumer Product S",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "o apply only when\nProducts that meet this definition of soap are regulated by the Consumer Product Safety Commission (CPSC), not by FDA. Please direct questions about these products, such as safety and labeling requirements, to CPSC.\nIf a cleanser does not meet all of the criteria for soap...\nIf a product intended to cleanse the human body does not meet all the criteria for soap, as listed above, it is either a cosmetic or a drug. For example:\nIf a product:\nit is regulated as a cosmetic. Example",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "it is either a cosmetic or a drug. For example:\nIf a product:\nit is regulated as a cosmetic. Examples of cosmetic uses include making the user more attractive, by acting as a deodorant, imparting fragrance to the user, or moisturizing the skin.\nIf a product:\nit is regulated as a drug, or possibly both a drug and a cosmetic. Examples include antibacterial cleansers and cleansers that are also intended to treat acne.\nIf a product:\nit may be identified in labeling as soap, but it is regulated as a",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "ded to treat acne.\nIf a product:\nit may be identified in labeling as soap, but it is regulated as a cosmetic.",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/it-cosmetic-drug-or-both-or-it-soap"
  },
  {
    "text": "A recall is a firm's removal or correction of a marketed product that FDA considers to be in violation of the laws we administer and against which we would initiate legal action, such as seizure [Title 21 of the Code of Federal Regulations (CFR), section 7.3(g)]. FDA strongly recommends that firms become familiar with the complete guidelines, including the components of a recall strategy, in 21 CFR Part 7. The following is an introduction.\nFDA has no authority under the FD&C Act to order a recal",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/fda-recall-policy-cosmetics"
  },
  {
    "text": "R Part 7. The following is an introduction.\nFDA has no authority under the FD&C Act to order a recall of a cosmetic, although it can request that a firm recall a product. However, we do have an active role in recalls. For example:\nUnder the guidelines in 21 CFR Part 7, you are expected to do the following:\nThe best way to minimize the burden of product recalls is to do a thorough job of preventing product adulteration and misbranding to begin with. But in case a recall does become necessary, com",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/fda-recall-policy-cosmetics"
  },
  {
    "text": "product adulteration and misbranding to begin with. But in case a recall does become necessary, companies can minimize the damage by being prepared in advance. The following are some tips:\nIn addition to the corrective actions of removing a violative product from the market and either destroying it or bringing it into compliance, you should take the kind of corrective actions that prevent a similar problem from occurring in the future. For example, you should--\nThese are some of the things an F",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/fda-recall-policy-cosmetics"
  },
  {
    "text": "ar problem from occurring in the future. For example, you should--\nThese are some of the things an FDA investigator will look for if we conduct an inspection related to a recall. To learn more about what to expect during a recall-related inspection, you may check FDA's Investigations Operations Manual, Chapter 8 (PDF 2.26 MB). To learn more about FDA's policies and procedures regarding recalls, you may check FDA's Regulatory Procedures Manual, Chapter 7, \"Recall Procedures.\"\nUpdated July 29, 200",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/fda-recall-policy-cosmetics"
  },
  {
    "text": "u may check FDA's Regulatory Procedures Manual, Chapter 7, \"Recall Procedures.\"\nUpdated July 29, 2002. This document is current. It is updated only as needed.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/fda-recall-policy-cosmetics"
  },
  {
    "text": "FDA often receives questions from soap makers about how their products are regulated. Here is information to help small-scale soap producers understand the laws and regulations they need to know about.\nHow are traditional soaps and synthetic detergents different?\nOrdinary soap is made by combining fats or oils and an alkali, such as lye. The fats and oils, which may be from animal, vegetable, or mineral sources, are degraded into free fatty acids, which then combine with the alkali to form crude",
    "url": "https://www.fda.gov/cosmetics/products/soap-faqs"
  },
  {
    "text": "ineral sources, are degraded into free fatty acids, which then combine with the alkali to form crude soap. The alkali reacts with the oils, turning what starts out as liquid into blocks of soap. When made properly, no lye remains in the finished product. In the past, people commonly made their own soap using animal fats and lye that had been extracted from wood ashes.\nToday there are very few true soaps on the market. Most body cleansers, both liquid and solid, are synthetic detergent products.",
    "url": "https://www.fda.gov/cosmetics/products/soap-faqs"
  },
  {
    "text": "soaps on the market. Most body cleansers, both liquid and solid, are synthetic detergent products. Detergent cleansers are popular because they make suds easily in water and don't form gummy deposits. Many of these detergent products are marketed as \"soap\" but are not true soap according to the regulatory definition of the word.\nWhat’s FDA's regulatory definition of soap (21 CFR 701.20)?\nFDA’s regulatory definition of soap includes the following three conditions; all three conditions must be me",
    "url": "https://www.fda.gov/cosmetics/products/soap-faqs"
  },
  {
    "text": "gulatory definition of soap includes the following three conditions; all three conditions must be met to be a soap under FDA’s regulatory definition:\nHow are different “soap” products regulated?\nWhat if my ingredients are “natural” or “organic”?\nTo learn more, see Product Testing of Cosmetics. To learn more about “organic” requirements, see ‘Organic’ Cosmetics and the National Organic Program (USDA).",
    "url": "https://www.fda.gov/cosmetics/products/soap-faqs"
  },
  {
    "text": "A).",
    "url": "https://www.fda.gov/cosmetics/products/soap-faqs"
  },
  {
    "text": "The following are resources on cosmetic label claims, expiration dating, ingredient names (nomenclature), and related regulatory and enforcement information.\nProper labeling is an important aspect of putting a cosmetic product on the market. FDA regulates cosmetic labeling under the authority of both the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling Act (FPLA). Here's where to learn about labeling requirements:\nCosmetic labeling must be truthful and not misl",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling"
  },
  {
    "text": ". Here's where to learn about labeling requirements:\nCosmetic labeling must be truthful and not misleading. Products intended to affect the structure or function of the body, or for a therapeutic purpose, such as treating or preventing disease, are subject to regulation as drugs. Here is information on claims that are sometimes made for cosmetic products:\nThere are no regulations or requirements under current United States law that require cosmetic manufacturers to print expiration dates on the",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling"
  },
  {
    "text": "nder current United States law that require cosmetic manufacturers to print expiration dates on the labels of cosmetic products, but cosmetic firms have a responsibility for the safety of their products. Here's where to learn more about shelf life and expiration dating.\nIdentifying ingredients on cosmetic labels can be a challenge. Here is information on requirements for ingredient nomenclature, labeling cosmetic products for the international market, and links to more resources.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling"
  },
  {
    "text": "abeling cosmetic products for the international market, and links to more resources.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling"
  },
  {
    "text": "The tables below are provided as a supplement to the information in the Summary of Color Additives Listed for Use in the United States in Food, Drugs, Cosmetics, and Medical Devices. They are intended for quick reference to help in determining which color additives may be used in different types of cosmetics, as provided for in Title 21 of the Code of Federal Regulations (CFR), Subpart C of Part 73 (Listing of Color Additives Exempt from Certification), Subpart C of Part 74 (Listing of Color Add",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredient-names/color-additives-permitted-use-cosmetics"
  },
  {
    "text": "3 (Listing of Color Additives Exempt from Certification), Subpart C of Part 74 (Listing of Color Additives Subject to Certification), and Subparts B, C, and D of Part 82 (Listing of Certified Provisionally Listed Colors and Specifications).\nFor additional information on the permitted use, specifications, and restrictions that apply to each color additive, please refer to the appropriate listing regulation, using the links provided in the tables. For more information on the use of color additives",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredient-names/color-additives-permitted-use-cosmetics"
  },
  {
    "text": "gulation, using the links provided in the tables. For more information on the use of color additives in cosmetics in general, please see Color Additives and Cosmetics.\nColor Additives That Are Exempt from Certification and Permitted for Use in Cosmetics (21 CFR Part 73 Subpart C—Cosmetics)\nColor Additives That Are Subject to Certification and Permitted for Use in Cosmetics*\nIncludes Straight Colors and Lakes\n(21 CFR Part 74 Subpart C—Cosmetics and 21 CFR Part 82 Subparts B, C, and D)\n*Includes s",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredient-names/color-additives-permitted-use-cosmetics"
  },
  {
    "text": "s and Lakes\n(21 CFR Part 74 Subpart C—Cosmetics and 21 CFR Part 82 Subparts B, C, and D)\n*Includes straight colors and lakes\n**Excludes lakes except where noted. Only aluminum lakes on alumina are permitted for designated lakes.\nApril 30, 2008; Updated June 20, 2008 and February 22, 2010. This information is current. It is updated only when necessary.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-ingredient-names/color-additives-permitted-use-cosmetics"
  },
  {
    "text": "FDA regulates products that we think of as “makeup” –such as lipstick, blush, foundation, face powder, eye shadow eye liner, and mascara--as cosmetics under the Federal Food, Drug, and Cosmetic Act.\nThe law does not require cosmetic products and ingredients (except for color additives not intended as coal-tar hair dyes) to have FDA approval before they go on the market, but it does require them to be safe when consumers use them according to their labeling, or as they are customarily used. Also,",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/makeup"
  },
  {
    "text": "be safe when consumers use them according to their labeling, or as they are customarily used. Also, any color additives used in cosmetics must be approved by FDA.\nSome makeup is labeled with sunscreen claims, such as “SPF” numbers. Sunscreen products intended to protect consumers from the sun are regulated as drugs. Products intended both as makeup and sun protection are both cosmetics and drugs. To learn more, see “Sunscreens.” If you have questions about sunscreen products, contact FDA’s Cent",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/makeup"
  },
  {
    "text": "To learn more, see “Sunscreens.” If you have questions about sunscreen products, contact FDA’s Center for Drug Evaluation and Research, at druginfo@fda.hhs.gov. To learn about sunscreen ingredients intended to protect the product from problems such as fading, see the regulation, “Cosmetics containing sunscreen ingredients” (21 CFR 700.35).\nMakeup Products That People Often Ask About\nInformation on Ingredients\nSafety Resources\nRegulatory Resources",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/makeup"
  },
  {
    "text": "n Ingredients\nSafety Resources\nRegulatory Resources",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/makeup"
  },
  {
    "text": "Firms may apply for an export certificate for cosmetic products via the Certificate Application Process (CAP) online. CAP is one of two modules within the CFSAN Export Certification Application and Tracking System (CFSAN eCATS) that can be accessed through the FDA Industry Systems (FIS) (https://www.access.fda.gov/).\nFor more information on how to apply for an export certificate please download the step-by-step instructions below.\n\nLaunch the\nFDA Industry Systems’ CFSAN Export Certification Appl",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetics-certificate-application-process-cap-help"
  },
  {
    "text": "e step-by-step instructions below.\n\nLaunch the\nFDA Industry Systems’ CFSAN Export Certification Application and Tracking System\n(CFSAN eCATS)\nOMB Approval Number: 0910-0793\nOMB Expiration Date: 8/31/2024\n\nDownload Step by Step Instructions \n(PDF 1.26MB)",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetics-certificate-application-process-cap-help"
  },
  {
    "text": "Color additives are subject to a strict system of approval under U.S. law [Federal Food, Drug, and Cosmetic Act (FD&C Act), sec. 721; 21 U.S.C. 379e]. Except in the case of coal-tar hair dyes, failure to meet U.S. color additive requirements causes a cosmetic to be adulterated [FD&C Act, sec. 601(e); 21 U.S. Code 361(e)]. Color additive violations are a common reason for detaining imported cosmetic products offered for entry into this country.\n\nAvailable in:\n\nIf your product (except coal-tar hai",
    "url": "https://www.fda.gov/industry/cosmetics/color-additives-and-cosmetics"
  },
  {
    "text": "c products offered for entry into this country.\n\nAvailable in:\n\nIf your product (except coal-tar hair dyes) contains a color additive, by law [FD&C Act, Sec. 721; 21 U.S.C. 379e; 21 CFR Parts 70 and 80] you must adhere to requirements for:\nThe FD&C Act Section 721(c) [21 U.S. C. 379e(c)] and color additive regulations [21 CFR Parts 70 and 80] separate approved color additives into two main categories: those subject to certification (sometimes called \"certifiable\") and those exempt from certifica",
    "url": "https://www.fda.gov/industry/cosmetics/color-additives-and-cosmetics"
  },
  {
    "text": "ies: those subject to certification (sometimes called \"certifiable\") and those exempt from certification. In addition, the regulations refer to other classifications, such as straight colors and lakes.\nSeveral precautions can help you avoid color additive violations that will cause your cosmetic to be adulterated:\nYes. No matter whether a particular color is subject to certification or exempt from certification, U.S. law prohibits its use in cosmetics (or any other FDA-regulated product) unless",
    "url": "https://www.fda.gov/industry/cosmetics/color-additives-and-cosmetics"
  },
  {
    "text": "certification, U.S. law prohibits its use in cosmetics (or any other FDA-regulated product) unless it is approved specifically for the intended use [FD&C Act, sec. 721(a)(1)(A); 21 U.S.C. 379e(a)(1)(A)].\nThe regulations also restrict intended use as follows:\nNo matter how exotic or novel the color additive or its intended use, it is subject to the same regulations as the more everyday colors and products. The following items are a sampling of some out-of-the-ordinary color additives. This list",
    "url": "https://www.fda.gov/industry/cosmetics/color-additives-and-cosmetics"
  },
  {
    "text": "products. The following items are a sampling of some out-of-the-ordinary color additives. This list is not exhaustive. Rather, it is intended to show how the regulations apply to such colors:",
    "url": "https://www.fda.gov/industry/cosmetics/color-additives-and-cosmetics"
  },
  {
    "text": "The resources listed below provide information on some potential contaminants in cosmetics, and their control. Under the law, cosmetics must not be harmful to consumers when used according to directions in the labeling, or in the customary or expected way.\nRelated Resources",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products-ingredients/potential-contaminants-cosmetics"
  },
  {
    "text": "A recall is a firm's removal or correction of a marketed product that FDA considers to be in violation of the laws we administer and against which we would initiate legal action, such as seizure [Title 21 of the Code of Federal Regulations (CFR), section 7.3(g)]. FDA strongly recommends that firms become familiar with the complete guidelines, including the components of a recall strategy, in 21 CFR Part 7. The following is an introduction.\nFDA has no authority under the FD&C Act to order a recal",
    "url": "https://www.fda.gov/cosmetics/recalls-alerts/fda-recall-policy-cosmetics"
  },
  {
    "text": "R Part 7. The following is an introduction.\nFDA has no authority under the FD&C Act to order a recall of a cosmetic, although it can request that a firm recall a product. However, we do have an active role in recalls. For example:\nUnder the guidelines in 21 CFR Part 7, you are expected to do the following:\nThe best way to minimize the burden of product recalls is to do a thorough job of preventing product adulteration and misbranding to begin with. But in case a recall does become necessary, com",
    "url": "https://www.fda.gov/cosmetics/recalls-alerts/fda-recall-policy-cosmetics"
  },
  {
    "text": "product adulteration and misbranding to begin with. But in case a recall does become necessary, companies can minimize the damage by being prepared in advance. The following are some tips:\nIn addition to the corrective actions of removing a violative product from the market and either destroying it or bringing it into compliance, you should take the kind of corrective actions that prevent a similar problem from occurring in the future. For example, you should--\nThese are some of the things an F",
    "url": "https://www.fda.gov/cosmetics/recalls-alerts/fda-recall-policy-cosmetics"
  },
  {
    "text": "ar problem from occurring in the future. For example, you should--\nThese are some of the things an FDA investigator will look for if we conduct an inspection related to a recall. To learn more about what to expect during a recall-related inspection, you may check FDA's Investigations Operations Manual, Chapter 8 (PDF 2.26 MB). To learn more about FDA's policies and procedures regarding recalls, you may check FDA's Regulatory Procedures Manual, Chapter 7, \"Recall Procedures.\"\nUpdated July 29, 200",
    "url": "https://www.fda.gov/cosmetics/recalls-alerts/fda-recall-policy-cosmetics"
  },
  {
    "text": "u may check FDA's Regulatory Procedures Manual, Chapter 7, \"Recall Procedures.\"\nUpdated July 29, 2002. This document is current. It is updated only as needed.",
    "url": "https://www.fda.gov/cosmetics/recalls-alerts/fda-recall-policy-cosmetics"
  },
  {
    "text": "If you are shipping cosmetics to the United States from another country, see “For Importers.”\nIf you are shipping cosmetics from the United States to another country, see “For Exporters.”\nFor Importers:\nIf you have questions about U.S. Customs requirements, you need to contact U.S. Customs and Border Protection.\nFor Exporters:",
    "url": "https://www.fda.gov/cosmetics/resources-industry-cosmetics/cosmetics-importers-exporters-fact-sheet"
  },
  {
    "text": "The Federal Food, Drug, and Cosmetic Act prohibits the distribution of cosmetics that are adulterated or misbranded in interstate commerce. Here is an introduction to what those terms mean.\nThe Federal Food, Drug, and Cosmetic Act (FD&C Act) prohibits, among other things,\nThis means that nearly everyone involved in cosmetics in interstate commerce, such as manufacturers, packers, distributors, and retailers, is responsible for assuring that he or she is not dealing in products that are adulterat",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "retailers, is responsible for assuring that he or she is not dealing in products that are adulterated or misbranded, even if someone else caused the adulteration or misbranding in the first place. If you introduce it into interstate commerce or receive it in interstate commerce, you are responsible. The law applies to components and packaging as well as to finished products.\nThe FD&C Act describes what constitutes interstate commerce, adulteration, and misbranding. It also authorizes FDA to tak",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "s what constitutes interstate commerce, adulteration, and misbranding. It also authorizes FDA to take legal action if cosmetics are adulterated or misbranded. In addition, the Fair Packaging and Labeling Act (FPLA) requires specific label information. Violations of the FPLA result in misbranding.\nSection 201(b) of the FD&C Act [21 U.S.C. 321(b)] tells what circumstances place a product in interstate commerce:\n\"(1) commerce between any State or Territory and any place outside thereof, and\n(2) com",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "te commerce:\n\"(1) commerce between any State or Territory and any place outside thereof, and\n(2) commerce within the District of Columbia or within any other Territory not organized with a legislative body.\"\n\"Interstate commerce\" applies to all steps in a product's manufacture, packaging, and distribution. It is very rare that a cosmetic product on the market is not in \"interstate commerce\" under the law. For example, at least some of your ingredients or packaging most likely originate from out",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "the law. For example, at least some of your ingredients or packaging most likely originate from out of state, or even out of the country. Likewise, it is foreseeable that your products will leave the state. Although there are certain exemptions [21 CFR 701.9], factors such as these generally cause the requirements of the FD&C Act to apply to your products.\nSection 601 of the FD&C Act [21 U.S.C. 361] describes what causes a cosmetic to be considered adulterated:\n\"A cosmetic shall be deemed to be",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "1] describes what causes a cosmetic to be considered adulterated:\n\"A cosmetic shall be deemed to be adulterated--\nNote that the law addresses--\nSection 602 of the FD&C Act [21 U.S.C. 362] describes what causes a cosmetic to be considered misbranded:\n\"A cosmetic shall be deemed to be misbranded--\nNote that under the FD&C Act, the term \"misbranding\" applies to--\n*Note: According to the FD&C Act, a determination that labeling is \"misleading\" includes considering both what the label says and what it",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "etermination that labeling is \"misleading\" includes considering both what the label says and what it fails to reveal:\n\"If an article is alleged to be misbranded because the labeling or advertising is misleading, then in determining whether the labeling or advertising is misleading there shall be taken into account (among other things) not only representations made or suggested by statement, word, design, device, or any combination thereof, but also the extent to which the labeling or advertising",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "design, device, or any combination thereof, but also the extent to which the labeling or advertising fails to reveal facts material in the light of such representations or material with respect to consequences which may result from the use of the article to which the labeling or advertising relates under the conditions of use prescribed in the labeling or advertising thereof or under such conditions of use as are customary or usual\" (FD&C Act, sec. 201(n); 21 U.S.C. 321(n)].\nIn addition, a cosme",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "ns of use as are customary or usual\" (FD&C Act, sec. 201(n); 21 U.S.C. 321(n)].\nIn addition, a cosmetic marketed in violation of the FPLA or any regulations issued under its authority is considered misbranded within the meaning of the FD&C Act [15 U.S.C.1456(a)]. For cosmetics offered for sale as consumer commodities, the FPLA--\nThe FPLA defines a consumer commodity, as it applies to FDA-regulated products, as:\n\"any food, drug, device, or cosmetic (as those terms are defined by the Federal Food,",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "products, as:\n\"any food, drug, device, or cosmetic (as those terms are defined by the Federal Food, Drug, and Cosmetic Act ..., and any other article, product, or commodity of any kind or class which is customarily produced or distributed for sale through retail sales agencies or instrumentalities for consumption by individuals, or use by individuals for purposes of personal care or in the performance of services ordinarily rendered within the household, and which usually is consumed or expende",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "mance of services ordinarily rendered within the household, and which usually is consumed or expended in the course of such consumption or use.\" [15 U.S.C.1459(a)]\nNote that the FPLA defines a consumer commodity by the way it is marketed, not the way it is labeled. Labeling a product with words such as \"For Professional Use Only\" does not keep your product from being considered a consumer commodity under the FPLA.\nLabeling regulations are very complex. Detailed information on cosmetic labeling i",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "y under the FPLA.\nLabeling regulations are very complex. Detailed information on cosmetic labeling is available in FDA's Cosmetic Labeling Manual and the labeling regulations themselves [21 CFR 701].\nback to top",
    "url": "https://www.fda.gov/cosmetics/laws-regulations/key-legal-concepts-interstate-commerce-adulterated-and-misbranded"
  },
  {
    "text": "Soaps & Lotions Main Page\nVarious products have been promoted in the skin care market as thigh and stomach slimmers. Some advertising claims also promise the reduction of \"cellulite\", waffly looking or orange-peel type skin caused by fatty deposits.\nAminophylline, an approved prescription drug used in the treatment of asthma, is an ingredient used in many of these thigh cream products that marketers claim will dissolve the fat and smooth the skin. Since some individuals suffer from allergic reac",
    "url": "https://www.fda.gov/cosmetics/products/thigh-creams-cellulite-creams"
  },
  {
    "text": "rs claim will dissolve the fat and smooth the skin. Since some individuals suffer from allergic reactions to ethylenediamine, a component of aminophylline, the FDA is concerned about the use of this ingredient in cosmetics.\nConsumers need to be aware of this potential for developing an allergic reaction and carefully read product labels and follow directions. Persons who suffer from asthma may wish to avoid these products so that they don't develop a sensitization (become allergic) to aminophyll",
    "url": "https://www.fda.gov/cosmetics/products/thigh-creams-cellulite-creams"
  },
  {
    "text": "h to avoid these products so that they don't develop a sensitization (become allergic) to aminophylline.\nDrugs, unlike cosmetics, alter the structure or function of the body and are subject to an intensive review and approval process by FDA before their release to the public. Thigh creams may more appropriately be classified as drugs under the Food, Drug, and Cosmetic Act since removal or reduction of cellulite affects the \"structure or function\" of the body.\nFebruary 24, 2000. This information",
    "url": "https://www.fda.gov/cosmetics/products/thigh-creams-cellulite-creams"
  },
  {
    "text": "n of cellulite affects the \"structure or function\" of the body.\nFebruary 24, 2000. This information is current. It is updated only when necessary.",
    "url": "https://www.fda.gov/cosmetics/products/thigh-creams-cellulite-creams"
  },
  {
    "text": "Companies exporting cosmetics from the United States to other countries often have questions about requirements of U.S. government and those of foreign governments. Here are answers to common questions.\nFor information on export certificates for cosmetics, see Cosmetic Export Certificates.\nFor information on importing cosmetics into the United States, see Information for Importers.\nOn this page\nDo exported cosmetics have to comply with the same requirements as cosmetics marketed in the United St",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-exporters"
  },
  {
    "text": "exported cosmetics have to comply with the same requirements as cosmetics marketed in the United States?\nCosmetic requirements in other countries are different from ours, and there may be situations when a product for export does not comply with the requirements of the Federal Food, Drug, & Cosmetic Act (FD&C Act) or Fair Packaging and Labeling Act (FPLA) for cosmetics marketed domestically. A product intended for export will not be considered adulterated or misbranded if it--\nHowever, cosmetic",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-exporters"
  },
  {
    "text": "oduct intended for export will not be considered adulterated or misbranded if it--\nHowever, cosmetic products sold or offered for sale in domestic commerce must comply with all applicable provisions of the FD&C Act, the FPLA, and any other related laws, as well as the regulations established under authority of these laws.\nHow do I learn other countries' requirements?\nIf you are an exporter, it is your responsibility to ensure that your products comply with regulations in the destination country.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-exporters"
  },
  {
    "text": "your responsibility to ensure that your products comply with regulations in the destination country. Significant differences exist among different countries. FDA cannot provide information on regulations in other countries. Embassies may be of assistance, or you may contact regulatory agencies in those countries directly for information.\nIf you are required by the importing country to obtain an export certificate, you may apply for one by filling out our online application.\nHow do I learn about",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-exporters"
  },
  {
    "text": "port certificate, you may apply for one by filling out our online application.\nHow do I learn about requirements other U.S. government agencies may have for exports?\nYou may need to work with other government agencies before exporting your products due to, for example, possible economic and trade sanctions, or hazardous material shipment concerns. Please refer to \"Other Government Agencies You May Need to Know About for a list of other government agencies and related links that may affect your d",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-exporters"
  },
  {
    "text": "Need to Know About for a list of other government agencies and related links that may affect your domestic or export business.\nIf you have questions about U.S. Customs requirements, you need to contact U.S. Customs and Border Protection.\nResources",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-exporters"
  },
  {
    "text": "It is important to use nail products safely, following labeled directions and paying attention to any warning statements. The following information answers common questions about some nail products and ingredients.\nHow Nail Products Are Regulated\nNail products for both home and salon use are regulated by the Food and Drug Administration. Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), these products are generally regulated as cosmetics [FD&C Act, section 201(i)].\nNail products intende",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "hese products are generally regulated as cosmetics [FD&C Act, section 201(i)].\nNail products intended to treat medical problems, such as nail fungus, are drugs. The information on this page is about nail products that are cosmetics. To learn more about the differences between cosmetics and drugs, see “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)\".\nBy law, nail products sold in the United States must be safe for consumers  when used according to directions on the label, or in the usual or",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "ates must be safe for consumers  when used according to directions on the label, or in the usual or customary way (see Key Legal Concepts: Interstate Commerce, Adulteration and Misbranding). Many nail products contain potentially harmful ingredients, but are allowed on the market because they are safe when used as directed. For example, some nail ingredients are harmful when swallowed, but not when used on the nails, because the nail is a barrier, which prevents absorption.\nThe labels of all cos",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "n used on the nails, because the nail is a barrier, which prevents absorption.\nThe labels of all cosmetics, whether marketed to consumers or salons, must include a warning statement whenever necessary or appropriate to prevent a health hazard that may occur with use of the product (21 CFR 740.1).\nCosmetics sold on a retail basis to consumers, such in stores or online, must also bear a list of ingredients, with the names of the ingredients listed in descending order of predominance. The requireme",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "edients, with the names of the ingredients listed in descending order of predominance. The requirement for an ingredient declaration does not apply, for example, to products used only at salons and to free samples. However, the products must have a list of ingredients if they are also sold at retail, even if they are labeled \"For professional use only\" (see Cosmetic Labeling: An Overview).\nUnder the law, cosmetic products and ingredients, including nail products, do not need FDA approval before",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "he law, cosmetic products and ingredients, including nail products, do not need FDA approval before they go on the market, with the exception of most color additives. However, FDA may take action against cosmetics that do not comply with the law, or against firms or individuals who violate the laws we enforce (See FDA Authority Over Cosmetics).\nWhile FDA regulates the nail products intended for use at home and in salons, state and local authorities regulate the operation of nail salons and the l",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "e at home and in salons, state and local authorities regulate the operation of nail salons and the licensing of manicurists and nail technicians. Also, the Occupational Safety and Health Administration (OSHA) has addressed the safety of employees in nail salons. To learn more, see “Health Hazards in Nail Salons,” on OSHA’s website.\nUsing Nail Products Safely\nConsumers should read labels of nail products carefully and follow any warnings. As noted above, some ingredients in nail products may be h",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "oducts carefully and follow any warnings. As noted above, some ingredients in nail products may be harmful if swallowed. Some can easily catch fire if exposed to the flame of the pilot light of a stove, a lit cigarette, or other heat source, such as the heating element of a curling iron. Nail products also can be dangerous if they get in the eyes. Infections and allergic reactions can occur with some nail products. Make sure to have good ventilation when you use nail products. If you have a reac",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "ome nail products. Make sure to have good ventilation when you use nail products. If you have a reaction to a nail product, please report it to FDA.\nSome Common Nail Product Ingredients\nHere is information about some nail product ingredients that people often ask about, or that raise special safety concerns:\nAcetonitrile in Artificial Nail Removers\nArtificial nail removers consist primarily of acetonitrile. Child-resistant packaging is required for all liquid household glue removers containing m",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "tonitrile. Child-resistant packaging is required for all liquid household glue removers containing more than 500 milligrams of acetonitrile in a single container [16 CFR 1700.14 (18)]. The Consumer Product Safety Commission (CPSC) enforces this requirement under the Poison Prevention Packaging Act [15 U.S.C. 1471-1476]. However, the fact that a product is in \"child-resistant\" packaging does not mean that a child could not possibly open it.\nLike any cosmetic product that may be hazardous if misus",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "an that a child could not possibly open it.\nLike any cosmetic product that may be hazardous if misused, it is important for these artificial nail removers to carry an appropriate warning on the label, along with directions for safe use.\nback to top\nFormaldehyde in Nail Hardeners and Nail Polishes\nFormaldehyde is an ingredient in some nail hardeners and nail polishes. It may be listed on the product label as formaldehyde or by different names, such as “formalin” and methylene glycol.” In nail har",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "t label as formaldehyde or by different names, such as “formalin” and methylene glycol.” In nail hardeners, formaldehyde bonds with the keratin that occurs naturally in the nails, making the nails harder. Using these nail hardeners often, however, may make nails brittle and more likely to break or peel. Nail products that contain formaldehyde may also cause skin irritation, as well as allergic reactions to this ingredient.\nOther nail products contain resins that form a strong coating on the nail",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "ctions to this ingredient.\nOther nail products contain resins that form a strong coating on the nails, rather than hardening the nails themselves. For example, toluene sulfonamide/formaldehyde resin (TSFR) is used in some nail polishes to make the coating tough and resilient. TSFR also helps the polish adhere to the nail, adds gloss and helps the product flow well when applied. There is evidence that some people may become allergic to TSFR.\nIf you are allergic to formaldehyde, have previously ex",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "hat some people may become allergic to TSFR.\nIf you are allergic to formaldehyde, have previously experienced an allergic reaction to nail preparations containing formaldehyde, or for any other reason wish to avoid this ingredient, be sure to read the ingredient statement on the label to learn whether the product contains formaldehyde or related ingredients, such as formalin, methylene glycol, or tolunesulfonamide/formaldehyde resin.\nMethacrylate Monomers in Artificial Nails (\"Acrylics\")\nArtific",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "tolunesulfonamide/formaldehyde resin.\nMethacrylate Monomers in Artificial Nails (\"Acrylics\")\nArtificial nails are composed primarily of acrylic polymers and are made by reacting together acrylic monomers, such as ethyl methacrylate monomer, with acrylic polymers, such as polymethylmethacrylate. When the reaction is completed, traces of the monomer are likely to remain in the polymer. For example, traces of methacrylate monomers remain after artificial nails are formed. The polymers themselves ar",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "traces of methacrylate monomers remain after artificial nails are formed. The polymers themselves are typically quite safe, but traces of the reactive monomers could result in an adverse reaction, such as redness, swelling, and pain in the nail bed, among people who have become sensitive (allergic) to methacrylates.\nIn the early 1970s, FDA received a number of complaints of injury associated with the use of artificial nails containing methyl methacrylate monomer. Among these injuries were report",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "the use of artificial nails containing methyl methacrylate monomer. Among these injuries were reports of fingernail damage and deformity, as well as contact dermatitis. Unlike methyl methacrylate monomer, ethyl methacrylate polymers were not associated with these injuries. Based on its investigations of the injuries and discussions with medical experts in the field of dermatology, FDA chose at that time to remove from the market products containing 100 percent methyl methacrylate monomer through",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "t time to remove from the market products containing 100 percent methyl methacrylate monomer through court proceedings, resulting in a preliminary injunction against one firm as well as several seizure actions and voluntary recalls.\nNo regulation specifically prohibits the use of methyl methacrylate monomer in cosmetic products.\nThe Cosmetic Ingredient Review (CIR) Expert PanelExternal Link Disclaimer1\n determined in 2002 that ethyl methacrylate is safe as used when application is accompanied by",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "imer1\n determined in 2002 that ethyl methacrylate is safe as used when application is accompanied by directions to avoid skin contact because of its sensitizing potential, that is, the possibility that a person might become allergic to it.\nMethyl methacrylate monomer is still used occasionally in some artificial nail products, and ethyl methacrylate monomer is used occasionally in acrylic nails. Both are sometimes found in other nail products, such as nail polishes. It is important to avoid cont",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "oth are sometimes found in other nail products, such as nail polishes. It is important to avoid contact with the skin in order to minimize the chance of an allergic reaction.\nMethacrylic Acid in Nail Primers\nDespite the similar names, methacrylic acid is different from methacrylate monomers. It also is used differently and raises different safety concerns. Methacrylic acid (MAA) has been used in nail primers to help acrylic nails adhere to the nail surfaces. Nail primers that contain MAA are mos",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "ail primers to help acrylic nails adhere to the nail surfaces. Nail primers that contain MAA are most commonly distributed through wholesale suppliers to nail salons and retail beauty supply stores, and they usually are labeled \"For Professional Use Only.\" However, some of these retail stores sell to both professionals and consumers.\nBecause of cases of poisoning and injury involving these products, CPSC requires child-resistant packaging for certain household products, including nail primers th",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "s, CPSC requires child-resistant packaging for certain household products, including nail primers that contain MAA. For details on these requirements, see the regulation at 16 CFR 1700. 14 (29).\nPhthalates in Nail Polishes and Other Nail Products\nPhthalates are a group of chemicals used in a wide variety of products, from toys to carpeting and medical tubing. In nail polishes, they are used primarily at concentrations of less than 10% as plasticizers, to reduce cracking by making the nails less",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "ily at concentrations of less than 10% as plasticizers, to reduce cracking by making the nails less brittle.\nDibutyl phthalate (DBP) has been used most commonly in nail polishes and some other products, such as nail hardeners, while dimethyl phthalate (DMP) and diethyl phthalate (DEP) are used occasionally. In FDA’s latest survey of phthalates in cosmetics, conducted in 2010, however, DBP was found in only a few nail polishes, while DEP and DMP were not found in any of the nail products surveyed",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "d in only a few nail polishes, while DEP and DMP were not found in any of the nail products surveyed. For information on health questions related to phthalates in cosmetics and a table of survey results, please see Phthalates.\nToluene in Nail Polishes and Other Nail Products\nToluene is used as a solvent in a variety of nail products, including some nail polishes, nail hardeners, and polish removers; however, its use is being phased-out. The CIR reviewed toluene in 1987, determining that it was s",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "s; however, its use is being phased-out. The CIR reviewed toluene in 1987, determining that it was safe for use in nail products at concentrations up to 50 percent, which is the highest concentration observed in nail products.\nThe CIR reviewed its toluene safety assessment again in 2005, along with new information. At that time, CIR confirmed that many of the new studies reported findings consistent with the data in its earlier safety assessment, in that any reported adverse effects occurred onl",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "nt with the data in its earlier safety assessment, in that any reported adverse effects occurred only at levels many times higher than those observed when people used nail polish, and that the number of nail products containing toluene had dropped sharply.\nReporting Adverse Nail Product Reactions\nIf you are a consumer or a nail technician who has had a bad reaction involving a nail product, please tell your doctor or other healthcare provider, then tell FDA. You can report health problems relate",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "tell your doctor or other healthcare provider, then tell FDA. You can report health problems related to cosmetics products, including nail products, to FDA by using the contact information at How to Report a Cosmetic Product Related Complaint | FDA.\nback to top",
    "url": "https://www.fda.gov/cosmetics/products/nail-care-products"
  },
  {
    "text": "November 8, 2023\nToday, the U.S. Food and Drug Administration (FDA) issued guidance on its intent to delay enforcement of the requirements for cosmetic product facility registration and cosmetic product listing requirements under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) for six months to help ensure that industry has sufficient time to submit such facility registration and product listing information.\nMoCRA provided new authorities to FDA including:\nResponsible person means",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-compliance-policy-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "duct listing information.\nMoCRA provided new authorities to FDA including:\nResponsible person means the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product in accordance with section 609(a) of the FD&C Act or section 4(a) of the Fair Packaging and Labeling Act.\nExemptions:\nMoCRA exempts certain small businesses from facility registration and product listing requirements.\nHowever, such exemptions do not apply to facilities that manuf",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-compliance-policy-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "ion and product listing requirements.\nHowever, such exemptions do not apply to facilities that manufacture or process, or responsible persons for, the following cosmetic products:\nExemptions also exist for certain products and facilities that are subject to requirements for drugs and devices.\nIn March 2023, FDA issued a Constituent Update FDA Has Stopped Accepting Submissions to the Voluntary Cosmetic Registration Program (VCRP) as a result of the facility registration and product listing author",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-compliance-policy-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "etic Registration Program (VCRP) as a result of the facility registration and product listing authorities mandated by MoCRA.\nIn August 2023, FDA issued draft guidance on cosmetic product facility registrations and product listings, as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The draft guidance, when finalized, will provide recommendations and instructions to assist persons submitting cosmetic product facility registrations and product listings to FDA.\nIn Septemb",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-compliance-policy-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "t persons submitting cosmetic product facility registrations and product listings to FDA.\nIn September 2023, FDA announced an opportunity to comment on its newly developed draft electronic submission portal (Cosmetics Direct) and paper forms (Forms FDA 5066 and 5067). FDA strongly encourages electronic submissions to facilitate efficiency and timeliness of data submission and management for the agency. FDA anticipates that electronic submission, technical assistance documents, and paper submissi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-compliance-policy-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "ency. FDA anticipates that electronic submission, technical assistance documents, and paper submission forms will be available in early December 2023.\nFDA does not intend to enforce the requirements related to cosmetic product facility registration and cosmetic product listing for an additional six months after the December 29, 2023, statutory deadline, or until July 1, 2024, to provide regulated industry additional time to comply with these requirements.\nIn addition, FDA does not intend to enfo",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-compliance-policy-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "industry additional time to comply with these requirements.\nIn addition, FDA does not intend to enforce the registration requirement for owners or operators of facilities that first engaged in manufacturing or processing a cosmetic product after December 29, 2022, or the listing requirement for cosmetic products first marketed after December 29, 2022, until July 1, 2024.\n\nSUBSCRIBE",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-compliance-policy-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "This section contains information on selected cosmetics products, ingredients, and potential contaminants.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products-ingredients"
  },
  {
    "text": "November 1, 2023\nToday, the U.S. Food and Drug Administration (FDA) is providing an update on ongoing activities related to the new cosmetic product facility registration and cosmetic product listing mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).\nIn August 2023, FDA issued draft guidance on cosmetic product facility registrations and product listings. FDA received more than 40 comments on the draft guidance and is in the process of evaluating the comments. The draft g",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-update-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "than 40 comments on the draft guidance and is in the process of evaluating the comments. The draft guidance, when finalized, will provide recommendations and instructions to assist persons submitting cosmetic product facility registrations and product listings to FDA. FDA intends to finalize the guidance as quickly as possible.\nIn September 2023, FDA announced an opportunity to comment on its newly developed draft electronic submission portal (Cosmetics Direct) and paper forms (Forms FDA 5066 an",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-update-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "y developed draft electronic submission portal (Cosmetics Direct) and paper forms (Forms FDA 5066 and 5067). FDA must obtain review and approval by the Office of Management and Budget (OMB) in the Executive Office of the President, under the Paperwork Reduction Act for the proposed collection of registration and listing information. The comment period recently closed and we are in the process of obtaining approval from OMB.\nIn October 2023, FDA announced publication of the Structured Product Lab",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-update-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "btaining approval from OMB.\nIn October 2023, FDA announced publication of the Structured Product Labeling (SPL) Implementation Guide with Validation Procedures. The Implementation Guide can be used to develop SPL authoring tools. In the future, once FDA begins accepting data, users may transmit SPL-formatted submissions through FDA’s Electronic Submissions Gateway (ESG), or SPL authoring software including Xforms, for cosmetic product facility registrations and product listings.\nFDA will provide",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-update-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "including Xforms, for cosmetic product facility registrations and product listings.\nFDA will provide more information on the launch date for electronic submission and paper submission forms in the coming weeks.\nFDA strongly encourages electronic submissions to facilitate efficiency and timeliness of data submission and management for the agency.\nIndustry can continue to prepare for registration and listing by reviewing the documents FDA has provided and being proactive in collecting the informat",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-update-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "d listing by reviewing the documents FDA has provided and being proactive in collecting the information required to complete their facility registrations and product listings.\nFor More Information:\nSubscribe to Constituent Updates",
    "url": "https://www.fda.gov/cosmetics/cosmetics-news-events/fda-issues-update-cosmetic-product-facility-registration-and-cosmetic-product-listing"
  },
  {
    "text": "The law does not require cosmetic labeling to have FDA approval before cosmetic products go on the market, and FDA does not have a list of approved or accepted claims for cosmetics. However, there are limits that apply to cosmetic labeling claims.\nUnder the law, information on cosmetic labeling, including claims, must be truthful and not misleading. In addition, if a product is marketed with claims for purposes such as treating or preventing disease, or affecting the structure or function of the",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-claims"
  },
  {
    "text": "s for purposes such as treating or preventing disease, or affecting the structure or function of the body—including the skin—it’s a drug according to the law, and it must meet the requirements for drugs, even if it affects the appearance.\nBecause FDA does not have the authority to approve claims before cosmetics go on the market, you may see cosmetics with claims that go beyond what the law permits. FDA monitors cosmetics on the market, and we can take action against companies that break the law",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-claims"
  },
  {
    "text": "s. FDA monitors cosmetics on the market, and we can take action against companies that break the laws we enforce. For example, FDA has issued warning letters to cosmetic firms that have made unapproved drug claims for products marketed as cosmetics.\nIn addition, while FDA regulates cosmetic labeling claims, the Federal Trade Commission regulates advertising claims.\nThe following resources answer some common questions about claims and cosmetic labeling:",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-claims"
  },
  {
    "text": "ome common questions about claims and cosmetic labeling:",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-claims"
  },
  {
    "text": "English\nفي حالة التعرض لأي رد فعل أو مشكلة فيما يتعلق بأي منتج تجميلي، تكون الخطوة الأولى حينئذ هي التوقف عن استخدام المنتج والاتصال بمقدم الرعاية الصحية الخاص بك. لا تقدم إدارة الغذاء والدواء (FDA، نحن) المشورة الطبية. وتكون الخطوة الثانية هي الإبلاغ عن المشكلة إلى إدارة الغذاء والدواء.\nالإبلاغ عن شكوى متعلقة بمنتج تجميلي\nأبلِغ إدارة الغذاء والدواء إذا عانيت من\nأي رد فعل بعد استخدام منتج تجميلي، مثل الطفح الجلدي، أو الاحمرار، أو الحروق، أو تساقط الشعر، أو الصداع، أو العدوى، أو المرض، أو أي رد ف",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "مثل الطفح الجلدي، أو الاحمرار، أو الحروق، أو تساقط الشعر، أو الصداع، أو العدوى، أو المرض، أو أي رد فعل آخر غير متوقع، سواء كان يتطلب علاجًا طبيًا أم لا.\nأي مشكلة تتعلق بمنتج تجميلي، مثل رائحة كريهة، أو تغير اللون، أو وجود مادة غريبة في المنتج، أو علامات أخرى للتلوث.\nأنواع المنتجات التي تعتبر منتجات تجميلية\nالمنتجات التجميلية ليست مثل المنتجات الدوائية، ويتم تنظيمها بشكلٍ مختلف من قِبل إدارة الغذاء والدواء. ترد فيما يلي بعض الأمثلة على المنتجات التجميلية:\nحبر الوشم والمكياج الدائم؛\nمنظفات الوجه و",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "والدواء. ترد فيما يلي بعض الأمثلة على المنتجات التجميلية:\nحبر الوشم والمكياج الدائم؛\nمنظفات الوجه والجسم والمرطبات ومستحضرات وكريمات البشرة الأخرى؛ و\nالماسكارا، وأحمر الشفاه، ومستحضرات التجميل الأخرى؛\nمزيلات العرق؛ و\nالمستحضرات والزيوت الخاصة بالأطفال؛\nمنتجات العناية بالشعر، الصبغات، البلسم، مستحضرات فرد الشعر/تنعيمه، مستحضرات تجعيد الشعر بشكل دائم؛ و\nكريمات ازالة الشعر؛\nطلاء الأظافر؛\nمنتجات الحلاقة؛\nالعطور والكولونيا؛\nدهانات الوجه ومواد الوشم المؤقت.\nكيف يمكن للمستهلكين والعاملين في مجال الصحة",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "اقة؛\nالعطور والكولونيا؛\nدهانات الوجه ومواد الوشم المؤقت.\nكيف يمكن للمستهلكين والعاملين في مجال الصحة الإبلاغ عن مشكلة تتعلق بمنتجات التجميل إلى إدارة الغذاء والدواء\nإذا كنت مستهلكًا أو أحد العاملين في مجال الصحة وترغب في الإبلاغ عن شكوى أو حدث سلبي (مثل مرض أو رد فعل تحسسي أو طفح جلدي أو تهيج أو ندبة أو تساقط الشعر) مرتبط بمنتج تجميلي، فيمكنك:\nملء وإرسال  نموذج الإبلاغ الطوعي عبر الإنترنت MedWatch  إلكترونيًا . تشجع إدارة الغذاء والدواء بشدة على تقديم الطلبات إلكترونيًا لتحقيق الكفاءة وتوفير الو",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "إلكترونيًا . تشجع إدارة الغذاء والدواء بشدة على تقديم الطلبات إلكترونيًا لتحقيق الكفاءة وتوفير الوقت في عملية تقديم البيانات وإدارتها.\nملء نموذج الإبلاغ الطوعي من قِبل المستهلكين MedWatch على ورق  وإرساله بالبريد أو الفاكس إلى إدارة الغذاء والدواء على العنوان:\nMedWatchFood and Drug Administration5600 Fishers LaneRockville, MD 20852الفاكس: 0178-332-800 (رقم مجاني).\nاتصل بمركز معلومات الأغذية ومستحضرات التجميل التابع لإدارة الغذاء والدواء (FCIC) على الرقم 1-888-SAFEFOOD (1-888-723-3366).\nكيف يقو",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "حضرات التجميل التابع لإدارة الغذاء والدواء (FCIC) على الرقم 1-888-SAFEFOOD (1-888-723-3366).\nكيف يقوم قطاع صناعة مستحضرات التجميل بالإبلاغ عن الأحداث السلبية الخطيرة\nتم سن قانون تحديث تنظيم مستحضرات التجميل لعام 2022  (MoCRA) في 29 ديسمبر 2022 . يقوم قانون MoCRA بتعديل الفصل السادس من قانون الغذاء والدواء ومستحضرات التجميل الفيدرالي وينص على أكبر توسع لسلطة إدارة الغذاء والدواء في تنظيم مستحضرات التجميل منذ عام 1938.\nيتطلب قانون MoCRA من الشخص المسؤول (انظر التعريف أدناه) الإبلاغ عن الأحداث السل",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "لتجميل منذ عام 1938.\nيتطلب قانون MoCRA من الشخص المسؤول (انظر التعريف أدناه) الإبلاغ عن الأحداث السلبية الخطيرة (انظر التعريف أدناه) المرتبطة باستخدام منتجات التجميل في الولايات المتحدة إلى إدارة الغذاء والدواء، في غضون 15 يوم عمل. يجب على الشخص المسؤول تضمين نسخة من ملصق المعلومات على أو داخل عبوة البيع بالتجزئة الخاصة بهذا المنتج التجميلي. إذا تلقى الشخص المسؤول معلومات طبية أو معلومات أخرى حول الحدث السلبي في غضون عام واحد من الإبلاغ الأولي إلى إدارة الغذاء والدواء، فيجب عليه تقديم هذه المعلو",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "الحدث السلبي في غضون عام واحد من الإبلاغ الأولي إلى إدارة الغذاء والدواء، فيجب عليه تقديم هذه المعلومات الجديدة إلى إدارة الغذاء والدواء في غضون 15 يوم عمل. ستتمكن إدارة الغذاء والدواء أيضًا من الوصول إلى بلاغات الأحداث السلبية أثناء عمليات التفتيش.\nيكون إلزاميًا على الأشخاص المسؤولين عن الصناعة تقديم بلاغات الأحداث السلبية الخطيرة (SAER) بشأن منتجات التجميل باستخدام نموذج FDA 3500A الحالي - الإبلاغ الإلزامي والقابل للتنزيل والملء في  MedWatch:   برنامج إدارة الغذاء والدواء لمعلومات السلامة والإ",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "اغ الإلزامي والقابل للتنزيل والملء في  MedWatch:   برنامج إدارة الغذاء والدواء لمعلومات السلامة والإبلاغ عن الأحداث السلبية - إلزامي (ملف PDF)  .\nيُرجى الاطلاع على  تعليمات ملء نموذج FDA 3500A  .\nقدِّم:\nالنموذج 3500A المكتمل\nوملف PDF مجمع كمرفق واحد يتضمن جميع المعلومات ذات الصلة لدعم بلاغ الحدث السلبي، مثل النسخ الممسوحة ضوئيًا لملصقات المعلومات وصور الحدث السلبي\nإلى إدارة الغذاء والدواء عبر البريد الإلكتروني على:  CosmeticAERS@fda.hhs.gov  أو عن طريق البريد إلى:\nFDA CDER Mail CenterAttn: Cosme",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "يد الإلكتروني على:  CosmeticAERS@fda.hhs.gov  أو عن طريق البريد إلى:\nFDA CDER Mail CenterAttn: Cosmetics MedWatch reportsWhite Oak Campus, Building 22, G020710903 New Hampshire Ave.Silver Spring, MD 20993\nتعمل إدارة الغذاء والدواء على تطوير عملية لتقديم البلاغات الإلزامية الخاصة بالأحداث السلبية لمنتجات التجميل إلكترونيًا.\nعلى الرغم من أن قانون MoCRA لا يُلزم الأشخاص المسؤولين في قطاع صناعة مستحضرات التجميل بتقديم بلاغات الأحداث السلبية غير الخطيرة لمنتجات التجميل إلى إدارة الغذاء والدواء، يمكنك",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "ات التجميل بتقديم بلاغات الأحداث السلبية غير الخطيرة لمنتجات التجميل إلى إدارة الغذاء والدواء، يمكنك تقديم بلاغات الأحداث السلبية غير الخطيرة طواعية باستخدام النموذج 3500A، وذلك باتباع نفس العملية الموضحة أعلاه بخصوص بلاغات الأحداث السلبية الإلزامية.\nالمصطلحات الرئيسية\nحدث سلبي خطير : حدث سلبي:\n(أ) يؤدي إلى:\nالوفاة؛\nأو تجربة مُهددة للحياة؛\nأو تلقي الرعاية كمريض داخلي بالمستشفى؛\nأو إعاقة أو عجز مستمر أو كبير؛\nأو شذوذ خِلقي أو عيب خِلقي؛\nأو عدوى؛\nأو تشوه كبير (بما في ذلك الطفح الجلدي الخطير والمست",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "مر أو كبير؛\nأو شذوذ خِلقي أو عيب خِلقي؛\nأو عدوى؛\nأو تشوه كبير (بما في ذلك الطفح الجلدي الخطير والمستمر، أو الحروق من الدرجة الثانية أو الثالثة، أو تساقط الشعر بشكل كبير، أو التغير المستمر أو الكبير في المظهر)، بخلاف ما هو مقصود في ظل ظروف الاستخدام المعتادة أو المعروفة؛ أو\n(ب) يتطلُّب، بناءً على حكم طبي معقول، تدخلاً طبيًا أو جراحيًا لمنع النتيجة الموضحة في العنصر (أ) أعلاه.\nالشخص المسؤول : الشركة المصنعة أو الجهة المسؤولة عن التعبئة أو الموزع لمنتج تجميلي يظهر اسمه على ملصق معلومات المنتج التجم",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "المصنعة أو الجهة المسؤولة عن التعبئة أو الموزع لمنتج تجميلي يظهر اسمه على ملصق معلومات المنتج التجميلي وفقًا للقسم 609(أ) من قانون الأغذية والأدوية ومستحضرات التجميل أو القسم 4 (أ) من قانون إنصاف التعبئة والتغليف و ملصقات المعلومات.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-compliance-enforcement/kyfyt-alablagh-n-shkwy-ttlq-bmntj-tjmyly"
  },
  {
    "text": "Available in:\nFDA often receives questions from cosmetics firms about requirements for importing cosmetics into the United States. Here are some commonly asked questions and our responses.\nTo learn about exporting cosmetics from the United States to other countries, see Information for Exporters: FAQs.\nHow does FDA monitor imports?\nFDA works closely with U.S. Customs and Border Protection (CBP) to monitor imports. Imported cosmetics are subject to examination by CBP at the time of entry. Foreign",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "monitor imports. Imported cosmetics are subject to examination by CBP at the time of entry. Foreign cosmetics that appear to be adulterated or misbranded may be refused entry into the United States. They must be brought into compliance, destroyed, or re-exported. Import refusals are listed on FDA’s website and are updated monthly.\nCan FDA answer my questions about U.S. Customs requirements?\nNo. You will need to contact U.S. Customs and Border Protection (CBP)directly to learn what Customs requi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "ou will need to contact U.S. Customs and Border Protection (CBP)directly to learn what Customs requirements apply to your imports. Useful resources on the CBP website include, for example, \"Importing into the United States: A Guide for Commercial Importers.\"\nback to top\nAre all imported cosmetics sampled and examined?\nNot all cosmetics are inspected or sampled upon entry into this country. In order to focus inspection efforts most efficiently, FDA issues Import Alerts to advise inspectors of tre",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "r to focus inspection efforts most efficiently, FDA issues Import Alerts to advise inspectors of trends in violations. Among the products addressed in Import Alerts are cosmetic-type products marketed with therapeutic claims that cause them to be considered unapproved new drugs under the law, cosmetics that are adulterated because of microbial contamination, failure to meet U.S. requirements for color additives, and bulk shipments of high-risk bovine tissue from BSE (bovine spongiform encephalop",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "olor additives, and bulk shipments of high-risk bovine tissue from BSE (bovine spongiform encephalopathy) countries. For a complete list, see Import Alerts for Industry: Cosmetics.\nHowever, examination of imported cosmetics is not limited to the types of products specified in Import Alerts. Also, the fact that a product has not been detained previously does not protect it from being detained in the future, if it appears to be in violation of U.S. law.\nWhile not all imported products are examined",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "e future, if it appears to be in violation of U.S. law.\nWhile not all imported products are examined at the time of entry, those not examined are still subject to all the legal requirements of the laws we enforce.\nDo imported and domestically produced cosmetics need to meet the same requirements?\nImported cosmetics must comply with the same laws and regulations that apply to those produced domestically. Cosmetic products and ingredients are not subject to premarket approval by FDA, with the exce",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "cally. Cosmetic products and ingredients are not subject to premarket approval by FDA, with the exception of color additives. However, they must be safe for consumers under labeled or customary conditions of use, and they must be properly labeled. Color additives must be approved for the intended use; some must be from batches certified by FDA. Firms and individuals who manufacture or market cosmetics are responsible for ensuring that their products are in compliance with U.S. law. To learn more",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "tics are responsible for ensuring that their products are in compliance with U.S. law. To learn more, see:\nand the related resources listed on those pages.\nback to top\nIs it necessary to receive FDA approval before importing cosmetics?\nCosmetic products and ingredients, other than color additives, do not need FDA approval before they go on the market. However, they must not be adulterated or misbranded. This means that they must be safe for consumers under labeled or customary conditions of use,",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "anded. This means that they must be safe for consumers under labeled or customary conditions of use, and they must be properly labeled. With the exception of color additives and those ingredients that are prohibited or restricted by FDA regulations, a cosmetic firm may use any ingredient, as long as it does not cause the product to be adulterated in any way. Companies and individuals who manufacture or market cosmetics have a legal responsibility for the safety and labeling of their products.\nRe",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "re or market cosmetics have a legal responsibility for the safety and labeling of their products.\nRemember, however, that some “personal care products” are drugs, or both cosmetics and drugs, under U.S. law. If your product is a drug under U.S. law, it is subject to the requirements for drugs, such as premarket approval. To learn more, see “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?).”\nDo I need to register with FDA in order to import cosmetics?\nNo. Firms importing products considered to",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "I need to register with FDA in order to import cosmetics?\nNo. Firms importing products considered to be solely cosmetics in the United States are not required to register with FDA, and a registration number is not required for importing cosmetics into this country. FDA encourages both domestic and foreign cosmetic firms to register their establishments and file Cosmetic Product Ingredient Statements with our Voluntary Cosmetic Registration Program (VCRP), but as its name indicates, participation",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "ts with our Voluntary Cosmetic Registration Program (VCRP), but as its name indicates, participation in this program is voluntary, not mandatory. Please note that the VCRP can only accept Cosmetic Product Ingredient Statements for cosmetics that are already on the market in the United States (21 CFR 720.2).\nIf your products are drugs, or both cosmetics and drugs, under U.S. law, however, they are subject to requirements for drug registration. Similarly, importers of cosmetic ingredients that are",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "subject to requirements for drug registration. Similarly, importers of cosmetic ingredients that are also classified as food products are required to meet the registration requirements of the Bioterrorism Act of 2002External Link Disclaimer.\nWhat are the international differences in the definitions of cosmetics and drugs?\nMany countries define drugs and cosmetics differently from the United States. For example, in some countries, sunscreens are regulated as cosmetics. In the United States, they",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": ". For example, in some countries, sunscreens are regulated as cosmetics. In the United States, they are regulated as drugs. Hair restoration, skin protectant, pain relief, anti-aging effects that involve the structure or function of the skin, and treatment of acne, dandruff, eczema, or irritated skin are other examples of claims that would cause products to be regulated as drugs (or in some cases, both cosmetics and drugs) in the United States. Cosmetics and drugs are subject to different requir",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "both cosmetics and drugs) in the United States. Cosmetics and drugs are subject to different requirements. To learn more about the differences between cosmetics and drugs under U.S. law, see “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)” and the additional resources listed on that page.\nDrugs are regulated by FDA’s Center for Drug Evaluation and Research (CDER). Please direct questions about drugs to CDER at CDERSmallBusiness@fda.hhs.gov or druginfo@fda.hhs.gov.\nWhat are some of the reas",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "ut drugs to CDER at CDERSmallBusiness@fda.hhs.gov or druginfo@fda.hhs.gov.\nWhat are some of the reasons cosmetics offered for import are refused entry into the United States?\nA cosmetic may be refused entry into the United States if it appears not to comply with applicable U.S. laws and regulations in any way. The following are just some of the most common reasons:\nRemember, these are just some common violations. Any violation of applicable U.S. laws and related regulations may result in a cosme",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "mmon violations. Any violation of applicable U.S. laws and related regulations may result in a cosmetic being detained.\nWhat ingredients are prohibited or restricted?\nIf you are an importer, it is essential for you to verify that the products you import comply with regulations that prohibit or restrict the use of certain ingredients. The country of origin may not have the same ingredient prohibitions and restrictions as the United States. But remember, any ingredient is prohibited if it causes t",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "ons and restrictions as the United States. But remember, any ingredient is prohibited if it causes the finished cosmetic product to be unsafe for consumers under labeled or customary conditions for use, even if there is no regulation specifically prohibiting or restricting its use in cosmetics. To learn more, see “Ingredients Prohibited or Restricted by FDA Regulations.”\nAre “natural” or “organic” cosmetics required to receive certification?\nFDA does not define or regulate terms such as “organic",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "cosmetics required to receive certification?\nFDA does not define or regulate terms such as “organic” and “natural.” However, the U.S. Department of Agriculture (USDA) does regulate the use of the term “organic” when used in terms of agricultural ingredient marketing. Questions about the use of organic agricultural ingredients should be directed to USDA. There are also private organizations that certify “natural” and other claims; however, these organizations are in no way affiliated with FDA.\nA",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "ertify “natural” and other claims; however, these organizations are in no way affiliated with FDA.\nAlso, remember that all cosmetics are required to be safe, regardless of the sources of their ingredients. An ingredient’s source does not determine its safety. To learn more, see “'Organic’ Cosmetics.”\nWhat are the labeling requirements for cosmetics?\nTo learn about cosmetic labeling, see “Labeling” and the additional resources listed on that page, such as the “Cosmetic Labeling Guide.” The follow",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "and the additional resources listed on that page, such as the “Cosmetic Labeling Guide.” The following are some of the more common labeling concerns affecting importers:\nResources\nback to top",
    "url": "https://www.fda.gov/cosmetics/cosmetics-international-activities/cosmetics-importers"
  },
  {
    "text": "Consumers and manufacturers sometimes have questions about the term \"cosmeceutical.\"\nThe term \"cosmeceutical\" has no meaning under the law. While the Federal Food, Drug, and Cosmetic Act (FD&C Act) does not recognize the term \"cosmeceutical,\" the cosmetic industry uses this word to refer to cosmetic products that have medicinal or drug-like benefits.\nA product can be a drug, a cosmetic or both. The FD&C Act defines drugs as those products that cure, treat, mitigate or prevent disease or that aff",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/cosmeceutical"
  },
  {
    "text": "e FD&C Act defines drugs as those products that cure, treat, mitigate or prevent disease or that affect the structure or function of the human body, if a product makes such claims it will be regulated as a drug. Cosmetics are intended to beautify, promote attractiveness, alter appearance or cleanse; they are not approved by FDA for sale nor are they intended to effect structure or function of the body.\nMore resources:\nJuly 6, 2017. This document is current and is updated only when necessary.",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/cosmeceutical"
  },
  {
    "text": "body.\nMore resources:\nJuly 6, 2017. This document is current and is updated only when necessary.",
    "url": "https://www.fda.gov/cosmetics/labeling-claims/cosmeceutical"
  },
  {
    "text": "On average people use 6 to 12 cosmetics products daily. Examples of some of these products include makeup, nail polishes, shaving cream and other grooming products, perfumes, face and body cleansers, haircare products, moisturizers, and other skincare products.\nThe Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is the most significant expansion of FDA’s authority to regulate cosmetics since the Federal Food, Drug, and Cosmetic (FD&C) Act was passed in 1938. This new law will help en",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "since the Federal Food, Drug, and Cosmetic (FD&C) Act was passed in 1938. This new law will help ensure the safety of cosmetic products many consumers use daily.\n\n\nAdverse Event: any health-related event associated with the use of a cosmetic product that is adverse\nFacility: any establishment (including an establishment of an importer) that manufactures or processes cosmetic products distributed in the United States\nResponsible Person: the manufacturer, packer, or distributor of a cosmetic prod",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "in the United States\nResponsible Person: the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product in accordance with section 609(a) of the FD&C Act or section 4(a) of the Fair Packaging and Labeling Act\nSerious Adverse Event: an adverse event that\nMoCRA provides new authorities to FDA including:\nRecords Access: If certain conditions are met, FDA can access and copy certain records related to a cosmetic product, including safety recor",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "e met, FDA can access and copy certain records related to a cosmetic product, including safety records.\nMandatory Recall Authority: If the agency determines that there is a reasonable probability that a cosmetic is adulterated or misbranded and the use of or exposure to the cosmetic will cause serious adverse health consequences or death, FDA has the authority to order a mandatory recall if the responsible person refuses to do so voluntarily.\nMoCRA establishes the following new requirements for",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "sponsible person refuses to do so voluntarily.\nMoCRA establishes the following new requirements for industry:\nAdverse Event Reporting: A responsible person is required to report serious adverse events associated with the use of cosmetic products in the United States to FDA within 15 business days. The responsible person must include a copy of the label on or within the retail packaging of such cosmetic product. If the responsible person receives medical or other information about the adverse eve",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "metic product. If the responsible person receives medical or other information about the adverse event within 1 year of the initial report to FDA, they must submit this new information to FDA within 15 business days. FDA will also have access to adverse event reports during an inspection.\nIt is mandatory for industry responsible persons to submit serious adverse event reports (SAER) for cosmetics by using the current Form FDA 3500A – Mandatory Reporting that is downloadable and fillable at MedWa",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "by using the current Form FDA 3500A – Mandatory Reporting that is downloadable and fillable at MedWatch: The FDA Safety Information and Adverse Event Reporting Program - Mandatory (PDF).\nPlease see the Instructions for Completing Form FDA 3500A. To learn more, see “How Industry Reports Serious Adverse Events” at How to Report a Cosmetic Product Related Complaint | FDA.\nFor more information about adverse events submitted to FDA, see FDA's Adverse Event Reporting System (FAERS) | FDA.\nFacility Reg",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "dverse events submitted to FDA, see FDA's Adverse Event Reporting System (FAERS) | FDA.\nFacility Registration: Manufacturers and processors must register their facilities with FDA and renew their registration every two years.\nProduct Listing: A responsible person must list each marketed cosmetic product with FDA, including product ingredients, and provide any updates annually.\n\nFor additional information, see Registration & Listing of Cosmetic Product Facilities and Products.\n\nSafety Substantiat",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "rmation, see Registration & Listing of Cosmetic Product Facilities and Products.\n\nSafety Substantiation: Companies and individuals who manufacture or market cosmetics have a responsibility to ensure the safety of their products. Neither the law nor FDA regulations require specific tests to demonstrate the safety of individual products or ingredients.\nMoCRA authorizes FDA to establish regulations for:\nMoCRA requires FDA to publish a report summarizing:\n\n\nMoCRA exempts certain small businesses fro",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "or:\nMoCRA requires FDA to publish a report summarizing:\n\n\nMoCRA exempts certain small businesses from GMP, registration, and product listing requirements.\nHowever, such exemptions do not apply to manufacturers or facilities that manufacture or process the following cosmetic products:\nExemptions also exist for certain products and facilities that are subject to requirements for drugs and devices.\n\n\nFDA hosted a webinar titled Modernization of Cosmetics Regulation Act of 2022 – Key Terms and Provi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "FDA hosted a webinar titled Modernization of Cosmetics Regulation Act of 2022 – Key Terms and ProvisionsExternal Link Disclaimer in April 2023. This stakeholder webinar provides an overview of the Modernization of Cosmetics Regulation Act of 2022.\nInquiries about MoCRA can be directed to QuestionsAboutMoCRA@fda.hhs.gov.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra"
  },
  {
    "text": "What ingredients are prohibited or restricted from use in cosmetics? You can find the information on what the law and FDA regulations say about cosmetic ingredients and safety below.\nAre harmful ingredients allowed in cosmetics?\nIt’s against the law for a cosmetic to contain any ingredient that makes the product harmful when consumers use it according to directions on the label, or in the customary or expected way. This is true whether or not there is a regulation that specifically prohibits or",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "y or expected way. This is true whether or not there is a regulation that specifically prohibits or restricts the use of the ingredient in cosmetics.\nThe one exception is for coal-tar hair dyes, which the law treats differently. Under the law, FDA cannot take action against a coal-tar hair dye for safety reasons as long as it has a special warning statement on the label and directions for a skin test. The caution statement reads as follows:\nCaution - This product contains ingredients which may c",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "est. The caution statement reads as follows:\nCaution - This product contains ingredients which may cause skin irritation on certain individuals and a preliminary test according to accompanying directions should first be made. This product must not be used for dyeing the eyelashes or eyebrows; to do may cause blindness.\nIt’s also important to understand that some cosmetics that are safe when people use them correctly may be unsafe when used the wrong way. Cosmetics must have any directions for us",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "use them correctly may be unsafe when used the wrong way. Cosmetics must have any directions for use or warning statements needed to make sure people use the products safely. For example, some ingredients may be safe in products such as cleansers that we wash off the skin immediately, but not in products that we leave on the skin for hours. Similarly, ingredients that are safe for use on the hair or nails may be unsafe when used on the skin or near the eyes.\nUnder U.S. law, cosmetic products an",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "or nails may be unsafe when used on the skin or near the eyes.\nUnder U.S. law, cosmetic products and ingredients, other than color additives, do not need FDA approval before they go on the market. Cosmetic manufacturers have a legal responsibility for the safety and labeling of their products.  FDA can and does take action against cosmetics on the market that do not comply with the law.\nWhat ingredients are prohibited or restricted by FDA regulations?\nAlthough it’s against the law to use any in",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "edients are prohibited or restricted by FDA regulations?\nAlthough it’s against the law to use any ingredient that makes a cosmetic harmful when used as intended, FDA has regulations that specifically prohibit or restrict the use of the following ingredients in cosmetics:\nWhat about color additives?\nWhat about drug ingredients?\nIf a product is intended for a therapeutic purpose, such as treating or preventing disease, it’s a drug under the law and must meet those requirements, such as premarket a",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "preventing disease, it’s a drug under the law and must meet those requirements, such as premarket approval by FDA, even if it affects the appearance. The presence of certain ingredients with a therapeutic use that is well-known to the public and industry is one factor that can determine whether a product is intended for use as a drug. FDA makes these decisions on a case-by-case basis. To learn more, see “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?).”\nWhy are different ingredients prohibi",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "re, see “Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?).”\nWhy are different ingredients prohibited in some other countries?\nDifferent countries and regions regulate cosmetics under different legal frameworks.\nUnder U.S. law, FDA does not have the authority to require cosmetic manufacturers to submit their safety data to FDA, and the burden is on FDA to prove that a particular product or ingredient is harmful when used as intended. We make these decisions based on reliable scientific informa",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "dient is harmful when used as intended. We make these decisions based on reliable scientific information available to us. FDA can take other countries’ decisions into consideration, but we can only take action within the legal and regulatory framework for cosmetics in the United States.\nMore Resources\n* \"Specified risk material\" means the brain, skull, eyes, trigeminal ganglia, spinal cord, vertebral column (excluding the vertebrae of the tail, the transverse processes of the thoracic and lumbar",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "ral column (excluding the vertebrae of the tail, the transverse processes of the thoracic and lumbar vertebrae, and the wings of the sacrum), and dorsal root ganglia of cattle 30 months and older and the tonsils and distal ileum of the small intestine of all cattle.\n** Tallow must be produced from tissues that are not prohibited cattle materials or must contain not more than 0.15 percent insoluble impurities as determined by the method entitled \"Insoluble Impurities\" (AOCS Official Method Ca 3a-",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "impurities as determined by the method entitled \"Insoluble Impurities\" (AOCS Official Method Ca 3a-46), American Oil Chemists' Society (AOCS), 5th Edition, 1997, incorporated by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part 51, or another method equivalent in accuracy, precision, and sensitivity to AOCS Official Method Ca 3a-46. You may obtain copies of the method from AOCSExternal Link Disclaimer, 2211 W. Bradley Ave. Champaign, IL 61821",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "Link Disclaimer, 2211 W. Bradley Ave. Champaign, IL 61821",
    "url": "https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics"
  },
  {
    "text": "The U.S. Food and Drug Administration (FDA) has amended the color additive regulations to no longer provide for the use of lead acetate in cosmetics intended for coloring hair on the scalp. This amendment was based on FDA’s determination that the available information no longer demonstrates a “reasonable certainty of no harm” – the safety standard for a color additive used in cosmetics – rather than on a determination that lead acetate in cosmetics intended for coloring the hair on the scalp has",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "an on a determination that lead acetate in cosmetics intended for coloring the hair on the scalp has been shown to cause harm under the conditions of use set forth in 21 CFR 73.2396.\nOn October 30, 2018, the FDA published a final rule to amend the color additive regulations to no longer provide for the use of lead acetate in cosmetics intended for coloring hair on the scalp. On April 1, 2019, the final rule was stayed because the agency received objections to its decision and a public hearing wa",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "final rule was stayed because the agency received objections to its decision and a public hearing was requested within the allowable timeframe. The agency has reviewed the objections and has determined that they did not raise issues of material fact that justify a hearing. Therefore, on January 6, 2022, the final rule was made effective. We intend to exercise enforcement discretion for 12 months following the effective date to provide industry with the opportunity to deplete their current stock",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "ollowing the effective date to provide industry with the opportunity to deplete their current stock and reformulate their hair dye products containing lead acetate.\nFor more information, please see the Constituent Update.\nThe FDA often receives questions about the safety and regulation of hair dyes. Most of these products belong to a category called “coal-tar” hair dyes.\nColor additives, with the exception of coal-tar hair dyes, need FDA approval before they’re permitted for use in cosmetics.\nTh",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "exception of coal-tar hair dyes, need FDA approval before they’re permitted for use in cosmetics.\nThe FDA’s ability to take action against coal-tar hair dyes associated with safety concerns is limited by law. It’s important to follow the directions on the label. It is also important to be an informed consumer and understand the risks.\nLearn more here:\nThe term “coal-tar colors” dates back to the time when these coloring materials were by-products of the coal industry. Today, most are made from p",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "ime when these coloring materials were by-products of the coal industry. Today, most are made from petroleum, but the original name is still used. Coal-tar hair dyes--those coal-tar colors used for dyeing hair--include permanent, semi-permanent, and temporary hair dyes.\nCoal-tar colors are also called “synthetic-organic” colors. That’s because, to a chemist, a “synthetic” compound is one formed from simpler compounds and an “organic” compound is one that contains carbon atoms.\nUnder the Federal",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "om simpler compounds and an “organic” compound is one that contains carbon atoms.\nUnder the Federal Food, Drug, and Cosmetic Act (FD&C Act), a law passed by Congress, color additives must be approved by FDA for their intended use before they are used in FDA-regulated products, including cosmetics. Other cosmetic ingredients do not need FDA approval. FDA can take action against a cosmetic on the market if it contains a poisonous or deleterious ingredient that may make the cosmetic harmful to cons",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "rket if it contains a poisonous or deleterious ingredient that may make the cosmetic harmful to consumers when used in the customary or expected way and used according to labeled directions.\nHow the law treats coal-tar hair dyes:\nBut there are limits to this exception:\nFDA reminds you to get the facts before using hair dyes and hair relaxers.\nWhile many people use coal-tar hair dyes, FDA is aware of the following problems:\nEye injuries: Hair dyes have caused eye injuries, including blindness, wh",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "of the following problems:\nEye injuries: Hair dyes have caused eye injuries, including blindness, when used in the eye area. Eyebrow and eyelash dyeing are not permitted uses of coal-tar hair dyes. To learn more, see “What does the law say about coal-tar hair dyes?”\nAllergic reactions: Some coal-tar hair dyes can cause allergic reactions or sensitization that may result in skin irritation and hair loss. People can develop sensitivities with repeated exposure. In addition, formulations may change",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "loss. People can develop sensitivities with repeated exposure. In addition, formulations may change over time. So, it’s possible to have a reaction even if you have dyed your hair in the past, without a problem. That’s why it’s important to follow the instructions and do the skin test before every use. Even if you don’t see a reaction to the skin test, it’s still possible to have a reaction when you dye your hair.\nOne hair dye ingredient, p-phenylenediamine, or “PPD,” has been implicated more p",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "you dye your hair.\nOne hair dye ingredient, p-phenylenediamine, or “PPD,” has been implicated more prominently in leading to allergic reactions. Some people may become allergic to PPD from other exposures, including occupational exposures. This is called “cross-sensitization.” Here are some examples;\nTemporary tattoo artists who use coal-tar hair dyes to color people’s skin are misusing these products and ingredients, because coal-tar hair dyes are not intended to be used for staining the skin.",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "ucts and ingredients, because coal-tar hair dyes are not intended to be used for staining the skin. To learn more, see “Temporary Tattoos, Henna/Mehndi and ‘Black Henna.’”\nIf you have a reaction to a hair dye, ask your healthcare provider about treatment. If you know what ingredient caused the problem, you may be able to find a product that doesn’t contain that ingredient. If you color your hair yourself, check the list of ingredients on the label for any you wish to avoid. If you have your hair",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "ourself, check the list of ingredients on the label for any you wish to avoid. If you have your hair colored at a salon, your stylist may be able to tell you the ingredients, or you may wish to check with the manufacturer.\nQuestions about hair dyes and cancer: In the 1980s, some coal-tar hair dyes were found to cause cancer in animals. FDA published a regulation requiring a special warning statement for all hair dye products containing these two ingredients:\nThe cosmetic industry has since refor",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "nt for all hair dye products containing these two ingredients:\nThe cosmetic industry has since reformulated coal-tar hair dye products, and we are no longer seeing these two ingredients in hair dyes.\nFDA continues to monitor research on hair dye safety. We do not have reliable evidence showing a link between cancer and coal-tar hair dyes on the market today. We are collecting adverse event data which helps us assess the safety of this class of ingredients. If you experience an adverse event or b",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "ich helps us assess the safety of this class of ingredients. If you experience an adverse event or bad reaction, please report that to the FDA (see below).\nback to top\nHair coloring materials made from plant or mineral sources are regulated the same as other color additives. They must be approved by FDA and listed in the color additive regulations.\nColor additives approved for use on hair include henna (from the Lawsonia plant) and bismuth citrate, which are used in hair dyes that may darken hai",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "henna (from the Lawsonia plant) and bismuth citrate, which are used in hair dyes that may darken hair gradually with repeated applications. On October 30, 2018, FDA repealed the regulation which provides for the use of lead acetate in hair dyes because there is no longer a reasonable certainty of no harm from the use of this color additive. Of note, temporary tattoos marketed as “black henna” contain PPD and may increase your risk of allergy to hair dyes. Hair dyes are not meant to be used for s",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "ain PPD and may increase your risk of allergy to hair dyes. Hair dyes are not meant to be used for staining your skin. (See above.)\nPeople sometime ask whether unusual colors such as pink, orange, blue, and green are regulated differently from other hair dyes. How a hair dye is regulated depends on whether it is a coal-tar hair dye or is made from plant or mineral materials, not on the shade.\nIf you have a reaction to a hair dye—or any other cosmetic product—first contact your healthcare provide",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "ou have a reaction to a hair dye—or any other cosmetic product—first contact your healthcare provider for any necessary medical help. Then, please tell FDA. The information you report is very important to help FDA monitor the safety of cosmetic products on the market. You can report a problem with a cosmetic product to FDA by using the contact information at How to Report a Cosmetic Product Related Complaint | FDA.",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "d Complaint | FDA.",
    "url": "https://www.fda.gov/cosmetics/products/hair-dyes"
  },
  {
    "text": "August 7, 2023\nThe U.S. Food and Drug Administration, today, issued draft guidance on cosmetic product facility registrations and product listings, as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).\nMarch 27, 2023\nThe U.S. Food and Drug Administration (FDA) has stopped accepting and processing submissions to the Voluntary Cosmetic Registration Program (VCRP) as a result of FDA’s plans to develop a program for submission of the facility registrations and product listin",
    "url": "https://www.fda.gov/cosmetics/voluntary-cosmetic-registration-program"
  },
  {
    "text": "of FDA’s plans to develop a program for submission of the facility registrations and product listings mandated by the “Modernization of Cosmetics Regulation Act of 2022” (MoCRA). For further information please see FDA Has Stopped Accepting Submissions to the Voluntary Cosmetic Registration Program (VCRP).\nVCRP information is available in the FDA.gov archiveExternal Link Disclaimer.\n\nFDA's Voluntary Cosmetic Registration Program (VCRP) is a reporting system for use by manufacturers, packers, and",
    "url": "https://www.fda.gov/cosmetics/voluntary-cosmetic-registration-program"
  },
  {
    "text": "ry Cosmetic Registration Program (VCRP) is a reporting system for use by manufacturers, packers, and distributors of cosmetic products that are in commercial distribution in the United States. There are two parts to the VCRP filing, described in detail in the sections below. You may participate in both parts of the program or only one part. The VCRP regulations can be found in 21 CFR, parts 710 and 720. The VCRP applies only to cosmetic products being sold to consumers in the United States. It d",
    "url": "https://www.fda.gov/cosmetics/voluntary-cosmetic-registration-program"
  },
  {
    "text": "d 720. The VCRP applies only to cosmetic products being sold to consumers in the United States. It does not apply to cosmetic products for professional use only, such as products used in beauty salons, spas, or skin care clinics. It also does not apply to products that are not for sale, such as hotel samples, free gifts, or cosmetic products you make in your home to give to your friends.\nThe VCRP assists FDA in carrying out its responsibility to regulate cosmetics marketed in the United States.",
    "url": "https://www.fda.gov/cosmetics/voluntary-cosmetic-registration-program"
  },
  {
    "text": "assists FDA in carrying out its responsibility to regulate cosmetics marketed in the United States. Because product filings and establishment registrations are not mandatory, voluntary submissions provide FDA with the best estimate of information available about cosmetic products and ingredients, their frequency of use, and businesses engaged in their manufacture and distribution (Federal Register, vol. 73, p. 76360, and vol. 69, p. 9339). Information from the VCRP database also has been used by",
    "url": "https://www.fda.gov/cosmetics/voluntary-cosmetic-registration-program"
  },
  {
    "text": ", vol. 73, p. 76360, and vol. 69, p. 9339). Information from the VCRP database also has been used by the Cosmetic Ingredient Review (CIR), an independent, industry-funded panel of scientific experts, to assist the CIR Expert Panel in establishing their priorities for assessing ingredient safety as part of their ingredient safety review (Federal Register, vol. 73, p. 76360).",
    "url": "https://www.fda.gov/cosmetics/voluntary-cosmetic-registration-program"
  },
  {
    "text": "Identifying ingredients on cosmetic labels can be a challenge. Here is information on requirements for ingredient nomenclature, labeling cosmetic products for the international market, and links to more resources.\nIf a cosmetic product is marketed on a retail basis to consumers—such as in stores, online, or “person to person”--the ingredients must be listed by their common or usual names, generally in descending order of predominance. FDA requires this information under the Fair Packaging and La",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetic-ingredient-names"
  },
  {
    "text": "y in descending order of predominance. FDA requires this information under the Fair Packaging and Labeling Act (FPLA). To learn all the requirements, including sources for ingredient names, read the regulation at 21 CFR 701.3.\nIn general, the ingredients must be listed on an information panel of the cosmetic package, where the consumer can easily find it when making a purchase. As an alternative, when cosmetics are distributed on a mail-order basis, the package mailed to the consumer may contain",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetic-ingredient-names"
  },
  {
    "text": "when cosmetics are distributed on a mail-order basis, the package mailed to the consumer may contain readily visible instructions for locating the ingredient declaration, such as in a product catalog (currently interpreted as including a website), or instructions for requesting a copy of the ingredient declaration. Mail-order distributors must respond promptly to such requests (21 CFR 701.3(r)).\nBecause the FPLA applies only to consumer commodities, the requirement for a list of ingredients does",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetic-ingredient-names"
  },
  {
    "text": "ecause the FPLA applies only to consumer commodities, the requirement for a list of ingredients does not apply to products distributed only--\nCosmetic companies sometimes ask FDA about identifying botanicals only by their Latin names, identifying color additives only by the “CI” numbers used in the European Union, or using terms from other languages, such as “Aqua” and “Parfum” instead of “Water” and “Fragrance.” Under the FPLA, however, ingredients must be listed by their “common or usual names",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetic-ingredient-names"
  },
  {
    "text": "and “Fragrance.” Under the FPLA, however, ingredients must be listed by their “common or usual names,” and FDA does not accept these alternatives as substitutes. But FDA does not object to their use in parentheses following the common or usual name in English (or Spanish, in Puerto Rico). Here are some examples:\nTo learn more, see “FDA Responses to Industry Requests” below.\nSome products, such as moisturizers marketed with “SPF” claims, are both cosmetics and drugs. Such products must comply wit",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetic-ingredient-names"
  },
  {
    "text": "moisturizers marketed with “SPF” claims, are both cosmetics and drugs. Such products must comply with the requirements for both product categories, including those for identifying ingredients. If you have questions about OTC drug requirements, such as  labeling, see “Status of OTC Rulemakings,” or contact FDA’s Center for Drug Evaluation and Research (CDER) at DrugInfo@fda.hhs.gov.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetic-ingredient-names"
  },
  {
    "text": "Back to Information for Exporters\nFirms exporting products from the United States are often asked by foreign governments or customers to supply a \"certificate\" as a required part of the process to import a product into their country. Please note:\nIf you export cosmetics from the United States, it is your responsibility to--\nFollow all applicable U.S. laws and regulations\nKnow the cosmetics requirements of the countries to which you export\nTo avoid unnecessary delays, please read the information",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "ments of the countries to which you export\nTo avoid unnecessary delays, please read the information below before you request a cosmetic export certificate.\nYou may apply for a cosmetic export certificate through CFSAN’s secure Web-based Certificate Application Process (CAP). CAP is one of  two modules within the CFSAN Export Certification Application and Tracking System (CFSAN eCATS), which can be accessed through the FDA Industry Systems (FIS) (https://www.access.fda.gov/oaa). After you create",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "accessed through the FDA Industry Systems (FIS) (https://www.access.fda.gov/oaa). After you create an account and log in to CAP, you may enter and submit a new application to request a certificate.\nFDA can only issue cosmetic export certificates for products whose intended use is solely as a cosmetic. A cosmetic is an article intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body or any part thereof for cleansing, beautifying, promoting",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "o, or otherwise applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or alternating the appearance, and articles intended for use as a component of any such articles, except that the term “cosmetic” does not include soap as defined in 21 CFR 701.20(a) (21 U.S.C. 201(i)).  Products that are intended to affect the structure or function of the body (other than foods), or to have a therapeutic effect such as treating or preventing disease, are drugs und",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "r than foods), or to have a therapeutic effect such as treating or preventing disease, are drugs under U.S. law (21 U.S.C. 321(g)(1)). Products marketed as \"soap\" may be cosmetics (i.e., if they do not meet the definition of “soap” in 21 CFR 701.20(a)) or drugs regulated by FDA, or they may be consumer products regulated by the Consumer Product Safety Commission, depending upon their composition and intended use.\nIntended use may be established based on a variety of factors, including-\nMany pers",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "nd intended use.\nIntended use may be established based on a variety of factors, including-\nMany personal care products are regulated as drugs under U.S. law, such as products with claims of--\nFor more information on whether your product is a cosmetic or a drug, or whether your \"soap\" is regulated by FDA or the Consumer Product Safety Commission, please refer to \"Cosmetics Q&A: Personal Care Products\" and \"Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?).\"\nFor information on how to request exp",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "ts\" and \"Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?).\"\nFor information on how to request export certificates for other FDA-regulated products, see--\nDrugs: CDER Exports\nMedical Devices: Exporting Medical Devices FAQs\nFoods (including dietary supplements): Export Certificates\nThe title of all FDA-issued cosmetic export certificates is “CERTIFICATE.” FDA does not issue Certificates of Free Sale for cosmetics or other types of cosmetic certificates. We cannot change the wording of our certi",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "ale for cosmetics or other types of cosmetic certificates. We cannot change the wording of our certificates, and we do not notarize them.\nWhen applying for a cosmetic export certificate, you will be asked whether you would like a certificate that is--\nOR\nEach certificate package includes a cover letter, certificate(s), “To Whom It May Concern” letter(s) (with your exporting company’s name and address), and an invoice for certificates delivered.\nRequests for cosmetic export certificates may take",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "ess), and an invoice for certificates delivered.\nRequests for cosmetic export certificates may take several weeks to process. The following factors may have a bearing on processing time:\nSome foreign governments may accept certificates issued by a state or local health department, board of trade, or trade association. Because FDA's resources are limited, we recommend that firms pursue alternative sources such as these for export certificates whenever possible, provided they are acceptable to the",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "sources such as these for export certificates whenever possible, provided they are acceptable to the country requiring a certificate.\nThe states listed below offer cosmetic export certificates. This list may not be all inclusive. If your state is not listed, you may wish to check with state authorities to determine whether your state does provide certificates for cosmetics.\nCalifornia:\nCalifornia Department of Public Health\nFood and Drug Branch Export Document Program\nTelephone: (916) 650-6500\nW",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "Department of Public Health\nFood and Drug Branch Export Document Program\nTelephone: (916) 650-6500\nWebsite:http://www.cdph.ca.gov/programs/Pages/FDBExportDocumentProgram.aspx  \nEmail: fdbinfo@cdph.ca.gov\nNew Jersey:\nNew Jersey Department of Health\nFood and Drug Safety Program\nTelephone: (609) 826-4935\nFax: (609) 826-4490\nWebsite: http://www.state.nj.us/health/foodanddrugsafety/cert_freesale.shtml\nEmail: peter.detroia@doh.state.nj.us\nTexas:\nBureau of Food and Drug Safety\nTexas Department of State",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "Email: peter.detroia@doh.state.nj.us\nTexas:\nBureau of Food and Drug Safety\nTexas Department of State Health Services\nTelephone: (512) 834-6626, ext. 2405\nWebsite: http://www.dshs.state.tx.us/fdlicense/cfsinstructions.shtmExternal Link Disclaimer\nSome governments may accept a certificate issued by a U.S. trade association, such as the Personal Care Products Council, the Independent Beauty Association, and the World Trade Center Denver.\nThe issuance of a certificate does not suggest or imply that",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "on, and the World Trade Center Denver.\nThe issuance of a certificate does not suggest or imply that FDA approves or sanctions the labels and labeling of the firm's products or that the firm's products are in compliance with the requirements of the FD&C Act, the FPLA, or related regulations. The issuance of a certificate does not preclude FDA from taking regulatory action against such products in the future, if such action is warranted. Further, a certificate does not constitute an admission, or",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "he future, if such action is warranted. Further, a certificate does not constitute an admission, or agreement, or determination by FDA that a product is a cosmetic as defined in section 201(i) of the FD&C Act.\nFDA does not require foreign governments to verify the authenticity of cosmetic export certificates, but some foreign governments may have this requirement. You will need to check with the country to which you are exporting to learn its authentication requirements.\nThere are two ways to au",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "ountry to which you are exporting to learn its authentication requirements.\nThere are two ways to authenticate your export certificate:\n(Please note the following system requirements for the Online Portal for Verification of Export Certificates for Food and Cosmetics: Google Chrome 49.0 or newer, Mozilla Firefox 43.0 or newer, or Microsoft Internet Explorer Edge).\nThe U.S. Department of State offers an apostille and authentication for FDA's cosmetic export certificate.  To request authentication",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "rs an apostille and authentication for FDA's cosmetic export certificate.  To request authentication services, send your original cosmetic export certificate that you downloaded and printed from FDA's Certificate Application Process (CAP), a DS-4194 Authentication Request Form, and payment to:\nOffice of Authentications\nU.S. Department of State\nCA/PPT/S/TO/AUT\n44132 Mercure Circle P.O. Box 1206\nSterling, VA 20166-1206\nPlease contact Ms. Dentira Hawkins, Branch Chief, with any questions at 202-485",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "rling, VA 20166-1206\nPlease contact Ms. Dentira Hawkins, Branch Chief, with any questions at 202-485-8000.\nIf you still have questions concerning cosmetic export certificates, please direct them to FDA's Office of Cosmetics and Colors at CAP-OCAC-CFSAN@fda.hhs.gov or (240) 402-1133.\nFor further information, including export certificates for other products regulated by FDA, see Guidance for Industry: Export Certificates.\n\nThis information is current. It is updated only when necessary.",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "y: Export Certificates.\n\nThis information is current. It is updated only when necessary.",
    "url": "https://www.fda.gov/cosmetics/exporters/cosmetic-export-certificates-faqs"
  },
  {
    "text": "Tattoos are used for various reasons including beauty, self-expression, and after certain reconstructive surgeries to simulate skin pigmentation. A tattoo is permanent when a needle inserts colored ink into skin.\nCommon types of tattoos include:\n\nInks used in intradermal tattoos, including permanent makeup, fall within the definition of cosmetics under the Federal Food, Drug, and Cosmetic Act. The actual practice of tattooing, including tattoo parlor practices and safety, is generally regulated",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "actual practice of tattooing, including tattoo parlor practices and safety, is generally regulated by local jurisdictions.\n\nBecause tattoos are permanent, they last a lifetime. Permanent makeup is a type of tattoo. A needle inserts colored ink into your skin to look like eyeliner, lip liner, eyebrows, or other makeup.\nThere are a variety of pigments and diluents being used in tattooing. More than 50 different pigments and shades are in use, and the list continues to grow. Although a number of c",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "50 different pigments and shades are in use, and the list continues to grow. Although a number of color additives are approved for use in cosmetics, none are approved for injection into the skin. Using an unapproved color additive in a tattoo ink makes the ink adulterated. Many pigments used in tattoo inks are not approved for skin contact. Some are industrial grade colors that are suitable for printers' ink or automobile paint.\nTattoos can cause adverse effects, and some can be irreversible.\nS",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "rinters' ink or automobile paint.\nTattoos can cause adverse effects, and some can be irreversible.\nSome risks include:\nWhen the FDA identifies a safety problem associated with a cosmetic, including a tattoo ink, the agency investigates and takes action, as appropriate, to prevent consumer illness or injury.\nUnlike most cosmetics, tattoo inks are injected into the dermal layer of the skin and present a unique challenge as they could potentially introduce harmful pathogens directly into the body.",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "nt a unique challenge as they could potentially introduce harmful pathogens directly into the body. Because of this unique challenge, it is important for tattoo inks to be manufactured using methods to ensure a product is free of all forms of viable microorganisms.\nOn June 12, 2023, the FDA issued “Insanitary Conditions at Tattoo Ink Manufacturing and Distribution Facilities; Draft Guidance for Industry” to help tattoo ink manufacturers and distributors recognize situations in which a tattoo ink",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "dustry” to help tattoo ink manufacturers and distributors recognize situations in which a tattoo ink may become contaminated with microorganisms, and thus, be potentially injurious to health. This guidance also recommends certain steps that manufacturers and distributors could take to help prevent the occurrence of these conditions, or to identify and remediate insanitary conditions that already exist during manufacturing and distribution.\nAdditionally, manufacturer testing of the final formulat",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "xist during manufacturing and distribution.\nAdditionally, manufacturer testing of the final formulated tattoo ink products to ensure the inks are free of any microorganisms can help protect consumer safety. For more information on testing methods, please see Microbiological Methods for Testing the Sterility of Tattoo Inks and Method for Isolation and Detection of Nontuberculous Mycobacteria in Tattoo Inks.\nThe tattoo manufacturer and distributor are responsible for the safety of the products tha",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "too Inks.\nThe tattoo manufacturer and distributor are responsible for the safety of the products that they sell to retailers.\nThe FDA monitors the safety of tattoos and permanent make-up and alerts the public when the agency becomes aware of any issues associated with inks.\nSafety Alerts/Recalls\nWarning Letters\nOther Actions\nThe FDA urges consumers and healthcare professionals to report adverse reactions from tattoos, permanent makeup, and temporary tattoos, as well as problems with tattoo remov",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "actions from tattoos, permanent makeup, and temporary tattoos, as well as problems with tattoo removal.\nConsumers and healthcare professionals can report problems to FDA by using the contact information at How to Report a Cosmetic Related Complaint | FDA.\nThe FDA continues to evaluate the extent and severity of adverse events associated with tattooing and is conducting research on tattoo inks. As new information is assessed, the FDA will consider whether additional actions are necessary to prote",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "new information is assessed, the FDA will consider whether additional actions are necessary to protect public health.\nA Tattoo for You? Seven Key Questions to ConsiderExternal Link Disclaimer\nThink Before You Ink: Are Tattoos Safe?\nCDC: Tattoo-Associated Nontuberculous Mycobacterial Skin Infections\nNew England Journal of Medicine: Tattoo Ink-Related Infections--Awareness, Diagnosis, Reporting, and PreventionExternal Link Disclaimer\nFollow FDA Cosmetics on TwitterExternal Link Disclaimer",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "PreventionExternal Link Disclaimer\nFollow FDA Cosmetics on TwitterExternal Link Disclaimer",
    "url": "https://www.fda.gov/cosmetics/cosmetic-products/tattoos-temporary-tattoos-permanent-makeup"
  },
  {
    "text": "Consumers and manufacturers sometimes have questions about the term \"cosmeceutical.\"\nThe term \"cosmeceutical\" has no meaning under the law. While the Federal Food, Drug, and Cosmetic Act (FD&C Act) does not recognize the term \"cosmeceutical,\" the cosmetic industry uses this word to refer to cosmetic products that have medicinal or drug-like benefits.\nA product can be a drug, a cosmetic or both. The FD&C Act defines drugs as those products that cure, treat, mitigate or prevent disease or that aff",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-claims/cosmeceutical"
  },
  {
    "text": "e FD&C Act defines drugs as those products that cure, treat, mitigate or prevent disease or that affect the structure or function of the human body, if a product makes such claims it will be regulated as a drug. Cosmetics are intended to beautify, promote attractiveness, alter appearance or cleanse; they are not approved by FDA for sale nor are they intended to effect structure or function of the body.\nMore resources:\nJuly 6, 2017. This document is current and is updated only when necessary.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-claims/cosmeceutical"
  },
  {
    "text": "body.\nMore resources:\nJuly 6, 2017. This document is current and is updated only when necessary.",
    "url": "https://www.fda.gov/cosmetics/cosmetics-labeling-claims/cosmeceutical"
  },
  {
    "text": "The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is the most significant expansion of FDA’s authority to regulate cosmetics since the Federal Food, Drug, and Cosmetic (FD&C) Act was passed in 1938. This new law will help ensure the safety of cosmetic products many consumers use daily.\nMoCRA provided new authorities to FDA including:\n\n\nManufacturers and processors must register their facilities with FDA and renew their registration every two years. FDA has the authority to suspend a",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "acilities with FDA and renew their registration every two years. FDA has the authority to suspend a facility’s registration if the agency determines that a cosmetic product manufactured or processed by the registered facility and distributed in the United States has a reasonable probability of causing serious adverse health consequences or death to humans, and the agency has a reasonable belief that other products manufactured or processed by the facility may be similarly affected because of a f",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "at other products manufactured or processed by the facility may be similarly affected because of a failure that cannot be isolated to a product or products, or is sufficiently pervasive to raise concerns about other products manufactured in the facility. If a facility’s registration is suspended, it is a prohibited act to distribute or sell (or otherwise introduce or deliver into commerce) in the United States cosmetic products from the facility.\n\n\n\n\nA responsible person must list each marketed",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "United States cosmetic products from the facility.\n\n\n\n\nA responsible person must list each marketed cosmetic product with FDA, including product ingredients, and provide any updates annually.\nResponsible person means the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product in accordance with section 609(a) of the FD&C Act or section 4(a) of the Fair Packaging and Labeling Act.\n\n\n\n\nMoCRA exempts certain small businesses from facility",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "a) of the Fair Packaging and Labeling Act.\n\n\n\n\nMoCRA exempts certain small businesses from facility registration and product listing requirements.\nHowever, such exemptions do not apply to facilities that manufacture or process, or responsible persons for, the following cosmetic products:\nExemptions also exist for certain products and facilities that are subject to requirements for drugs and devices.\n\n\n\nFDA has developed a tool to help you decide if you are required to register a cosmetic product",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "s.\n\n\n\nFDA has developed a tool to help you decide if you are required to register a cosmetic product facility. To use the tool, visit Decision Tool and answer a series of questions.\nBelow are options for registration and listing submissions.\nCosmetics Direct\nCosmetics Direct is an FDA provided Structured Product Labeling (SPL) authoring tool, for cosmetic product facility registration and cosmetic product listing, that contains user friendly data entry forms, performs initial validations, create",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "product listing, that contains user friendly data entry forms, performs initial validations, creates and saves the SPL submission, and submits the SPL to FDA for internal processing without having to use the Electronic Submissions Gateway (ESG).\nSPL, an established document sanctioned by health level seven (HL7) for the exchange of product and facility-related information, serves as a foundational reference for regulatory guidance documents and product labeling content exchange. It enforces con",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "l reference for regulatory guidance documents and product labeling content exchange. It enforces control over crucial product information, resulting in a standard for product labeling. The FDA has adopted SPL to enhance patient/customer safety and product usability within its consumer base. In 2005, the FDA mandated the use of XML compliant with the SPL standard for electronic submissions. This standard defines the content and structure of product labeling required for submission to the FDA. Con",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "andard defines the content and structure of product labeling required for submission to the FDA. Consistent structure and standard terminology are employed to enhance the accuracy and reliability of product information. For additional information, see the Structured Product Labeling (SPL) Implementation Guide with Validation Procedures.\nElectronic Submissions Gateway (ESG)\nAs an alternative, cosmetic product  facility registrations and cosmetic product listing may be submitted online through FDA",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "tic product  facility registrations and cosmetic product listing may be submitted online through FDA’s Electronic Submissions Gateway (ESG), or any Structured Product Labeling (SPL) authoring software including SPL Xforms. The FDA ESG system requires users to apply for a free account before submitting data, a process which can take one to three weeks. FDA therefore urges registrants to apply for ESG accounts well in advance of the statutory deadline for data submission. Technical assistance is a",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "SG accounts well in advance of the statutory deadline for data submission. Technical assistance is available for users by contacting the ESG at ESGHelpDesk@fda.hhs.gov.\nSPL Xforms\nXforms is one option of creating an SPL file with cosmetic product facility registration and cosmetic product listing information.\nOn July 29, 2024, FDA announced the release of the following new features for cosmetic product listing in Cosmetics Direct:\nAs we continue to add new features to the system we will provide",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "oduct listing in Cosmetics Direct:\nAs we continue to add new features to the system we will provide updates on our Web sites, Cosmetics Direct and Registration & Listing of Cosmetic Product Facilities and Products.\nFDA strongly encourages electronic submissions to facilitate efficiency and timeliness of data submission and management for the agency. Paper forms are available below:\nGuidance for Industry: Registration and Listing of Cosmetic Product Facilities and Products (December 2024)FDA guid",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "dustry: Registration and Listing of Cosmetic Product Facilities and Products (December 2024)FDA guidance on cosmetic product facility registrations and product listings, as mandated by the MoCRA.\nGuidance for Industry: Compliance Policy for Cosmetic Product Facility Registration and Cosmetic Product Listing (November 2023)FDA guidance on its intent to delay enforcement of the requirements for cosmetic product facility registration and cosmetic product listing requirements under the MoCRA for six",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "etic product facility registration and cosmetic product listing requirements under the MoCRA for six months to help ensure that industry has sufficient time to submit such facility registration and product listing information.\nFEI Search Portal for Required Facility Registration NumberFDA intends to use the FDA Establishment Identifier (FEI) as the required facility registration number. To facilitate the registration process, the owner or operator of a facility will need to obtain an FEI number",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "ate the registration process, the owner or operator of a facility will need to obtain an FEI number before submitting the facility registration. To determine if an entity already has an FEI number, please refer to the FEI Search Portal. If your firm does not have an FEI number assigned by FDA, see How can I request an FEI? at FEI Search Portal.\nFDA welcomes voluntary registration and listing submissions for those cosmetic product facilities and products that are not required to register, i.e., i",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "ssions for those cosmetic product facilities and products that are not required to register, i.e., if entities exempt from MoCRA registration and listing provisions want to make a submission then they can make it voluntarily. If you voluntarily register or list, information for all fields designated as mandatory will need to be filled due to technical limitations of the system.\nCosmetic product facility registration and cosmetic product listing is neither a cosmetic approval program nor a promot",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "cility registration and cosmetic product listing is neither a cosmetic approval program nor a promotional tool. FDA does not issue “certificates” for cosmetic product facility registrations or cosmetic product listings.\nThe summary table below provides the number of the unique, active cosmetic product facilities registered and unique, active cosmetic products listed under MoCRA.\nMoCRA Registration of Cosmetic ProductFacilities and Cosmetic Product Listings(Since December 18, 2023)\nNumber of uniq",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "of Cosmetic ProductFacilities and Cosmetic Product Listings(Since December 18, 2023)\nNumber of unique, active facility registrations1,2,3\n10,820\nNumber of unique, active product listings1,2,4\n681,831\n1Data Sources = Cosmetics Direct, Electronic Submission Gateway (ESG), Structured Product Labeling (SPL) authoring software, and paper submissions2Data as of March 31, 2025    3Unique, active facility registrations = the number of active cosmetic product facilities registered4Unique, active product",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  },
  {
    "text": "y registrations = the number of active cosmetic product facilities registered4Unique, active product listings = the number of active cosmetic products listed\nAdditional information about the number of unique, active cosmetic product facilities that have registered with FDA under MoCRA can be downloaded here.",
    "url": "https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products"
  }
]